<SEC-DOCUMENT>0001104659-23-063213.txt : 20230522
<SEC-HEADER>0001104659-23-063213.hdr.sgml : 20230522
<ACCEPTANCE-DATETIME>20230522170108
ACCESSION NUMBER:		0001104659-23-063213
CONFORMED SUBMISSION TYPE:	F-3
PUBLIC DOCUMENT COUNT:		15
REFERENCES 429:			333-271549
FILED AS OF DATE:		20230522
DATE AS OF CHANGE:		20230522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BELITE BIO, INC
		CENTRAL INDEX KEY:			0001889109
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-272125
		FILM NUMBER:		23945395

	BUSINESS ADDRESS:	
		STREET 1:		12750 HIGH BLUFF DRIVE SUITE 475
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		858-246-6240

	MAIL ADDRESS:	
		STREET 1:		12750 HIGH BLUFF DRIVE SUITE 475
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-3
<SEQUENCE>1
<FILENAME>tm2316412-1_f3.htm
<DESCRIPTION>F-3
<TEXT>
<html>
  <head>
    <title>tm2316412-1_f3 - none - 5.203166s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:27pt;width:541.31pt;">
        <div style="text-align:center; width:541.31pt; line-height:9pt;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">As filed with the Securities and Exchange Commission on May 22, 2023</font>
        </div>
        <div style="margin-top:1.1pt; text-align:right; width:541.31pt; line-height:9pt;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">Registration No. 333-&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;</font>&#8203;</div>
        <div style="margin-top:5.1pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 5.1pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.1pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 2.1pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.1pt; text-align:center; width:541.31pt; line-height:13pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">UNITED STATES </font>
          <br >
          <font style="letter-spacing:-0.24pt;">SECURITIES AND EXCHANGE COMMISSION </font>
        </div>
        <div style="margin-top:0.1pt; text-align:center; width:541.31pt; line-height:9pt;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">Washington, D.C. 20549</font><font style="font-weight:normal;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:4.6pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 4.60000000000001pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.1pt; text-align:center; width:541.31pt; line-height:13pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">FORM F-3 </font>
        </div>
        <div style="margin-top:0.09pt; text-align:center; width:541.31pt; line-height:9pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">REGISTRATION STATEMENT</font>
          <br >
          <font style="letter-spacing:-0.16pt;">UNDER </font>
          <br >
          <font style="letter-spacing:-0.16pt;">THE SECURITIES ACT OF 1933</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:4.6pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 4.59999999999999pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.1pt; text-align:center; width:541.31pt; line-height:13pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">Belite Bio, Inc</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="margin-top:1.1pt; text-align:center; width:541.31pt; line-height:8pt;font-size:7pt;">
          <font style="letter-spacing:0.14pt;">(Exact name of Registrant as specified in its charter) </font>
        </div>
        <div style="margin-top:4.367pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 4.36666666666667pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.7pt; text-align:center; width:541.31pt; line-height:9pt;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">Not Applicable</font><font style="font-weight:normal;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:1.2pt; text-align:center; width:541.31pt; line-height:8pt;font-size:7pt;">
          <font style="letter-spacing:0.14pt;">(Translation of Registrant&#8217;s name into English)</font><font style="font-size:8pt;">&#8203;<font style="letter-spacing:0.16pt;"> </font></font>
        </div>
        <div style="margin-top:4.7pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 4.69999999999999pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="width:541.31pt;margin-top:4.30000000000001pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9.58pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.44pt;">
              <div style="text-align:center;font-weight:bold;font-size:8pt;">
                <font style="letter-spacing:-0.16pt;">Cayman Islands</font>
              </div>
              <div style="margin-top:1.61pt; text-align:center; line-height:7pt;">
                <font style="letter-spacing:0.14pt;">(State or other jurisdiction of</font>
                <br >
                <font style="letter-spacing:0.14pt;">incorporation or organization) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.44pt;">
              <div style="text-align:center;font-weight:bold;font-size:8pt;">
                <font style="letter-spacing:-0.16pt;">2834</font>
              </div>
              <div style="margin-top:1.61pt; text-align:center; line-height:7pt;">
                <font style="letter-spacing:0.14pt;">(Primary Standard Industrial</font>
                <br >
                <font style="letter-spacing:0.14pt;">Classification Code Number) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.43pt;">
              <div style="text-align:center;font-weight:bold;font-size:8pt;">
                <font style="letter-spacing:-0.16pt;">Not Applicable</font>
              </div>
              <div style="margin-top:1.61pt; text-align:center; line-height:7pt;">
                <font style="letter-spacing:0.14pt;">(I.R.S. Employer</font>
                <br >
                <font style="letter-spacing:0.14pt;">Identification Number)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.4pt; text-align:center; width:541.31pt; line-height:9pt;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">12750 High Bluff Drive Suite 475, </font>
          <br >
          <font style="letter-spacing:-0.16pt;">San Diego, CA 92130 </font>
          <br >
          <font style="letter-spacing:-0.16pt;">Telephone: +1-858-246-6240</font><font style="font-weight:normal;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:541.31pt; line-height:8pt;font-size:7pt;">
          <font style="letter-spacing:0.14pt;">(Address, including zip code, and telephone number, including area code, of Registrant&#8217;s principal executive offices) </font>
        </div>
        <div style="margin-top:5.357pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 5.35666666666665pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.7pt; text-align:center; width:541.31pt; line-height:9pt;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">Puglisi &amp; Associates </font>
          <br >
          <font style="letter-spacing:-0.16pt;">850 Library Avenue, Suite 204 </font>
          <br >
          <font style="letter-spacing:-0.16pt;">Newark, DE 19711 </font>
          <br >
          <font style="letter-spacing:-0.16pt;">Telephone: +1-302-738-6680</font><font style="font-weight:normal;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:541.31pt; line-height:8pt;font-size:7pt;">
          <font style="letter-spacing:0.14pt;">(Name, address, including zip code, and telephone number, including area code, of agent for service) </font>
        </div>
        <div style="margin-top:5.367pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 5.36666666666667pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.7pt; text-align:center; width:541.31pt; line-height:9pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">Copies to:</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:3.5pt; text-align:center; width:541.31pt; line-height:9pt;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">Portia Ku, Esq. </font>
          <br >
          <font style="letter-spacing:-0.16pt;">Vincent Lin, Esq. </font>
          <br >
          <font style="letter-spacing:-0.16pt;">O&#8217;Melveny &amp; Myers LLP </font>
          <br >
          <font style="letter-spacing:-0.16pt;">Times Square Tower </font>
          <br >
          <font style="letter-spacing:-0.16pt;">7 Times Square </font>
          <br >
          <font style="letter-spacing:-0.16pt;">New York, NY 10036 </font>
          <br >
          <font style="letter-spacing:-0.16pt;">+1-212-326-2000</font><font style="font-weight:normal;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:4.7pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 4.69999999999999pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:20pt; margin-top:6.7pt; width:521.31pt; line-height:9pt;">
          <font style="font-weight:bold;letter-spacing:-0.16pt;">Approximate date of commencement of proposed sale to the public:</font><font style="letter-spacing:0.16pt;"> From time to time after the effective date of this Registration Statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:9pt;">
          <font style="letter-spacing:0.16pt;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box.&#160;&#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:9pt;">
          <font style="letter-spacing:0.16pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933, check the following box. &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:9pt;">
          <font style="letter-spacing:0.16pt;">If this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:9pt;">
          <font style="letter-spacing:0.16pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:9pt;">
          <font style="letter-spacing:0.16pt;">If this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule&#160;462(e) under the Securities Act, check the following box. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:9pt;">
          <font style="letter-spacing:0.16pt;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities Act, check the following box. &#9744; </font>
        </div>
        <div style="margin-left:20pt; margin-top:3.5pt; width:521.31pt; line-height:9pt;">
          <font style="letter-spacing:0.16pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933. </font>
        </div>
        <div style="margin-left:20pt; margin-top:3.5pt; width:521.31pt; line-height:9pt;">
          <font style="letter-spacing:0.16pt;">Emerging growth company &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:9pt;">
          <font style="letter-spacing:0.16pt;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:9pt;">
          <font style="letter-spacing:0.16pt;">The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April&#160;5, 2012. </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:9pt;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">We hereby amend this Registration Statement on such date or dates as may be necessary to delay its effective date until we file a further amendment which will specifically state that this Registration Statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine.</font><font style="font-weight:normal;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:9pt;font-weight:bold;">
          <font style="letter-spacing:-0.16pt;">Pursuant to the provisions of Rule&#160;429 under the Securities Act, the prospectus contained in this registration statement also relates to the Company&#8217;s registration statement on Form F-3 (File No. 333-271549). Upon effectiveness, this registration statement will also act as a post-effective amendment to such earlier registration statement.</font><font style="font-weight:normal;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:5.2pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 5.20000000000005pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.2pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 2.20000000000005pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPLANATORY NOTE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;1, 2023, the Company filed a registration statement on Form F-3 with the SEC (File No.&#160;333-271549) (the &#8220;Prior Registration Statement&#8221;) related to the offer from time to time of up to $300,000,000 of the Company&#8217;s American Depositary Shares, or ADSs, each representing one ordinary share, par value $0.0001 per share, which was subsequently declared effective by the SEC on May&#160;9, 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Rule&#160;429 under the Securities Act, this registration statement combines all of the $300,000,000 of ADSs that remain unsold from the $300,000,000 of ADSs registered pursuant to the Prior Registration Statement, which are registered hereby for the offer and sale from time to time by the Company, together with up to $300,000,000 of ADSs, ordinary shares, preferred shares, warrants, overallotment purchase rights, subscription rights, units, capital notes and/or debt securities registered hereby, to enable an aggregate of up to $300,000,000 of ADSs, ordinary shares, preferred shares, warrants, overallotment purchase rights, subscription rights, units, capital notes and/or debt securities to be offered pursuant to the combined prospectus. Pursuant to Rule&#160;429 under the Securities Act, this registration statement also constitutes a post-effective amendment to the Prior Registration Statement, and such post-effective amendment shall hereafter become effective concurrently with the effectiveness of this registration statement in accordance with Section&#160;8(c) of the Securities Act.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="position:relative;overflow-x:hidden;min-height:775.71pt;page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="position:absolute;top:738.83pt;left:48.66pt;height:30.02pt;width:706pt;transform-origin:0pt -0pt;transform:rotate(-90deg) translate(0%, 0%);">
        <div style="text-align:justify; width:706pt; line-height:9.5pt;font-weight:bold;color:#FC0014;font-family:Helvetica, Arial, sans-serif;font-size:8pt;">
          <font style="letter-spacing:-0.08pt;">The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is declared effective. This prospectus is not an offer to sell the securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</font><font style="color:#000000;letter-spacing:-0.08pt;"> </font>
          <br >
        </div>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:87.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;color:#FC0014;">
          <font style="letter-spacing:-0.2pt;">Subject to Completion, dated May 22, 2023</font><font style="font-weight:normal;color:#000000;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROSPECTUS</font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Up to $300,000,000 of</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="lg_belite-4clr.jpg" alt="[MISSING IMAGE: lg_belite-4clr.jpg]" height="57" width="92" >
        </div>
        <div style="margin-top:16.61pt; text-align:center; width:456pt; line-height:15.5pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">American Depositary Shares representing Ordinary Shares,</font>
          <br >
          <font style="letter-spacing:-0.28pt;">Ordinary Shares, Preferred Shares, Warrants,</font>
          <br >
          <font style="letter-spacing:-0.28pt;">Overallotment Purchase Rights, Subscription Rights,</font>
          <br >
          <font style="letter-spacing:-0.28pt;">Units, Capital Notes and/or Debt Securities</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">Belite Bio, Inc</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus relates to the offer and sale by Belite Bio, Inc, a holding company incorporated in the Cayman Islands in March&#160;2018, from time to time of up to $300,000,000 of (i)&#160;our American Depositary Shares, or ADSs, each representing one ordinary share, par value $0.0001 per share, ordinary shares, preferred shares, warrants, overallotment purchase rights, subscription rights, units, capital notes and/or debt securities and (ii)&#160;our ADSs previously registered pursuant to our registration statement on Form F-3 (File No. 333-271549), which we filed with the SEC on May&#160;1, 2023 and was declared effective by the SEC on May&#160;9, 2023, or the Prior Registration Statement. Pursuant to Rule&#160;429 under the Securities Act of 1933, as amended, or the Securities Act, this prospectus updates the Prior Registration Statement and includes ADSs previously registered by us pursuant to such Prior Registration Statement. We refer to the ADSs, ordinary shares, preferred shares, warrants, overallotment purchase rights, subscription rights, units, capital notes and/or debt securities collectively as &#8220;securities&#8221; in this prospectus. Any time we offer securities covered by this prospectus, we will provide a prospectus supplement, if required. Any such prospectus supplement will provide specific information about the terms of that offering and may also add, update or change information contained in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may offer our securities for sale directly to purchasers or through underwriters, dealers or agents to be designated at a future date. If any underwriters, dealers or agents are involved in the sale of any securities, their names, and any applicable purchase price, fee, commission or discount arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement. See the &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Plan of Distribution</font><font style="letter-spacing:0.2pt;">&#8221; and &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">About this Prospectus</font><font style="letter-spacing:0.2pt;">&#8221; sections for more information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our principal executive offices are located at 12750 High Bluff Drive Suite 475, San Diego, CA 92130, and our telephone number is +1-858-246-6240. Our registered address in the Cayman Islands is located at the offices of Maples Corporate Services Limited at PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You should read this prospectus and the applicable prospectus supplement as well as the documents incorporated or deemed to be incorporated by reference in this prospectus carefully before you invest in our securities together with additional information described under the heading &#8220;Where You Can Find More Information.&#8221; Our ADSs are quoted on the Nasdaq Capital Market under the symbol &#8220;BLTE.&#8221; The closing price of our ADSs, as reported on the Nasdaq Capital Market on May&#160;19, 2023, was $23.02. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Investing in our securities involves risks. We are a holding company incorporated in the Cayman Islands. As a holding company with no material operations of our own, we conduct operations primarily through our direct and indirect wholly owned subsidiaries established in the US, Australia, Hong Kong and the People&#8217;s Republic of China, or the PRC. The securities offered in this prospectus are securities of our Cayman Islands holding company, not of our operating subsidiaries.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We do not have any substantive operations or employees in the PRC at present and the clinical trials in the PRC in connection with our product candidate are conducted via a contract research organization. However, we may still be subject to certain legal and operational risks associated with our clinical trials conducted in the PRC, including those changes in the legal, political and economic policies of the Chinese government, the </font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">relations between China and the United States, or Chinese or United States regulations, which may materially and adversely affect our business, financial condition, results of operations and the market price of our securities. Any such changes could significantly limit or completely hinder our ability to offer or continue to offer our securities to investors, and could cause the value of our securities to significantly decline or become worthless. Although we are not a China-based issuer, there remains regulatory uncertainty with respect to the implementation and interpretation of laws in China. Such laws and regulations, including China&#8217;s new Data Security Law, Cybersecurity Review Measures, Personal Information Protection Law, and any other future laws and regulations, may require us to incur significant expenses and could materially affect our ability to conduct our business, accept non-PRC investments or list on a U.S. or foreign exchange.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">Although the audit report included in this prospectus is prepared by U.S. auditors who are currently inspected by the Public Company Accounting Oversight Board (the &#8220;PCAOB&#8221;), there is no guarantee that future audit reports will be prepared by auditors that are completely inspected by the PCAOB and, as such, our investors may in the future be deprived of such inspections, which could result in limitations or restrictions to our ability to access the U.S. capital markets. Furthermore, trading in our securities may be prohibited under the Holding Foreign Companies Accountable Act or the Accelerating Holding Foreign Companies Accountable Act (if enacted) if the SEC subsequently determines our audit work is performed by auditors that the PCAOB is unable to inspect or investigate completely or the SEC identifies us as a Commission-Identified Issuer, and as a result, U.S. national securities exchanges, such as Nasdaq, may determine to delist our securities. The PCAOB currently has access to inspect the working papers of our auditor. Our principal auditor is not headquartered in Mainland China or Hong Kong and was not identified in the Determination Report issued on December&#160;16, 2021 as a firm subject to the PCAOB&#8217;s determination.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">We are a &#8220;controlled company&#8221; as defined under the Nasdaq Stock Market Rules. Lin Bioscience International Ltd., our principal shareholder, holds more than 50% of the shareholder voting power of our outstanding share capital, and can exert substantial influence over matters such as electing directors and approving material mergers, acquisitions, strategic collaborations or other business combination transactions. For so long as we remain a controlled company as defined under that rule, we are exempt from, and our shareholders generally are not provided with the benefits of, some of the Nasdaq Stock Market corporate governance requirements, including that our board be comprised of a majority of independent directors.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">As a holding company, we may rely on cash dividends, distributions and other transfers from our subsidiaries to make dividend payments. As of the date of this prospectus, there have not been any such dividends or other distributions from our subsidiaries. In addition, none of our subsidiaries have ever issued any dividends or distributions to us or to U.S. investors. See the section titled &#8220;</font><font style="font-style:italic;letter-spacing:-0.2pt;">Our Company&#8201;&#8212;&#8201;Cash Transfers and Dividend Distribution</font><font style="font-weight:normal;letter-spacing:0.2pt;">&#8221; </font><font style="letter-spacing:-0.2pt;">beginning on page 5 of the prospectus.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">We are an &#8220;emerging growth company&#8221; and a &#8220;foreign private issuer&#8221; under applicable U.S. federal securities laws and are eligible for reduced public company reporting requirements.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">Risks associated with an investment in our securities will be described in the applicable prospectus supplement and certain of our filings with the Securities and Exchange Commission, as described under &#8220;</font><font style="font-style:italic;letter-spacing:-0.2pt;">Risk Factors</font><font style="letter-spacing:-0.2pt;">&#8221; on page <a href="#tRIFA">11</a> of this prospectus.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">Neither the United States Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">This prospectus is dated &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, 2023.</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:237.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:353.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:427.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tATP"><font style="letter-spacing:0.2pt;">ABOUT THIS PROSPECTUS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tATP">1</a></font> <a href="#tATP"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tOUCO"><font style="letter-spacing:0.2pt;">OUR COMPANY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOUCO">3</a></font> <a href="#tOUCO"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSRF"><font style="letter-spacing:0.2pt;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSRF">9</a></font> <a href="#tCSRF"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRIFA"><font style="letter-spacing:0.2pt;">RISK FACTORS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRIFA">11</a></font> <a href="#tRIFA"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tOSAE"><font style="letter-spacing:0.2pt;">OFFER STATISTICS AND EXPECTED TIMETABLE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOSAE">12</a></font> <a href="#tOSAE"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUOP"><font style="letter-spacing:0.2pt;">USE OF PROCEEDS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUOP">13</a></font> <a href="#tUOP"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCAP"><font style="letter-spacing:0.2pt;">CAPITALIZATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCAP">14</a></font> <a href="#tCAP"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOSC"><font style="letter-spacing:0.2pt;">DESCRIPTION OF SHARE CAPITAL </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOSC">15</a></font> <a href="#tDOSC"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOAD"><font style="letter-spacing:0.2pt;">DESCRIPTION OF AMERICAN DEPOSITARY SHARES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOAD">25</a></font> <a href="#tDOAD"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOW"><font style="letter-spacing:0.2pt;">DESCRIPTION OF WARRANTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOW">35</a></font> <a href="#tDOW"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOOP"><font style="letter-spacing:0.2pt;">DESCRIPTION OF OVERALLOTMENT PURCHASE RIGHTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOOP">36</a></font> <a href="#tDOOP"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOSR"><font style="letter-spacing:0.2pt;">DESCRIPTION OF SUBSCRIPTION RIGHTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOSR">37</a></font> <a href="#tDOSR"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOU"><font style="letter-spacing:0.2pt;">DESCRIPTION OF UNITS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOU">38</a></font> <a href="#tDOU"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOCN"><font style="letter-spacing:0.2pt;">DESCRIPTION OF CAPITAL NOTES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOCN">39</a></font> <a href="#tDOCN"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDDS"><font style="letter-spacing:0.2pt;">DESCRIPTION OF DEBT SECURITIES </font> </a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tDDS"><font style="letter-spacing:0.2pt;">40</font> </a>
            </td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTAX"><font style="letter-spacing:0.2pt;">TAXATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTAX">46</a></font> <a href="#tTAX"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPOD"><font style="letter-spacing:0.2pt;">PLAN OF DISTRIBUTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPOD">47</a></font> <a href="#tPOD"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tWYCF"><font style="letter-spacing:0.2pt;">WHERE YOU CAN FIND MORE INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWYCF">49</a></font> <a href="#tWYCF"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tIBR"><font style="letter-spacing:0.2pt;">INCORPORATION BY REFERENCE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tIBR">50</a></font> <a href="#tIBR"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEOCL"><font style="letter-spacing:0.2pt;">ENFORCEABILITY OF CIVIL LIABILITIES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEOCL">51</a></font> <a href="#tEOCL"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLEMA"><font style="letter-spacing:0.2pt;">LEGAL MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLEMA">53</a></font> <a href="#tLEMA"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXP"><font style="letter-spacing:0.2pt;">EXPERTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEXP">54</a></font> <a href="#tEXP"></a></td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tOFEX"><font style="letter-spacing:0.2pt;">OFFERING EXPENSES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOFEX">55</a></font>
            </td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tATP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABOUT THIS PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This document is called a prospectus and is part of a registration statement filed with the Securities and Exchange Commission, or the SEC, using a &#8220;shelf&#8221; registration process. Under this process we may, from time to time, offer and sell, in one or more offerings, up to $300,000,000 of our securities. The offer and sale of our securities under this prospectus may be made from time to time, in one or more offerings, in any manner described under the section in this prospectus entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Plan of Distribution</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus only provides you with a general description of the securities that we may offer. Each time we sell our securities, we will provide a prospectus supplement containing specific information about the offering, if required. Any such prospectus supplement may include a discussion of any risk factors or other special considerations that apply to that offering. The prospectus supplement may also add, update or change the information in this prospectus. If there is any inconsistency between the information in this prospectus and any prospectus supplement, you should rely on the information in that prospectus supplement. Before purchasing any of our securities, you should carefully read the registration statement, including exhibits to the registration statement, this prospectus and any prospectus supplement together with additional information incorporated by reference herein and described under the headings &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation by Reference.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">When acquiring any securities described in this prospectus, you should rely only on the information provided in this prospectus and in any applicable prospectus supplement, including the information incorporated by reference. Neither we nor any underwriter, dealer or agent have authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not offering our securities in any jurisdiction where the offer or sale is prohibited. You should not assume that the information in this prospectus, any prospectus supplement or any document incorporated by reference is truthful or complete at any date other than the date mentioned on the cover page of any such document. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may sell our securities to underwriters who will sell the securities to the public at a fixed offering price or at varying prices determined at the time of sale. The applicable prospectus supplement will contain the names of the underwriters, dealers or agents, if any, together with the terms of offering, the compensation of those underwriters, dealers or agents and the net proceeds to us. Any underwriters, dealers or agents participating in the offering may be deemed &#8220;underwriters&#8221; within the meaning of the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">When we refer to &#8220;Belite,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and the &#8220;Company,&#8221; we mean Belite Bio, Inc, together with its direct and indirect wholly owned subsidiaries, Belite Bio Holdings Corp., Belite Bio, LLC, RBP4 Pty Ltd, Belite Bio (HK) Limited and Belite Bio (Shanghai) Limited. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All references in this prospectus to &#8220;$&#8221;, &#8220;US$&#8221;, &#8220;USD&#8221;, &#8220;U.S. dollars&#8221; and &#8220;dollars&#8221; are to the legal currency of the United States, all references to &#8220;AUD&#8221; are to the legal currency of Australia and all references to &#8220;Renminbi&#8221; or &#8220;RMB&#8221; are to the legal currency of China. Our reporting currency is the U.S. dollar. The functional currency of the Company&#8217;s subsidiaries located in the United States and Hong Kong is U.S. dollars. The functional currency of the Company&#8217;s subsidiary located in Australia is AUD, and the functional currency of the Company&#8217;s subsidiary located in China is RMB. Unless otherwise stated, all translations from AUD to U.S. dollars and from U.S. dollars to AUD in this prospectus are made at a rate of AUD0.6783 to US$1.00, and all translations from RMB to U.S. dollars and from U.S. dollars to RMB in this prospectus are made at the rate of RMB6.964 to US$1.00. We make no representation that any RMB, AUD or U.S. dollar amounts could have been, or could be, converted into U.S. dollars, AUD or RMB, as the case may be, at any particular rate, or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The &#8220;Belite Bio&#8221; and &#8220;</font><font style="font-family:MSungHK-Light;">&#20493;&#20142;&#29983;&#29289;&#8221;</font><font style="letter-spacing:0.2pt;"> names and logos are our trademarks, trade names and service marks. This prospectus contains additional trademarks, service marks, logos, copyrights and trade names of others, which are the property of their respective owners. All trademarks, service marks, logos, copyrights and trade names appearing in this prospectus are, to our knowledge, the property of their respective owners. We do not intend our use or display of other companies&#8217; trademarks, service marks, logos, copyrights or trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies. Solely for convenience, the trademarks, service marks, logos, copyrights and trade names referred to in this prospectus are without the </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> and </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8482;</font><font style="letter-spacing:0.2pt;"> symbols. Such references are not intended to indicate, in any way, that we </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:592pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks, logos, copyrights and trade names or that the applicable owner will not assert its rights to these trademarks, service marks, logos, copyrights and trade names. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tOUCO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OUR COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Business Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases which have significant unmet medical needs such as (i)&#160;atrophic age-related macular degeneration (AMD), commonly known as Geographic Atrophy (GA) in advanced dry AMD, and (ii)&#160;autosomal recessive Stargardt disease type 1, or STGD1, both of which cause progressive loss of vision leading to permanent blindness. Our drug development pipeline also includes a small molecule, orally administered compound which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Tinlarebant (LBS-008)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our lead product candidate, Tinlarebant (a/k/a LBS-008), is an orally administered, once-a-day tablet intended as an early intervention for maintaining the health and integrity of retinal tissues in STGD1 and GA patients. STGD1 is a rare monogenetic juvenile-onset macular dystrophy that is characterized by the aberrant and excessive accumulation of toxic vitamin A byproducts known as bisretinoids and cellular debris, or lipofuscin, which precedes the death of retinal tissue and loss of vision. Although an orphan disease, STGD1 is the most common juvenile macular degeneration. Dry AMD is a heterogenous condition that arises from a complex interplay between age, genetics and environmental factors, such as diet and smoking, but has a pathology and course of disease that strongly resembles that of STGD1, particularly in intermediate and advanced stages. Currently, there are no FDA approved treatments for STGD1 and no approved orally administered treatments for GA. Therefore, if approved, Tinlarebant would be a novel oral therapeutic addressing an unmet medical need in both STGD1 and GA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In both STGD1 and GA, the accumulation of bisretinoid toxins has been implicated in progression of retinal disease. Bisretinoids are cytotoxic byproducts of vitamin A (retinol) derived from circulating retinol. As a result, it is hypothesized that reduction of retinol delivery to the eye may reduce bisretinoid accumulation and slow disease progression in STGD1 and GA patients. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The sole carrier protein for delivery of retinol to the eye is serum retinol binding protein 4, or RBP4. Developed from our RBP4 intellectual property portfolio, or RBP4 IP Portfolio, Tinlarebant was designed to be a potent and reversible RBP4 antagonist. As an RBP4 antagonist, Tinlarebant reduces the amount of retinol entering the visual cycle thereby reducing the formation of bisretinoid toxins which will ultimately preserve the health of the retina. We hold a worldwide exclusive license of the RBP4 IP Portfolio from Columbia University, which contains disclosure directed to over 400 structurally distinct RBP4 antagonists under patent protection in major pharmaceutical markets worldwide, including the United States, the European Union, China, Australia, Japan, South Korea and India. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Tinlarebant was designed to target RBP4 as a means to sustain reduced retinol delivery to the eye and reduce the accumulation of bisretinoids in ocular tissue. Our available data suggest that this therapeutic approach could potentially slow disease progression and vision loss in patients affected with STGD1, which shares strong pathophysiologic similarities with GA. In clinical trials, Tinlarebant has demonstrated a target specificity and potency that we believe could be clinically meaningful for STGD1 and GA patients. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To support the clinical development of Tinlarebant, as of mid-2020, we had completed one Phase&#160;1 single ascending dose, or SAD, study in 40 healthy adult subjects in the U.S., one Phase&#160;1 SAD study in 39&#160;healthy adult subjects and one Phase&#160;1 multiple ascending dose, or MAD, study in 32 healthy adult subjects in Australia. These studies involved 111 healthy adult subjects in total and evaluated the safety, toxicity, pharmacokinetics, or PK, and pharmacodynamics, or PD, of Tinlarebant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To support the clinical development of Tinlarebant in STGD1, following completion of the foregoing studies, an open-label, dose-finding Phase&#160;1b/2 clinical trial in adolescent STGD1 subjects was initiated in Australia and Taiwan. The study design includes two portions: the Phase&#160;1b portion was a 1-month dose finding study which enrolled 11 adolescent STGD1 subjects; and the Phase&#160;2 portion is a 2-year extension of the Phase&#160;1b portion in which the 11 STGD1 subjects participating in Phase&#160;1b rolled over into the Phase&#160;2 </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:33.85pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">portion. Two additional adolescent STGD1 subjects were enrolled, giving a total of 13 adolescent STGD1 subjects, in the Phase&#160;2 study. The PD data from the Phase&#160;1b portion has shown that during the repeat dosing, Tinlarebant can achieve a sustained mean RBP4 reduction of over 70%, relative to baseline values. The Phase&#160;2 portion of this study is ongoing. We have obtained 6-month, 12-month, and 18-month treatment data which we believe show slowing of lesion growth. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Based on data from the Phase&#160;1b/2 study, we have initiated a Phase&#160;3 clinical trial named &#8220;DRAGON&#8221; in adolescent STGD1 patients. This study, which is a multi-center, randomized, double masked, placebo controlled study to evaluate the safety and efficacy of Tinlarebant in the treatment of adolescent STGD1 patients, has commenced in the U.S., the United Kingdom, Germany, Netherlands, France, Belgium, Switzerland, China, Hong Kong, Taiwan, and Australia. As of May&#160;19, 2023, we have enrolled 62 subjects for the DRAGON trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To support the clinical development of Tinlarebant in GA, in addition to the foregoing Phase&#160;1 studies completed as of mid-2020, we have also recently completed a Phase&#160;1b dose-finding study in healthy adults to determine the appropriate dose for subjects with similar age and body mass index as GA patients. This study was an open-label, parallel, single-dose, clinical trial designed to evaluate the PK and PD of Tinlarebant in healthy subjects aged between 50 to 85. We identified a dose that we believe produces the desired PD effect against RBP4. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We confirmed the clinical trial design of our Phase&#160;3 study in GA patients with the FDA in November&#160;2022. This study is designed to evaluate the safety and efficacy of Tinlarebant in patients with GA associated with dry AMD. Following the IND amendment submitted to FDA in January&#160;2023, we plan to commence enrollment in a Phase&#160;3 study named &#8220;PHOENIX&#8221; in mid-2023. PHOENIX will be a multicenter, randomized, double-masked, placebo-controlled study to evaluate the safety and efficacy of Tinlarebant in GA subjects. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LBS-009</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">LBS-009 is an anti-RBP4 oral therapy targeting liver disease, including NAFLD, NASH, and T2D. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">NAFLD occurs when an excess accumulation of fat damages the liver. It is estimated that approximately 1.8&#160;billion adult patients suffer from NAFLD worldwide as of 2021. Over time, liver damage and the associated inflammation can lead to the development of NASH, which impacts an estimate of more than 9&#160;million adult patients in the United States alone as of 2021. As the disease progresses, it can lead to cirrhosis and eventually, complete liver failure. NAFLD and NASH are a growing unmet need for which no FDA-approved treatments are currently available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">T2D is a chronic disease that occurs when the body cannot effectively use insulin, the hormone that regulates blood sugar levels. The health impact of T2D is profound, potentially causing damage to the eyes, heart, blood vessels, kidneys, and nerves. T2D is on the rise, with approximately 536&#160;million adult patients globally as of 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">LBS-009 is a small molecule designed to compete with retinol for RBP4 binding. When bound to LBS-009, RBP4 can no longer form a large molecular weight complex with transthyretin, or TTR. Without TTR, the RBP4/LBS-009 complex can be removed from circulation by renal filtration. We believe that modulating RBP4 concentrations systemically with LBS-009 has a significant therapeutic potential for treating patients suffering from metabolically associated diseases, including NAFLD, NASH and T2D. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">LBS-009 is currently in preclinical development. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Organizational Structure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following diagram illustrates our corporate structure as of the date of this prospectus: </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="fc_organization-bwlr.jpg" alt="[MISSING IMAGE: fc_organization-bwlr.jpg]" height="317" width="581" >
        </div>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash Transfers and Dividend Distribution</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our cash is primarily held by our holding company, Belite. Belite is permitted under the laws of the Cayman Islands to provide funding to our subsidiaries through capital contributions or loans, and there are currently no restrictions on transferring funds between our Cayman Islands holding company and subsidiaries in the U.S., Australia and Hong Kong. Our ability to make loans and additional capital contribution to our PRC subsidiary may be restricted by PRC law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the normal course of our business, Belite evaluates the financial condition and capital needs of our subsidiaries periodically and provides funding for their operations via equity investments and intercompany loans. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our subsidiaries outside of mainland China are permitted, under the respective laws of the U.S., Australia and Hong Kong, to provide funding to Belite through dividend distribution without restrictions on the amount of the funds. Our PRC subsidiary generates no revenue as of the date of this prospectus, but should it generate revenue in the future, its ability to distribute dividends to us will be limited by foreign exchange restrictions. In addition, restrictions on currency exchanges in China may limit our ability to freely convert Renminbi to fund any future business activities outside China or other payments in U.S. dollars, and capital control measures imposed by the Chinese government may limit our ability to use capital from our PRC subsidiary for business purposes outside of China. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and trade and service-related foreign exchange transactions, cannot be made in currencies other than Renminbi without complying with certain procedural requirements of the State Administration of Foreign Exchange, or SAFE. Specifically, approval from or registration with appropriate government authorities is required where Renminbi is to be converted into another currency and remitted out of China to pay capital expenses, such as the repayment of loans denominated in currencies other than Renminbi. As a result, we may need to obtain SAFE approval or registration to use cash generated from the operations of our PRC subsidiary to pay off its debt in a currency other than Renminbi owed to entities outside China, or to make other capital expenditure payments outside China in a currency other than Renminbi. On the other hand, the PRC Enterprise Tax Law (EIT Law) and its implementation rules provide that a withholding tax rate of up to 10% will be applicable to dividends payable by Chinese companies to non-PRC-resident enterprises unless otherwise exempted or reduced according to treaties or arrangements between the PRC central government and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">governments of other countries or regions where the non-PRC-resident enterprises are incorporated. As of the date of this prospectus, we have not received nor do we have any present plan to receive dividends paid by our U.S., Australia, Hong Kong and PRC subsidiaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have not adopted any specific cash management policies and procedures in relation to how funds are transferred within/through our group. Our management monitors the cash position of each entity within our group regularly, and prepares budgets for our subsidiaries on a monthly basis. In the event that there is a need for cash or a potential short-term cashflow shortages, it would be reported to our chief financial officer and, subject to the approval by our board of directors, we will enter into an intercompany loan arrangement for relevant subsidiary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Board of Directors has discretion as to whether to distribute dividends, subject to certain requirements of Cayman Islands law. In addition, subject to the provisions in our articles of association, our shareholders may by ordinary resolution declare a dividend not exceeding the amount recommended by our Board of Directors. As of the date of this prospectus, we have not paid and do not have any present plan to declare or pay any dividends in the foreseeable future. We currently intend to retain most of our available funds and any future earnings to fund the development and growth of our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary of Risk Factors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An investment in our securities is subject to a number of risks that if realized could materially affect our business, financial condition, results of operations, cash flows and access to liquidity. Investors should carefully consider all of the information in this prospectus, the documents incorporated by reference herein and any accompanying prospectus supplement before making an investment in the securities. The following list summarizes some, but not all, of these risks. Please read the information in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; in this prospectus and in our most recent Annual Report on Form 20-F for a more thorough description of these and other risks. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Our business is highly dependent on the success of our lead product candidate, Tinlarebant (a/k/a LBS-008). If we are unable to develop, obtain marketing approval for or successfully commercialize Tinlarebant, either alone or through a collaboration, or if we experience significant delays in doing so, our business could be harmed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Both of our product candidates (i.e. Tinlarebant and LBS-009) are in clinical or preclinical development. If we are unable to complete clinical development and obtain regulatory approval to ultimately commercialize our product candidates, or if we experience significant delays in doing so, our business, financial condition, results of operations and prospects will be materially harmed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">We have recorded net cash outflow from operating activities since our inception and will need to obtain additional financing to fund our operations. If we are unable to obtain such financing, we may be unable to complete the development and commercialization of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">We have a limited operating history and no history of commercializing pharmaceutical products, which may make it difficult to evaluate the prospects for our future viability; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The regulatory approval processes of the FDA, the TGA, the NMPA, the EMA and other comparable regulatory authorities are time-consuming and may evolve over time, and if we are ultimately unable to obtain regulatory approval for our product candidates, our business will be substantially harmed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">All material aspects of the research, development, manufacturing and commercialization of pharmaceutical products are heavily regulated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If we are unable to obtain and maintain patent and other intellectual property protection for our product candidates, or if the scope of such intellectual property rights obtained is not sufficiently broad, third parties could develop and commercialize products and technologies similar or identical to ours and compete directly against us, and our ability to successfully commercialize any product or technology may be adversely affected; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">We depend on intellectual property licensed from third parties, and our current and future licensors may not always act in our best interest. If we fail to comply with our obligations under our intellectual </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">property licenses, if the licenses are terminated or if disputes regarding these licenses arise, we could lose significant rights that are important to our business; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">If we fail to implement and maintain an effective system of internal controls, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent fraud, and investor confidence and the market price of our securities may be materially and adversely affected; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Our future success depends on our ability to attract, retain and motivate senior management and qualified scientific employees; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As we rely on third parties to conduct our preclinical studies, clinical trials, contract manufacture drug substances and drug products, and provide other important services related to product development, regulatory submissions, and commercialization, if we lose our relationships with these third parties or if they do not successfully carry out their contractual duties, comply with applicable laws, or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our product candidates and our business could be substantially harmed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">We expect to seek to establish collaborations and, if we are not able to establish them on commercially reasonable terms, we may have to alter our development and commercialization plans; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As a result of our principal shareholder, Lin Bioscience International Ltd.&#8217;s significant share ownership position in us, it is able to influence corporate matters and a conflict of interest may arise between our principal shareholder and us. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Implications of Being an Emerging Growth Company</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are an &#8220;emerging growth company&#8221; pursuant to the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements compared to those that are otherwise applicable generally to public companies. These provisions include exemption from the auditor attestation requirement under Section&#160;404 of the Sarbanes-Oxley Act of 2002 in the assessment of the emerging growth company&#8217;s internal control over financial reporting. The JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. Pursuant to the JOBS Act, we have elected to take advantage of the benefits of this extended transition period for complying with new or revised accounting standards. As a result, our operating results and financial statements may not be comparable to the operating results and financial statements of other companies who have adopted the new or revised accounting standards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will remain an emerging growth company until the earliest of (a)&#160;the last day of the fiscal year during which we have total annual gross revenues of at least US$1.235&#160;billion; (b)&#160;December&#160;31, 2027; (c)&#160;the date on which we have, during the preceding three-year period, issued more than US$1.0&#160;billion in non-convertible debt; or (d)&#160;the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur if the market value of the ADSs that are held by non-affiliates exceeds US$700&#160;million as of the last business day of our most recently completed second fiscal quarter. Once we cease to be an emerging growth company, we will not be entitled to the exemptions provided in the JOBS Act discussed above. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Implications of Being a Foreign Private Issuer</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We report under the Exchange Act as a non-U.S. company with foreign private issuer status. This means that, even after we no longer qualify as an emerging growth company, as long as we qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:334pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form&#160;10-Q containing unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant events. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may take advantage of these exemptions until such time as we are no longer a foreign private issuer. We would cease to be a foreign private issuer at such time as more than 50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances applies: (i)&#160;the majority of our executive officers or directors are U.S. citizens or residents, (ii)&#160;more than 50% of our assets are located in the United States or (iii)&#160;our business is administered principally in the United States. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Implications of being a Controlled Company</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a &#8220;controlled company&#8221; as defined under the Nasdaq Stock Market Rules, because one of our shareholders holds more than 50% of our voting power. As a result, for so long as we remain a controlled company as defined under that rule, we are exempt from, and our shareholders generally are not provided with the benefits of, some of the Nasdaq Stock Market corporate governance requirements, including that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a majority of our board of directors must be independent directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our compensation committee must be composed entirely of independent directors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our corporate governance and nomination committee must be composed entirely of independent directors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, three of our seven directors were independent and the remaining four directors, including our chief executive officer and chief financial officer, were appointed by our controlling shareholder. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCSRF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus, the documents incorporated by reference herein and any accompanying prospectus supplement may contain or incorporate forward-looking statements that are based on our management&#8217;s belief and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements stated in or implied by these forward-looking statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All statements other than statements of historical facts are forward-looking statements. These forward-looking statements are made under the &#8220;safe harbor&#8221; provision under Section&#160;27A of the Securities Act and 21E of the Exchange Act and as defined in the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; or &#8220;would&#8221; or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect results. You should refer to the &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; section of this prospectus, any accompanying prospectus supplement, and our annual reports on Form 20-F and reports on Form 6-K filed with the SEC and incorporated by reference into this prospectus for specific risks that could cause actual results to be significantly different from those stated in or implied by these forward-looking statements. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. Forward-looking statements speak only as of the date made and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should read this prospectus, any accompanying prospectus supplement and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially different from any future results stated in or implied by these forward-looking statements. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Forward-looking statements in this prospectus include, but are not limited to, statements about: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing of the initiation, progress and potential results of our preclinical studies, clinical trials and our discovery programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing and likelihood of regulatory filings and approvals, including with respect to additional indications beyond the initial indication for which we are seeking approval for our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to advance our product candidates into drugs, and the successful completion of clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the approval, commercialization, pricing and reimbursement of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the competitive landscape and size of the market opportunity for our product candidates, including our estimates of the number of patients who suffer from the diseases we are targeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">estimates of our costs, expenses, future revenues, capital expenditures and our needs for additional financing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to attract and retain senior management and key employees; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our future business development, financial condition and results of operations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">future developments, trends, conditions and competitive landscape in the industry and markets in which we operate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our strategies, plans, objectives and goals and our ability to successfully implement these strategies, plans, objectives and goals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:422pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">costs associated with enforcing or defending against intellectual property infringement, misappropriation or violation, product liability and other claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to establish and maintain collaborations or licensing agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to identify and integrate new product candidates, technologies and/or suitable acquisition targets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to effectively manage our growth; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes to regulatory and operating conditions in our industry and markets; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the potential impact of COVID-19 and other epidemics on our current and future business development, financial condition and results of operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; section of this prospectus, any accompanying prospectus supplement, and our annual reports on Form 20-F and reports on Form 6-K filed with the SEC and incorporated by reference into this prospectus discusses the principal contingencies and uncertainties to which we believe we are subject, which should be considered in evaluating any forward-looking statements contained or incorporated by reference in this prospectus or in any prospectus supplement.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:488pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Investing in our securities involves risks. Before making an investment decision, you should carefully consider the risks described under &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Risk Factors</font><font style="letter-spacing:0.2pt;">&#8221; in the applicable prospectus supplement and in our most recent annual report on Form 20-F, and in our updates, if any, to those risk factors in our reports on Form 6-K incorporated by reference into this prospectus, together with all of the other information appearing in this prospectus or incorporated by reference into this prospectus and any applicable prospectus supplement, in light of your particular investment objectives and financial circumstances. In addition to those risk factors, there may be additional risks and uncertainties of which management is not aware or focused on or that management deems immaterial. Our business, financial condition or results of operations could be materially adversely affected by any of these risks. The trading price of our securities could decline due to any of these risks, and you may lose all or part of your investment. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tOSAE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:572pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">OFFER STATISTICS AND EXPECTED TIMETABLE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">We may, from time to time pursuant to this prospectus (as may be detailed in a prospectus supplement), offer and sell, in one or more offerings, up to $300,000,000 of our securities. The price per security offered will depend on a number of factors that may be relevant at the time of offer. See &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Plan of Distribution</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:500pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">USE OF PROCEEDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our management will have broad discretion over the use of the net proceeds from the sale of our securities pursuant to this prospectus, both in terms of the purposes for which they will be used and the amounts that will be allocated for each purpose. We intend to use the net proceeds from the sale of any securities offered under this prospectus for our clinical trials and further clinical development of Tinlarebant, funding our research and development of our other pipeline products and for working capital and other general corporate purposes, unless otherwise indicated in the applicable prospectus supplement or free writing prospectus. We will set forth in the applicable prospectus supplement or free writing prospectus our intended use for the net proceeds received from the sale of any securities sold pursuant to the prospectus supplement or free writing prospectus. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCAP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:572pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CAPITALIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Our capitalization will be set forth in a prospectus supplement to this prospectus or in a report of foreign private issuer on Form 6-K subsequently furnished to the SEC and specifically incorporated herein by reference. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOSC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF SHARE CAPITAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are a Cayman Islands exempted company incorporated with limited liability and our affairs are governed by our memorandum and articles of association, the Companies Act (As Revised) of the Cayman Islands, which we refer to as the Companies Act below, and the common law of the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, our authorized share capital is US$50,000 divided into 500,000,000 shares comprised of (i)&#160;400,000,000 ordinary shares of a par value of US$0.0001 each, and (ii)&#160;100,000,000 undesignated shares of a par value of US$0.0001 each of such class or classes (however designated) as the board of directors may determine in accordance with our third amended and restated memorandum and articles of association. As of the date of this prospectus, 25,226,255 ordinary shares were issued and outstanding. All of our issued and outstanding ordinary shares are fully paid. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Third Amended and Restated Memorandum and Articles of Association</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following are summaries of material provisions of our current third amended and restated memorandum and articles of association that became effective immediately prior to the completion of our initial public offering, or IPO, in April&#160;2022 (our &#8220;Memorandum and Articles of Association&#8221;) insofar as they relate to the material terms of our ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Objects of Our Company</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under our Memorandum and Articles of Association, the objects of our company are unrestricted, and we have the full power and authority to carry out any object not prohibited by the laws of the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Ordinary Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our ordinary shares are issued in registered form and are issued when registered in our register of members. We may not issue shares to bearer. Our shareholders, whether residents or non- residents of the Cayman Islands, may freely hold and vote their shares as described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our directors may from time to time declare dividends (including interim dividends) and other distributions on our shares in issue and authorize payment of the same out of the funds of our company lawfully available therefor. In addition, our shareholders may declare dividends by ordinary resolution, but no dividend may exceed the amount recommended by our directors. Under the laws of the Cayman Islands, our company may pay a dividend out of either profit or share premium account; provided that in no circumstances may a dividend be paid if that would result in our company being unable to pay its debts as they fall due in the ordinary course of business immediately following the date on which the dividend is paid. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Voting Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Holders of our ordinary shares have the right to receive notice of, attend, speak and vote at general meetings of our company. Holders of ordinary shares shall, at all times, vote together as one class on all matters submitted to a vote by the members at any such general meeting. On all matters subject to a vote at general meetings of our company, (1)&#160;on a show of hands, each shareholder shall be entitled to one vote, whereas (2)&#160;on a poll, each shareholder shall be entitled to one vote per ordinary share. Our ordinary shares vote together as a single class on all matters submitted to a vote of our shareholders, except as may otherwise be required by law. Voting at any meeting of shareholders shall be decided by way of a poll save that the chairman of the meeting may, in good faith, allow a resolution which relates purely to a procedural or administrative matter to be voted on by a show of hands. Where a show of hands is allowed, before or on the declaration of the results of the show of hands, a poll may be demanded by the chairman of such meeting or any shareholder present in person or by proxy at the meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes of the ordinary shares which are cast by those of our shareholders who attend and vote at the meeting, while a special resolution requires the affirmative vote of no less than two-thirds of the votes of the ordinary shares which are cast by those of our shareholders who attend and vote at the meeting. Under the Companies Act, a special resolution will be required in order for our company to effect certain important matters as stipulated in the Companies Act, such as a change of name or making changes to our Memorandum and Articles of Association. Our shareholders may, among other things, divide or combine their shares by ordinary resolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">General Meetings of Shareholders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As a Cayman Islands exempted company, we are not obliged by the Companies Act to call shareholders&#8217; annual general meetings. Our Memorandum and Articles of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Association provide that we may (but are not obliged to, unless as required by applicable law or the Nasdaq Stock Market rules) in each year hold a general meeting as our annual general meeting in which case we will specify the meeting as such in the notices calling it, and the annual general meeting will be held at such time and place as may be determined by our directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Shareholders&#8217; general meetings may be convened by the chairman of our Board of Directors or a majority of our directors (acting by a resolution of our board). Advance notice of at least seven calendar days is required for the convening of our annual general shareholders&#8217; meeting (if any) and any other general meeting of our shareholders. A quorum required for any general meeting of shareholders consists of one or more of our shareholders holding shares which carry in aggregate (or representing by proxy) not less than one-third of all votes attaching to the issued and outstanding shares in our company entitled to vote at such general meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a company&#8217;s articles of association. Our Memorandum and Articles of Association provide that upon the requisition of any one or more of our shareholders holding shares which carry in aggregate not less than one-third of all votes attaching to all issued and outstanding shares of our company entitled to vote at general meetings, our board will be required to convene an extraordinary general meeting and put the resolutions so requisitioned to a vote at such meeting. However, our Memorandum and Articles of Association do not provide our shareholders with any right to put any proposals before annual general meetings or extraordinary general meetings not called by such shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Transfer of Ordinary Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to the restrictions set out below, any of our shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or any other form approved by our Board of Directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Board of Directors may, in its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up or on which we have a lien. Our Board of Directors may also decline to register any transfer of any ordinary share unless: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the instrument of transfer is lodged with us, accompanied by the certificate for the ordinary shares to which it relates and such other evidence as our Board of Directors may reasonably require to show the right of the transferor to make the transfer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the instrument of transfer is in respect of only one class of ordinary shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the instrument of transfer is properly stamped, if required; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in the case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed four; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a fee of such maximum sum as Nasdaq Stock Market may determine to be payable or such lesser sum as our directors may from time to time require is paid to us in respect thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If our directors refuse to register a transfer they must, within three calendar&#160;months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The registration of transfers may, after compliance with any notice required of the Nasdaq Stock Market, be suspended and the register closed at such times and for such periods as our Board of Directors may, in its absolute discretion, from time to time determine; provided, however, that the registration of transfers may not be suspended nor the register closed for more than 30 calendar days in any calendar year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Liquidation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On the winding up of our company, if the assets available for distribution amongst our shareholders shall be more than sufficient to repay the whole of the share capital at the commencement of the winding up, the surplus will be distributed amongst our shareholders in proportion to the par value of the shares held by them at the commencement of the winding up, subject to a deduction from those shares in respect of which there are monies due, of all monies payable to our company for unpaid calls or otherwise. If our assets available for distribution are insufficient to repay all of the paid-up capital, such assets shall be </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">distributed so that, as nearly as may be, the losses are borne by our shareholders in proportion to the par value of the shares held by them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Calls on Shares and Forfeiture of Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our Board of Directors may from time to time make calls upon shareholders for any amounts unpaid on their shares in a notice served to such shareholders at least 14 calendar days prior to the specified time and place of payment. The shares that have been called upon and remain unpaid are subject to forfeiture. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Redemption, Repurchase and Surrender of Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We may issue shares on terms that such shares are subject to redemption, at our option or at the option of the holders of these shares, on such terms and in such manner as may be determined, before the issue of such shares, by our Board of Directors or by our shareholders by ordinary resolution. Our company may also redeem or repurchase any of our shares on such terms and in such manner as have been approved by our Board of Directors or by an ordinary resolution of our shareholders. Under the Companies Act, the redemption or repurchase of any share may be paid out of our Company&#8217;s profits or out of the proceeds of a new issue of shares made for the purpose of such redemption or repurchase, or out of capital (including share premium account and capital redemption reserve) if our company can, immediately following such payment, pay its debts as they fall due in the ordinary course of business. In addition, under the Companies Act no such share may be redeemed or repurchased (a)&#160;unless it is fully paid up, (b)&#160;if such redemption or repurchase would result in there being no shares outstanding or (c)&#160;if the company has commenced liquidation. In addition, our company may accept the surrender of any fully paid share for no consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Variation of Rights of Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Whenever the capital of our company is divided into different classes, the rights attached to any such class may, subject to any rights or restrictions for the time being attached to any class, only be materially adversely varied or abrogated with the consent in writing of the holders of not less than a majority of the issued shares of that class or with the sanction of an ordinary resolution passed at a separate meeting of the holders of the shares of that class. The rights conferred upon the holders of the shares of any class issued shall not, subject to any rights or restrictions for the time being attached to any class, be deemed to be materially adversely varied or abrogated by the creation, allotment, or issue of further shares ranking </font><font style="font-style:italic;letter-spacing:0.2pt;">pari&#160;passu</font><font style="letter-spacing:0.2pt;"> with or subsequent to such existing class of shares, or the redemption or purchase of any shares of any class by our company. The rights of the holders of shares shall not be deemed to be materially adversely varied or abrogated by the creation or issue of shares with preferred or other rights including, without limitation, the creation of shares with enhanced or weighted voting rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Issuance of Additional Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our Memorandum and Articles of Association authorize our Board of Directors to issue additional ordinary shares from time to time as our Board of Directors may determine, to the extent of available authorized but unissued shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Memorandum and Articles of Association also authorize our Board of Directors to establish from time to time one or more series of preferred shares and to determine, with respect to any series of preferred shares, the terms and rights of that series, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the designation of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the dividend rights, dividend rates, conversion rights, voting rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the rights and terms of redemption and liquidation preferences; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any other powers, preferences and relative, participating, optional and other special rights. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Board of Directors may issue preferred shares without action by our shareholders to the extent authorized but unissued. Issuance of these shares may dilute the voting power of holders of ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Inspection of Books and Records</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Holders of our ordinary shares will have no general right under Cayman Islands law to inspect or obtain copies of our list of shareholders or our corporate records (other than our Memorandum and Articles of Association, our register of mortgages and charges, and copies of any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">special resolutions passed by our shareholders). However, we provide our shareholders with annual audited financial statements that are filed in our annual reports on Form 20-F. See &#8220;Where You Can Find More Information.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Anti-Takeover Provisions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Some provisions of our Memorandum and Articles of Association may discourage, delay or prevent a change of control of our company or management that shareholders may consider favorable, including provisions that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">authorize our Board of Directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and restrictions of such preferred shares without any further vote or action by our shareholders; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">limit the ability of shareholders to requisition and convene general meetings of shareholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, under Cayman Islands law, our directors may only exercise the rights and powers granted to them under our Memorandum and Articles of Association for a proper purpose and for what they believe in good faith to be in the best interests of our company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Changes in Capital.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our shareholders may from time to time by ordinary resolution: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">increase our share capital by such sum, to be divided into shares of such classes and amount, as the resolution shall prescribe; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">consolidate and divide all or any of our share capital into shares of a larger amount than our existing shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sub-divide our existing shares, or any of them into shares of a smaller amount, provided that in the subdivision the proportion between the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in case of the share from which the reduced share is derived; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and diminish the amount of our share capital by the amount of the shares so canceled. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our shareholders may by special resolution, subject to confirmation by the Grand Court of the Cayman Islands on an application by our company for an order confirming such reduction, reduce our share capital or any capital redemption reserve in any manner permitted by law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Exempted Company</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We are an exempted company with limited liability under the Companies Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. The requirements for an exempted company are essentially the same as for an ordinary company except that an exempted company: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">does not have to file an annual return of its shareholders with the Registrar of Companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">is not required to open its register of members for inspection; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">does not have to hold an annual general meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">may issue shares with no par value; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Limited liability&#8221; means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Differences in Corporate Law</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act is derived, to a large extent, from the older Companies Acts of England but does not follow recent English statutory enactments and, accordingly, there are significant differences between the Companies Act and the current Companies Act of England. In addition, the Companies Act differs from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of certain </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">significant differences between the provisions of the Companies Act applicable to us and the laws applicable to companies incorporated in the United States and their shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Mergers and Similar Arrangements.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Companies Act permits mergers and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman Islands companies. For these purposes, (i)&#160;&#8220;merger&#8221; means the merging of two or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies as the surviving company, and (ii)&#160;a &#8220;consolidation&#8221; means the combination of two or more constituent companies into a consolidated company and the vesting of the undertaking, property and liabilities of such companies to the consolidated company. In order to effect such a merger or consolidation, the directors of each constituent company must approve a written plan of merger or consolidation, which must then be authorized by (a)&#160;a special resolution of the shareholders of each constituent company, and (b)&#160;such other authorization, if any, as may be specified in such constituent company&#8217;s articles of association. The written plan of merger or consolidation must be filed with the Registrar of Companies of the Cayman Islands together with a declaration as to the solvency of the consolidated or surviving company, a list of the assets and liabilities of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to the members and creditors of each constituent company and that notification of the merger or consolidation will be published in the Cayman Islands Gazette. Court approval is not required for a merger or consolidation which is effected in compliance with these statutory procedures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A merger between a Cayman parent company and its Cayman subsidiary or subsidiaries does not require authorization by a resolution of shareholders of that Cayman subsidiary if a copy of the plan of merger is given to every member of that Cayman subsidiary to be merged unless that member agrees otherwise. For this purpose, a company is a &#8220;parent&#8221; of a subsidiary if it holds issued shares that together represent at least ninety&#160;percent (90%) of the votes at a general meeting of the subsidiary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The consent of each holder of a fixed or floating security interest over a constituent company is required unless this requirement is waived by a court in the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Save in certain limited circumstances, a shareholder of a Cayman constituent company who dissents from the merger or consolidation is entitled to payment of the fair value of his shares (which, if not agreed between the parties, will be determined by the Cayman Islands court) upon dissenting to a merger or consolidation, provide the dissenting shareholder complies strictly with the procedures set out in the Companies Act. The exercise of dissenter rights will preclude the exercise by the dissenting shareholder of any other rights to which he or she might otherwise be entitled by virtue of holding shares, save for the right to seek relief on the grounds that the merger or consolidation is void or unlawful. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Separate from the statutory provisions relating to mergers and consolidations, the Companies Act also contains statutory provisions that facilitate the reconstruction and amalgamation of companies by way of schemes of arrangement, provided that the arrangement is approved (a)&#160;75% in value of shareholders; or (b)&#160;a majority in number representing 75% in value of creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder has the right to express to the court the view that the transaction ought not to be approved, the court can be expected to approve the arrangement if it determines that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the statutory provisions as to the required majority vote have been met; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the shareholders have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion of the minority to promote interests adverse to those of the class; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his interest; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act also contains a statutory power of compulsory acquisition which may facilitate the &#8220;squeeze out&#8221; of dissentient minority shareholder upon a tender offer. When a tender offer is made and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">accepted by holders of 90.0% of the shares within four&#160;months, the offeror may, within a two-month period commencing on the expiration of such four-month period, require the holders of the remaining shares to transfer such shares to the offeror on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to succeed in the case of an offer which has been so approved unless there is evidence of fraud, bad faith or collusion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If an arrangement and reconstruction by way of scheme of arrangement is thus approved and sanctioned, or if a tender offer is made and accepted in accordance with the foregoing statutory procedures, a dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of Delaware corporations, providing rights to receive payment in cash for the judicially determined value of the shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shareholders&#8217; Suits.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company, and as a general rule a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority in the Cayman Islands, the Cayman Islands court can be expected to follow and apply the common law principles (namely the rule in Foss v. Harbottle and the exceptions thereto) so that a non-controlling shareholder may be permitted to commence a class action against or derivative actions in the name of the company to challenge actions where: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a company acts or proposes to act illegally or ultra vires; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the act complained of, although not ultra vires, could only be effected duly if authorized by more than a simple majority vote that has not been obtained; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">those who control the company are perpetrating a &#8220;fraud on the minority.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Indemnification of Directors and Executive Officers and Limitation of Liability.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Cayman Islands law does not limit the extent to which a company&#8217;s memorandum and articles of association may provide for indemnification of directors and officers, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Memorandum and Articles of Association provide that we shall indemnify our directors and officers, against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by such director or officer, other than by reason of such person&#8217;s dishonesty, willful default or fraud, in or about the conduct of our company&#8217;s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil proceedings concerning our company or its affairs in any court whether in the Cayman Islands or elsewhere. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation. In addition, we have entered into indemnification agreements with our directors and executive officers that provide such persons with additional indemnification beyond that provided in our Memorandum and Articles of Association. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Directors&#8217; Fiduciary Duties.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director acts in a manner he reasonably believes to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, the director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a matter of Cayman Islands law, a director of a Cayman Islands exempted company is in the position of a fiduciary with respect to the company and therefore it is considered that he owes the following duties to the company&#8201;&#8212;&#8201;a duty to act bona fide in the best interests of the company, a duty not to make a profit based on his position as director (unless the company permits him to do so), a duty not to put himself in a position where the interests of the company conflict with his personal interest or his duty to a third party, and a duty to exercise powers for the purpose for which such powers were intended. A director of a Cayman Islands exempted company owes to the company a duty to act with skill and care. It was previously considered that a director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth courts have moved towards an objective standard with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shareholder Action by Written Consent</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders to act by written consent by amendment to its certificate of incorporation. Cayman Islands law and our Memorandum and Articles of Association provide that shareholders may approve corporate matters by way of a unanimous written resolution signed by or on behalf of each shareholder who would have been entitled to vote on such matter at a general meeting without a meeting being held, and any such resolution in writing shall be as valid and effective as if the same had been passed at a general meeting of our company duly convened and held. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shareholder Proposals.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting of shareholders; provided that it complies with the notice provisions in the governing documents. A special meeting may be called by the Board of Directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a company&#8217;s articles of association. Our Memorandum and Articles of Association allow any one or more of our shareholders holding shares which carry in aggregate not less than one-third of the total number votes attaching to all issued and outstanding shares of our company as of the date of the deposit that are entitled to vote at general meetings to requisition an extraordinary general meeting of our shareholders, in which case our board is obliged to convene an extraordinary general meeting and to put the resolutions so requisitioned to a vote at such meeting. Other than this right to requisition a shareholders&#8217; meeting, our Memorandum and Articles of Association do not provide our shareholders with any other right to put proposals before annual general meetings or extraordinary general meetings. As a Cayman Islands exempted company, we are not obliged by law to call shareholders&#8217; annual general meetings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Cumulative Voting.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation&#8217;s certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a Board of Directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholder&#8217;s voting power with respect to electing such director. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There are no prohibitions in relation to cumulative voting under the laws of the Cayman Islands, but our Memorandum and Articles of Association do not provide for cumulative voting. As a result, our shareholders are not afforded any less protections or rights on this issue than shareholders of a Delaware corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Removal of Directors.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a director of a corporation with a classified board may be removed only for cause with the approval of a majority of the issued and outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Memorandum and Articles of Association, directors may be removed by an ordinary resolution of our shareholders. A director&#8217;s office shall be vacated if the director (i)&#160;becomes bankrupt or makes any arrangement or composition with his creditors; (ii)&#160;dies or is found to be or becomes of unsound mind; (iii)&#160;resigns his office by notice in writing; (iv)&#160;is prohibited by any applicable law or the Nasdaq Stock Market rules from being a director; (v)&#160;without special leave of absence from our board, is absent from meetings of our board for three consecutive meetings and our board resolves that his office be vacated; or (vi)&#160;is removed from office pursuant to any other provision of our Memorandum and Articles of Association. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Transactions with Interested Shareholders.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Delaware General Corporation Law contains a business combination statute applicable to Delaware corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an &#8220;interested shareholder&#8221; for three&#160;years following the date that such person becomes an interested shareholder. An interested shareholder generally is a person or a group who or which owns or owned 15% or more of the target&#8217;s outstanding voting shares within the past three&#160;years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an interested shareholder, the Board of Directors approves either the business combination or the transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate the terms of any acquisition transaction with the target&#8217;s Board of Directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cayman Islands law has no comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business combination statute. However, although Cayman Islands law does not regulate transactions between a company and its significant shareholders, it does provide that such transactions must be entered into bona fide in the best interests of the company and not with the effect of constituting a fraud on the minority shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dissolution; Winding up.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, unless the Board of Directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the Board of Directors may it be approved by a simple majority of the corporation&#8217;s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by either an order of the courts of the Cayman Islands or by the Board of Directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under Cayman Islands law, a company may be wound up by either an order of the courts of the Cayman Islands or by a special resolution of its members or, if the company is unable to pay its debts as they fall due, by an ordinary resolution of its members. The court has authority to order winding up in a number of specified circumstances including where it is, in the opinion of the court, just and equitable to do so. Under the Companies Act, our company may be dissolved, liquidated or wound up by a special resolution of our shareholders, or, if we are unable to pay our debts as they fall due, by an ordinary resolution of our shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Variation of Rights of Shares.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under our Memorandum and Articles of Association, if our share capital is divided into more than one class of shares, the rights attached to any such class may only be materially adversely varied or abrogated with the consent in writing of the holders of not less than a majority of the issued shares of that class or with the sanction of an ordinary resolution passed at a separate meeting of the holders of the shares of that class. The rights conferred upon the holders of the shares of any class issued with preferred or other rights shall not, subject to any rights or restrictions for the time being attached to the shares of that class, be deemed to be materially adversely varied or abrogated by the creation, allotment or issue of further shares ranking pari&#160;passu with or subsequent to them or the redemption or purchase of any shares of any class by our company. The rights of the holders of shares shall not be deemed to be materially adversely varied or abrogated by the creation or issue of shares with preferred or other rights including, without limitation, the creation of shares with enhanced or weighted voting rights. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Amendment of Governing Documents.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation&#8217;s governing documents may be amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under the Companies Act and our Memorandum and Articles of Association, our Memorandum and Articles of Association may only be amended by a special resolution of our shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Rights of Non-resident or Foreign Shareholders.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;There are no limitations imposed by our Memorandum and Articles of Association on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions in our Memorandum and Articles of Association that require our company to disclose shareholder ownership above any particular ownership threshold. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">History of Securities Issuances</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of our securities issuances in the past three&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ordinary Shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;31, 2020, we issued 727,676 ordinary shares to the optionees for the options exercised. Specifically, we issued: (i)&#160;367,515 ordinary shares to Yu-Hsin Lin, our Founder, Chief Executive Officer and Chairman of the Board of Directors; (ii)&#160;257,260 ordinary shares to Hao-Yuan Chuang, our Chief Financial Officer; (iii)&#160;36,751 ordinary shares to Hung-Wei Chen; (iv)&#160;22,050 ordinary shares to Wan-Shan Chen; (v)&#160;22,050 ordinary shares to Ming-Chiu Wu; and (vi)&#160;22,050 ordinary shares to Yun-Ju Huang, in their exercise of options granted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;31, 2021, we issued 706,406 ordinary shares to the optionees for the options exercised. Specifically, we issued: (i)&#160;364,213 ordinary shares to Yu-Hsin Lin, our Founder, Chief Executive Officer and Chairman of the Board of Directors; (ii)&#160;254,950 ordinary shares to Hao-Yuan Chuang, our Chief Financial Officer; (iii)&#160;21,684 ordinary shares to Hung-Wei Chen; (iv)&#160;23,463 ordinary shares to Wan-Shan Chen; (v)&#160;20,243 ordinary shares to Ming-Chiu Wu; and (vi)&#160;21,853 ordinary shares to Yun-Ju Huang, in their exercise of options granted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2022, we completed our IPO on the Nasdaq Capital Market pursuant to which we issued 6,000,000 ADSs, representing 6,000,000 ordinary shares, at $6.00 per share for gross proceeds of $36.0&#160;million. On May&#160;20, 2022, the underwriter partially exercised its over-allotment option to purchase 772,091 ADS, resulting in additional net proceeds of $4.3&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with our IPO, we adopted the 2022 Performance Incentive Plan, to provide additional incentives to selected employees, directors and consultants, and to enable our company to obtain and retain the services of these individuals. The 2022 Performance Incentive Plan enables us to grant share options, share appreciation rights and other awards to our employees, directors and consultants. The initial aggregate amount of ordinary shares that may be issued under the 2022 Performance Incentive Plan is 1,748,667, provided that the shares reserved under the 2022 Performance Incentive Plan shall automatically increase on the first trading day in January of each calendar year during the term of the 2022 Performance Incentive Plan, commencing in January&#160;2023, by an amount equal to (i)&#160;four&#160;percent (4%) of the total number of ordinary shares issued and outstanding on December&#160;31 of the immediately preceding calendar year or (ii)&#160;such lesser number of ordinary shares as may be established by our Board of Directors. As of May&#160;19, 2023, there were 1,090,123 shares remaining available for grant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of May&#160;19, 2023, there were 1,638,667 options outstanding under the 2022 Performance Incentive Plan, with a weighted average exercise price of $6.00, of which 350,466 shares were vested. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred Shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;24, 2020, we closed a private placement transaction pursuant to which we sold an aggregate of 5,443,272 Series&#160;B Preferred Shares for an aggregate consideration of $23,000,000 in cash. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All of our preferred shares were automatically converted into ordinary shares immediately prior to the completion of our IPO. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:480pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Depositary, Transfer Agent and Registrar</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary for the ADSs is Deutsche Bank Trust Company Americas. Our ordinary share register is maintained by Maples Fund&#160;Services (Cayman) Limited. The share register reflects only record owners of our ordinary shares. Holders of our ADSs will not be treated as one of our shareholders and their names will therefore not be entered in our share register. The depositary, the custodian or their nominees will be the holder of the shares underlying our ADSs. Holders of our ADSs have a right to receive the ordinary shares underlying their ADSs. For discussion on our ADSs and ADS holder rights, see &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Description of American Depositary Shares</font><font style="letter-spacing:0.2pt;">&#8221; in this prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our ADSs are listed on the Nasdaq Capital Market under the symbol &#8220;BLTE.&#8221;</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOAD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF AMERICAN DEPOSITARY SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">American Depositary Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Deutsche Bank Trust Company Americas, as depositary, will register and deliver the ADSs. Each ADS will represent ownership of one ordinary share, deposited with Deutsche Bank AG, Hong Kong Branch, as custodian for the depositary. Each ADS will also represent ownership of any other securities, cash or other property which may be held by the depositary. The depositary&#8217;s corporate trust office at which the ADSs will be administered is located at 1 Columbus Circle, New York, NY 10019, USA. The principal executive office of the depositary is located at 1 Columbus Circle, New York, NY 10019, USA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Direct Registration System, or DRS, is a system administered by The Depository Trust Company, or DTC, pursuant to which the depositary may register the ownership of uncertificated ADSs, which ownership shall be evidenced by periodic statements issued by the depositary to the ADS holders entitled thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will not treat ADS holders as our shareholders and accordingly, you, as an ADS holder, will not have shareholder rights. Cayman Islands law governs shareholder rights. The depositary will be the holder of the ordinary shares underlying your ADSs. As a holder of ADSs, you will have ADS holder rights. A&#160;deposit agreement among us, the depositary and you, as an ADS holder, and the beneficial owners of ADSs sets out ADS holder rights as well as the rights and obligations of the depositary. The laws of the State of New York govern the deposit agreement and the ADSs. See &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Jurisdiction and Arbitration</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the material provisions of the deposit agreement. For more complete information, you should read the entire deposit agreement and the form of American Depositary Receipt. For directions on how to obtain copies of those documents, see &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find More Information</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Holding the ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How will you hold your ADSs?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may hold ADSs either (1)&#160;directly (a)&#160;by having an American Depositary Receipt, or ADR, which is a certificate evidencing a specific number of ADSs, registered in your name, or (b)&#160;by holding ADSs in DRS, or (2)&#160;indirectly through your broker or other financial institution. If you hold ADSs directly, you are an ADS holder. This description assumes you hold your ADSs directly. ADSs will be issued through DRS, unless you specifically request certificated ADRs. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS holders described in this section. You should consult with your broker or financial institution to find out what those procedures are. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends and Other Distributions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How will you receive dividends and other distributions on the ordinary shares?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary has agreed to pay to you the cash dividends or other distributions it or the custodian receives on ordinary shares or other deposited securities, after deducting its fees and expenses. You will receive these distributions in proportion to the number of ordinary shares your ADSs represent as of the record date (which will be as close as practicable to the record date for our ordinary shares) set by the depositary with respect to the ADSs. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Cash.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The depositary will convert or cause to be converted any cash dividend or other cash distribution we pay on the ordinary shares or any net proceeds from the sale of any ordinary shares, rights, securities or other entitlements under the terms of the deposit agreement into U.S. dollars if it can do so on a practicable basis, and can transfer the U.S. dollars to the United States and will distribute promptly the amount thus received. If the depositary shall determine in its judgment that such conversions or transfers are not practical or lawful or if any government approval or license is needed and cannot be obtained at a reasonable cost within a reasonable period or otherwise sought, the deposit agreement allows the depositary to distribute the foreign currency only to those </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">ADS holders to whom it is possible to do so. It will hold or cause the custodian to hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid and such funds will be held for the respective accounts of the ADS holders. It will not invest the foreign currency and it will not be liable for any interest for the respective accounts of the ADS holders. </font>
        </div>
        <div style="margin-left:30pt; margin-top:8pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before making a distribution, any taxes or other governmental charges, together with fees and expenses of the depositary, that must be paid, will be deducted. See &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Taxation</font><font style="letter-spacing:0.2pt;">.&#8221; It will distribute only whole U.S. dollars and cents and will round down fractional cents to the nearest whole cent. </font><font style="font-style:italic;letter-spacing:0.2pt;">If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some or all of the value of the distribution.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Shares.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;For any ordinary shares we distribute as a dividend or free distribution, either (1)&#160;the depositary will distribute additional ADSs representing such ordinary shares or (2)&#160;existing ADSs as of the applicable record date will represent rights and interests in the additional ordinary shares distributed, to the extent reasonably practicable and permissible under law, in either case, net of applicable fees, charges and expenses incurred by the depositary and taxes and/or other governmental charges. The depositary will only distribute whole ADSs. It will try to sell ordinary shares which would require it to deliver a fractional ADS and distribute the net proceeds in the same way as it does with cash. The depositary may sell a portion of the distributed ordinary shares sufficient to pay its fees and expenses, and any taxes and governmental charges, in connection with that distribution. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Elective Distributions in Cash or Shares.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If we offer holders of our ordinary shares the option to receive dividends in either cash or shares, the depositary, after consultation with us and having received timely notice as described in the deposit agreement of such elective distribution by us, has discretion to determine to what extent such elective distribution will be made available to you as a holder of the ADSs. We must timely first instruct the depositary to make such elective distribution available to you and furnish it with satisfactory evidence that it is legal to do so. The depositary could decide it is not legal or reasonably practicable to make such elective distribution available to you. In such case, the depositary shall, on the basis of the same determination as is made in respect of the ordinary shares for which no election is made, distribute either cash in the same way as it does in a cash distribution, or additional ADSs representing ordinary shares in the same way as it does in a share distribution. The depositary is not obligated to make available to you a method to receive the elective dividend in shares rather than in ADSs. There can be no assurance that you will be given the opportunity to receive elective distributions on the same terms and conditions as the holders of ordinary shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rights to Purchase Additional Shares.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If we offer holders of our ordinary shares any rights to subscribe for additional shares, the depositary shall having received timely notice as described in the deposit agreement of such distribution by us, consult with us, and we must determine whether it is lawful and reasonably practicable to make these rights available to you. We must first instruct the depositary to make such rights available to you and furnish the depositary with satisfactory evidence that it is legal to do so. If the depositary decides it is not legal or reasonably practicable to make the rights available but that it is lawful and reasonably practicable to sell the rights, the depositary will endeavor to sell the rights and in a riskless principal capacity or otherwise, at such place and upon such terms (including public or private sale) as it may deem proper distribute the net proceeds in the same way as it does with cash. The depositary will allow rights that are not distributed or sold to lapse. In that case, you will receive no value for them. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:30pt; margin-top:8pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the depositary makes rights available to you, it will establish procedures to distribute such rights and enable you to exercise the rights upon your payment of applicable fees, charges and expenses incurred by the depositary and taxes and/or other governmental charges. The Depositary shall not be obliged to make available to you a method to exercise such rights to subscribe for ordinary shares (rather than ADSs). </font>
        </div>
        <div style="margin-left:30pt; margin-top:8pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">U.S. securities laws may restrict transfers and cancellation of the ADSs represented by shares purchased upon exercise of rights. For example, you may not be able to trade these ADSs freely in the United States. In this case, the depositary may deliver restricted depositary shares that have the same terms as the ADSs described in this section except for changes needed to put the necessary restrictions in place. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There can be no assurance that you will be given the opportunity to exercise rights on the same terms and conditions as the holders of ordinary shares or be able to exercise such rights. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Other Distributions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to receipt of timely notice, as described in the deposit agreement, from us with the request to make any such distribution available to you, and provided the depositary has determined such distribution is lawful and reasonably practicable and feasible and in accordance with the terms of the deposit agreement, the depositary will distribute to you anything else we distribute on deposited securities by any means it may deem practicable, upon your payment of applicable fees, charges and expenses incurred by the depositary and taxes and/or other governmental charges. If any of the conditions above are not met, the depositary will endeavor to sell, or cause to be sold, what we distributed and distribute the net proceeds in the same way as it does with cash; or, if it is unable to sell such property, the depositary may dispose of such property in any way it deems reasonably practicable under the circumstances for nominal or no consideration, such that you may have no rights to or arising from such property. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, shares, rights or anything else to ADS holders. This means that you may not receive the distributions we make on our shares or any value for them if we and/or the depositary determines that it is illegal or not practicable for us or the depositary to make them available to you. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Deposit, Withdrawal and Cancellation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How are ADSs issued?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary will deliver ADSs if you or your broker deposit ordinary shares or evidence of rights to receive ordinary shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons entitled thereto. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do ADS holders cancel an American Depositary Share?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You may turn in your ADSs at the depositary&#8217;s corporate trust office or by providing appropriate instructions to your broker. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will deliver the ordinary shares and any other deposited securities underlying the ADSs to you or a person you designate at the office of the custodian. Or, at your request, risk and expense, the depositary will deliver the deposited securities at its corporate trust office, to the extent permitted by law. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do ADS holders interchange between Certificated ADSs and Uncertificated ADSs?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You may surrender your ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR and will send you a statement confirming that you are the owner of uncertificated ADSs. Alternatively, upon receipt by the depositary of a proper instruction from a holder of uncertificated ADSs requesting the exchange of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to you an ADR evidencing those ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do you vote?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You may instruct the depositary to vote the ordinary shares or other deposited securities underlying your ADSs at any meeting at which you are entitled to vote pursuant to any applicable law, the provisions of our Memorandum and Articles of Association, and the provisions of or governing the deposited securities. </font><font style="font-style:italic;letter-spacing:0.2pt;">Otherwise, you could exercise your right to vote directly if you withdraw the ordinary shares. However, you may not know about the meeting sufficiently enough in advance to withdraw the ordinary shares.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we ask for your instructions and upon timely notice from us by regular, ordinary mail delivery, or by electronic transmission, as described in the deposit agreement, the depositary will notify you of the upcoming meeting at which you are entitled to vote pursuant to any applicable law, the provisions of our Memorandum and Articles of Association, and the provisions of or governing the deposited securities, and arrange to deliver our voting materials to you. The materials will include or reproduce (a)&#160;such notice of meeting or solicitation of consents or proxies; (b)&#160;a statement that the ADS holders at the close of business on the ADS record date will be entitled, subject to any applicable law, the provisions of our Memorandum and Articles of Association, and the provisions of or governing the deposited securities, to instruct the depositary as to the exercise of the voting rights, if any, pertaining to the ordinary shares or other deposited securities represented by such holder&#8217;s ADSs; and (c)&#160;a brief statement as to the manner in which such instructions may be given to the depositary or deemed given in accordance with the second to last sentence of this paragraph if no instruction is received by the depositary to give a discretionary proxy to a person designated by us. Voting instructions may be given only in respect of a number of ADSs representing an integral number of ordinary shares or other deposited securities. For instructions to be valid, the depositary must receive them in writing on or before the date specified. The depositary will try, as far as practical, subject to applicable law and the provisions of our Memorandum and Articles of Association, to vote or to have its agents vote the ordinary shares or other deposited securities (in person or by proxy) as you instruct. The depositary will only vote or attempt to vote as you instruct. If we timely requested the depositary to solicit your instructions but no instructions are received by the depositary from an owner with respect to any of the deposited securities represented by the ADSs of that owner on or before the date established by the depositary for such purpose, the depositary shall deem that owner to have instructed the depositary to give a discretionary proxy to a person designated by us with respect to such deposited securities, and the depositary shall give a discretionary proxy to a person designated by us to vote such deposited securities. However, no such instruction shall be deemed given and no such discretionary proxy shall be given with respect to any matter if we inform the depositary we do not wish such proxy given, substantial opposition exists or the matter materially and adversely affects the rights of holders of the ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote the ordinary shares underlying your ADSs. In addition, there can be no assurance that ADS holders and beneficial owners generally, or any holder or beneficial owner in particular, will be given the opportunity to vote or cause the custodian to vote on the same terms and conditions as the holders of our ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. </font><font style="font-style:italic;letter-spacing:0.2pt;">This means that you may not be able to exercise your right to vote and you may have no recourse if the ordinary shares underlying your ADSs are not voted as you requested.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to give you a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to deposited securities, if we request the depositary to act, we will give the depositary notice of any such meeting and details concerning the matters to be voted at least 30 business days in advance of the meeting date. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compliance with Regulations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Information Requests</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each ADS holder and beneficial owner shall (a)&#160;provide such information as we or the depositary may request pursuant to law, including, without limitation, relevant Cayman Islands law, any applicable law of the United States of America, our Memorandum and Articles of Association, any resolutions of our Board of Directors adopted pursuant to such Memorandum and Articles of Association, the requirements of any markets or exchanges upon which the ordinary shares, ADSs or ADRs are listed or traded, or to any requirements of any electronic book-entry system by which the ADSs or ADRs may be transferred, regarding the capacity in which they own or owned ADRs, the identity of any other persons then or previously interested in such ADRs and the nature of such interest, and any other applicable matters, and (b)&#160;be bound by and subject to applicable provisions of the laws of the Cayman Islands, our Memorandum and Articles of Association, and the requirements of any markets or exchanges upon which the ADSs, ADRs or ordinary shares are listed or traded, or pursuant to any requirements of any electronic book-entry system by which </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the ADSs, ADRs or ordinary shares may be transferred, to the same extent as if such ADS holder or beneficial owner held ordinary shares directly, in each case irrespective of whether or not they are ADS holders or beneficial owners at the time such request is made. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disclosure of Interests</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each ADS holder and beneficial owner shall comply with our requests pursuant to Cayman Islands law, the rules and requirements of the Nasdaq Stock Market and any other stock exchange on which the ordinary shares are, or will be, registered, traded or listed or our Memorandum and Articles of Association, which requests are made to provide information, inter alia, as to the capacity in which such ADS holder or beneficial owner owns ADS and regarding the identity of any other person interested in such ADS and the nature of such interest and various other matters, whether or not they are ADS holders or beneficial owners at the time of such requests. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fees and Expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As an ADS holder, you will be required to pay the following service fees to the depositary bank and certain taxes and governmental charges (in addition to any applicable fees, expenses, taxes and other governmental charges payable on the deposited securities represented by any of your ADSs): </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:252pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Service </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:192pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fees </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:252pt;">
              <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">To any person to which ADSs are issued or to any person to which a distribution is made in respect of ADS distributions pursuant to stock dividends or other free distributions of stock, bonus distributions, stock splits or other distributions (except where converted to cash) </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:192pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS issued </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:252pt;">
              <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Cancellation of ADSs, including the case of termination of the deposit agreement </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS cancelled </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:252pt;">
              <div style=" float:left; line-height:10pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Distribution of cash dividends </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:192pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS held </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:252pt;">
              <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Distribution of cash entitlements (other than cash dividends) and/or cash proceeds from the sale of rights, securities and other entitlements </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS held </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:252pt;">
              <div style=" float:left; line-height:10pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Distribution of ADSs pursuant to exercise of rights. </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:192pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS held </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:252pt;">
              <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Distribution of securities other than ADSs or rights to purchase additional ADSs </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS held </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:252pt;">
              <div style=" float:left; line-height:10pt; text-align:left; width:20pt;white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8226;</font>
                <br >
              </div>
              <div style=" line-height:10pt; text-align:left; margin-left:20pt;">
                <!--blacklining:none;-->
                <font style="letter-spacing:0.2pt;">Depositary services </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS held on the applicable record date(s) established by the depositary bank</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.71pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As an ADS holder, you will also be responsible for paying certain fees and expenses incurred by the depositary bank and certain taxes and governmental charges (in addition to any applicable fees, expenses, taxes and other governmental charges payable on the deposited securities represented by any of your ADSs) such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fees for the transfer and registration of ordinary shares charged by the registrar and transfer agent for the ordinary shares in the Cayman Islands (i.e., upon deposit and withdrawal of ordinary shares). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Expenses incurred for converting foreign currency into U.S. dollars. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Expenses for cable, telex and fax transmissions and for delivery of securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Taxes and duties upon the transfer of securities, including any applicable stamp duties, any stock transfer charges or withholding taxes (i.e., when ordinary shares are deposited or withdrawn from deposit). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fees and expenses incurred in connection with the delivery or servicing of ordinary shares on deposit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fees and expenses incurred in connection with complying with exchange control regulations and other regulatory requirements applicable to ordinary shares, deposited securities, ADSs and ADRs. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.82pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.82pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Any applicable fees and penalties thereon. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary fees payable upon the issuance and cancellation of ADSs are typically paid to the depositary bank by the brokers (on behalf of their clients) receiving the newly issued ADSs from the depositary bank and by the brokers (on behalf of their clients) delivering the ADSs to the depositary bank for cancellation. The brokers in turn charge these fees to their clients. Depositary fees payable in connection with distributions of cash or securities to ADS holders and the depositary services fee are charged by the depositary bank to the holders of record of ADSs as of the applicable ADS record date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary fees payable for cash distributions are generally deducted from the cash being distributed or by selling a portion of distributable property to pay the fees. In the case of distributions other than cash (i.e., share dividends, rights), the depositary bank charges the applicable fee to the ADS record date holders concurrent with the distribution. In the case of ADSs registered in the name of the investor (whether certificated or uncertificated in direct registration), the depositary bank sends invoices to the applicable record date ADS holders. In the case of ADSs held in brokerage and custodian accounts (via DTC), the depositary bank generally collects its fees through the systems provided by DTC (whose nominee is the registered holder of the ADSs held in DTC) from the brokers and custodians holding ADSs in their DTC accounts. The brokers and custodians who hold their clients&#8217; ADSs in DTC accounts in turn charge their clients&#8217; accounts the amount of the fees paid to the depositary banks. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event of refusal to pay the depositary fees, the depositary bank may, under the terms of the deposit agreement, refuse the requested service until payment is received or may set off the amount of the depositary fees from any distribution to be made to the ADS holder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary may make payments to us or reimburse us for certain costs and expenses, by making available a portion of the ADS fees collected in respect of the ADR program or otherwise, upon such terms and conditions as we and the depositary bank agree from time to time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Payment of Taxes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You will be responsible for any taxes or other governmental charges payable, or which become payable, on your ADSs or on the deposited securities represented by any of your ADSs. The depositary may refuse to register or transfer your ADSs or allow you to withdraw the deposited securities represented by your ADSs until such taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented by your ADSs to pay any taxes owed and you will remain liable for any deficiency. If the depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to you any net proceeds, or send to you any property, remaining after it has paid the taxes. You agree to indemnify us, the depositary, the custodian and each of our and their respective agents, directors, employees and affiliates for, and hold each of them harmless from, any claims with respect to taxes (including applicable interest and penalties thereon) arising from any refund of taxes, reduced rate of withholding at source or other tax benefit obtained for you. Your obligations under this paragraph shall survive any transfer of ADRs, any surrender of ADRs and withdrawal of deposited securities or the termination of the deposit agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reclassifications, Recapitalizations and Mergers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">If we: </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Then: </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Change the nominal or par value of our ordinary shares </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">The cash, shares or other securities received by the depositary will become deposited securities. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Reclassify, split up or consolidate any of the deposited securities </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Each ADS will automatically represent its equal share of the new deposited securities. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Distribute securities on the ordinary shares that are not distributed to you, or Recapitalize, reorganize, merge, liquidate, sell all or substantially all of our assets, or take any similar action </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">The depositary may distribute some or all of the cash, shares or other securities it received. It may also deliver new ADSs or ask you to surrender your outstanding ADRs in exchange for new ADRs identifying the new deposited securities.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amendment and Termination</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How may the deposit agreement be amended?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may agree with the depositary to amend the deposit agreement and the form of ADR without your consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, including expenses incurred in connection with foreign exchange control regulations and other charges specifically payable by ADS holders under the deposit agreement, or materially prejudices a substantial existing right of ADS holders, it will not become effective for outstanding ADSs until 30&#160;days after the depositary notifies ADS holders of the amendment. </font><font style="font-style:italic;letter-spacing:0.2pt;">At the time an amendment becomes effective, you are considered, by continuing to hold your ADSs, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended</font><font style="letter-spacing:0.2pt;">. If any new laws are adopted, which would require the deposit agreement to be amended in order to comply therewith, we and the depositary may amend the deposit agreement in accordance with such laws and such amendment may become effective before notice thereof is given to ADS holders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How may the deposit agreement be terminated?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary will terminate the deposit agreement if we ask it to do so, in which case the depositary will give notice to you at least 90&#160;days prior to termination. The depositary may also terminate the deposit agreement if the depositary has told us that it would like to resign, or if we have removed the depositary, and in either case we have not appointed a new depositary within 90&#160;days. In either such case, the depositary must notify you at least 30&#160;days before termination. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After termination, the depositary and its agents will do the following under the deposit agreement but nothing else: collect distributions on the deposited securities, sell rights and other property and deliver ordinary shares and other deposited securities upon cancellation of ADSs after payment of any fees, charges, taxes or other governmental charges. Six&#160;months or more after the date of termination, the depositary may sell any remaining deposited securities by public or private sale. After that, the depositary will hold the money it received on the sale, as well as any other cash it is holding under the deposit agreement, for the </font><font style="font-style:italic;letter-spacing:0.2pt;">pro&#160;rata</font><font style="letter-spacing:0.2pt;"> benefit of the ADS holders that have not surrendered their ADSs. It will not invest the money and has no liability for interest. After such sale, the depositary&#8217;s only obligations will be to account for the money and other cash. After termination, we shall be discharged from all obligations under the deposit agreement except for our obligations to the depositary thereunder. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Books of Depositary</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary will maintain ADS holder records at its depositary office. You may inspect such records at such office during regular business hours but solely for the purpose of communicating with other holders in the interest of business matters relating to the Company, the ADRs and the deposit agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary will maintain facilities in the Borough of Manhattan, The City of New York to record and process the issuance, cancellation, combination, split-up and transfer of ADRs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These facilities may be closed at any time or from time to time when such action is deemed necessary or advisable by the depositary in connection with the performance of its duties under the deposit agreement or at our reasonable written request. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limitations on Obligations and Liability</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limits on our Obligations and the Obligations of the Depositary and the Custodian; Limits on Liability to Holders of ADSs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement expressly limits our obligations and the obligations of the depositary and the custodian. It also limits our liability and the liability of the depositary. The depositary and the custodian: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are only obligated to take the actions specifically set forth in the deposit agreement without gross negligence or willful misconduct; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are not liable if any of us or our respective controlling persons or agents are prevented or forbidden from, or subjected to any civil or criminal penalty or restraint on account of, or delayed in, doing or performing any act or thing required by the terms of the deposit agreement and any ADR, by reason of any provision of any present or future law or regulation of the United States or any state thereof, the Cayman Islands or any other country, or of any other governmental authority or regulatory authority or stock exchange, or on account of the possible criminal or civil penalties or restraint, or by reason of any provision, present or future, of our Memorandum and Articles of Association or any provision of or governing any deposited securities, or by reason of any act of God or war or other circumstances beyond its control (including, without limitation, nationalization, expropriation, currency restrictions, work stoppage, strikes, civil unrest, revolutions, rebellions, explosions and computer failure); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are not liable by reason of any exercise of, or failure to exercise, any discretion provided for in the deposit agreement or in our Memorandum and Articles of Association or provisions of or governing deposited securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are not liable for any action or inaction of the depositary, the custodian or us or their or our respective controlling persons or agents in reliance upon the advice of or information from legal counsel, any person presenting ordinary shares for deposit or any other person believed by it in good faith to be competent to give such advice or information; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to holders of ADSs under the terms of the deposit agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are not liable for any special, consequential, indirect or punitive damages for any breach of the terms of the deposit agreement, or otherwise; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">may rely upon any documents we believe in good faith to be genuine and to have been signed or presented by the proper party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">disclaim any liability for any action or inaction or inaction of any of us or our respective controlling persons or agents in reliance upon the advice of or information from legal counsel, accountants, any person presenting ordinary shares for deposit, holders and beneficial owners (or authorized representatives) of ADSs, or any person believed in good faith to be competent to give such advice or information; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">disclaim any liability for inability of any holder to benefit from any distribution, offering, right or other benefit made available to holders of deposited securities but not made available to holders of ADS. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary and any of its agents also disclaim any liability (i)&#160;for any failure to carry out any instructions to vote, the manner in which any vote is cast or the effect of any vote or failure to determine that any distribution or action may be lawful or reasonably practicable or for allowing any rights to lapse in accordance with the provisions of the deposit agreement, (ii)&#160;the failure or timeliness of any notice from us, the content of any information submitted to it by us for distribution to you or for any inaccuracy of any translation thereof, (iii)&#160;any investment risk associated with the acquisition of an interest in the deposited securities, the validity or worth of the deposited securities, the credit-worthiness of any third party, (iv)&#160;for any tax consequences that may result from ownership of ADSs, ordinary shares or deposited securities, or (v)&#160;for any acts or omissions made by a successor depositary whether in connection with a previous act or omission of the depositary or in connection with any matter arising wholly after the removal or resignation of the depositary, provided that in connection with the issue out of which such potential liability arises the depositary performed its obligations without gross negligence or willful misconduct while it acted as depositary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the deposit agreement, we and the depositary agree to indemnify each other under certain circumstances. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Jurisdiction and Arbitration</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The laws of the State of New York govern the deposit agreement and the ADSs and we have agreed with the depositary that the federal or state courts in the City of New York shall have exclusive jurisdiction </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to hear and determine any dispute arising from or in connection with the deposit agreement and that the depositary will have the right to refer any claim or dispute arising from the relationship created by the deposit agreement to arbitration in accordance with the Commercial Arbitration Rules of the American Arbitration Association. The arbitration provisions of the deposit agreement do not preclude you from pursuing claims under the Securities Act or the Exchange Act in federal or state courts. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Jury Trial Waiver</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement provides that each party to the deposit agreement (including each holder, beneficial owner and holder of interests in the ADRs) irrevocably waives, to the fullest extent permitted by applicable law, any right it may have to a trial by jury in any lawsuit or proceeding against us or the depositary arising out of or relating to our shares, the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable based on the facts and circumstances of that case in accordance with the applicable law. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Requirements for Depositary Actions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before the depositary will issue, deliver or register a transfer of an ADS, split-up, subdivide or combine ADSs, make a distribution on an ADS, or permit withdrawal of ordinary shares, the depositary may require: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any ordinary shares or other deposited securities and payment of the applicable fees, expenses and charges of the depositary; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">satisfactory proof of the identity and genuineness of any signature or any other matters contemplated in the deposit agreement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with (A)&#160;any laws or governmental regulations relating to the execution and delivery of ADRs or ADSs or to the withdrawal or delivery of deposited securities and (B)&#160;such reasonable regulations and procedures as the depositary may establish, from time to time, consistent with the deposit agreement and applicable laws, including presentation of transfer documents. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary may refuse to issue and deliver ADSs or register transfers of ADSs generally when the register of the depositary or our transfer books are closed or at any time if the depositary or we determine that it is necessary or advisable to do so. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Your Right to Receive the Shares Underlying Your ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You have the right to cancel your ADSs and withdraw the underlying ordinary shares at any time except: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">when temporary delays arise because: (1)&#160;the depositary has closed its transfer books or we have closed our transfer books; (2)&#160;the transfer of ordinary shares is blocked to permit voting at a shareholders&#8217; meeting; or (3)&#160;we are paying a dividend on our ordinary shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">when you owe money to pay fees, taxes and similar charges; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of ordinary shares or other deposited securities, or other circumstances specifically contemplated by Section&#160;I.A.(l) of the General Instructions to Form F-6 (as such General Instructions may be amended from time to time); or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">for any other reason if the depositary or we determine, in good faith, that it is necessary or advisable to prohibit withdrawals. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary shall not knowingly accept for deposit under the deposit agreement any ordinary shares or other deposited securities required to be registered under the provisions of the Securities Act, unless a registration statement is in effect as to such ordinary shares. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This right of withdrawal may not be limited by any other provision of the deposit agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:512pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Direct Registration System</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">In the deposit agreement, all parties to the deposit agreement acknowledge that the DRS and Profile Modification System, or Profile, will apply to uncertificated ADSs upon acceptance thereof to DRS by DTC. DRS is the system administered by DTC pursuant to which the depositary may register the ownership of uncertificated ADSs, which ownership shall be evidenced by periodic statements issued by the depositary to the ADS holders entitled thereto. Profile is a required feature of DRS which allows a DTC participant, claiming to act on behalf of an ADS holder, to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account of that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register such transfer. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOW">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF WARRANTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may issue warrants to purchase ADSs and/or ordinary shares and/or preferred shares. Warrants may be issued independently or together with any other securities and may be attached to, or separate from, such securities. We will evidence each series of warrants by warrant certificates that we may issue under a separate agreement. We may enter into a warrant agreement with a warrant agent. We may also choose to act as our own warrant agent. The terms of any warrants to be issued and a description of the material provisions of the applicable warrant agreement will be set forth in the applicable prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The applicable prospectus supplement will describe the following terms of any warrants in respect of which this prospectus is being delivered: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the title of such warrants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the aggregate number of such warrants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the price or prices at which such warrants will be issued and exercised; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the currency or currencies in which the price of such warrants will be payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the securities purchasable upon exercise of such warrants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the date on which the right to exercise such warrants shall commence and the date on which such right shall expire; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable, the date on and after which such warrants and the related securities will be separately transferable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">information with respect to book-entry procedures, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any material Cayman and United States federal income tax consequences; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the anti-dilution provisions of the warrants, if any; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any other material terms of such warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable on such exercise, including, in the case of warrants to purchase ADSs or ordinary shares, the right to receive dividends, if any, or, payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We issued to The Benchmark Company, LLC, as the representative of the underwriters of our initial public offering, warrants to purchase a number of ADSs equal to 2.5% of the ADSs sold by us in our initial public offering, including ADSs sold upon the exercise of the option to purchase additional ADSs (the &#8220;Representative&#8217;s Warrants&#8221;). The Representative&#8217;s Warrants have an exercise price equal to US$7.50 per ADS. The Representative&#8217;s Warrants are exercisable until April&#160;29, 2027. The Representative&#8217;s Warrants are also exercisable on a cashless basis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The description in the applicable prospectus supplement of any warrants we offer will not necessarily be complete and will be qualified in its entirety by reference to the applicable warrant agreement, which will be filed with the SEC if we offer warrants. For more information on how you can obtain copies of the applicable warrant agreement if we offer warrants, see &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation By Reference&#8221; of this prospectus. We urge you to read any applicable prospectus supplement and the applicable warrant agreement, in their entirety. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:64pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF OVERALLOTMENT PURCHASE RIGHTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may issue overallotment purchase rights to purchase ADSs and/or ordinary shares and/or preferred shares and/or warrants and/or subscription rights and/or&#160;units. Overallotment purchase rights may be issued independently or together with any other securities and may be attached to, or separate from, such securities. Any overallotment purchase rights will be issued under a form of overallotment purchase right and/or overallotment purchase agreement to be filed with the SEC. The terms of any overallotment purchase rights to be issued and a description of the material provisions of the applicable form of overallotment purchase right will be set forth in the applicable prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The applicable prospectus supplement relating to any overallotment purchase rights we offer, if any, will, to the extent applicable, include specific terms relating to the offering, including some or all of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the form of such overallotment purchase rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the aggregate number of such overallotment purchase rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the price or prices at which such overallotment purchase rights will be issued and exercised; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the currency or currencies in which the price of such overallotment purchase rights will be payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the securities purchasable upon exercise of such overallotment purchase rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the date on which the right to exercise such overallotment purchase rights shall commence and the date on which such right shall expire; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable, the minimum or maximum amount of such overallotment purchase rights which may be exercised at any one time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable, the designation and terms of the securities with which such overallotment purchase rights are issued and the number of such overallotment purchase rights issued with each such security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable, the date on and after which such overallotment purchase rights and the related securities will be separately transferable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable, any provisions for cashless exercise of the overallotment purchase rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable; any exercise limitations with respect to the ownership limitations by the holder exercising the overallotment purchase rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">information with respect to book-entry procedures, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the anti-dilution provisions of the overallotment purchase rights, if any; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any other terms of such warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The description in the applicable prospectus supplement of any overallotment purchase rights we offer will not necessarily be complete and will be qualified in its entirety by reference to the applicable form of overallotment purchase right, which will be filed with the SEC if we offer overallotment purchase rights. For more information on how you can obtain copies of the applicable form of overallotment purchase right if we offer overallotment purchase rights, see &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation By Reference&#8221; of this prospectus. We urge you to read the applicable form of overallotment purchase right and any applicable prospectus supplement in their entirety. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOSR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:190pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF SUBSCRIPTION RIGHTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may issue subscription rights to purchase our ordinary shares, and/or preferred shares, and/or ADSs. These subscription rights may be issued independently or together with any other security offered hereby and may or may not be transferable by the shareholder receiving the subscription rights in such offering. In connection with any offering of subscription rights, we may enter into a standby arrangement with one or more underwriters or other purchasers pursuant to which the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for after such offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The prospectus supplement relating to any subscription rights we offer, if any, will, to the extent applicable, include specific terms relating to the offering, including some or all of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the price, if any, for the subscription rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the exercise price payable for each ordinary share, and/or preferred share, and/or ADS upon the exercise of the subscription rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of subscription rights to be issued to each shareholder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number and terms of the ordinary shares, and/or preferred shares, and/or ADSs, which may be purchased per subscription right; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which the subscription rights are transferable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any other terms of the subscription rights, including the terms, procedures and limitations relating to the exchange and exercise of the subscription rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the date on which the right to exercise the subscription rights shall commence, and the date on which the subscription rights shall expire; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which the subscription rights may include an over-subscription privilege with respect to unsubscribed securities; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable, the material terms of any standby underwriting or purchase arrangement which may be entered into by us in connection with the offering of subscription rights. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The description in the applicable prospectus supplement of any subscription rights we offer will not necessarily be complete and will be qualified in its entirety by reference to the applicable subscription right agreement, which will be filed with the SEC if we offer subscription rights. For more information on how you can obtain copies of the applicable subscription right agreement if we offer subscription rights, see &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation By Reference&#8221; of this prospectus. We urge you to read the applicable subscription right agreement and any applicable prospectus supplement in their entirety. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOU">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:346pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF UNITS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may issue&#160;units comprised of one or more of the other securities that may be offered under this prospectus, in any combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately at any time, or at any time before a specified date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The prospectus supplement relating to any&#160;units we offer, if any, will, to the extent applicable, include specific terms relating to the offering, including some or all of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the material terms of the&#160;units and of the securities comprising the&#160;units, including whether and under what circumstances those securities may be held or transferred separately; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any material provisions relating to the issuance, payment, settlement, transfer or exchange of the&#160;units or of the securities comprising the&#160;units; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any material provisions of the governing unit agreement that differ from those described above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The description in the applicable prospectus supplement of any&#160;units we offer will not necessarily be complete and will be qualified in its entirety by reference to the applicable unit agreement, which will be filed with the SEC if we offer&#160;units. For more information on how you can obtain copies of the applicable unit agreement if we offer&#160;units, see &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation By Reference&#8221; of this prospectus. We urge you to read the applicable unit agreement and any applicable prospectus supplement in their entirety. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOCN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:352pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF CAPITAL NOTES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may from time to time offer and sell under this prospectus capital notes, referred to herein as equity equivalent capital notes. When we offer to sell a particular series of capital notes, we will describe the specific terms of the series in a prospectus supplement. We will also indicate in the prospectus supplement whether the general terms and provisions described in this prospectus apply to a particular series of capital notes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The capital notes are instruments of equity and not debt. Unless otherwise specified in a prospectus supplement, (i)&#160;the face amounts of the capital notes will not bear interest nor will they be linked to any index, (ii)&#160;the face amounts of the capital notes will only payable by us out of distributions made upon the winding-up, liquidation or dissolution of our company on a pari&#160;passu and pro&#160;rata basis with the holders of our ordinary shares and (iii)&#160;we will have no right to prepay or redeem the equity equivalent capital notes. In addition, the holder may at any time, convert the face amount of the equity equivalent capital notes, in whole or in part, without payment of any additional consideration, into ADSs or ordinary shares, as set forth in the equity equivalent capital note, at a conversion price agreed with the holder. Unless otherwise specified in a prospectus supplement, the equity equivalent capital notes shall have no maturity date and the right to convert into ADSs or ordinary shares shall not expire. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The terms of any particular series of equity equivalent capital notes will be set forth in the purchase agreement with the purchasers and the governing capital note certificate, each of which will be incorporated by reference as an exhibit to the registration statement of which this prospectus forms a part. The foregoing summary of the equity equivalent capital notes is not complete. We encourage you to read the purchase agreement and capital note certificate, because they, and not this summary, will govern your rights as a holder of equity equivalent capital notes. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDDS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF DEBT SECURITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may issue debt securities from time to time, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. While the terms we have summarized below will apply generally to any debt securities that we may offer under this prospectus, we will describe the particular terms of any debt securities that we may offer in more detail in the applicable prospectus supplement. The terms of any debt securities offered under a prospectus supplement may differ from the terms described below. Unless the context requires otherwise, whenever we refer to the indenture, we also are referring to any supplemental indentures that specify the terms of a particular series of debt securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will issue the debt securities under the indenture that we will enter into with the trustee named in the indenture. The indenture will be qualified under the Trust Indenture Act of 1939, as amended (the &#8220;Trust Indenture Act&#8221;). We have filed the form of indenture as an exhibit to the registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus is a part or will be incorporated by reference from reports that we file with the SEC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following summary of material provisions of the debt securities and the indenture is subject to, and qualified in its entirety by reference to, all of the provisions of the indenture applicable to a particular series of debt securities. We urge you to read the applicable prospectus supplements and any related free writing prospectuses related to the debt securities that we may offer under this prospectus, as well as the complete indenture that contains the terms of the debt securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The indenture does not limit the amount of debt securities that we may issue. It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit that we may designate. Except for the limitations on consolidation, merger and sale of all or&#160;substantially all of our assets contained in the indenture, the terms of the indenture do not contain any covenants or other provisions designed to give holders of any debt securities protection against changes in our operations, financial condition or transactions involving us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may issue the debt securities issued under the indenture as &#8220;discount securities,&#8221; which means they may be sold at a discount below their stated principal amount. These debt securities, as well as other debt securities that are not issued at a discount, may be issued with &#8220;original issue discount&#8221; &#8203;(&#8220;OID&#8221;), for U.S. federal income tax purposes because of interest payment and other characteristics or terms of the debt securities. Material U.S. federal income tax considerations applicable to debt securities issued with OID&#160;will be described in more detail in any applicable prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will describe in the applicable prospectus supplement the terms of the series of debt securities being offered, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the title of the series of debt securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any limit upon the aggregate principal amount that may be issued; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the maturity date or dates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the form of the debt securities of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the applicability of any guarantees; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether or not the debt securities will be secured or unsecured, and the terms of any secured debt; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether the debt securities rank as senior debt, senior subordinated debt, subordinated debt, or any combination thereof, and the terms of any subordination; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the price (expressed as a&#160;percentage of the aggregate principal amount thereof) at which such debt securities will be issued is a price other than the principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration of the maturity thereof, or if applicable, the portion of the principal amount of such debt securities that is convertible into another security or the method by which any such portion shall be determined; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the interest rate or rates, which may be fixed or variable, or the method for determining the rate and the date interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such dates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.29pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our right, if any, to defer payment of interest and the maximum length of any such deferral period; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable, the date or dates after which, or the period or periods during which, and the price or prices at which, we may, at our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions and the terms of those redemption provisions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the date or dates, if any, on which, and the price or prices at which we are obligated, pursuant to any mandatory sinking fund or analogous fund provisions or otherwise, to redeem, or at the holder&#8217;s option to purchase, the series of debt securities and the currency or currency unit in which the debt securities are payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the denominations in which we will issue the series of debt securities, if other than denominations of $1,000 and any integral multiple thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any and all terms, if applicable, relating to any auction or remarketing of the debt securities of that series and any security for our obligations with respect to such debt securities and any other terms which may be advisable in connection with the marketing of debt securities of that series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether the debt securities of the series shall be issued in whole or in part in the form of a global security or securities; the terms and conditions, if any, upon which such global security or securities may be exchanged in whole or in part for other individual securities; and the depositary for such global security or securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if applicable, the provisions relating to conversion or exchange of any debt securities of the series and the terms and conditions upon which such debt securities will be so convertible or exchangeable, including the conversion or exchange price, as applicable, or how it will be calculated and may be adjusted, any mandatory or optional (at our option or the holders&#8217; option) conversion or exchange features, the applicable conversion or exchange period and the manner of settlement for any conversion or exchange; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if other than the full principal amount thereof, the portion of the principal amount of debt securities of the series which shall be payable upon declaration of acceleration of the maturity thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">additions to or changes in the covenants applicable to the particular debt securities being issued, including, among others, the consolidation, merger, or sale covenant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">additions to or changes in the events of default with respect to the securities and any change in the right of the trustee or the holders to declare the principal, premium, if any, and interest, if any, with respect to such securities to be due and payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">additions to or changes in or deletions of the provisions relating to covenant defeasance and legal defeasance; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">additions to or changes in the provisions relating to satisfaction and discharge of the indenture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">additions to or changes in the provisions relating to the modification of the indenture both with and without the consent of holders of debt securities issued under the indenture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the currency of payment of debt securities if other than U.S. dollars and the manner of determining the equivalent amount in U.S. dollars; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether interest will be payable in cash or additional debt securities at our or the holders&#8217; option and the terms and conditions upon which the election may be made; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the terms and conditions, if any, upon which we will pay amounts in addition to the stated interest, premium, if any and principal amounts of the debt securities of the series to any holder that is not a &#8220;United States person&#8221; for federal tax purposes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any restrictions on transfer, sale or assignment of the debt securities of the series; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities, any other additions or changes in the provisions of the indenture, and any terms that may be required by us or advisable under applicable laws or regulations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conversion or Exchange Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will set forth in the applicable prospectus supplement the terms on which a series of debt securities may be convertible into or exchangeable for our ordinary shares or our other securities. We will include provisions as to settlement upon conversion or exchange and whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of ordinary shares or our other securities that the holders of the series of debt securities receive would be subject to adjustment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consolidation, Merger, or Sale</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the indenture will not contain any covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of our assets as an entirety or substantially as an entirety. However, any successor to or acquirer of such assets (other than a subsidiary of ours) must assume all of our obligations under the indenture or the debt securities, as appropriate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Events of Default Under the Indenture</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the following are events of default under the indenture with respect to any series of debt securities that we may issue: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if we fail to pay any installment of interest on any series of debt securities, as and when the same&#160;shall become due and payable, and such default continues for a period of 90&#160;days; provided, however, that a valid extension of an interest payment period by us in accordance with the terms of any indenture supplemental thereto shall not constitute a default in the payment of interest for this purpose; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if we fail to pay the principal of, or premium, if any, on any series of debt securities as and when the same shall become due and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment required by any sinking or analogous fund established with respect to such series; provided, however, that a valid extension of the maturity of such debt securities in accordance with the terms of any indenture supplemental thereto shall not constitute a default in the payment of principal or premium, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if we fail to observe or perform any other covenant or agreement contained in the debt securities or the indenture, other than a covenant specifically relating to another series of debt securities, and our failure continues for 90&#160;days after we receive written notice of such failure, requiring the same to be remedied and stating that such is a notice of default thereunder, from the trustee or holders of at least 25% in aggregate principal amount of the outstanding debt securities of the applicable series; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if specified events of bankruptcy, insolvency, or reorganization occur. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If an event of default with respect to debt securities of any series occurs and is continuing, other than an event of default specified in the last bullet point above, the trustee or the holders of at least 25% in aggregate principal&#160;amount of the outstanding debt securities of that series, by notice to us in writing, and to the trustee if notice is given by such holders, may declare the unpaid principal of, premium, if any, and accrued interest, if any, due and payable immediately. If an event of default specified in the last bullet point above occurs with respect to us, the principal amount of and accrued interest, if any, of each issue of debt securities then outstanding shall be due and payable without any notice or other action on the part of the trustee or any holder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The holders of a majority in principal amount of the outstanding debt securities of an affected series may waive any default or event of default with respect to the series and its consequences, except defaults or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">events of default regarding payment of principal, premium, if any, or interest, unless we have cured the default or event of default in accordance with the indenture. Any waiver shall cure the default or event of default. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the terms of the indenture, if an event of default under an indenture shall occur and be continuing, the trustee will be under no obligation to exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable series of debt securities, unless such holders have offered the trustee reasonable indemnity. The holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any trust or power conferred on the trustee, with respect to the debt securities of that series, provided that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the direction so given by the holder is not in conflict with any law or the applicable indenture; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">subject to its duties under the Trust Indenture Act, the trustee need not take any action that might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A holder of the debt securities of any series will have the right to institute a proceeding under the indenture or to appoint a receiver or trustee, or to seek other remedies only if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the holder has given written notice to the trustee of a continuing event of default with respect to that series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series have made written request; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">such holders have offered to the trustee indemnity satisfactory to it against the costs, expenses and liabilities to be incurred by the trustee in compliance with the request; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series other conflicting directions within 90&#160;days after the notice, request and offer. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These limitations do not apply to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on, the debt securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will periodically file statements with the trustee regarding our compliance with specified covenants in the indenture. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Modification of Indenture; Waiver</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and the trustee may change an indenture without the consent of any holders with respect to specific matters: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to cure any ambiguity, defect or inconsistency in the indenture or in the debt securities of any series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to comply with the provisions described above in the subsection entitled &#8220;&#8212; Consolidation, Merger, or Sale;&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to provide for uncertificated debt securities in addition to or in place of certificated debt securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to add to our covenants, restrictions, conditions or provisions such new covenants, restrictions, conditions or provisions for the benefit of the holders of all or any series of debt securities, to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or provisions an event of default or to surrender any right or power conferred upon us in the indenture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to add to, delete from or revise the conditions, limitations, and restrictions on the authorized&#160;amount, terms, or purposes of issue, authentication, and delivery of debt securities, as set forth in the indenture; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to make any change that does not adversely affect the interests of any holder of debt securities of any series in any material respect; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to provide for the issuance of and establish the form and terms and conditions of the debt securities of any series as provided above in the subsection entitled &#8220;&#8212; General&#8221; to establish the form of any certifications required to be furnished pursuant to the terms of the indenture or any series of debt securities, or to add to the rights of the holders of any series of debt securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to evidence and provide for the acceptance of appointment under any indenture by a successor trustee; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to comply with any requirements of the SEC in connection with the qualification of any indenture under the Trust Indenture Act. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the indenture, the rights of holders of a series of debt securities may be changed by us and the trustee with the written consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of each series that is affected. However, unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, we and the trustee may make the following changes only with the consent of each holder of any outstanding debt securities affected: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">extending the fixed maturity of any debt securities of any series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reducing the principal amount, reducing the rate of or extending the time of payment of interest, or reducing any premium payable upon the redemption of any series of any debt securities; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reducing the&#160;percentage of debt securities, the holders of which are required to consent to any amendment, supplement, modification or waiver. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Discharge</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each indenture provides that we can elect to be discharged from our obligations with respect to one or more series of debt securities, except for specified obligations, including obligations to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide for payment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">register the transfer or exchange of debt securities of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">replace stolen, lost or mutilated debt securities of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">pay principal of and premium and interest on any debt securities of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintain paying agencies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">hold monies for payment in trust; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">recover excess money held by the trustee; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compensate and indemnify the trustee; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">appoint any successor trustee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to exercise our rights to be discharged, we must deposit with the trustee money or government obligations sufficient to pay all the principal of, any premium, if any, and interest on, the debt securities of the series on the dates payments are due. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Form, Exchange, and Transfer</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will issue the debt securities of each series only in fully registered form without coupons and, unless we provide otherwise in the applicable prospectus supplement, in denominations of $1,000 and any integral multiple thereof. The indenture provides that we may issue debt securities of a series in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf of, The Depository Trust Company (&#8220;DTC&#8221;), or another depositary named by us and identified in the applicable prospectus supplement with respect to that series. To the extent the debt securities of a series are issued in global form and as book-entry, a description of terms relating to any book-entry securities will be set forth in the applicable prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the option of the holder, subject to the terms of the indenture and the limitations applicable to global securities described in the applicable prospectus supplement, the holder of the debt securities of any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">series can exchange the debt securities for other debt securities of the same series, in any authorized denomination and of like tenor and aggregate principal amount. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Subject to the terms of the indenture and the limitations applicable to global securities set forth in the applicable prospectus supplement, holders of the debt securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the form of transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar or at the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that the holder presents for transfer or exchange, we will impose no service charge for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will name in the applicable prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place of payment for the debt securities of each series. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we elect to redeem the debt securities of any series, we will not be required to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">issue, register the transfer of, or exchange any debt securities of that series during a period beginning at the opening of business 15&#160;days before the day of mailing of a notice of redemption of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">register the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Information Concerning the Trustee</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The trustee, other than during the occurrence and continuance of an event of default under an&#160;indenture, will undertake to perform only those duties as are specifically set forth in the applicable indenture. Upon an event of default under an indenture, the trustee must use the same degree of care as a prudent person&#160;would exercise or use in the conduct of its own affairs. Subject to this provision, the trustee is under no obligation to exercise any of the powers given it by the indenture at the request of any holder of debt securities unless it is offered reasonable security and indemnity against the costs, expenses and liabilities that it might incur. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Payment and Paying Agents</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless we otherwise indicate in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular record date for the interest.We will pay principal of and any premium and interest on the debt securities of a particular series at the office of the paying agents designated by us, except that unless we otherwise indicate in the applicable prospectus supplement, we will make interest payments by check that we will mail to the holder or by&#160;wire transfer to certain holders. Unless we otherwise indicate in the applicable prospectus supplement, we will designate the corporate trust office of the trustee as our sole paying agent for payments with respect to&#160;debt securities of each series. We will name in the applicable prospectus supplement any other paying agents that we initially designate for the debt securities of a particular series. We will maintain a paying agent in each place of payment for the debt securities of a particular series. All money we pay to a paying agent or the trustee for the payment of the principal of or any premium or interest on any debt securities that remains unclaimed at the end of two&#160;years after such principal, premium or interest has become due and payable will be repaid to us, and the holder of the debt security thereafter may look only to us for payment thereof. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Governing Law</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The indenture and the debt securities will be governed by and construed in accordance with the internal laws of the State of New York, except to the extent that the Trust Indenture Act is applicable. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTAX">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:572pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">TAXATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The material U.S. federal income tax consequences relating to the purchase, ownership and disposition of any of the securities offered by this prospectus will be set forth in the prospectus supplement pertaining to those securities. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPOD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PLAN OF DISTRIBUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may sell or distribute our securities from time to time in one or more public or private transactions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">through underwriters; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">through agents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to dealers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">directly to one or more purchasers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in &#8220;at the market&#8221; offerings, within the meaning of Rule&#160;415(a)(4) of the Securities Act, to or through a market maker or into an existing trading market on an exchange or otherwise; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in block trades; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">through a combination of any of the above; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any other method permitted pursuant to applicable law. Any sale or distribution may be effected by us: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">at market prices prevailing at the time of sale; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">at varying prices determined at the time of sale; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">at negotiated or fixed prices. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At any time a particular offer of the securities is made, a prospectus supplement, if required, will be distributed and set forth the terms of each specific offering, including the name or names of any underwriters or agents, the purchase price of the securities and the proceeds to us from such sales or distribution, any delayed delivery arrangements, any underwriting discounts and other items constituting underwriters&#8217; compensation, any initial public offering price and any discounts or concessions allowed or re-allowed or paid to dealers. Any initial public offering price and any discounts or concessions allowed or re-allowed or paid to dealers may be changed from time to time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we may distribute the securities as a dividend or in a rights offering to our existing security holders. In some cases, we or dealers acting for us or on behalf of us may also repurchase the securities and reoffer them to the public by one or more of the methods described above. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Through Underwriters</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If underwriters are used in a sale or distribution, the securities will be acquired by the underwriters for their own account and may be resold from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale. The securities may be offered to the public either through underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting as underwriters. The underwriter or underwriters with respect to a particular underwritten offering and, if an underwriting syndicate is used, the managing underwriter or underwriters will be set forth on the cover of such prospectus supplement. Unless otherwise set forth in the prospectus supplement, the underwriters will be obligated to purchase all the securities if any are purchased. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During and after an offering through underwriters, the underwriters may purchase and sell or distribute the securities in the open market. These transactions may include overallotment and stabilizing transactions and purchases to cover syndicate short positions created in connection with the offering. The underwriters also may impose a penalty bid, under which selling concessions allowed to syndicate members or other broker-dealers for the securities they sell or distribute for their account may be reclaimed by the syndicate if the syndicate repurchases the securities in stabilizing or covering transactions. These activities may stabilize, maintain or otherwise affect the market price of the securities, which may be higher than the price that might otherwise prevail in the open market, and, if commenced, may be discontinued at any time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Through Agents or to Dealers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may sell or distribute the securities directly or through agents we designate from time to time. Unless otherwise indicated in a prospectus supplement, any such agent will be acting on a best efforts basis for the period of its appointment. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:84pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If dealers are used in any of the sales or distribution of the securities covered by this prospectus, we will sell those securities to dealers as principals. The dealers may then resell the securities to the public at varying prices the dealers determine at the time of resale. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Direct Sales</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may sell or distribute the securities directly to institutional investors or others who may be deemed to be underwriters within the meaning of the Securities Act with respect to any sale thereof. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Delayed Delivery</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If so indicated in a prospectus supplement, we may authorize agents, underwriters or dealers to solicit offers from certain types of institutions to purchase the securities from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. These contracts will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set forth the commission payable for solicitation of such contracts. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Derivative Transactions and Hedging</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We and the underwriters may engage in derivative transactions involving the securities. These derivatives may consist of short sale transactions and other hedging activities. The underwriters may acquire a long or short position in the securities, hold or resell securities acquired and purchase options or futures on the securities and other derivative instruments with returns linked to or related to changes in the price of the securities. In order to facilitate these derivative transactions, we may enter into security lending or repurchase agreements with the underwriters. The underwriters may carry out the derivative transactions through sales or distributions of the securities to the public, including short sales, or by lending the securities in order to facilitate short sale transactions by others. The underwriters may also use the securities purchased or borrowed from us or others (or, in the case of derivatives, securities received from us in settlement of those derivatives) to directly or indirectly settle sales of the securities or close out any related open borrowings of the securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Loans of Securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may loan or pledge the securities to a financial institution or other third party that in turn may sell the securities using this prospectus and an applicable prospectus supplement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Agents, dealers and direct purchasers that participate in the distribution of the offered securities may be underwriters as defined in the Securities Act and any discounts or commissions they receive from us and any profit on the resale of the offered securities by them may be treated as underwriting discounts and commissions under the Securities Act. Agents, dealers and underwriters may be entitled under agreements entered into with us to indemnification by us against certain civil liabilities, including liabilities under the Securities Act, or to contribution with respect to payments which such agents, dealers or underwriters may be required to make in respect thereof. Agents, dealers and underwriters may be customers of, engage in transactions with, or perform services on our behalf. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:308pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have filed with the SEC a registration statement on Form F-3, of which this prospectus is part, with respect to the securities we will offer. This prospectus and any accompanying prospectus supplement do not contain all of the information set forth in the registration statement and the exhibits and schedules to the registration statement. For further information, we refer you to the registration statement and the exhibits and schedules filed as part of the registration statement. If a document has been filed as an exhibit to the registration statement, we refer you to the copy of the document that has been filed. Each statement in this prospectus relating to a document filed as an exhibit is qualified in all respects by the filed exhibit. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are subject to the informational requirements of the Exchange Act. Accordingly, we are required to file reports and other information with the SEC, including annual reports on Form 20-F and reports on Form&#160;6-K. The SEC maintains an internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our board members, executive officers, and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section&#160;16 of the Exchange Act. In addition, we are not required under the Exchange Act to file periodic reports and consolidated financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will send our transfer agent a copy of all notices of our general meetings of shareholders and other reports, communications and information that are made generally available to shareholders. The transfer agent has agreed to mail to all shareholders a notice containing the information (or a summary of the information) contained in any notice of a meeting of our shareholders received by the transfer agent and will make available to all shareholders such notices and all such other reports and communications received by the transfer agent. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tIBR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:120pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INCORPORATION BY REFERENCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The SEC allows us to &#8220;incorporate by reference&#8221; into this prospectus the information in documents we file with it. This means that we can disclose important information to you by referring you to those documents. Each document incorporated by reference is current only as of the date of such document, and the incorporation by reference of such documents shall not create any implication that there has been no change in our affairs since the date thereof or that the information contained therein is current as of any time subsequent to its date. The information incorporated by reference is considered to be a part of this prospectus and should be read with the same care. When we update the information contained in documents that have been incorporated by reference by making future filings with the SEC, the information incorporated by reference in this prospectus is considered to be automatically updated and superseded. In other words, in the case of a conflict or inconsistency between information contained in this prospectus and information incorporated by reference into this prospectus, you should rely on the information contained in the document that was filed later. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We incorporate by reference the documents listed below: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;"><a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1889109/000110465923040145/blte-20221231x20f.htm">our Annual Report on Form 20-F (File No. 001-41359) for the fiscal year ended December&#160;31, 2022, filed with the SEC on March&#160;31, 2023;</a> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the description of our Ordinary Shares contained in our <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922047868/tm2132809d18_8a12b.htm">registration statement on Form 8-A, filed with the SEC on April&#160;20, 2022</a>, and any amendment or report filed with the SEC for the purpose of updating the description; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">with respect to each offering of securities under this prospectus, each subsequent annual report on Form 20-F and each report of foreign private issuer on Form 6-K that indicates that it is being incorporated by reference, in each case, that we file with or furnish to the SEC on or after the date on which this registration statement is first filed with the SEC and until the termination or completion of that offering under this prospectus; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the information specifically incorporated by reference herein from our report of foreign private issuer on Form 6-K filed with the SEC on <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465923049650/tm2313536d1_6k.htm">April&#160;25, 2023</a> and <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465923058628/tm2315170d1_6k.htm">May&#160;11, 2023</a>. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless expressly incorporated by reference, nothing in this prospectus shall be deemed to incorporate by reference information furnished to, but not filed with, the SEC. Copies of all documents incorporated by reference in this prospectus, other than exhibits to those documents unless such exhibits are specially incorporated by reference in this prospectus, will be provided at no cost to each person, including any beneficial owner, who receives a copy of this prospectus on the written or oral request of that person made to: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Belite Bio, Inc </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12750 High Bluff Drive Suite 475, </font> <br ><font style="letter-spacing:0.2pt;">San Diego, CA 92130</font> <br ><font style="letter-spacing:0.2pt;">Tel: +1-858-246-6240</font> <br ><font style="letter-spacing:0.2pt;">Attention: Chief Financial Officer </font></div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tEOCL">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ENFORCEABILITY OF CIVIL LIABILITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are incorporated under the laws of the Cayman Islands as an exempted company with limited liability. We are incorporated in the Cayman Islands to take advantage of certain benefits associated with being a Cayman Islands exempted company, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">political and economic stability, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an effective judicial system, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a favorable tax system, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of foreign exchange control or currency restrictions, and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the availability of professional and support services. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, certain disadvantages accompany incorporation in the Cayman Islands. These disadvantages include but are not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Cayman Islands has a less developed body of securities laws as compared to the United States and these securities laws provide significantly less protection to investors as compared to the United States; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Cayman Islands companies may not have standing to sue before the federal courts of the United States. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Memorandum and Articles of Association does not contain provisions requiring that disputes, including those arising under the securities laws of the United States, between us, our officers, directors, and shareholders, be arbitrated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Most of our directors and officers are nationals or residents of jurisdictions other than the United States and most of their assets are located outside the United States. As a result, it may be difficult for a shareholder to effect service of process within the United States upon these individuals, or to bring an action against us or these individuals in the United States, or to enforce against us or them judgments obtained in United States courts, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States. As of the date of this prospectus, none of our officers, directors or other members of our senior management are located in China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have appointed Puglisi &amp; Associates, located at 850 Library Avenue, Suite 204, Newark, Delaware&#160;19711, as our agent upon whom process may be served in any action brought against us under the securities laws of the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Maples and Calder (Hong Kong) LLP, our counsel as to Cayman Islands law, has advised us that there is uncertainty as to whether the courts of the Cayman Islands would (a)&#160;recognize or enforce judgments of U.S. courts obtained against us or our directors or officers that are predicated upon the civil liability provisions of the federal securities laws of the United States or the securities laws of any state in the United States, or (b)&#160;entertain original actions brought in the Cayman Islands against us or our directors or officers that are predicated upon the federal securities laws of the United States or the securities laws of any state in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Maples and Calder (Hong Kong) LLP has informed us that although there is no statutory enforcement in the Cayman Islands of judgments obtained in the federal or state courts of the United States (and the Cayman Islands are not a party to any treaties for the reciprocal enforcement or recognition of such judgments), the courts of the Cayman Islands would recognize and enforce a final and conclusive judgement in personam obtained in federal or state courts in the United States under which a sum of money is payable (other than a sum of money payable in respect of multiple damages, taxes or other charges of a like nature, a fine or a penalty or similar fiscal or revenue obligations) or, in certain circumstances, an in personam judgment for non-monetary relief, and would give a judgment based thereon provided that: (a)&#160;such courts had proper jurisdiction over the parties subject to such judgment; (b)&#160;such courts did not contravene the rules of the natural justice of Cayman Islands; (c)&#160;such judgment was not obtained by fraud; (d)&#160;such judgment was not obtained in a manner, and is not of a kind the enforcement of which, is contrary to natural justice or the public policy of the Cayman Islands; (e)&#160;no new admissible evidence relevant to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:544pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">action is submitted prior to the rendering of the judgment by the courts of the Cayman Islands; and (f)&#160;there is due compliance with the correct procedures under the laws of the Cayman Islands. However, the Cayman Islands courts are unlikely to enforce a punitive judgment of a United States court predicated upon the civil liability provisions of the federal securities laws in the United States without retrial on the merits if such judgment is determined by the courts of the Cayman Islands to give rise to obligations to make payments that may be regarded as fines, penalties or punitive in nature. A Cayman Islands court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLEMA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:524pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">We are being represented by O&#8217;Melveny &amp; Myers LLP with respect to legal matters of U.S. federal securities and New York State law. The validity of the offered securities and certain other matters of Cayman Islands law will be passed upon for us by Maples and Calder (Hong Kong) LLP. Certain legal matters as to PRC law will be passed upon for us by Commerce &amp; Finance Law Offices. O&#8217;Melveny &amp; Myers LLP may rely upon Maples and Calder (Hong Kong) LLP with respect to matters governed by Cayman Islands law and may rely upon Commerce &amp; Finance Law Offices with respect to matters governed by PRC law. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tEXP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:540pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The financial statements incorporated in this Prospectus by reference to the <a style="-sec-extract:exhibit" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1889109/000110465923040145/blte-20221231x20f.htm">Annual Report on Form&#160;20-F for the year ended December&#160;31, 2022</a> have been so incorporated in reliance on the report of Marcum Asia CPAs LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The office of Marcum Asia CPAs LLP is located at 7 Penn Plaza, Suite 830, New York, NY 10001. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tOFEX">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:416pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OFFERING EXPENSES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is an estimate of the expenses that we may incur in connection with a possible offering of securities registered under this registration statement. </font>
        </div>
        <table style="width:416pt;height:115pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:358.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SEC registration fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">33,060.00 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">FINRA filing fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">500.00 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Printing expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:8pt;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:8pt;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accounting fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:8pt;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Transfer agent and trustee fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:8pt;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Miscellaneous </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:8pt;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;font-size:8pt;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">These fees are calculated based on the securities offered and the number of issuances and accordingly cannot be estimated at this time.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART II</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INFORMATION NOT REQUIRED IN PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;8.&nbsp;&nbsp;&nbsp;Indemnification of directors and officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cayman Islands law does not limit the extent to which a company&#8217;s articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated articles of association provide that we shall indemnify our directors and officers (each an indemnified person) against all actions, costs, charges, expenses, losses, and damages incurred or sustained by such indemnified person, other than by reason of such person&#8217;s own dishonesty, willful default or fraud, in or about the conduct of our company&#8217;s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions as a director or officer of our company, which is to include without prejudice to the generality of the foregoing, any costs, expenses, losses or damages incurred by such indemnified person in defending (whether successfully or otherwise) any civil proceedings concerning our company or its affairs in any court whether in the Cayman Islands or elsewhere. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the indemnification agreements, the form of which was filed as Exhibit&#160;10.4 to the Registration Statement on Form F-1, as amended (File No. 333-264134), which was declared effective by the SEC on April&#160;28, 2022, we agree to indemnify our directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being such a director or officer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;9.&nbsp;&nbsp;&nbsp;Exhibits</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The exhibits listed on the exhibit index at the end of this Registration Statement have been furnished together with this Registration Statement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;10.&nbsp;&nbsp;&nbsp;Undertakings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The undersigned registrant hereby undertakes: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: </font>
        </div>
        <div style="text-indent:60pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;to include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;to reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or any decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(3)&nbsp;&nbsp;&nbsp;to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that paragraphs (a)(i)(1), (a)(i)(2) and (a)(i)(3) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Registration Statement, or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of the Registration Statement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;To file a post-effective amendment to the Registration Statement to include any financial statements required by Item&#160;8.A of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section&#160;10(a)(3) of the Securities Act of 1933 need not be furnished, provided, that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, a post-effective amendment need not be filed to include financial statements and information required by Section&#160;10(a)(3) of the Securities Act of 1933 or Rule&#160;3-19 of Regulation&#160;S-X if such financial statements and information are contained in periodic reports filed with or furnished to the SEC by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in this Form F-3. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;each prospectus filed by the registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the Registration Statement as of the date the filed prospectus was deemed part of and included in the Registration Statement; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;each prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii)&#160;or (x)&#160;for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(vi)&nbsp;&nbsp;&nbsp;That, for the purpose of determining liability of the undersigned registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities of the undersigned registrant, the undersigned registrant undertakes that in a primary offering of its securities pursuant to this Registration Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:256pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(3)&nbsp;&nbsp;&nbsp;the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(4)&nbsp;&nbsp;&nbsp;any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:174.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT INDEX</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:332.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:36.91pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exhibit&#160;No </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:407.09pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Description </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">1.1* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:407.09pt;">
              <font style="letter-spacing:0.2pt;">Form of Underwriting Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.1** </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex3-2.htm">Third Amended and Restated Memorandum and Articles of Association, as currently in effect</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.2** </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex4-2.htm">Specimen Certificate for Ordinary Shares</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.3** </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:407.09pt;white-space:normal;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex4-3.htm">Deposit Agreement, among Belite Bio, Inc, the depositary, and the holders and beneficial owners of American Depositary Shares issued thereunder</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.4** </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex4-3.htm">Specimen American Depositary Receipt (included in Exhibit&#160;4.3)</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.5* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <font style="letter-spacing:0.2pt;">Form of Warrant </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.6* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <font style="letter-spacing:0.2pt;">Form of Overallotment Purchased Right </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.7* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <font style="letter-spacing:0.2pt;">Form of Subscription Right Agreement (including form of Right Certificate) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.8* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <font style="letter-spacing:0.2pt;">Form of Unit Agreement (including form of Unit Certificate) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.9* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <font style="letter-spacing:0.2pt;">Form of Capital Note </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">4.10</font><font style="letter-spacing:0.2pt;">&#8224;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm2316412d2_ex4-10.htm">Form of Indenture</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">5.1</font><font style="letter-spacing:0.2pt;">&#8224; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:407.09pt;white-space:normal;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm2316412d2_ex5-1.htm">Opinion of Maples and Calder (Hong Kong) LLP regarding the validity of the securities being registered</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="margin-left:5pt;letter-spacing:0.2pt;">5.2</font><font style="letter-spacing:0.2pt;">&#8224;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm2316412d2_ex5-2.htm">Opinion of O&#8217;Melveny &amp; Myers LLP</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="letter-spacing:0.2pt;">23.1&#8224; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm2316412d2_ex5-1.htm">Consent of Maples and Calder (Hong Kong) LLP (included in Exhibit&#160;5.1)</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="letter-spacing:0.2pt;">23.2&#8224; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm2316412d2_ex23-2.htm">Consent of Friedman LLP </a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="letter-spacing:0.2pt;">23.3&#8224; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm2316412d2_ex23-3.htm">Consent of Marcum Asia CPAs LLP </a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="letter-spacing:0.2pt;">23.4&#8224; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm2316412d2_ex23-4.htm">Consent of Commerce &amp; Finance Law Offices</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="letter-spacing:0.2pt;">23.5&#8224;</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm2316412d2_ex5-2.htm">Consent of O&#8217;Melveny &amp; Myers LLP (included in Exhibit 5.2)</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="letter-spacing:0.2pt;">24.1&#8224; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a href="#tSIG">Powers of Attorney (included on signature page to the registration statement)</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.91pt;">
              <font style="letter-spacing:0.2pt;">107&#8224; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:407.09pt;">
              <div style="letter-spacing:0.2pt;">
                <a style="-sec-extract:exhibit" href="tm2316412d2_ex-filingfees.htm">Filing Fee Table</a>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To be filed as an exhibit to a post-effective amendment to this Registration Statement or as an exhibit to a report of foreign private issuer on Form 6-K to be filed under the Exchange Act and incorporated herein by reference. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">**</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Previously filed with the Registration Statement on Form F-1 (File No. 333-264134), filed with the SEC on April&#160;5, 2022. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8224;</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Filed herewith.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSIG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Taipei, Taiwan, on May 22, 2023. </font>
        </div>
        <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Belite Bio, Inc</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:240pt; line-height:12pt; margin-top:11.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:11.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:260pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Yu-Hsin Lin</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="white-space:nowrap; margin-left:260pt; margin-top:2pt; width:196pt;">
          <div style="margin-left: 0pt; width: 196pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:260pt; margin-top:1.51pt; width:196pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Name: &#8201;Yu-Hsin Lin</font>
          <br >
          <font style="letter-spacing:0.2pt;">Title: &nbsp;&nbsp;&nbsp;Chief Executive Officer </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">POWER OF ATTORNEY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each person whose signature appears below constitutes and appoints each of Yu-Hsin Lin and Hao- Yuan Chuang as attorneys-in-fact with full power of substitution for him or her in any and all capacities to do any and all acts and all things and to execute any and all instruments which said attorney and agent may deem necessary or desirable to enable the registrant to comply with the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and any rules, regulations and requirements of the Securities and Exchange Commission thereunder, in connection with this Registration Statement, including, without limitation, the power and authority to sign the name of each of the undersigned in the capacities indicated below to this Registration Statement to be filed with the Securities and Exchange Commission, to any and all amendments or supplements to such Registration Statement, whether such amendments or supplements are filed before or after the effective date of such Registration Statement, and to any and all instruments or documents filed as part of or in connection with such Registration Statement or any and all amendments thereto, whether such amendments are filed before or after the effective date of such Registration Statement; and each of the undersigned hereby ratifies and confirms all that such attorney and agent shall do or cause to be done by virtue hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated: </font>
        </div>
        <table style="width:456pt;height:295.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:132pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Signature and Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:204pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Title </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:96pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:41.25pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:13.917pt 0pt 0.5pt 0pt; width:132pt;text-align:left;vertical-align:top;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Yu-Hsin Lin</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 132pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Yu-Hsin Lin </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:13.917pt 0pt 0.5pt 0pt; width:204pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Chief Executive Officer, Chairman of the Board of Directors (Principal Executive Officer) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:13.917pt 0pt 0.5pt 0pt; width:96pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">May 22, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:41pt; white-space:nowrap;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:132pt;white-space:normal;text-align:left;vertical-align:top;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Wan-Shan Chen</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 132pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Wan-Shan Chen </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:204pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">May 22, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:41pt; white-space:nowrap;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:132pt;white-space:normal;text-align:left;vertical-align:top;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Hung-Wei Chen</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 132pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Hung-Wei Chen </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:204pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">May 22, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:41pt; white-space:normal;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:132pt;text-align:left;vertical-align:top;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Hao-Yuan Chuang</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 132pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Hao-Yuan Chuang </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:204pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Chief Financial Officer, Director (Principal Financial and Accounting Officer) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:96pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">May 22, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:41pt; white-space:nowrap;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:132pt;white-space:normal;text-align:left;vertical-align:top;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ John M. Longo</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 132pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">John M. Longo </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:204pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">May 22, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:41pt; white-space:nowrap;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:132pt;white-space:normal;text-align:left;vertical-align:top;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Ita Lu</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 132pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Ita Lu </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:204pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">May 22, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:12pt;white-space:nowrap;text-align:center;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:132pt;white-space:normal;text-align:left;vertical-align:top;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Gary C. Biddle</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 132pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Gary C. Biddle </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:204pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Director </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">May 22, 2023</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:490pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Belite Bio, Inc has signed this registration statement on May 22, 2023. </font>
        </div>
        <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Authorized U.S. Representative </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Puglisi &amp; Associates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:240pt; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:260pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Donald J. Puglisi</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="white-space:nowrap; margin-left:260pt; margin-top:2.5pt; width:196pt;">
          <div style="margin-left: 0pt; width: 196pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:260pt; margin-top:2pt; width:196pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: &#8201;Donald J. Puglisi </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title:&nbsp;&nbsp;&nbsp;Managing Director</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.10
<SEQUENCE>2
<FILENAME>tm2316412d2_ex4-10.htm
<DESCRIPTION>EXHIBIT 4.10
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.10</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Belite Bio,&nbsp;Inc,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[TRUSTEE],</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Trustee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDENTURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dated
as of [</B></FONT>&#9679;<B>], 20__</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>T</B></FONT><B><FONT STYLE="font-size: 10pt">ABLE
</FONT>O<FONT STYLE="font-size: 10pt">F</FONT> C<FONT STYLE="font-size: 10pt">ONTENTS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 80%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>P</B></FONT><B><FONT STYLE="font-size: 10pt">AGE</FONT></B></TD>
    </TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;1 DEFINITIONS</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions of Terms</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designation and Terms of Securities</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;of Securities and Trustee&#8217;s Certificate</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">6</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.03</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominations: Provisions for Payment</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">6</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.04</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Execution and Authentications</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.05</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration of Transfer and Exchange</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.06</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temporary Securities</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>9</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.07</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mutilated, Destroyed, Lost or Stolen Securities</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.08</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancellation</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>9</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.09</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benefits of Indenture</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.10</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authenticating Agent</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.11</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global Securities</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.12</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CUSIP Numbers</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;3 REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of Redemption</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.03</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment Upon Redemption</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.04</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sinking Fund</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.05</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Satisfaction of Sinking Fund Payments with Securities</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.06</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption of Securities for Sinking Fund</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;4 COVENANTS</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of Principal, Premium and Interest</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintenance of Office or Agency</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.03</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paying Agents</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.04</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment to Fill Vacancy in Office of Trustee</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>T</B></FONT><B><FONT STYLE="font-size: 10pt">ABLE
</FONT>O<FONT STYLE="font-size: 10pt">F</FONT> C<FONT STYLE="font-size: 10pt">ONTENTS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(</B></FONT><B><FONT STYLE="font-size: 10pt">CONTINUED</FONT>)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 80%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>P</B></FONT><B><FONT STYLE="font-size: 10pt">AGE</FONT></B></TD>
    </TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;5 SECURITYHOLDERS&#8217; LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company to Furnish Trustee Names and Addresses of Securityholders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preservation Of Information; Communications With Securityholders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.03</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reports by the Company</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.04</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reports by the Trustee</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;6 REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Events of Default</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collection of Indebtedness and Suits for Enforcement by Trustee</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">17<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.03</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application of Moneys Collected</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.04</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitation on Suits</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.05</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights and Remedies Cumulative; Delay or Omission Not Waiver</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.06</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Control by Securityholders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.07</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Undertaking to Pay Costs</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;7 CONCERNING THE TRUSTEE</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Duties and Responsibilities of Trustee</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Rights of Trustee</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.03</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee Not Responsible for Recitals or Issuance or Securities</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.04</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;Hold Securities</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.05</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moneys Held in Trust</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.06</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation and Reimbursement</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.07</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reliance on Officer&#8217;s Certificate</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.08</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disqualification; Conflicting Interests</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.09</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Trustee Required; Eligibility</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.10</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignation and Removal; Appointment of Successor</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.11</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acceptance of Appointment By Successor</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.12</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger, Conversion, Consolidation or Succession to Business</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>T</B></FONT><B><FONT STYLE="font-size: 10pt">ABLE
</FONT>O<FONT STYLE="font-size: 10pt">F</FONT> C<FONT STYLE="font-size: 10pt">ONTENTS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(</B></FONT><B><FONT STYLE="font-size: 10pt">CONTINUED</FONT>)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 15%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>P</B></FONT><B><FONT STYLE="font-size: 10pt">AGE</FONT></B></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.13</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferential Collection
    of Claims Against the Company</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.14</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of Default</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;8
    CONCERNING THE SECURITYHOLDERS</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evidence of Action by
    Securityholders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">26</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proof of Execution by
    Securityholders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">26</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.03</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Who May&nbsp;be Deemed
    Owners</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">26</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.04</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Securities Owned
    by Company Disregarded</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">26</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.05</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actions Binding on Future
    Securityholders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">27</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;9
    SUPPLEMENTAL INDENTURES</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">27</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental Indentures
    Without the Consent of Securityholders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">27</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental Indentures
    With Consent of Securityholders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.03</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of Supplemental
    Indentures</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.04</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Affected
    by Supplemental Indentures</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.05</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Execution of Supplemental
    Indentures</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;10
    SUCCESSOR ENTITY</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">29</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company May&nbsp;Consolidate,
    Etc.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">29</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successor Entity Substituted</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;11
    SATISFACTION AND DISCHARGE</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">30</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Satisfaction and Discharge
    of Indenture</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">30</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discharge of Obligations</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">30</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.03</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposited Moneys to
    be Held in Trust</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">30</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.04</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of Moneys Held
    by Paying Agents</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">30</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.05</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment to Company</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">30</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;12
    IMMUNITY OF INCORPORATORS, SHAREHOLDERS, OFFICERS AND DIRECTORS</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">31</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Recourse</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD>
    </TR>

<TR>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;13
    MISCELLANEOUS PROVISIONS</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">31</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.01</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect on Successors
    and Assigns</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">31</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.02</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actions by Successor</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">31</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.03</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surrender of Company
    Powers</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">31</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>T</B></FONT><B><FONT STYLE="font-size: 10pt">ABLE
</FONT>O<FONT STYLE="font-size: 10pt">F</FONT> C<FONT STYLE="font-size: 10pt">ONTENTS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(</B></FONT><B><FONT STYLE="font-size: 10pt">CONTINUED</FONT>)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 15%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>P</B></FONT><B><FONT STYLE="font-size: 10pt">AGE</FONT></B></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.04</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">31</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.05</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing Law; Jury
    Trial Waiver</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.06</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment of Securities
    as Debt</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">32</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.07</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificates and Opinions
    as to Conditions Precedent</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">32</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.08</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments on Business
    Days</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">32</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.09</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conflict with Trust
    Indenture Act</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">32</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.10</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">33</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.11</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separability</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">33</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.12</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance Certificates</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">33</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.13</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patriot Act</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">33</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.14</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Force Majeure</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">33</FONT></TD>
    </TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.12</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table of Contents; Headings</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">33</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDENTURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I</B></FONT><B><FONT STYLE="font-size: 10pt">NDENTURE</FONT></B>,
dated as of [&#9679;], 20__, among Belite Bio,&nbsp;Inc,<B>&nbsp;</B>a Cayman Islands exempted company (the &#8220;Company&#8221;), and
[<B>T<FONT STYLE="font-size: 10pt">RUSTEE</FONT></B>], as trustee (the &#8220;Trustee&#8221;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>W</B></FONT><B><FONT STYLE="font-size: 10pt">HEREAS</FONT></B>,
for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance
of debt securities (hereinafter referred to as the &#8220;Securities&#8221;), in an unlimited aggregate principal amount to be issued
from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by
the certificate of the Trustee;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>W</B></FONT><B><FONT STYLE="font-size: 10pt">HEREAS</FONT></B>,
to provide the terms and conditions upon which the Securities are to be authenticated, issued and delivered, the Company has duly authorized
the execution of this Indenture; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>W</B></FONT><B><FONT STYLE="font-size: 10pt">HEREAS</FONT></B>,
all things necessary to make this Indenture a valid agreement of the Company, in accordance with its terms, have been done.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>N</B></FONT><B><FONT STYLE="font-size: 10pt">OW</FONT>,
T<FONT STYLE="font-size: 10pt">HEREFORE</FONT></B>, in consideration of the premises and the purchase of the Securities by the holders
thereof, it is mutually covenanted and agreed as follows for the equal and ratable benefit of the holders of Securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;1.01
Definitions of Terms</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The terms defined in this Section&nbsp;(except
as in this Indenture or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires) for all
purposes of this Indenture and of any indenture supplemental hereto shall have the respective meanings specified in this Section&nbsp;and
shall include the plural as well as the singular. All other terms used in this Indenture that are defined in the Trust Indenture Act of
1939, as amended, or that are by reference in such Act defined in the Securities Act of 1933, as amended (except as herein or any indenture
supplemental hereto otherwise expressly provided or unless the context otherwise requires), shall have the meanings assigned to such terms
in said Trust Indenture Act and in said Securities Act as in force at the date of the execution of this instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Authenticating Agent</I></B>&#8221;
means the Trustee or an authenticating agent with respect to all or any of the series of Securities appointed by the Trustee pursuant
to Section&nbsp;2.10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Bankruptcy Law</I></B>&#8221; means
Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Board of Directors</I></B>&#8221;
means the Board of Directors (or the functional equivalent thereof) of the Company or any duly authorized committee of such Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Board Resolution</I></B>&#8221; means
a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors
(or duly authorized committee thereof) and to be in full force and effect on the date of such certification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Business Day</I></B>&#8221; means,
with respect to any series of Securities, any day other than a day on which federal or state banking institutions in the Borough of Manhattan,
the City of New York, or in the city of the Corporate Trust Office of the Trustee, are authorized or obligated by law, executive order
or regulation to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Commission</I></B>&#8221; means the
Securities and Exchange Commission, as from time to time constituted, created under the Exchange Act, or, if at any time after the execution
of this instrument such Commission is not existing and performing the duties now assigned to it under the Trust Indenture Act, then the
body performing such duties at such time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Company</I></B>&#8221; means Belite
Bio,&nbsp;Inc, an exempted company duly organized and existing under the laws of the Cayman Islands, and, subject to the provisions of
Article&nbsp;Ten, shall also include its successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Corporate Trust Office</I></B>&#8221;
means the office of the Trustee at which, at any particular time, its corporate trust business shall be principally administered, which
office at the date hereof is located at <U>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Custodian</I></B>&#8221; means any
receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Defaulted Interest</I></B>&#8221;
has the meaning set forth in Section&nbsp;2.03.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Depositary</I></B>&#8221; means,
with respect to Securities of any series for which the Company shall determine that such Securities will be issued as a Global Security,
The Depository Trust Company, another clearing agency, or any successor registered as a clearing agency under the Exchange Act, or other
applicable statute or regulation, which, in each case, shall be designated by the Company pursuant to either Section&nbsp;2.01 or 2.11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Event of Default</I></B>&#8221; means,
with respect to Securities of a particular series, any event specified in Section&nbsp;6.01, continued for the period of time, if any,
therein designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Exchange Act</I></B>&#8221; means
the United States Securities and Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated by the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The term &#8220;<B><I>given</I></B>&#8221;, &#8220;<B><I>mailed</I></B>&#8221;,
 &#8220;<B><I>notify</I></B>&#8221; or &#8220;<B><I>sent</I></B>&#8221; with respect to any notice to be given to a Securityholder pursuant
to this Indenture, shall mean notice (x)&nbsp;given to the Depositary (or its designee) pursuant to the standing instructions from the
Depositary or its designee, including by electronic mail in accordance with accepted practices or procedures at the Depositary (in the
case of a Global Security) or (y)&nbsp;mailed to such Securityholder by first class mail, postage prepaid, at its address as it appears
on the Security Register (in the case of a definitive Security). Notice so &#8220;given&#8221; shall be deemed to include any notice to
be &#8220;mailed&#8221; or &#8220;delivered,&#8221; as applicable, under this Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Global Security</I></B>&#8221; means
a Security issued to evidence all or a part of any series of Securities which is executed by the Company and authenticated and delivered
by the Trustee to the Depositary or pursuant to the Depositary&#8217;s instruction, all in accordance with the Indenture, which shall
be registered in the name of the Depositary or its nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Governmental Obligations</I></B>&#8221;
means securities that are (a)&nbsp;direct obligations of the United States of America for the payment of which its full faith and credit
is pledged or (b)&nbsp;obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States
of America, the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America that,
in either case, are not callable or redeemable at the option of the issuer thereof at any time prior to the stated maturity of the Securities,
and shall also include a depositary receipt issued by a bank or trust company as custodian with respect to any such Governmental Obligation
or a specific payment of principal of or interest on any such Governmental Obligation held by such custodian for the account of the holder
of such depositary receipt; provided, however, that (except as required by law) such custodian is not authorized to make any deduction
from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the Governmental
Obligation or the specific payment of principal of or interest on the Governmental Obligation evidenced by such depositary receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>herein</I></B>&#8221;, &#8220;<B><I>hereof</I>&#8221;</B>
and &#8220;<B><I>hereunder</I></B>&#8221;, and other words of similar import, refer to this Indenture as a whole and not to any particular
Article, Section&nbsp;or other subdivision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Indenture</I></B>&#8221; means this
instrument as originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental hereto
entered into in accordance with the terms hereof and shall include the terms of particular series of Securities established as contemplated
by Section&nbsp;2.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Interest Payment Date</I></B>&#8221;,
when used with respect to any installment of interest on a Security of a particular series, means the date specified in such Security
or in a Board Resolution or in an indenture supplemental hereto with respect to such series as the fixed date on which an installment
of interest with respect to Securities of that series is due and payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Officer</I></B>&#8221; means, with
respect to the Company, the chairman of the Board of Directors, a chief executive officer, a president, a chief financial officer, a chief
operating officer, any executive vice president, any senior vice president, any vice president, the treasurer or any assistant treasurer,
the controller or any assistant controller or the secretary or any assistant secretary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Officer&#8217;s Certificate</I></B>&#8221;
means a certificate signed by any Officer. Each such certificate shall include the statements provided for in Section&nbsp;13.07, if and
to the extent required by the provisions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Opinion of Counsel</I></B>&#8221;
means an opinion in writing subject to customary exceptions of legal counsel, who may be an employee of or counsel for the Company, that
is delivered to the Trustee in accordance with the terms hereof. Each such opinion shall include the statements provided for in Section&nbsp;13.07,
if and to the extent required by the provisions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Outstanding</I></B>&#8221;,
when used with reference to Securities of any series, means, subject to the provisions of Section&nbsp;8.04, as of any particular
time, all Securities of that series theretofore authenticated and delivered by the Trustee under this Indenture, except
(a)&nbsp;Securities theretofore canceled by the Trustee or any paying agent, or delivered to the Trustee or any paying agent for
cancellation or that have previously been canceled; (b)&nbsp;Securities or portions thereof for the payment or redemption of which
moneys or Governmental Obligations in the necessary amount shall have been deposited in trust with the Trustee or with any paying
agent (other than the Company) or shall have been set aside and segregated in trust by the Company (if the Company shall act as its
own paying agent); provided, however, that if such Securities or portions of such Securities are to be redeemed prior to the
maturity thereof, notice of such redemption shall have been given as provided in Article&nbsp;Three, or provision satisfactory to
the Trustee shall have been made for giving such notice; and (c)&nbsp;Securities in lieu of or in substitution for which other
Securities shall have been authenticated and delivered pursuant to the terms of Section&nbsp;2.07.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Person</I></B>&#8221; means any individual,
corporation, partnership, joint venture, joint-stock company, limited liability company, association, trust, unincorporated organization,
any other entity or organization, including a government or political subdivision or an agency or instrumentality thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Predecessor Security</I></B>&#8221;
of any particular Security means every previous Security evidencing all or a portion of the same debt as that evidenced by such particular
Security; and, for the purposes of this definition, any Security authenticated and delivered under Section&nbsp;2.07 in lieu of a lost,
destroyed or stolen Security shall be deemed to evidence the same debt as the lost, destroyed or stolen Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Responsible Officer</I></B>&#8221;
when used with respect to the Trustee means any officer within the Corporate Trust Office of the Trustee (or any successor group of the
Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated
officers and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred because
of his or her knowledge of and familiarity with the particular subject and in each case who shall have direct responsibility for the administration
of this Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Securities</I></B>&#8221; has the
meaning stated in the first recital of this Indenture and more particularly means any Securities authenticated and delivered under this
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Securities Act</I></B>&#8221; means
the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Securityholder</I></B>&#8221;, &#8220;<B><I>holder
of Securities</I></B>&#8221;, &#8220;<B><I>registered holder</I></B>&#8221;, or other similar term, means the Person or Persons in whose
name or names a particular Security is registered on the Security Register kept for that purpose in accordance with the terms of this
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Security Register</I></B>&#8221;
and &#8220;<B><I>Security Registrar</I></B>&#8221; shall have the meanings as set forth in Section&nbsp;2.05.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Subsidiary</I></B>&#8221; means,
with respect to any Person, any corporation, association, partnership or other business entity of which more than 50% of the total voting
power of shares of capital stock or other interests (including partnership interests) entitled (without regard to the occurrence of any
contingency) to vote in the election of directors, managers, general partners or trustees thereof is at the time owned or controlled,
directly or indirectly, by (i)&nbsp;such Person; (ii)&nbsp;such Person and one or more Subsidiaries of such Person; or (iii)&nbsp;one
or more Subsidiaries of such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Trustee</I></B>&#8221; means <U>[</U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>]</U>,
and, subject to the provisions of Article&nbsp;Seven, shall also include its successors and assigns, and, if at any time there is more
than one Person acting in such capacity hereunder, &#8220;Trustee&#8221; shall mean each such Person. The term &#8220;Trustee&#8221; as
used with respect to a particular series of the Securities shall mean the trustee with respect to that series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<B><I>Trust Indenture Act</I></B>&#8221;
means the Trust Indenture Act of 1939, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&#8220;U.S.A.
Patriot Act&#8221;</I></B></FONT> means the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and
Obstruct Terrorism Act of 2001, Pub. L. 107-56, as amended and signed into law October&nbsp;26, 2001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION
AND EXCHANGE OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.01
Designation and Terms of Securities</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>The
aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited. The Securities may
be issued in one or more series up to the aggregate principal amount of Securities of that series from time to time authorized by or pursuant
to a Board Resolution or pursuant to one or more indentures supplemental hereto. Prior to the initial issuance of Securities of any series,
there shall be established in or pursuant to a Board Resolution, and set forth in an Officer&#8217;s Certificate, or established in one
or more indentures supplemental hereto:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(1)&nbsp;</B></FONT>the
title of the Securities of the series (which shall distinguish the Securities of that series from all other Securities);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(2)&nbsp;</B></FONT>any
limit upon the aggregate principal amount of the Securities of that series that may be authenticated and delivered under this Indenture
(except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities
of that series);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(3)&nbsp;</B></FONT>the
maturity date or dates on which the principal of the Securities of the series is payable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(4)&nbsp;</B></FONT>the
form of the Securities of the series including the form of the certificate of authentication for such series;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(5)&nbsp;</B></FONT>the
applicability of any guarantees;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(6)&nbsp;</B></FONT>whether
or not the Securities will be secured or unsecured, and the terms of any secured debt;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(7)&nbsp;</B></FONT>whether
the Securities rank as senior debt, senior subordinated debt, subordinated debt or any combination thereof, and the terms of any subordination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(8)&nbsp;</B></FONT>if
the price (expressed as a percentage of the aggregate principal amount thereof) at which such Securities will be issued is a price other
than the principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration of the maturity
thereof, or if applicable, the portion of the principal amount of such Securities that is convertible into another security or the method
by which any such portion shall be determined;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(9)&nbsp;</B></FONT>the
interest rate or rates, which may be fixed or variable, or the method for determining the rate and the date interest will begin to accrue,
the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such dates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(10)&nbsp;</B></FONT>the
Company&#8217;s right, if any, to defer the payment of interest and the maximum length of any such deferral period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(11)
</B></FONT>if applicable, the date or dates after which, or the period or periods during which, and the price or prices at which, the
Company may at its option, redeem the series of Securities pursuant to any optional or provisional redemption provisions and the terms
of those redemption provisions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(12)
</B></FONT>the date or dates, if any, on which, and the price or prices at which the Company is obligated, pursuant to any mandatory sinking
fund or analogous fund provisions or otherwise, to redeem, or at the Securityholder&#8217;s option to purchase, the series of Securities
and the currency or currency unit in which the Securities are payable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(13)
</B></FONT>the denominations in which the Securities of the series shall be issuable, if other than denominations of one thousand U.S.
dollars ($1,000) or any integral multiple thereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(14)
</B></FONT>any and all terms, if applicable, relating to any auction or remarketing of the Securities of that series and any security
for the obligations of the Company with respect to such Securities and any other terms which may be advisable in connection with the marketing
of Securities of that series;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(15)
</B></FONT>whether the Securities of the series shall be issued in whole or in part in the form of a Global Security or Securities; the
terms and conditions, if any, upon which such Global Security or Securities may be exchanged in whole or in part for other individual
Securities; and the Depositary for such Global Security or Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(16)
</B></FONT>if applicable, the provisions relating to conversion or exchange of any Securities of the series and the terms and conditions
upon which such Securities will be so convertible or exchangeable, including the conversion or exchange price, as applicable, or how it
will be calculated and may be adjusted, any mandatory or optional (at the Company&#8217;s option or the holders&#8217; option) conversion
or exchange features, the applicable conversion or exchange period and the manner of settlement for any conversion or exchange, which
may, without limitation, include the payment of cash as well as the delivery of securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(17)
</B></FONT>if other than the full principal amount thereof, the portion of the principal amount of Securities of the series which shall
be payable upon declaration of acceleration of the maturity thereof pursuant to Section&nbsp;6.01;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(18)
</B></FONT>additions to or changes in the covenants applicable to the series of Securities being issued, including, among others, the
consolidation, merger or sale covenant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(19)
</B></FONT>additions to or changes in the Events of Default with respect to the Securities and any change in the right of the Trustee
or the Securityholders to declare the principal, premium, if any, and interest, if any, with respect to such Securities to be due and
payable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(20)
</B></FONT>additions to or changes in or deletions of the provisions relating to covenant defeasance and legal defeasance;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(21)
</B></FONT>additions to or changes in the provisions relating to satisfaction and discharge of this Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(22)
</B></FONT>additions to or changes in the provisions relating to the modification of this Indenture both with and without the consent
of Securityholders of Securities issued under this Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(23)
</B></FONT>the currency of payment of Securities if other than U.S. dollars and the manner of determining the equivalent amount in U.S.
dollars;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(24)
</B></FONT>whether interest will be payable in cash or additional Securities at the Company&#8217;s or the Securityholders&#8217; option
and the terms and conditions upon which the election may be made;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(25)
</B></FONT>the terms and conditions, if any, upon which the Company shall pay amounts in addition to the stated interest, premium, if
any and principal amounts of the Securities of the series to any Securityholder that is not a &#8220;United States person&#8221; for federal
tax purposes;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(26)
</B></FONT>any restrictions on transfer, sale or assignment of the Securities of the series;<B>&nbsp;</B>and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(27)
</B></FONT>any other specific terms, preferences, rights or limitations of, or restrictions on, the Securities, any other additions or
changes in the provisions of this Indenture, and any terms that may be required by us or advisable under applicable laws or regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All Securities of any one series shall be substantially
identical except as may otherwise be provided in or pursuant to any such Board Resolution or in any indentures supplemental hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If any of the terms of the series are established
by action taken pursuant to a Board Resolution of the Company, a copy of an appropriate record of such action shall be certified by the
secretary or an assistant secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officer&#8217;s Certificate
of the Company setting forth the terms of the series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Securities of any particular series may be issued
at various times, with different dates on which the principal or any installment of principal is payable, with different rates of interest,
if any, or different methods by which rates of interest may be determined, with different dates on which such interest may be payable
and with different redemption dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.02
Form&nbsp;of Securities and Trustee&#8217;s Certificate</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Securities of any series and the Trustee&#8217;s
certificate of authentication to be borne by such Securities shall be substantially of the tenor and purport as set forth in one or more
indentures supplemental hereto or as provided in a Board Resolution, and set forth in an Officer&#8217;s Certificate, and they may have
such letters, numbers or other marks of identification or designation and such legends or endorsements printed, lithographed or engraved
thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as may be required to
comply with any law or with any rule&nbsp;or regulation made pursuant thereto or with any rule&nbsp;or regulation of any securities exchange
on which Securities of that series may be listed, or to conform to usage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.03
Denominations: Provisions for Payment</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Securities shall be issuable as registered
Securities and in the denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, subject to Section&nbsp;2.01(a)(13).
The Securities of a particular series shall bear interest payable on the dates and at the rate specified with respect to that series.
Subject to Section&nbsp;2.01(a)(23), the principal of and the interest on the Securities of any series, as well as any premium thereon
in case of redemption or repurchase thereof prior to maturity, and any cash amount due upon conversion or exchange thereof, shall be payable
in the coin or currency of the United States of America that at the time is legal tender for public and private debt, at the office or
agency of the Company maintained for that purpose. Each Security shall be dated the date of its authentication. Interest on the Securities
shall be computed on the basis of a 360-day year composed of twelve 30-day months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The interest installment on any Security that
is payable, and is punctually paid or duly provided for, on any Interest Payment Date for Securities of that series shall be paid to the
Person in whose name said Security (or one or more Predecessor Securities) is registered at the close of business on the regular record
date for such interest installment. In the event that any Security of a particular series or portion thereof is called for redemption
and the redemption date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such Interest Payment
Date, interest on such Security will be paid upon presentation and surrender of such Security as provided in Section&nbsp;3.03.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any interest on any Security that is payable,
but is not punctually paid or duly provided for, on any Interest Payment Date for Securities of the same series (herein called &#8220;Defaulted
Interest&#8221;) shall forthwith cease to be payable to the registered holder on the relevant regular record date by virtue of having
been such holder; and such Defaulted Interest shall be paid by the Company, at its election, as provided in clause (1)&nbsp;or clause
(2)&nbsp;below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(1)&nbsp;</B></FONT>The
Company may make payment of any Defaulted Interest on Securities to the Persons in whose names such Securities (or their respective Predecessor
Securities) are registered in the Security Register at the close of business on a special record date for the payment of such Defaulted
Interest, which shall be fixed in the following manner: the Company shall notify the Trustee in writing of the amount of Defaulted Interest
proposed to be paid on each such Security and the date of the proposed payment, and at the same time the Company shall deposit with the
Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements
satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to be held in trust
for the benefit of the Persons entitled to such Defaulted Interest as in this clause provided. Thereupon the Trustee shall fix a special
record date for the payment of such Defaulted Interest which shall not be more than 15 nor less than 10 days prior to the date of the
proposed payment and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly
notify the Company of such special record date and, in the name and at the expense of the Company, shall cause notice of the proposed
payment of such Defaulted Interest and the special record date therefor to be sent, to each Securityholder not less than 10 days prior
to such special record date. Notice of the proposed payment of such Defaulted Interest and the special record date therefor having been
sent as aforesaid, such Defaulted Interest shall be paid to the Persons in whose names such Securities (or their respective Predecessor
Securities) are registered in the Security Register on such special record date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(2)&nbsp;</B></FONT>The
Company may make payment of any Defaulted Interest on any Securities in any other lawful manner not inconsistent with the requirements
of any securities exchange on which such Securities may be listed, and upon such notice as may be required by such exchange, if, after
notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable
by the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Unless otherwise set forth in a Board Resolution
or one or more indentures supplemental hereto establishing the terms of any series of Securities pursuant to Section&nbsp;2.01 hereof,
the term &#8220;regular record date&#8221; as used in this Section&nbsp;with respect to a series of Securities and any Interest Payment
Date for such series shall mean either the fifteenth day of the month immediately preceding the month in which an Interest Payment Date
established for such series pursuant to Section&nbsp;2.01 hereof shall occur, if such Interest Payment Date is the first day of a month,
or the first day of the month in which an Interest Payment Date established for such series pursuant to Section&nbsp;2.01 hereof shall
occur, if such Interest Payment Date is the fifteenth day of a month, whether or not such date is a Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to the foregoing provisions of this Section,
each Security of a series delivered under this Indenture upon transfer of or in exchange for or in lieu of any other Security of such
series shall carry the rights to interest accrued and unpaid, and to accrue, that were carried by such other Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.04
Execution and Authentications</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Securities shall be signed on behalf of the
Company by one of its Officers. Signatures may be in the form of a manual or facsimile signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company may use the facsimile signature of
any Person who shall have been an Officer (at the time of execution), notwithstanding the fact that at the time the Securities shall be
authenticated and delivered or disposed of such Person shall have ceased to be such an officer of the Company. The Securities may contain
such notations, legends or endorsements required by law, stock exchange rule&nbsp;or usage. Each Security shall be dated the date of its
authentication by the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A Security shall not be valid until authenticated
manually by an authorized signatory of the Trustee, or by an Authenticating Agent. Such signature shall be conclusive evidence that the
Security so authenticated has been duly authenticated and delivered hereunder and that the holder is entitled to the benefits of this
Indenture. At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities of
any series executed by the Company to the Trustee for authentication, together with a written order of the Company for the authentication
and delivery of such Securities, signed by an Officer, and the Trustee in accordance with such written order shall authenticate and deliver
such Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon the Company&#8217;s delivery of any such
authentication order to the Trustee at any time after the initial issuance of Securities under this Indenture, the Trustee shall be provided
with, and (subject to Sections 315(a)&nbsp;through 315(d)&nbsp;of the Trust Indenture Act) shall be fully protected in relying upon, (1)&nbsp;an
Opinion of Counsel or reliance letter and (2)&nbsp;an Officer&#8217;s Certificate stating that all conditions precedent to the execution,
authentication and delivery of such Securities are in conformity with the provisions of this Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Trustee shall not be required to authenticate
such Securities if the issue of such Securities pursuant to this Indenture will affect the Trustee&#8217;s own rights, duties or immunities
under the Securities and this Indenture or otherwise in a manner that is not reasonably acceptable to the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.05
Registration of Transfer and Exchange</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>Securities
of any series may be exchanged upon presentation thereof at the office or agency of the Company designated for such purpose, for other
Securities of such series of authorized denominations, and for a like aggregate principal amount, upon payment of a sum sufficient to
cover any tax or other governmental charge in relation thereto, all as provided in this Section. In respect of any Securities so surrendered
for exchange, the Company shall execute, the Trustee shall authenticate and such office or agency shall deliver in exchange therefor the
Security or Securities of the same series that the Securityholder making the exchange shall be entitled to receive, bearing numbers not
contemporaneously outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>The
Company shall keep, or cause to be kept, at its office or agency designated for such purpose a register or registers (herein referred
to as the &#8220;Security Register&#8221;) in which, subject to such reasonable regulations as it may prescribe, the Company shall register
the Securities and the transfers of Securities as in this Article&nbsp;provided and which at all reasonable times shall be open for inspection
by the Trustee. The registrar for the purpose of registering Securities and transfer of Securities as herein provided shall be appointed
as authorized by Board Resolution or Supplemental Indenture (the &#8220;Security Registrar&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon surrender for transfer of any Security at
the office or agency of the Company designated for such purpose, the Company shall execute, the Trustee shall authenticate and such office
or agency shall deliver in the name of the transferee or transferees a new Security or Securities of the same series as the Security presented
for a like aggregate principal amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company initially appoints the Trustee as
Security Registrar for each series of Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All Securities presented or surrendered for exchange
or registration of transfer, as provided in this Section, shall be accompanied (if so required by the Company or the Security Registrar)
by a written instrument or instruments of transfer, in form satisfactory to the Company or the Security Registrar, duly executed by the
registered holder or by such holder&#8217;s duly authorized attorney in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>Except
as provided pursuant to Section&nbsp;2.01 pursuant to a Board Resolution, and set forth in an Officer&#8217;s Certificate, or established
in one or more indentures supplemental to this Indenture, no service charge shall be made for any exchange or registration of transfer
of Securities, or issue of new Securities in case of partial redemption of any series or repurchase, conversion or exchange of less than
the entire principal amount of a Security, but the Company may require payment of a sum sufficient to cover any tax or other governmental
charge in relation thereto, other than exchanges pursuant to Section&nbsp;2.06, Section&nbsp;3.03(b)&nbsp;and Section&nbsp;9.04 not involving
any transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;</B></FONT>The
Company and the Security Registrar shall not be required (i)&nbsp;to issue, exchange or register the transfer of any Securities during
a period beginning at the opening of business 15 days before the day of the sending of a notice of redemption of less than all the Outstanding
Securities of the same series and ending at the close of business on the day of such sending, nor (ii)&nbsp;to register the transfer of
or exchange any Securities of any series or portions thereof called for redemption or surrendered for repurchase, but not validly withdrawn,
other than the unredeemed portion of any such Securities being redeemed in part or not surrendered for repurchase, as the case may be.
The provisions of this Section&nbsp;2.05 are, with respect to any Global Security, subject to Section&nbsp;2.11 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Trustee shall have no obligation or duty to
monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable law
with respect to any transfer of any interest in any Security (including any transfers between or among Depositary participants or beneficial
owners of interests in any Global Security) other than to require delivery of such certificates and other documentation or evidence as
are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to determine
substantial compliance as to form with the express requirements hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.06
Temporary Securities</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pending the preparation of definitive Securities
of any series, the Company may execute, and the Trustee shall authenticate and deliver, temporary Securities (printed, lithographed or
typewritten) of any authorized denomination. Such temporary Securities shall be substantially in the form of the definitive Securities
in lieu of which they are issued, but with such omissions, insertions and variations as may be appropriate for temporary Securities, all
as may be determined by the Company. Every temporary Security of any series shall be executed by the Company and be authenticated by the
Trustee upon the same conditions and in substantially the same manner, and with like effect, as the definitive Securities of such series.
Without unnecessary delay the Company will execute and will furnish definitive Securities of such series and thereupon any or all temporary
Securities of such series may be surrendered in exchange therefor (without charge to the Securityholders), at the office or agency of
the Company designated for the purpose, and the Trustee shall authenticate and such office or agency shall deliver in exchange for such
temporary Securities an equal aggregate principal amount of definitive Securities of such series, unless the Company advises the Trustee
to the effect that definitive Securities need not be executed and furnished until further notice from the Company. Until so exchanged,
the temporary Securities of such series shall be entitled to the same benefits under this Indenture as definitive Securities of such series
authenticated and delivered hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.07
Mutilated, Destroyed, Lost or Stolen Securities</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In case any temporary or definitive Security shall
become mutilated or be destroyed, lost or stolen, the Company (subject to the next succeeding sentence) shall execute, and upon the Company&#8217;s
request the Trustee (subject as aforesaid) shall authenticate and deliver, a new Security of the same series, bearing a number not contemporaneously
outstanding, in exchange and substitution for the mutilated Security, or in lieu of and in substitution for the Security so destroyed,
lost or stolen. In every case the applicant for a substituted Security shall furnish to the Company and the Trustee such security or indemnity
as may be required by them to save each of them harmless, and, in every case of destruction, loss or theft, the applicant shall also furnish
to the Company and the Trustee evidence to their satisfaction of the destruction, loss or theft of the applicant&#8217;s Security and
of the ownership thereof. The Trustee may authenticate any such substituted Security and deliver the same upon the written request or
authorization of any officer of the Company. Upon the issuance of any substituted Security, the Company may require the payment of a sum
sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the
fees and expenses of the Trustee) connected therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In case any Security that has matured or is about
to mature shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security, pay or authorize
the payment of the same (without surrender thereof except in the case of a mutilated Security) if the applicant for such payment shall
furnish to the Company and the Trustee such security or indemnity as they may require to save them harmless, and, in case of destruction,
loss or theft, evidence to the satisfaction of the Company and the Trustee of the destruction, loss or theft of such Security and of the
ownership thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Every replacement Security issued pursuant to
the provisions of this Section&nbsp;shall constitute an additional contractual obligation of the Company whether or not the mutilated,
destroyed, lost or stolen Security shall be found at any time, or be enforceable by anyone, and shall be entitled to all the benefits
of this Indenture equally and proportionately with any and all other Securities of the same series duly issued hereunder. All Securities
shall be held and owned upon the express condition that the foregoing provisions are exclusive with respect to the replacement or payment
of mutilated, destroyed, lost or stolen Securities, and shall preclude (to the extent lawful) any and all other rights or remedies, notwithstanding
any law or statute existing or hereafter enacted to the contrary with respect to the replacement or payment of negotiable instruments
or other securities without their surrender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.08
Cancellation</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All Securities surrendered for the purpose of
payment, redemption, repurchase, exchange, registration of transfer or conversion shall, if surrendered to the Company or any paying agent
(or any other applicable agent), be delivered to the Trustee for cancellation, or, if surrendered to the Trustee, shall be cancelled by
it, and no Securities shall be issued in lieu thereof except as expressly required or permitted by any of the provisions of this Indenture.
On request of the Company at the time of such surrender, the Trustee shall deliver to the Company canceled Securities held by the Trustee.
In the absence of such request the Trustee may dispose of canceled Securities in accordance with its standard procedures and deliver a
certificate of disposition to the Company. If the Company shall otherwise acquire any of the Securities, however, such acquisition shall
not operate as a redemption or satisfaction of the indebtedness represented by such Securities unless and until the same are delivered
to the Trustee for cancellation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.09
Benefits of Indenture</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Nothing in this Indenture or in the Securities,
express or implied, shall give or be construed to give to any Person, other than the parties hereto and the holders of the Securities
any legal or equitable right, remedy or claim under or in respect of this Indenture, or under any covenant, condition or provision herein
contained; all such covenants, conditions and provisions being for the sole benefit of the parties hereto and of the holders of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.10
Authenticating Agent</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">So long as any of the Securities of any series
remain Outstanding there may be an Authenticating Agent for any or all such series of Securities which the Trustee shall have the right
to appoint. Said Authenticating Agent shall be authorized to act on behalf of the Trustee to authenticate Securities of such series issued
upon exchange, transfer or partial redemption, repurchase or conversion thereof, and Securities so authenticated shall be entitled to
the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder. All references
in this Indenture to the authentication of Securities by the Trustee shall be deemed to include authentication by an Authenticating Agent
for such series. Each Authenticating Agent shall be acceptable to the Company and shall be a corporation that has a combined capital and
surplus, as most recently reported or determined by it, sufficient under the laws of any jurisdiction under which it is organized or in
which it is doing business to conduct a trust business, and that is otherwise authorized under such laws to conduct such business and
is subject to supervision or examination by federal or state authorities. If at any time any Authenticating Agent shall cease to be eligible
in accordance with these provisions, it shall resign immediately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any Authenticating Agent may at any time resign
by giving written notice of resignation to the Trustee and to the Company. The Trustee may at any time (and upon request by the Company
shall) terminate the agency of any Authenticating Agent by giving written notice of termination to such Authenticating Agent and to the
Company. Upon resignation, termination or cessation of eligibility of any Authenticating Agent, the Trustee may appoint an eligible successor
Authenticating Agent acceptable to the Company. Any successor Authenticating Agent, upon acceptance of its appointment hereunder, shall
become vested with all the rights, powers and duties of its predecessor hereunder as if originally named as an Authenticating Agent pursuant
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.11
Global Securities</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>If
the Company shall establish pursuant to Section&nbsp;2.01 that the Securities of a particular series are to be issued as a Global Security,
then the Company shall execute and the Trustee shall, in accordance with Section&nbsp;2.04, authenticate and deliver, a Global Security
that (i)&nbsp;shall represent, and shall be denominated in an amount equal to the aggregate principal amount of, all of the Outstanding
Securities of such series, (ii)&nbsp;shall be registered in the name of the Depositary or its nominee, (iii)&nbsp;shall be delivered by
the Trustee to the Depositary or pursuant to the Depositary&#8217;s instruction (or if the Depositary names the Trustee as its custodian,
retained by the Trustee), and (iv)&nbsp;shall bear a legend substantially to the following effect: &#8220;Except as otherwise provided
in Section&nbsp;2.11 of the Indenture, this Security may be transferred, in whole but not in part, only to another nominee of the Depositary
or to a successor Depositary or to a nominee of such successor Depositary.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>Notwithstanding
the provisions of Section&nbsp;2.05, the Global Security of a series may be transferred, in whole but not in part and in the manner provided
in Section&nbsp;2.05, only to another nominee of the Depositary for such series, or to a successor Depositary for such series selected
or approved by the Company or to a nominee of such successor Depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>If
at any time the Depositary for a series of the Securities notifies the Company that it is unwilling or unable to continue as Depositary
for such series or if at any time the Depositary for such series shall no longer be registered or in good standing under the Exchange
Act, or other applicable statute or regulation, and a successor Depositary for such series is not appointed by the Company within 90 days
after the Company receives such notice or becomes aware of such condition, as the case may be, or if an Event of Default has occurred
and is continuing and the Company has received a request from the Depositary or from the Trustee, this Section&nbsp;2.11 shall no longer
be applicable to the Securities of such series and the Company will execute, and subject to Section&nbsp;2.04, the Trustee will authenticate
and deliver the Securities of such series in definitive registered form without coupons, in authorized denominations, and in an aggregate
principal amount equal to the principal amount of the Global Security of such series in exchange for such Global Security. In addition,
the Company may at any time determine that the Securities of any series shall no longer be represented by a Global Security and that the
provisions of this Section&nbsp;2.11 shall no longer apply to the Securities of such series. In such event the Company will execute and,
subject to Section&nbsp;2.04, the Trustee, upon receipt of an Officer&#8217;s Certificate evidencing such determination by the Company,
will authenticate and deliver the Securities of such series in definitive registered form without coupons, in authorized denominations,
and in an aggregate principal amount equal to the principal amount of the Global Security of such series in exchange for such Global Security.
Upon the exchange of the Global Security for such Securities in definitive registered form without coupons, in authorized denominations,
the Global Security shall be canceled by the Trustee. Such Securities in definitive registered form issued in exchange for the Global
Security pursuant to this Section&nbsp;2.11(c)&nbsp;shall be registered in such names and in such authorized denominations as the Depositary,
pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee. The Trustee shall deliver
such Securities to the Depositary for delivery to the Persons in whose names such Securities are so registered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;2.12
CUSIP Numbers</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company in issuing the Securities may use
 &#8220;CUSIP&#8221; numbers (if then generally in use), and, if so, the Trustee shall use &#8220;CUSIP&#8221; numbers in notices of redemption
as a convenience to Securityholders; provided that any such notice may state that no representation is made as to the correctness of such
numbers either as printed on the Securities or as contained in any notice of a redemption and that reliance may be placed only on the
other elements of identification printed on the Securities, and any such redemption shall not be affected by any defect in or omission
of such numbers. The Company will promptly notify the Trustee of any change in the &#8220;CUSIP&#8221; numbers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;3.01
Redemption</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company may redeem the Securities of any series
issued hereunder on and after the dates and in accordance with the terms established for such series pursuant to Section&nbsp;2.01 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;3.02
Notice of Redemption</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>In
case the Company shall desire to exercise such right to redeem all or, as the case may be, a portion of the Securities of any series in
accordance with any right the Company reserved for itself to do so pursuant to Section&nbsp;2.01 hereof, the Company shall, or shall cause
the Trustee to, give notice of such redemption to holders of the Securities of such series to be redeemed by mailing (or with regard to
any Global Security held in book entry form, by electronic mail in accordance with the applicable procedures of the Depositary), a notice
of such redemption not less than 30 days and not more than 90 days before the date fixed for redemption of that series to such Securityholders,
unless a shorter period is specified in the Securities to be redeemed. Any notice that is mailed in the manner herein provided shall be
conclusively presumed to have been duly given, whether or not the registered holder receives the notice. In any case, failure duly to
give such notice to the holder of any Security of any series designated for redemption in whole or in part, or any defect in the notice,
shall not affect the validity of the proceedings for the redemption of any other Securities of such series or any other series. In the
case of any redemption of Securities prior to the expiration of any restriction on such redemption provided in the terms of such Securities
or elsewhere in this Indenture, the Company shall furnish the Trustee with an Officer&#8217;s Certificate evidencing compliance with any
such restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each such notice of redemption shall identify
the Securities to be redeemed (including CUSIP numbers, if any), specify the date fixed for redemption and the redemption price at which
Securities of that series are to be redeemed, and shall state that payment of the redemption price of such Securities to be redeemed will
be made at the office or agency of the Company, upon presentation and surrender of such Securities, that interest accrued to the date
fixed for redemption will be paid as specified in said notice, that from and after said date interest will cease to accrue and that the
redemption is from a sinking fund, if such is the case. If less than all the Securities of a series are to be redeemed, the notice to
the holders of Securities of that series to be redeemed in part shall specify the particular Securities to be so redeemed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In case any Security is to be redeemed in part
only, the notice that relates to such Security shall state the portion of the principal amount thereof to be redeemed, and shall state
that on and after the redemption date, upon surrender of such Security, a new Security or Securities of such series in principal amount
equal to the unredeemed portion thereof will be issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>If
less than all the Securities of a series are to be redeemed, the Company shall give the Trustee at least 45 days&#8217; notice
(unless a shorter notice shall be satisfactory to the Trustee) in advance of the date fixed for redemption as to the aggregate
principal amount of Securities of the series to be redeemed, and thereupon the Securities to be redeemed shall be selected, by lot,
on a pro rata basis, or in such other manner as the Company shall deem appropriate and fair in its discretion and that may provide
for the selection of a portion or portions (equal to one thousand U.S. dollars ($1,000) or any integral multiple thereof) of the
principal amount of such Securities of a denomination larger than $1,000, the Securities to be redeemed and shall thereafter
promptly notify the Company in writing of the numbers of the Securities to be redeemed, in whole or in part. The Company may, if and
whenever it shall so elect, by delivery of instructions signed on its behalf by an Officer, instruct the Trustee or any paying agent
to call all or any part of the Securities of a particular series for redemption and to give notice of redemption in the manner set
forth in this Section, such notice to be in the name of the Company or its own name as the Trustee or such paying agent may deem
advisable. In any case in which notice of redemption is to be given by the Trustee or any such paying agent, the Company shall
deliver or cause to be delivered to, or permit to remain with, the Trustee or such paying agent, as the case may be, such Security
Register, transfer books or other records, or suitable copies or extracts therefrom, sufficient to enable the Trustee or such paying
agent to give any notice by mail that may be required under the provisions of this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;3.03
Payment Upon Redemption</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>If
the giving of notice of redemption shall have been completed as above provided, the Securities or portions of Securities of the series
to be redeemed specified in such notice shall become due and payable on the date and at the place stated in such notice at the applicable
redemption price, together with interest accrued to, but excluding, the date fixed for redemption and interest on such Securities or portions
of Securities shall cease to accrue on and after the date fixed for redemption, unless the Company shall default in the payment of such
redemption price and accrued interest with respect to any such Security or portion thereof. On presentation and surrender of such Securities
on or after the date fixed for redemption at the place of payment specified in the notice, said Securities shall be paid and redeemed
at the applicable redemption price for such series, together with interest accrued thereon to, but excluding, the date fixed for redemption
(but if the date fixed for redemption is an Interest Payment Date, the interest installment payable on such date shall be payable to the
registered holder at the close of business on the applicable record date pursuant to Section&nbsp;2.03).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>Upon
presentation of any Security of such series that is to be redeemed in part only, the Company shall execute and the Trustee shall authenticate
and the office or agency where the Security is presented shall deliver to the Securityholder thereof, at the expense of the Company, a
new Security of the same series of authorized denominations in principal amount equal to the unredeemed portion of the Security so presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;3.04
Sinking Fund</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The provisions of Sections 3.04, 3.05 and 3.06
shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified as contemplated by
Section&nbsp;2.01 for Securities of such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The minimum amount of any sinking fund payment
provided for by the terms of Securities of any series is herein referred to as a &#8220;mandatory sinking fund payment,&#8221; and any
payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as an &#8220;optional
sinking fund payment&#8221;. If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may
be subject to reduction as provided in Section&nbsp;3.05. Each sinking fund payment shall be applied to the redemption of Securities of
any series as provided for by the terms of Securities of such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;3.05
Satisfaction of Sinking Fund Payments with Securities</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company (i)&nbsp;may deliver Outstanding Securities
of a series and (ii)&nbsp;may apply as a credit Securities of a series that have been redeemed either at the election of the Company pursuant
to the terms of such Securities or through the application of permitted optional sinking fund payments pursuant to the terms of such Securities,
in each case in satisfaction of all or any part of any sinking fund payment with respect to the Securities of such series required to
be made pursuant to the terms of such Securities as provided for by the terms of such series, provided that such Securities have not been
previously so credited. Such Securities shall be received and credited for such purpose by the Trustee at the redemption price specified
in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;3.06
Redemption of Securities for Sinking Fund</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Not less than 45 days prior to each sinking fund
payment date for any series of Securities (unless a shorter period shall be satisfactory to the Trustee), the Company will deliver to
the Trustee an Officer&#8217;s Certificate specifying the amount of the next ensuing sinking fund payment for that series pursuant to
the terms of the series, the portion thereof, if any, that is to be satisfied by delivering and crediting Securities of that series pursuant
to Section&nbsp;3.05 and the basis for such credit and will, together with such Officer&#8217;s Certificate, deliver to the Trustee any
Securities to be so delivered. Not less than 30 days before each such sinking fund payment date the Securities to be redeemed upon such
sinking fund payment date shall be selected in the manner specified in Section&nbsp;3.02 and the Company shall cause notice of the redemption
thereof to be given in the name of and at the expense of the Company in the manner provided in Section&nbsp;3.02. Such notice having been
duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Section&nbsp;3.03.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COVENANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;4.01
Payment of Principal, Premium and Interest</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company will duly and punctually pay or cause
to be paid the principal of (and premium, if any) and interest on the Securities of that series at the time and place and in the manner
provided herein and established with respect to such Securities. Payments of principal on the Securities may be made at the time provided
herein and established with respect to such Securities by U.S. dollar check drawn on and mailed to the address of the Securityholder entitled
thereto as such address shall appear in the Security Register, or U.S. dollar wire transfer to, a U.S. dollar account if such Securityholder
shall have furnished wire instructions to the Trustee no later than 15 days prior to the relevant payment date. Payments of interest on
the Securities may be made at the time provided herein and established with respect to such Securities by U.S. dollar check mailed to
the address of the Securityholder entitled thereto as such address shall appear in the Security Register, or U.S. dollar wire transfer
to, a U.S. dollar account if such Securityholder shall have furnished wire instructions in writing to the Security Registrar and the Trustee
no later than 15 days prior to the relevant payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;4.02
Maintenance of Office or Agency</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">So long as any series of the Securities remain
Outstanding, the Company agrees to maintain an office or agency with respect to each such series and at such other location or locations
as may be designated as provided in this Section&nbsp;4.02, where (i)&nbsp;Securities of that series may be presented for payment, (ii)&nbsp;Securities
of that series may be presented as herein above authorized for registration of transfer and exchange, and (iii)&nbsp;notices and demands
to or upon the Company in respect of the Securities of that series and this Indenture may be given or served, such designation to continue
with respect to such office or agency until the Company shall, by written notice signed by any officer authorized to sign an Officer&#8217;s
Certificate and delivered to the Trustee, designate some other office or agency for such purposes or any of them. If at any time the Company
shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations,
notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as
its agent to receive all such presentations, notices and demands. The Company initially appoints the Corporate Trust Office of the Trustee
as its paying agent with respect to the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;4.03
Paying Agents</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>If
the Company shall appoint one or more paying agents for all or any series of the Securities, other than the Trustee, the Company will
cause each such paying agent to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject
to the provisions of this Section:</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(1)&nbsp;</B></FONT>that
it will hold all sums held by it as such agent for the payment of the principal of (and premium, if any) or interest on the Securities
of that series (whether such sums have been paid to it by the Company or by any other obligor of such Securities) in trust for the benefit
of the Persons entitled thereto;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(2)&nbsp;</B></FONT>that
it will give the Trustee notice of any failure by the Company (or by any other obligor of such Securities) to make any payment of the
principal of (and premium, if any) or interest on the Securities of that series when the same shall be due and payable;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(3)&nbsp;</B></FONT>that
it will, at any time during the continuance of any failure referred to in the preceding paragraph (a)(2)&nbsp;above, upon the written
request of the Trustee, forthwith pay to the Trustee all sums so held in trust by such paying agent; and</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(4)&nbsp;</B></FONT>that
it will perform all other duties of paying agent as set forth in this Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>If
the Company shall act as its own paying agent with respect to any series of the Securities, it will on or before each due date of the
principal of (and premium, if any) or interest on Securities of that series, set aside, segregate and hold in trust for the benefit of
the Persons entitled thereto a sum sufficient to pay such principal (and premium, if any) or interest so becoming due on Securities of
that series until such sums shall be paid to such Persons or otherwise disposed of as herein provided and will promptly notify the Trustee
of such action, or any failure (by it or any other obligor on such Securities) to take such action. Whenever the Company shall have one
or more paying agents for any series of Securities, it will, prior to each due date of the principal of (and premium, if any) or interest
on any Securities of that series, deposit with the paying agent a sum sufficient to pay the principal (and premium, if any) or interest
so becoming due, such sum to be held in trust for the benefit of the Persons entitled to such principal, premium or interest, and (unless
such paying agent is the Trustee) the Company will promptly notify the Trustee of this action or failure so to act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>Notwithstanding
anything in this Section&nbsp;to the contrary, (i)&nbsp;the agreement to hold sums in trust as provided in this Section&nbsp;is subject
to the provisions of Section&nbsp;11.05, and (ii)&nbsp;the Company may at any time, for the purpose of obtaining the satisfaction and
discharge of this Indenture or for any other purpose, pay, or direct any paying agent to pay, to the Trustee all sums held in trust by
the Company or such paying agent, such sums to be held by the Trustee upon the same terms and conditions as those upon which such sums
were held by the Company or such paying agent; and, upon such payment by the Company or any paying agent to the Trustee, the Company or
such paying agent shall be released from all further liability with respect to such money.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;4.04
Appointment to Fill Vacancy in Office of Trustee</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company, whenever necessary to avoid or fill
a vacancy in the office of Trustee, will appoint, in the manner provided in Section&nbsp;7.10, a Trustee, so that there shall at all times
be a Trustee hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITYHOLDERS&#8217; LISTS AND REPORTS BY
THE COMPANY AND THE TRUSTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;5.01
Company to Furnish Trustee Names and Addresses of Securityholders</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company will furnish or cause to be furnished
to the Trustee (a)&nbsp;within 15 days after each regular record date (as defined in Section&nbsp;2.03) a list, in such form as the Trustee
may reasonably require, of the names and addresses of the holders of each series of Securities as of such regular record date, provided
that the Company shall not be obligated to furnish or cause to furnish such list at any time that the list shall not differ in any respect
from the most recent list furnished to the Trustee by the Company and (b)&nbsp;at such other times as the Trustee may request in writing
within 30 days after the receipt by the Company of any such request, a list of similar form and content as of a date not more than 15
days prior to the time such list is furnished; provided, however, that, in either case, no such list need be furnished for any series
for which the Trustee shall be the Security Registrar.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;5.02
Preservation Of Information; Communications With Securityholders</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>The
Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses of the holders
of Securities contained in the most recent list furnished to it as provided in Section&nbsp;5.01 and as to the names and addresses of
holders of Securities received by the Trustee in its capacity as Security Registrar (if acting in such capacity).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>The
Trustee may destroy any list furnished to it as provided in Section&nbsp;5.01 upon receipt of a new list so furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>Securityholders
may communicate as provided in Section&nbsp;312(b)&nbsp;of the Trust Indenture Act with other Securityholders with respect to their rights
under this Indenture or under the Securities, and, in connection with any such communications, the Trustee shall satisfy its obligations
under Section&nbsp;312(b)&nbsp;of the Trust Indenture Act in accordance with the provisions of Section&nbsp;312(b)&nbsp;of the Trust Indenture
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;5.03
Reports by the Company</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>The
Company will at all times comply with Section&nbsp;314(a)&nbsp;of the Trust Indenture Act. The Company covenants and agrees to provide
(which delivery may be via electronic mail) to the Trustee within 30 days, after the Company files the same with the Commission, copies
of the annual reports and of the information, documents and other reports (or copies of such portions of any of the foregoing as the Commission
may from time to time by rules&nbsp;and regulations prescribe) that the Company is required to file with the Commission pursuant to Section&nbsp;13
or Section&nbsp;15(d)&nbsp;of the Exchange Act; provided, however, the Company shall not be required to deliver to the Trustee any correspondence
filed with the Commission or any materials for which the Company has sought and received confidential treatment by the Commission; and
provided further, that so long as such filings by the Company are available on the Commission&#8217;s Electronic Data Gathering, Analysis
and Retrieval System (EDGAR), or any successor system, such filings shall be deemed to have been filed with the Trustee for purposes hereof
without any further action required by the Company. For the avoidance of doubt, a failure by the Company to file annual reports, information
and other reports with the Commission within the time period prescribed thereof by the Commission shall not be deemed a breach of this
Section&nbsp;5.03.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>Delivery
of reports, information and documents to the Trustee under Section&nbsp;5.03 is for informational purposes only and the information and
the Trustee&#8217;s receipt of the foregoing shall not constitute constructive notice of any information contained therein, or determinable
from information contained therein including the Company&#8217;s compliance with any of their covenants thereunder (as to which the Trustee
is entitled to rely exclusively on an Officer&#8217;s Certificate). The Trustee is under no duty to examine any such reports, information
or documents delivered to the Trustee or filed with the Commission via EDGAR to ensure compliance with the provision of this Indenture
or to ascertain the correctness or otherwise of the information or the statements contained therein. The Trustee shall have no responsibility
or duty whatsoever to ascertain or determine whether the above referenced filings with the Commission on EDGAR (or any successor system)
has occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;5.04
Reports by the Trustee</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>If
required by Section&nbsp;313(a)&nbsp;of the Trust Indenture Act, the Trustee, within sixty (60) days after each May&nbsp;1, shall send
to the Securityholders a brief report dated as of such May&nbsp;1, which complies with Section&nbsp;313(a)&nbsp;of the Trust Indenture
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>The
Trustee shall comply with Section&nbsp;313(b)&nbsp;and 313(c)&nbsp;of the Trust Indenture Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>A
copy of each such report shall, at the time of such transmission to Securityholders, be filed by the Trustee with the Company, with each
securities exchange upon which any Securities are listed (if so listed) and also with the Commission. The Company agrees to notify the
Trustee when any Securities become listed on any securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: 1 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS
ON EVENT OF DEFAULT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;6.01
Events of Default</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>Whenever
used herein with respect to Securities of a particular series, &#8220;Event of Default&#8221; means any one or more of the following events
that has occurred and is continuing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(1)&nbsp;</B></FONT>the
Company defaults in the payment of any installment of interest upon any of the Securities of that series, as and when the same shall become
due and payable, and such default continues for a period of 90 days; provided, however, that a valid extension of an interest payment
period by the Company in accordance with the terms of any indenture supplemental hereto shall not constitute a default in the payment
of interest for this purpose;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(2)&nbsp;</B></FONT>the
Company defaults in the payment of the principal of (or premium, if any, on) any of the Securities of that series as and when the same
shall become due and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment required by any sinking
or analogous fund established with respect to that series; provided, however, that a valid extension of the maturity of such Securities
in accordance with the terms of any indenture supplemental hereto shall not constitute a default in the payment of principal or premium,
if any;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(3)&nbsp;</B></FONT>the
Company fails to observe or perform any other of its covenants or agreements with respect to that series contained in this Indenture or
otherwise established with respect to that series of Securities pursuant to Section&nbsp;2.01 hereof (other than a covenant or agreement
that has been expressly included in this Indenture solely for the benefit of one or more series of Securities other than such series)
for a period of 90 days after the date on which written notice of such failure, requiring the same to be remedied and stating that such
notice is a &#8220;Notice of Default&#8221; hereunder, shall have been given to the Company by the Trustee, by registered or certified
mail, or to the Company and the Trustee by the holders of at least 25% in principal amount of the Securities of that series at the time
Outstanding;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(4)&nbsp;</B></FONT>the
Company pursuant to or within the meaning of any Bankruptcy Law (i)&nbsp;commences a voluntary case, (ii)&nbsp;consents to the entry of
an order for relief against it in an involuntary case, (iii)&nbsp;consents to the appointment of a Custodian of it or for all or substantially
all of its property or (iv)&nbsp;makes a general assignment for the benefit of its creditors; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(5)&nbsp;</B></FONT>a
court of competent jurisdiction enters an order under any Bankruptcy Law that (i)&nbsp;is for relief against the Company in an involuntary
case, (ii)&nbsp;appoints a Custodian of the Company for all or substantially all of its property or (iii)&nbsp;orders the liquidation
of the Company, and the order or decree remains unstayed and in effect for 90 days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>In
each and every such case (other than an Event of Default specified in clause (4)&nbsp;or clause (5)&nbsp;above), unless the principal
of all the Securities of that series shall have already become due and payable, either the Trustee or the holders of not less than 25%
in aggregate principal amount of the Securities of that series then Outstanding hereunder, by notice in writing to the Company (and to
the Trustee if given by such Securityholders), may declare the principal of (and premium, if any, on) and accrued and unpaid interest
on all the Securities of that series to be due and payable immediately, and upon any such declaration the same shall become and shall
be immediately due and payable. If an Event of Default specified in clause (4)&nbsp;or clause (5)&nbsp;above occurs, the principal of
and accrued and unpaid interest on all the Securities of that series shall automatically be immediately due and payable without any declaration
or other act on the part of the Trustee or the holders of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>At
any time after the principal of (and premium, if any, on) and accrued and unpaid interest on the Securities of that series shall have
been so declared due and payable, and before any judgment or decree for the payment of the moneys due shall have been obtained or entered
as hereinafter provided, the holders of a majority in aggregate principal amount of the Securities of that series then Outstanding hereunder,
by written notice to the Company and the Trustee, may rescind and annul such declaration and its consequences if: (i)&nbsp;the Company
has paid or deposited with the Trustee a sum sufficient to pay all matured installments of interest upon all the Securities of that series
and the principal of (and premium, if any, on) any and all Securities of that series that shall have become due otherwise than by acceleration
(with interest upon such principal and premium, if any, and, to the extent that such payment is enforceable under applicable law, upon
overdue installments of interest, at the rate per annum expressed in the Securities of that series to the date of such payment or deposit)
and the amount payable to the Trustee under Section&nbsp;7.06, and (ii)&nbsp;any and all Events of Default under the Indenture with respect
to such series, other than the nonpayment of principal on (and premium, if any, on) and accrued and unpaid interest on Securities of that
series that shall not have become due by their terms, shall have been remedied or waived as provided in Section&nbsp;6.06.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No such rescission and annulment shall extend
to or shall affect any subsequent default or impair any right consequent thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;</B></FONT>In
case the Trustee shall have proceeded to enforce any right with respect to Securities of that series under this Indenture and such proceedings
shall have been discontinued or abandoned because of such rescission or annulment or for any other reason or shall have been determined
adversely to the Trustee, then and in every such case, subject to any determination in such proceedings, the Company and the Trustee shall
be restored respectively to their former positions and rights hereunder, and all rights, remedies and powers of the Company and the Trustee
shall continue as though no such proceedings had been taken.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;6.02
Collection of Indebtedness and Suits for Enforcement by Trustee</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>The
Company covenants that (i)&nbsp;in case it shall default in the payment of any installment of interest on any of the Securities of a series,
or in any payment required by any sinking or analogous fund established with respect to that series as and when the same shall have become
due and payable, and such default shall have continued for a period of 90 days, or (ii)&nbsp;in case it shall default in the payment of
the principal of (or premium, if any, on) any of the Securities of a series when the same shall have become due and payable, whether upon
maturity of the Securities of a series or upon redemption or upon declaration or otherwise then, upon demand of the Trustee, the Company
will pay to the Trustee, for the benefit of the holders of the Securities of that series, the whole amount that then shall have been become
due and payable on all such Securities for principal (and premium, if any) or interest, or both, as the case may be, with interest upon
the overdue principal (and premium, if any) and (to the extent that payment of such interest is enforceable under applicable law) upon
overdue installments of interest at the rate per annum expressed in the Securities of that series; and, in addition thereto, such further
amount as shall be sufficient to cover the costs and expenses of collection, and the amount payable to the Trustee under Section&nbsp;7.06.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>If
the Company shall fail to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust,
shall be entitled and empowered to institute any action or proceedings at law or in equity for the collection of the sums so due and unpaid,
and may prosecute any such action or proceeding to judgment or final decree, and may enforce any such judgment or final decree against
the Company or other obligor upon the Securities of that series and collect the moneys adjudged or decreed to be payable in the manner
provided by law or equity out of the property of the Company or other obligor upon the Securities of that series, wherever situated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>In
case of any receivership, insolvency, liquidation, bankruptcy, reorganization, readjustment, arrangement, composition or judicial proceedings
affecting the Company, or its creditors or property, the Trustee shall have power to intervene in such proceedings and take any action
therein that may be permitted by the court and shall (except as may be otherwise provided by law) be entitled to file such proofs of claim
and other papers and documents as may be necessary or advisable in order to have the claims of the Trustee and of the holders of Securities
of such series allowed for the entire amount due and payable by the Company under the Indenture at the date of institution of such proceedings
and for any additional amount that may become due and payable by the Company after such date, and to collect and receive any moneys or
other property payable or deliverable on any such claim, and to distribute the same after the deduction of the amount payable to the Trustee
under Section&nbsp;7.06; and any receiver, assignee or trustee in bankruptcy or reorganization is hereby authorized by each of the holders
of Securities of such series to make such payments to the Trustee, and, in the event that the Trustee shall consent to the making of such
payments directly to such Securityholders, to pay to the Trustee any amount due it under Section&nbsp;7.06.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;</B></FONT>All
rights of action and of asserting claims under this Indenture, or under any of the terms established with respect to Securities of that
series, may be enforced by the Trustee without the possession of any of such Securities, or the production thereof at any trial or other
proceeding relative thereto, and any such suit or proceeding instituted by the Trustee shall be brought in its own name as trustee of
an express trust, and any recovery of judgment shall, after provision for payment to the Trustee of any amounts due under Section&nbsp;7.06,
be for the ratable benefit of the holders of the Securities of such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In case of an Event of Default hereunder, the
Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings
as the Trustee shall deem most effectual to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise,
whether for the specific enforcement of any covenant or agreement contained in the Indenture or in aid of the exercise of any power granted
in this Indenture, or to enforce any other legal or equitable right vested in the Trustee by this Indenture or by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Nothing contained herein shall be deemed to authorize
the Trustee to authorize or consent to or accept or adopt on behalf of any Securityholder any plan of reorganization, arrangement, adjustment
or composition affecting the Securities of that series or the rights of any Securityholder thereof or to authorize the Trustee to vote
in respect of the claim of any Securityholder in any such proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;6.03
Application of Moneys Collected</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any moneys collected by the Trustee pursuant to
this Article&nbsp;with respect to a particular series of Securities shall be applied in the following order, at the date or dates fixed
by the Trustee and, in case of the distribution of such moneys on account of principal (or premium, if any) or interest, upon presentation
of the Securities of that series, and notation thereon of the payment, if only partially paid, and upon surrender thereof if fully paid:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">FIRST: To the payment of costs and expenses of
collection and of all amounts payable to the Trustee under Section&nbsp;7.06;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">SECOND: To the payment of the amounts then due
and unpaid upon Securities of such series for principal (and premium, if any) and interest, in respect of which or for the benefit of
which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on
such Securities for principal (and premium, if any) and interest, respectively; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">THIRD: To the payment of the remainder, if any,
to the Company or any other Person lawfully entitled thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;6.04
Limitation on Suits</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No holder of any Security of any series shall
have any right by virtue or by availing of any provision of this Indenture to institute any suit, action or proceeding in equity or at
law upon or under or with respect to this Indenture or for the appointment of a receiver or trustee, or for any other remedy hereunder,
unless (i)&nbsp;such Securityholder previously shall have given to the Trustee written notice of an Event of Default and of the continuance
thereof with respect to the Securities of such series specifying such Event of Default, as hereinbefore provided; (ii)&nbsp;the holders
of not less than 25% in aggregate principal amount of the Securities of such series then Outstanding shall have made written request upon
the Trustee to institute such action, suit or proceeding in its own name as Trustee hereunder; (iii)&nbsp;such Securityholder or Securityholders
shall have offered to the Trustee indemnity satisfactory to it against the costs, expenses and liabilities to be incurred in compliance
with such request; (iv)&nbsp;the Trustee for 90 days after its receipt of such notice, request and offer of indemnity, shall have failed
to institute any such action, suit or proceeding and (v)&nbsp;during such 90 day period, the holders of a majority in principal amount
of the Securities of that series do not give the Trustee a direction inconsistent with the request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Notwithstanding anything contained herein to the
contrary or any other provisions of this Indenture, the right of any holder of any Security to receive payment of the principal of (and
premium, if any) and interest on such Security, as therein provided, on or after the respective due dates expressed in such Security (or
in the case of redemption, on the redemption date), or to institute suit for the enforcement of any such payment on or after such respective
dates or redemption date, shall not be impaired or affected without the consent of such holder and by accepting a Security hereunder it
is expressly understood, intended and covenanted by the taker and holder of every Security of such series with every other such taker
and holder and the Trustee, that no one or more holders of Securities of such series shall have any right in any manner whatsoever by
virtue or by availing of any provision of this Indenture to affect, disturb or prejudice the rights of the holders of any other of such
Securities, or to obtain or seek to obtain priority over or preference to any other such holder, or to enforce any right under this Indenture,
except in the manner herein provided and for the equal, ratable and common benefit of all holders of Securities of such series. For the
protection and enforcement of the provisions of this Section, each and every Securityholder and the Trustee shall be entitled to such
relief as can be given either at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;6.05
Rights and Remedies Cumulative; Delay or Omission Not Waiver</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>Except
as otherwise provided in Section&nbsp;2.07, all powers and remedies given by this Article&nbsp;to the Trustee or to the Securityholders
shall, to the extent permitted by law, be deemed cumulative and not exclusive of any other powers and remedies available to the Trustee
or the holders of the Securities, by judicial proceedings or otherwise, to enforce the performance or observance of the covenants and
agreements contained in this Indenture or otherwise established with respect to such Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>No
delay or omission of the Trustee or of any holder of any of the Securities to exercise any right or power accruing upon any Event of Default
occurring and continuing as aforesaid shall impair any such right or power, or shall be construed to be a waiver of any such default or
an acquiescence therein; and, subject to the provisions of Section&nbsp;6.04, every power and remedy given by this Article&nbsp;or by
law to the Trustee or the Securityholders may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee
or by the Securityholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;6.06
Control by Securityholders</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The holders of a majority in aggregate principal
amount of the Securities of any series at the time Outstanding, determined in accordance with Section&nbsp;8.04, shall have the right
to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or
power conferred on the Trustee with respect to such series; provided, however, that such direction shall not be in conflict with any rule&nbsp;of
law or with this Indenture or subject the Trustee in its sole discretion to personal liability. Subject to the provisions of Section&nbsp;7.01,
the Trustee shall have the right to decline to follow any such direction if the Trustee in good faith shall, by a Responsible Officer
or officers of the Trustee, determine that the proceeding so directed, subject to the Trustee&#8217;s duties under the Trust Indenture
Act, would involve the Trustee in personal liability or might be unduly prejudicial to the Securityholders not involved in the proceeding.
The holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding affected thereby, determined
in accordance with Section&nbsp;8.04, may on behalf of the holders of all of the Securities of such series waive any past default in the
performance of any of the covenants contained herein or established pursuant to Section&nbsp;2.01 with respect to such series and its
consequences, except a default in the payment of the principal of, or premium, if any, or interest on, any of the Securities of that series
as and when the same shall become due by the terms of such Securities otherwise than by acceleration (unless such default has been cured
and a sum sufficient to pay all matured installments of interest and principal and any premium has been deposited with the Trustee (in
accordance with Section&nbsp;6.01(c)). Upon any such waiver, the default covered thereby shall be deemed to be cured for all purposes
of this Indenture and the Company, the Trustee and the holders of the Securities of such series shall be restored to their former positions
and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other default or impair any right consequent
thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;6.07
Undertaking to Pay Costs</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All parties to this Indenture agree, and each
holder of any Securities by such holder&#8217;s acceptance thereof shall be deemed to have agreed, that any court may in its discretion
require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action
taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and
that such court may in its discretion assess reasonable costs, including reasonable attorneys&#8217; fees and expenses, against any party
litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions
of this Section&nbsp;shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder, or group of
Securityholders, holding more than 10% in aggregate principal amount of the Outstanding Securities of any series, or to any suit instituted
by any Securityholder for the enforcement of the payment of the principal of (or premium, if any) or interest on any Security of such
series, on or after the respective due dates expressed in such Security or established pursuant to this Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE&nbsp;7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONCERNING THE TRUSTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.01
Certain Duties and Responsibilities of Trustee</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>The
Trustee, prior to the occurrence of an Event of Default with respect to the Securities of a series and after the curing of all Events
of Default with respect to the Securities of that series that may have occurred, shall undertake to perform with respect to the Securities
of such series such duties and only such duties as are specifically set forth in this Indenture, and no implied covenants shall be read
into this Indenture against the Trustee. In case an Event of Default with respect to the Securities of a series has occurred (that has
not been cured or waived), the Trustee shall exercise with respect to Securities of that series such of the rights and powers vested in
it by this Indenture, and use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances
in the conduct of his or her own affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>No
provision of this Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure
to act, or its own willful misconduct, except that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;</B></FONT>prior
to the occurrence of an Event of Default with respect to the Securities of a series and after the curing or waiving of all such Events
of Default with respect to that series that may have occurred:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(A)&nbsp;</B></FONT>the
duties and obligations of the Trustee shall with respect to the Securities of such series be determined solely by the express provisions
of this Indenture, and the Trustee shall not be liable with respect to the Securities of such series except for the performance of such
duties and obligations as are specifically set forth in this Indenture, and no implied covenants or obligations shall be read into this
Indenture against the Trustee; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(B)&nbsp;</B></FONT>in
the absence of bad faith on the part of the Trustee, the Trustee may with respect to the Securities of such series conclusively rely,
as to the truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions furnished to
the Trustee and conforming to the requirements of this Indenture; but in the case of any such certificates or opinions that by any provision
hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether
or not they conform to the requirements of this Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;</B></FONT>the
Trustee shall not be liable to any Securityholder or to any other Person for any error of judgment made in good faith by a Responsible
Officer or Responsible Officers of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent
facts;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&nbsp;</B></FONT>the
Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction
of the holders of not less than a majority in principal amount of the Securities of any series at the time Outstanding relating to the
time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred
upon the Trustee under this Indenture with respect to the Securities of that series;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&nbsp;</B></FONT>none
of the provisions contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur personal financial
liability in the performance of any of its duties or in the exercise of any of its rights or powers if there is reasonable ground for
believing that the repayment of such funds or liability is not reasonably assured to it under the terms of this Indenture or adequate
indemnity against such risk is not reasonably assured to it;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(v)&nbsp;</B></FONT>The
Trustee shall not be required to give any bond or surety in respect of the performance of its powers or duties hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(vi)&nbsp;</B></FONT>The
permissive right of the Trustee to do things enumerated in this Indenture shall not be construed as a duty of the Trustee; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(vii)&nbsp;</B></FONT>No
Trustee shall have any duty or responsibility for any act or omission of any other Trustee appointed with respect to a series of Securities
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.02
Certain Rights of Trustee</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Except as otherwise provided in Section&nbsp;7.01:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>The
Trustee may conclusively rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement,
instrument, opinion, report, notice, request, consent, order, approval, bond, security or other paper or document believed by it to be
genuine and to have been signed or presented by the proper party or parties;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>Any
request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by a Board Resolution or an instrument
signed in the name of the Company by any authorized Officer of the Company (unless other evidence in respect thereof is specifically prescribed
herein);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>The
Trustee may consult with counsel and the opinion or written advice of such counsel or, if requested, any Opinion of Counsel shall be full
and complete authorization and protection in respect of any action taken or suffered or omitted hereunder in good faith and in reliance
thereon;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;</B></FONT>The
Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction
of any of the Securityholders pursuant to the provisions of this Indenture, unless such Securityholders shall have offered to the Trustee
security or indemnity reasonably acceptable to the Trustee against the costs, expenses and liabilities that may be incurred therein or
thereby; nothing contained herein shall, however, relieve the Trustee of the obligation, upon the occurrence of an Event of Default with
respect to a series of the Securities (that has not been cured or waived), to exercise with respect to Securities of that series such
of the rights and powers vested in it by this Indenture, and to use the same degree of care and skill in their exercise, as a prudent
man would exercise or use under the circumstances in the conduct of his or her own affairs;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;</B></FONT>The
Trustee shall not be liable for any action taken or omitted to be taken by it in good faith and believed by it to be authorized or within
the discretion or rights or powers conferred upon it by this Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;</B></FONT>The
Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument,
opinion, report, notice, request, consent, order, approval, bond, security, or other papers or documents or inquire as to the performance
by the Company of one of its covenants under this Indenture, unless requested in writing so to do by the holders of not less than a majority
in principal amount of the Outstanding Securities of the particular series affected thereby (determined as provided in Section&nbsp;8.04);
provided, however, that if the payment within a reasonable time to the Trustee of the costs, expenses or liabilities likely to be incurred
by it in the making of such investigation is, in the opinion of the Trustee, not reasonably assured to the Trustee by the security afforded
to it by the terms of this Indenture, the Trustee may require security or indemnity reasonably acceptable to the Trustee against such
costs, expenses or liabilities as a condition to so proceeding. The reasonable expense of every such examination shall be paid by the
Company or, if paid by the Trustee, shall be repaid by the Company upon demand;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;</B></FONT>The
Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys
and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care
by it hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;</B></FONT>In
no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out
of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents,
acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions
of utilities, communications or computer (software and hardware) services; it being understood that the Trustee shall use reasonable efforts
which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;</B></FONT>In
no event shall the Trustee be responsible or liable for special, indirect, punitive or consequential loss or damage of any kind whatsoever
(including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or
damage and regardless of the form of action; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)&nbsp;</B></FONT>The
Trustee agrees to accept and act upon instructions or directions pursuant to this Indenture sent by unsecured e-mail, facsimile transmission
or other similar unsecured electronic methods; provided, however, that such instructions or directions shall be signed by an authorized
representative of the party providing such instructions or directions. If the party elects to give the Trustee e-mail or facsimile instructions
(or instructions by a similar electronic method) and the Trustee in its discretion elects to act upon such instructions, the Trustee&#8217;s
understanding of such instructions shall be deemed controlling. The Trustee shall not be liable for any losses, costs or expenses arising
directly or indirectly from the Trustee&#8217;s reliance upon and compliance with such instructions notwithstanding such instructions
conflict or are inconsistent with a subsequent written instruction. The party providing electronic instructions agrees to assume all risks
arising out of the use of such electronic methods to submit instructions and directions to the Trustee, including without limitation the
risk of the Trustee acting on unauthorized instructions, and the risk or interception and misuse by third parties. The Trustee may request
that the Company deliver an Officer&#8217;s Certificate setting forth the names of individuals and/or titles of officers authorized at
such time to furnish the Trustee with Officer&#8217;s Certificates, Company Orders and any other matters or directions pursuant to this
Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)&nbsp;</B></FONT>The
rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified,
are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder and under the Securities, and each agent,
custodian or other person employed to act under this Indenture; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(l)&nbsp;</B></FONT>The
Trustee shall not be deemed to have knowledge of any Default or Event of Default (other than an Event of Default constituting the failure
to pay the interest on, or the principal of, the Securities if the Trustee also serves as the paying agent for such Securities) until
the Trustee shall have received written notification in the manner set forth in this Indenture or a Responsible Officer of the Trustee
shall have obtained actual knowledge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.03
Trustee Not Responsible for Recitals or Issuance or Securities</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>The
recitals contained herein and in the Securities shall be taken as the statements of the Company, and the Trustee assumes no responsibility
for the correctness of the same. The Trustee shall not be responsible for any statement in any registration statement, prospectus, or
any other document in connection with the sale of Securities. The Trustee shall not be responsible for any rating on the Securities or
any action or omission of any rating agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>The
Trustee makes no representations as to the validity or sufficiency of this Indenture or of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>The
Trustee shall not be accountable for the use or application by the Company of any of the Securities or of the proceeds of such Securities,
or for the use or application of any moneys paid over by the Trustee in accordance with any provision of this Indenture or established
pursuant to Section&nbsp;2.01, or for the use or application of any moneys received by any paying agent other than the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.04
May&nbsp;Hold Securities</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Trustee or any paying agent or Security Registrar,
in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have if it were not
Trustee, paying agent or Security Registrar.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.05
Moneys Held in Trust</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to the provisions of Section&nbsp;11.05,
all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which they were
received, but need not be segregated from other funds except to the extent required by law. The Trustee shall be under no liability for
interest on any moneys received by it hereunder except such as it may agree with the Company to pay thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.06
Compensation and Reimbursement</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>The
Company shall pay to the Trustee for each of its capacities hereunder from time to time compensation for its services as the Company and
the Trustee shall from time to time agree upon in writing. The Trustee&#8217;s compensation shall not be limited by any law on compensation
of a trustee of an express trust. The Company shall reimburse the Trustee upon request for all reasonable out-of-pocket expenses incurred
by it. Such expenses shall include the reasonable compensation and expenses of the Trustee&#8217;s agents and counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>The
Company shall indemnify each of the Trustee in each of its capacities hereunder against any loss, liability or expense (including the
cost of defending itself and including the reasonable compensation and expenses of the Trustee&#8217;s agents and counsel) incurred by
it except as set forth in Section&nbsp;7.06(c)&nbsp;in the exercise or performance of its powers, rights or duties under this Indenture
as Trustee or Agent. The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. The Company shall defend
the claim and the Trustee shall cooperate in the defense. The Trustee may have one separate counsel and the Company shall pay the reasonable
fees and expenses of such counsel. The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably
withheld. This indemnification shall apply to officers, directors, employees, shareholders and agents of the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>The
Company need not reimburse any expense or indemnify against any loss or liability incurred by the Trustee or by any officer, director,
employee, shareholder or agent of the Trustee through negligence or bad faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;</B></FONT>To
ensure the Company&#8217;s payment obligations in this Section, the Trustee shall have a lien prior to the Securities on all funds or
property held or collected by the Trustee, except that held in trust to pay principal of or interest on particular Securities. When the
Trustee incurs expenses or renders services in connection with an Event of Default specified in Section&nbsp;6.01(4)&nbsp;or (5), the
expenses (including the reasonable fees and expenses of its counsel) and the compensation for services in connection therewith are to
constitute expenses of administration under any bankruptcy law. The provisions of this Section&nbsp;7.06 shall survive the termination
of this Indenture and the resignation or removal of the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.07
Reliance on Officer&#8217;s Certificate</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Except as otherwise provided in Section&nbsp;7.01,
whenever in the administration of the provisions of this Indenture the Trustee shall deem it reasonably necessary or desirable that a
matter be proved or established prior to taking or suffering or omitting to take any action hereunder, such matter (unless other evidence
in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part of the Trustee, be deemed
to be conclusively proved and established by an Officer&#8217;s Certificate delivered to the Trustee and such certificate, in the absence
of negligence or bad faith on the part of the Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted
to be taken by it under the provisions of this Indenture upon the faith thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.08
Disqualification; Conflicting Interests</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Trustee has or shall acquire any &#8220;conflicting
interest&#8221; within the meaning of Section&nbsp;310(b)&nbsp;of the Trust Indenture Act, the Trustee and the Company shall in all respects
comply with the provisions of Section&nbsp;310(b)&nbsp;of the Trust Indenture Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.09
Corporate Trustee Required; Eligibility</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There shall at all times be a Trustee with respect
to the Securities issued hereunder which shall at all times be a corporation organized and doing business under the laws of the United
States of America or any state or territory thereof or of the District of Columbia, or a corporation or other Person permitted to act
as trustee by the Commission, authorized under such laws to exercise corporate trust powers, having a combined capital and surplus of
at least fifty million U.S. dollars ($50,000,000), and subject to supervision or examination by federal, state, territorial, or District
of Columbia authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If such corporation or other Person publishes
reports of condition at least annually, pursuant to law or to the requirements of the aforesaid supervising or examining authority, then
for the purposes of this Section, the combined capital and surplus of such corporation or other Person shall be deemed to be its combined
capital and surplus as set forth in its most recent report of condition so published. The Company may not, nor may any Person directly
or indirectly controlling, controlled by, or under common control with the Company, serve as Trustee. In case at any time the Trustee
shall cease to be eligible in accordance with the provisions of this Section, the Trustee shall resign immediately in the manner and with
the effect specified in Section&nbsp;7.10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.10
Resignation and Removal; Appointment of Successor</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>The
Trustee or any successor hereafter appointed may at any time resign with respect to the Securities of one or more series by giving written
notice thereof to the Company and the Securityholders of such series. Upon receiving such notice of resignation, the Company shall promptly
appoint a successor trustee with respect to Securities of such series by written instrument, in duplicate, executed by order of the Board
of Directors, one copy of which instrument shall be delivered to the resigning Trustee and one copy to the successor trustee. If no successor
trustee shall have been so appointed and have accepted appointment within 30 days after the sending of such notice of resignation, the
resigning Trustee may petition any court of competent jurisdiction for the appointment of a successor trustee with respect to Securities
of such series, or any Securityholder of that series who has been a bona fide holder of a Security or Securities for at least six months
may on behalf of himself and all others similarly situated, petition any such court for the appointment of a successor trustee. Such court
may thereupon after such notice, if any, as it may deem proper and prescribe, appoint a successor trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>In
case at any time any one of the following shall occur:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;</B></FONT>the
Trustee shall fail to comply with the provisions of Section&nbsp;7.08 after written request therefor by the Company or by any Securityholder
who has been a bona fide holder of a Security or Securities for at least six months; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;</B></FONT>the
Trustee shall cease to be eligible in accordance with the provisions of Section&nbsp;7.09 and shall fail to resign after written request
therefor by the Company or by any such Securityholder; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&nbsp;</B></FONT>the
Trustee shall become incapable of acting, or shall be adjudged a bankrupt or insolvent, or commence a voluntary bankruptcy proceeding,
or a receiver of the Trustee or of its property shall be appointed or consented to, or any public officer shall take charge or control
of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">then, in any such case, the Company may remove
the Trustee with respect to all Securities and appoint a successor trustee by written instrument, in duplicate, executed by order of the
Board of Directors, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or
any Securityholder who has been a bona fide holder of a Security or Securities for at least six months may, on behalf of that holder and
all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor
trustee. Such court may thereupon after such notice, if any, as it may deem proper and prescribe, remove the Trustee and appoint a successor
trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>The
holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding may at any time remove the
Trustee with respect to such series by so notifying the Trustee and the Company and may appoint a successor Trustee for such series with
the consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;</B></FONT>Any
resignation or removal of the Trustee and appointment of a successor trustee with respect to the Securities of a series pursuant to any
of the provisions of this Section&nbsp;shall become effective upon acceptance of appointment by the successor trustee as provided in Section&nbsp;7.11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;</B></FONT>Any
successor trustee appointed pursuant to this Section&nbsp;may be appointed with respect to the Securities of one or more series or all
of such series, and at any time there shall be only one Trustee with respect to the Securities of any particular series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.11
Acceptance of Appointment By Successor</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>In
case of the appointment hereunder of a successor trustee with respect to all Securities, every such successor trustee so appointed shall
execute, acknowledge and deliver to the Company and to the retiring Trustee an instrument accepting such appointment, and thereupon the
resignation or removal of the retiring Trustee shall become effective and such successor trustee, without any further act, deed or conveyance,
shall become vested with all the rights, powers, trusts and duties of the retiring Trustee; but, on the request of the Company or the
successor trustee, such retiring Trustee shall, upon payment of any amounts due to it pursuant to the provisions of Section&nbsp;7.06,
execute and deliver an instrument transferring to such successor trustee all the rights, powers, and trusts of the retiring Trustee and
shall duly assign, transfer and deliver to such successor trustee all property and money held by such retiring Trustee hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>In
case of the appointment hereunder of a successor trustee with respect to the Securities of one or more (but not all) series, the Company,
the retiring Trustee and each successor trustee with respect to the Securities of one or more series shall execute and deliver an indenture
supplemental hereto wherein each successor trustee shall accept such appointment and which (i)&nbsp;shall contain such provisions as shall
be necessary or desirable to transfer and confirm to, and to vest in, each successor trustee all the rights, powers, trusts and duties
of the retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor trustee relates,
(ii)&nbsp;shall contain such provisions as shall be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties
of the retiring Trustee with respect to the Securities of that or those series as to which the retiring Trustee is not retiring shall
continue to be vested in the retiring Trustee, and (iii)&nbsp;shall add to or change any of the provisions of this Indenture as shall
be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, it being understood that
nothing herein or in such supplemental indenture shall constitute such Trustees co-trustees of the same trust, that each such Trustee
shall be trustee of a trust or trusts hereunder separate and apart from any trust or trusts hereunder administered by any other such Trustee
and that no Trustee shall be responsible for any act or failure to act on the part of any other Trustee hereunder; and upon the execution
and delivery of such supplemental indenture the resignation or removal of the retiring Trustee shall become effective to the extent provided
therein, such retiring Trustee shall with respect to the Securities of that or those series to which the appointment of such successor
trustee relates have no further responsibility for the exercise of rights and powers or for the performance of the duties and obligations
vested in the Trustee under this Indenture, and each such successor trustee, without any further act, deed or conveyance, shall become
vested with all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series to
which the appointment of such successor trustee relates; but, on request of the Company or any successor trustee, such retiring Trustee
shall duly assign, transfer and deliver to such successor trustee, to the extent contemplated by such supplemental indenture, the property
and money held by such retiring Trustee hereunder with respect to the Securities of that or those series to which the appointment of such
successor trustee relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>Upon
request of any such successor trustee, the Company shall execute any and all instruments for more fully and certainly vesting in and confirming
to such successor trustee all such rights, powers and trusts referred to in paragraph (a)&nbsp;or (b)&nbsp;of this Section, as the case
may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;</B></FONT>No
successor trustee shall accept its appointment unless at the time of such acceptance such successor trustee shall be qualified and eligible
under this Article.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;</B></FONT>Upon
acceptance of appointment by a successor trustee as provided in this Section, the Company shall send notice of the succession of such
trustee hereunder to the Securityholders. If the Company fails to send such notice within ten days after acceptance of appointment by
the successor trustee, the successor trustee shall cause such notice to be sent at the expense of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.12
Merger, Conversion, Consolidation or Succession to Business</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any corporation into which the Trustee may be
merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to
which the Trustee shall be a party, or any corporation succeeding to all or substantially all the corporate trust business of the Trustee,
including the administration of the trust created by this Indenture, shall be the successor of the Trustee hereunder, provided that such
corporation shall be qualified under the provisions of Section&nbsp;7.08 and eligible under the provisions of Section&nbsp;7.09, without
the execution or filing of any paper or any further act on the part of any of the parties hereto, anything herein to the contrary notwithstanding.
In case any Securities shall have been authenticated, but not delivered, by the Trustee then in office, any successor by merger, conversion
or consolidation to such authenticating Trustee may adopt such authentication and deliver the Securities so authenticated with the same
effect as if such successor Trustee had itself authenticated such Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.13
Preferential Collection of Claims Against the Company</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Trustee shall comply with Section&nbsp;311(a)&nbsp;of
the Trust Indenture Act, excluding any creditor relationship described in Section&nbsp;311(b)&nbsp;of the Trust Indenture Act. A Trustee
who has resigned or been removed shall be subject to Section&nbsp;311(a)&nbsp;of the Trust Indenture Act to the extent included therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;7.14
Notice of Default</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If any Event of Default occurs and is continuing
and if such Event of Default is known to a Responsible Officer of the Trustee, the Trustee shall send to each Securityholder in the manner
and to the extent provided in Section&nbsp;313(c)&nbsp;of the Trust Indenture Act notice of the Event of Default within the earlier of
90 days after it occurs and 30 days after it is known to a Responsible Officer of the Trustee or written notice of it is received by the
Trustee, unless such Event of Default has been cured; <I>provided, however</I>, that, except in the case of a default in the payment of
the principal of (or premium, if any) or interest on any Security, the Trustee shall be protected in withholding such notice if and so
long as the Responsible Officers of the Trustee in good faith determine that the withholding of such notice is in the interest of the
Securityholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONCERNING THE SECURITYHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;8.01
Evidence of Action by Securityholders</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Whenever in this Indenture it is provided that
the holders of a majority or specified percentage in aggregate principal amount of the Securities of a particular series may take any
action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action),
the fact that at the time of taking any such action the holders of such majority or specified percentage of that series have joined therein
may be evidenced by any instrument or any number of instruments of similar tenor executed by such holders of Securities of that series
in person or by agent or proxy appointed in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Company shall solicit from the Securityholders
of any series any request, demand, authorization, direction, notice, consent, waiver or other action, the Company may, at its option,
as evidenced by an Officer&#8217;s Certificate, fix in advance a record date for such series for the determination of Securityholders
entitled to give such request, demand, authorization, direction, notice, consent, waiver or other action, but the Company shall have no
obligation to do so. If such a record date is fixed, such request, demand, authorization, direction, notice, consent, waiver or other
action may be given before or after the record date, but only the Securityholders of record at the close of business on the record date
shall be deemed to be Securityholders for the purposes of determining whether Securityholders of the requisite proportion of Outstanding
Securities of that series have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver
or other action, and for that purpose the Outstanding Securities of that series shall be computed as of the record date; provided, however,
that no such authorization, agreement or consent by such Securityholders on the record date shall be deemed effective unless it shall
become effective pursuant to the provisions of this Indenture not later than six months after the record date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;8.02
Proof of Execution by Securityholders</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to the provisions of Section&nbsp;7.01,
proof of the execution of any instrument by a Securityholder (such proof will not require notarization) or his or her agent or proxy and
proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>The
fact and date of the execution by any such Person of any instrument may be proved in any reasonable manner acceptable to the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>The
ownership of Securities shall be proved by the Security Register of such Securities or by a certificate of the Security Registrar thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Trustee may require such additional proof of any matter referred
to in this Section&nbsp;as it shall deem necessary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;8.03
Who May&nbsp;be Deemed Owners</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Prior to the due presentment for registration
of transfer of any Security, the Company, the Trustee, any paying agent and any Security Registrar may deem and treat the Person in whose
name such Security shall be registered upon the books of the Security Registrar as the absolute owner of such Security (whether or not
such Security shall be overdue and notwithstanding any notice of ownership or writing thereon made by anyone other than the Security Registrar)
for the purpose of receiving payment of or on account of the principal of, premium, if any, and (subject to Section&nbsp;2.03) interest
on such Security and for all other purposes; and neither the Company nor the Trustee nor any paying agent nor any Security Registrar shall
be affected by any notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;8.04
Certain Securities Owned by Company Disregarded</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In determining whether the holders of the
requisite aggregate principal amount of Securities of a particular series have concurred in any direction, consent or waiver under
this Indenture, the Securities of that series that are owned by the Company or any other obligor on the Securities of that series or
by any Person directly or indirectly controlling or controlled by or under common control with the Company or any other obligor on
the Securities of that series shall be disregarded and deemed not to be Outstanding for the purpose of any such determination,
except that for the purpose of determining whether the Trustee shall be protected in relying on any such direction, consent or
waiver, only Securities of such series that the Trustee actually knows are so owned shall be so disregarded. The Securities so owned
that have been pledged in good faith may be regarded as Outstanding for the purposes of this Section, if the pledgee shall establish
to the satisfaction of the Trustee the pledgee&#8217;s right so to act with respect to such Securities and that the pledgee is not a
Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company or any such
other obligor. In case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full
protection to the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;8.05
Actions Binding on Future Securityholders</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At any time prior to (but not after) the evidencing
to the Trustee, as provided in Section&nbsp;8.01, of the taking of any action by the holders of the majority or percentage in aggregate
principal amount of the Securities of a particular series specified in this Indenture in connection with such action, any holder of a
Security of that series that is shown by the evidence to be included in the Securities the holders of which have consented to such action
may, by filing written notice with the Trustee, and upon proof of holding as provided in Section&nbsp;8.02, revoke such action so far
as concerns such Security. Except as aforesaid any such action taken by the holder of any Security shall be conclusive and binding upon
such holder and upon all future holders and owners of such Security, and of any Security issued in exchange therefor, on registration
of transfer thereof or in place thereof, irrespective of whether or not any notation in regard thereto is made upon such Security. Any
action taken by the holders of the majority or percentage in aggregate principal amount of the Securities of a particular series specified
in this Indenture in connection with such action shall be conclusively binding upon the Company, the Trustee and the holders of all the
Securities of that series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;9</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUPPLEMENTAL INDENTURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;9.01
Supplemental Indentures Without the Consent of Securityholders</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition to any supplemental indenture otherwise
authorized by this Indenture, the Company and the Trustee may from time to time and at any time enter into an indenture or indentures
supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect), without the consent of the Securityholders,
for one or more of the following purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>to
cure any ambiguity, defect, or inconsistency herein or in the Securities of any series;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>to
comply with Article&nbsp;Ten;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>to
provide for uncertificated Securities in addition to or in place of certificated Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;</B></FONT>to
add to the covenants, restrictions, conditions or provisions relating to the Company for the benefit of the holders of all or any series
of Securities (and if such covenants, restrictions, conditions or provisions are to be for the benefit of less than all series of Securities,
stating that such covenants, restrictions, conditions or provisions are expressly being included solely for the benefit of such series),
to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions
or provisions an Event of Default, or to surrender any right or power herein conferred upon the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;</B></FONT>to
add to, delete from, or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes of issue, authentication,
and delivery of Securities, as herein set forth;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;</B></FONT>to
make any change that does not adversely affect the rights of any Securityholder in any material respect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;</B></FONT>to
provide for the issuance of and establish the form and terms and conditions of the Securities of any series as provided in Section&nbsp;2.01,
to establish the form of any certifications required to be furnished pursuant to the terms of this Indenture or any series of Securities,
or to add to the rights of the holders of any series of Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;</B></FONT>to
evidence and provide for the acceptance of appointment hereunder by a successor trustee; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;</B></FONT>to
comply with any requirements of the Commission or any successor in connection with the qualification of this Indenture under the Trust
Indenture Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Trustee is hereby authorized to join with
the Company in the execution of any such supplemental indenture, and to make any further appropriate agreements and stipulations that
may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture that affects the Trustee&#8217;s
own rights, duties or immunities under this Indenture or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any supplemental indenture authorized by the provisions
of this Section&nbsp;may be executed by the Company and the Trustee without the consent of the holders of any of the Securities at the
time Outstanding, notwithstanding any of the provisions of Section&nbsp;9.02.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;9.02
Supplemental Indentures With Consent of Securityholders</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">With the consent (evidenced as provided in Section&nbsp;8.01)
of the holders of not less than a majority in aggregate principal amount of the Securities of each series affected by such supplemental
indenture or indentures at the time Outstanding, the Company, when authorized by a Board Resolution, and the Trustee may from time to
time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture
Act as then in effect) for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of
this Indenture or of any supplemental indenture or of modifying in any manner not covered by Section&nbsp;9.01 the rights of the holders
of the Securities of such series under this Indenture; provided, however, that no such supplemental indenture shall, without the consent
of the holders of each Security then Outstanding and affected thereby, (a)&nbsp;extend the fixed maturity of any Securities of any series,
or reduce the principal amount thereof, or reduce the rate or extend the time of payment of interest thereon, or reduce any premium payable
upon the redemption thereof or (b)&nbsp;reduce the aforesaid percentage of Securities, the holders of which are required to consent to
any such supplemental indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">It shall not be necessary for the consent of the
Securityholders of any series affected thereby under this Section&nbsp;to approve the particular form of any proposed supplemental indenture,
but it shall be sufficient if such consent shall approve the substance thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;9.03
Effect of Supplemental Indentures</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon the execution of any supplemental indenture
pursuant to the provisions of this Article&nbsp;or of Section&nbsp;10.01, this Indenture shall, with respect to such series, be and be
deemed to be modified and amended in accordance therewith and the respective rights, limitations of rights, obligations, duties and immunities
under this Indenture of the Trustee, the Company and the holders of Securities of the series affected thereby shall thereafter be determined,
exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions of any
such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;9.04
Securities Affected by Supplemental Indentures</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Securities of any series affected by a supplemental
indenture, authenticated and delivered after the execution of such supplemental indenture pursuant to the provisions of this Article&nbsp;or
of Section&nbsp;10.01, may bear a notation in form approved by the Company, provided such form meets the requirements of any securities
exchange upon which such series may be listed, as to any matter provided for in such supplemental indenture. If the Company shall so determine,
new Securities of that series so modified as to conform, in the opinion of the Board of Directors, to any modification of this Indenture
contained in any such supplemental indenture may be prepared by the Company, authenticated by the Trustee and delivered in exchange for
the Securities of that series then Outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;9.05
Execution of Supplemental Indentures</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon the request of the Company, accompanied by
its Board Resolutions authorizing the execution of any such supplemental indenture, and upon the filing with the Trustee of evidence of
the consent of Securityholders required to consent thereto as aforesaid, the Trustee shall join with the Company in the execution of such
supplemental indenture unless such supplemental indenture affects the Trustee&#8217;s own rights, duties or immunities under this Indenture
or otherwise, in which case the Trustee may in its discretion but shall not be obligated to enter into such supplemental indenture. The
Trustee, subject to the provisions of Section&nbsp;7.01, shall receive an Officer&#8217;s Certificate or an Opinion of Counsel as conclusive
evidence that any supplemental indenture executed pursuant to this Article&nbsp;is authorized or permitted by the terms of this Article&nbsp;and
that all conditions precedent to the execution of the supplemental indenture have been complied with; provided, however, that such Officer&#8217;s
Certificate or Opinion of Counsel need not be provided in connection with the execution of a supplemental indenture that establishes the
terms of a series of Securities pursuant to Section&nbsp;2.01 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Promptly after the execution by the Company and
the Trustee of any supplemental indenture pursuant to the provisions of this Section, the Company shall (or shall direct the Trustee to)
send a notice, setting forth in general terms the substance of such supplemental indenture, to the Securityholders of all series affected
thereby .as their names and addresses appear upon the Security Register. Any failure of the Company to send, or cause the sending of,
such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;10</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUCCESSOR ENTITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Section&nbsp;10.01 Company May&nbsp;Consolidate,
Etc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Nothing contained in this Indenture shall prevent
any consolidation or merger of the Company with or into any other Person (whether or not affiliated with the Company) or successive consolidations
or mergers in which the Company or its successor or successors shall be a party or parties, or shall prevent any sale, conveyance, transfer
or other disposition of the property of the Company or its successor or successors as an entirety, or substantially as an entirety, to
any other Person (whether or not affiliated with the Company or its successor or successors); provided, however, the Company hereby covenants
and agrees that, upon any such consolidation or merger (in each case, if the Company is not the survivor of such transaction) or any such
sale, conveyance, transfer or other disposition (other than a sale, conveyance, transfer or other disposition to a Subsidiary of the Company),
the due and punctual payment of the principal of (premium, if any) and interest on all of the Securities of all series in accordance with
the terms of each series, according to their tenor, and the due and punctual performance and observance of all the covenants and conditions
of this Indenture with respect to each series or established with respect to such series pursuant to Section&nbsp;2.01 to be kept or performed
by the Company shall be expressly assumed, by supplemental indenture (which shall conform to the provisions of the Trust Indenture Act,
as then in effect) reasonably satisfactory in form to the Trustee executed and delivered to the Trustee by the entity formed by such consolidation,
or into which the Company shall have been merged, or by the entity which shall have acquired such property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;10.02
Successor Entity Substituted</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>In
case of any such consolidation, merger, sale, conveyance, transfer or other disposition and upon the assumption by the successor entity
by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the obligations set forth
under Section&nbsp;10.01 on all of the Securities of all series Outstanding, such successor entity shall succeed to and be substituted
for the Company with the same effect as if it had been named as the Company herein, and thereupon the predecessor corporation shall be
relieved of all obligations and covenants under this Indenture and the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>In
case of any such consolidation, merger, sale, conveyance, transfer or other disposition, such changes in phraseology and form (but not
in substance) may be made in the Securities thereafter to be issued as may be appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B></FONT>Nothing
contained in this Article&nbsp;shall require any action by the Company in the case of a consolidation or merger of any Person into the
Company where the Company is the survivor of such transaction, or the acquisition by the Company, by purchase or otherwise, of all or
any part of the property of any other Person (whether or not affiliated with the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;11</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SATISFACTION AND DISCHARGE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;11.01
Satisfaction and Discharge of Indenture</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If at any time: (a)&nbsp;the Company shall have
delivered to the Trustee for cancellation all Securities of a series theretofore authenticated and not delivered to the Trustee for cancellation
(other than any Securities that shall have been destroyed, lost or stolen and that shall have been replaced or paid as provided in Section&nbsp;2.07
and Securities for whose payment money or Governmental Obligations have theretofore been deposited in trust or segregated and held in
trust by the Company and thereupon repaid to the Company or discharged from such trust, as provided in Section&nbsp;11.05); or (b)&nbsp;all
such Securities of a particular series not theretofore delivered to the Trustee for cancellation shall have become due and payable, or
are by their terms to become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory
to the Trustee for the giving of notice of redemption, and the Company shall deposit or cause to be deposited with the Trustee as trust
funds the entire amount in moneys or Governmental Obligations or a combination thereof, sufficient in the opinion of a nationally recognized
firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay at maturity or upon
redemption all Securities of that series not theretofore delivered to the Trustee for cancellation, including principal (and premium,
if any) and interest due or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company
shall also pay or cause to be paid all other sums payable hereunder with respect to such series by the Company then this Indenture shall
thereupon cease to be of further effect with respect to such series except for the provisions of Sections 2.03, 2.05, 2.07, 4.01, 4.02,
4.03, 7.10, 11.05 and 13.04, that shall survive until the date of maturity or redemption date, as the case may be, and Sections 7.06 and
11.05, that shall survive to such date and thereafter, and the Trustee, on demand of the Company and at the cost and expense of the Company
shall execute proper instruments acknowledging satisfaction of and discharging this Indenture with respect to such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;11.02
Discharge of Obligations</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If at any time all such Securities of a particular
series not heretofore delivered to the Trustee for cancellation or that have not become due and payable as described in Section&nbsp;11.01
shall have been paid by the Company by depositing irrevocably with the Trustee as trust funds moneys or an amount of Governmental Obligations
sufficient to pay at maturity or upon redemption all such Securities of that series not theretofore delivered to the Trustee for cancellation,
including principal (and premium, if any) and interest due or to become due to such date of maturity or date fixed for redemption, as
the case may be, and if the Company shall also pay or cause to be paid all other sums payable hereunder by the Company with respect to
such series, then after the date such moneys or Governmental Obligations, as the case may be, are deposited with the Trustee the obligations
of the Company under this Indenture with respect to such series shall cease to be of further effect except for the provisions of Sections
2.03, 2.05, 2.07, 4,01, 4.02, 4,03, 7.06, 7.10, 11.05 and 13.04 hereof that shall survive until such Securities shall mature and be paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Thereafter, Sections 7.06 and 11.05 shall survive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;11.03
Deposited Moneys to be Held in Trust</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All moneys or Governmental Obligations deposited
with the Trustee pursuant to Sections 11.01 or 11.02 shall be held in trust and shall be available for payment as due, either directly
or through any paying agent (including the Company acting as its own paying agent), to the holders of the particular series of Securities
for the payment or redemption of which such moneys or Governmental Obligations have been deposited with the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;11.04
Payment of Moneys Held by Paying Agents</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the satisfaction and discharge
of this Indenture all moneys or Governmental Obligations then held by any paying agent under the provisions of this Indenture shall, upon
demand of the Company, be paid to the Trustee and thereupon such paying agent shall be released from all further liability with respect
to such moneys or Governmental Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;11.05
Repayment to Company</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any moneys or Governmental Obligations deposited
with any paying agent or the Trustee, or then held by the Company, in trust for payment of principal of or premium, if any, or interest
on the Securities of a particular series that are not applied but remain unclaimed by the holders of such Securities for at least two
years after the date upon which the principal of (and premium, if any) or interest on such Securities shall have respectively become due
and payable, or such other shorter period set forth in applicable escheat or abandoned or unclaimed property law, shall be repaid to the
Company on May&nbsp;31 of each year or upon the Company&#8217;s request or (if then held by the Company) shall be discharged from such
trust; and thereupon the paying agent and the Trustee shall be released from all further liability with respect to such moneys or Governmental
Obligations, and the holder of any of the Securities entitled to receive such payment shall thereafter, as a general creditor, look only
to the Company for the payment thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;12</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IMMUNITY OF INCORPORATORS, SHAREHOLDERS, OFFICERS
AND DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;12.01
No Recourse</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No recourse under or upon any obligation, covenant
or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect thereof, shall be had against
any incorporator, shareholder, officer or director, past, present or future as such, of the Company or of any predecessor or successor
corporation, either directly or through the Company or any such predecessor or successor corporation, whether by virtue of any constitution,
statute or rule&nbsp;of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this
Indenture and the obligations issued hereunder are solely corporate obligations, and that no such personal liability whatever shall attach
to, or is or shall be incurred by, the incorporators, shareholders, officers or directors as such, of the Company or of any predecessor
or successor corporation, or any of them, because of the creation of the indebtedness hereby authorized, or under or by reason of the
obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom; and that any and all
such personal liability of every name and nature, either at common law or in equity or by constitution or statute, of, and any and all
such rights and claims against, every such incorporator, shareholder, officer or director as such, because of the creation of the indebtedness
hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities
or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture
and the issuance of such Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;13</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MISCELLANEOUS PROVISIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.01
Effect on Successors and Assigns</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All the covenants, stipulations, promises and
agreements in this Indenture made by or on behalf of the Company shall bind its successors and assigns, whether so expressed or not.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.02
Actions by Successor</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any act or proceeding by any provision of this
Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and may be done and performed
with like force and effect by the corresponding board, committee or officer of any corporation that shall at the time be the lawful successor
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.03
Surrender of Company Powers</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company by instrument in writing executed
by authority of its Board of Directors and delivered to the Trustee may surrender any of the powers reserved to the Company, and thereupon
such power so surrendered shall terminate both as to the Company and as to any successor corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.04
Notices</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Except as otherwise expressly provided herein,
any notice, request or demand that by any provision of this Indenture is required or permitted to be given, made or served by the Trustee,
the Security Registrar, any paying or other agent under this Indenture or by the holders of Securities or by any other Person pursuant
to this Indenture to or on the Company may be given or served by being deposited in first class mail, postage prepaid, addressed (until
another address is filed in writing by the Company with the Trustee), as follows:<U>&nbsp;&nbsp;&nbsp;&nbsp;</U>. Any notice, election,
request or demand by the Company or any Securityholder or by any other Person pursuant to this Indenture to or upon the Trustee shall
be deemed to have been sufficiently given or made, for all purposes, if given or made in writing at the Corporate Trust Office of the
Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.05
Governing Law; Jury Trial Waiver</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This Indenture and each Security shall be governed
by, and construed in accordance with, the internal laws of the State of New York, except to the extent that the Trust Indenture Act is
applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">EACH PARTY HERETO, AND EACH HOLDER OF A SECURITY
BY ACCEPTANCE THEREOF, HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY&nbsp;HAVE TO A TRIAL BY JURY
IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS INDENTURE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.06
Treatment of Securities as Debt</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">It is intended that the Securities will be treated
as indebtedness and not as equity for federal income tax purposes. The provisions of this Indenture shall be interpreted to further this
intention.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.07
Certificates and Opinions as to Conditions Precedent</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B></FONT>Upon
any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company
shall furnish to the Trustee an Officer&#8217;s Certificate stating that all conditions precedent provided for in this Indenture (other
than the certificate to be delivered pursuant to Section&nbsp;13.12) relating to the proposed action have been complied with and, if requested,
an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have been complied with, except that in
the case of any such application or demand as to which the furnishing of such documents is specifically required by any provision of this
Indenture relating to such particular application or demand, no additional certificate or opinion need be furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B></FONT>Each
certificate or opinion provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition or covenant
in this Indenture (other than the certificate to be delivered pursuant to Section&nbsp;13.12 of this Indenture or Section&nbsp;314(a)(1)&nbsp;of
the Trust Indenture Act) shall include (i)&nbsp;a statement that the Person making such certificate or opinion has read such covenant
or condition; (ii)&nbsp;a brief statement as to the nature and scope of the examination or investigation upon which the statements or
opinions contained in such certificate or opinion are based; (iii)&nbsp;a statement that, in the opinion of such Person, he has made such
examination or investigation as is reasonably necessary to enable him to express an informed opinion as to whether or not such covenant
or condition has been complied with; and (iv)&nbsp;a statement as to whether or not, in the opinion of such Person, such condition or
covenant has been complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.08
Payments on Business Days</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Except as provided pursuant to Section&nbsp;2.01
pursuant to a Board Resolution, and set forth in an Officer&#8217;s Certificate, or established in one or more indentures supplemental
to this Indenture, in any case where the date of maturity of interest or principal of any Security or the date of redemption of any Security
shall not be a Business Day, then payment of interest or principal (and premium, if any) may be made on the next succeeding Business
Day with the same force and effect as if made on the nominal date of maturity or redemption, and no interest shall accrue for the period
after such nominal date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.09
Conflict with Trust Indenture Act</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If and to the extent that any provision of this
Indenture limits, qualifies or conflicts with the duties imposed by Section&nbsp;318(c)&nbsp;of the Trust Indenture Act, such imposed
duties shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.10
Counterparts</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This Indenture may be executed in any number of
counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument. The
exchange of copies of this Indenture and of signature pages&nbsp;by facsimile or PDF transmission shall constitute effective execution
and delivery of this Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures
of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.11
Separability</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In case any one or more of the provisions contained
in this Indenture or in the Securities of any series shall for any reason be held to be invalid, illegal or unenforceable in any respect,
such invalidity, illegality or unenforceability shall not affect any other provisions of this Indenture or of such Securities, but this
Indenture and such Securities shall be construed as if such invalid or illegal or unenforceable provision had never been contained herein
or therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.12
Compliance Certificates</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company shall deliver to the Trustee, within 120 days after the
end of each fiscal year during which any Securities of any series were outstanding, an officer&#8217;s certificate stating whether or
not the signers know of any Event of Default that occurred during such fiscal year. Such certificate shall contain a certification from
the principal executive officer, principal financial officer or principal accounting officer of the Company that a review has been conducted
of the activities of the Company and the Company&#8217;s performance under this Indenture and that the Company has complied with all conditions
and covenants under this Indenture. For purposes of this Section&nbsp;13.12, such compliance shall be determined without regard to any
period of grace or requirement of notice provided under this Indenture. If the officer of the Company signing such certificate has knowledge
of such an Event of Default, the certificate shall describe any such Event of Default and its status.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.13
U.S.A Patriot Act</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The parties hereto acknowledge that in accordance with Section&nbsp;326
of the U.S.A. Patriot Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money
laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship
or opens an account with the Trustee. The parties to this Indenture agree that they will provide the Trustee with such information as
it may request in order for the Trustee to satisfy the requirements of the U.S.A. Patriot Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;13.14
Force Majeure</B></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In no event shall the Trustee, the Security Registrar,
any paying agent or any other agent under this Indenture be responsible or liable for any failure or delay in the performance of its obligations
hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including without limitation, strikes, work
stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions,
loss or malfunctions or utilities, communications or computer (software and hardware) services; it being understood that the Trustee,
the Security Registrar, any paying agent or any other agent under this Indenture shall use reasonable efforts which are consistent with
accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Section&nbsp;13.15 Table of Contents; Headings.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The table of contents and headings of the articles
and sections of this Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof,
and will not modify or restrict any of the terms or provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I</B></FONT><B><FONT STYLE="font-size: 10pt">N</FONT>
W<FONT STYLE="font-size: 10pt">ITNESS</FONT> W<FONT STYLE="font-size: 10pt">HEREOF</FONT></B>, the parties hereto have caused this Indenture
to be duly executed all as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BELITE BIO,&nbsp;INC</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; width: 45%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD>
    </TR>

<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>

<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[T</B></FONT><B><FONT STYLE="font-size: 10pt">RUSTEE</FONT>]</B>,
as Trustee</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; width: 45%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD>
    </TR>

<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>

<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CROSS-REFERENCE TABLE (1)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 59%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 39%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;of Trust Indenture Act of 1939, as Amended</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section&nbsp;of Indenture </B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">310(a)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.09</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">310(b)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.08</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.10</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">310(c)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inapplicable</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311(a)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.13</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311(b)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.13</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">311(c)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inapplicable</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">312(a)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.01</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.02(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">312(b)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.02(c)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">312(c)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.02(c)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">313(a)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.04(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">313(b)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.04(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">313(c)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.04(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.04(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">313(d)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.04(c)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314(a)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.12</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314(b)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inapplicable</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314(c)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.07(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314(d)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inapplicable</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314(e)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.07(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">314(f)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inapplicable</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">315(a)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.01(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.01(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">315(b)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.14</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">315(c)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.01</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">315(d)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.01(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">315(e)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.07</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316(a)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.06</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.04</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316(b)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.04</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316(c)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.01</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">317(a)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.02</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">317(b)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.03</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">318(a)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.09</FONT></TD></TR>
  </TABLE>
<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>tm2316412d2_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm2316412d2_ex5-1img01.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 10%; text-align: left"><FONT STYLE="font-size: 10pt"><B>Our ref</B></FONT></TD><TD STYLE="text-align: justify; width: 90%">YCU/740921-000004/26519435v2</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Belite Bio,&nbsp;Inc</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">12750 High Bluff Drive Suite&nbsp;475</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">San Diego, CA 92130</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">22 May&nbsp;2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Sirs</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Belite Bio,&nbsp;Inc</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as Cayman Islands legal advisers
to Belite Bio,&nbsp;Inc (the &quot;<B>Company</B>&quot;) in connection with the Company&rsquo;s registration statement on Form&nbsp;F-3,
including all amendments or supplements thereto (the &quot;<B>Registration Statement</B>&quot;), filed with the Securities and Exchange
Commission under the U.S. Securities Act of 1933, as amended to date relating to securities to be issued and sold by the Company from
time to time. Such securities include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">certain ordinary shares of the Company with a par value of US$0.0001 each (the &quot;<B>Shares</B>&quot;),
including in the form of American depositary shares, each representing one Share (the &quot;<B>ADSs</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">certain preferred shares of the Company with a par value of US$0.0001 each (the &quot;<B>Preferred Shares</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">warrants to subscribe for ADSs, Shares and/or Preferred Shares of the Company (the &quot;<B>Warrants</B>&quot;)
to be issued under warrant agreements to be entered into between the Company and the warrant agent for such Warrants thereunder (the &quot;<B>Warrant
Agreements</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">overallotment purchase rights to purchase ADSs, Shares, Preferred Shares, Warrants, Subscription Rights
(as defined below) and/or Units (as defined below) of the Company (the &quot;<B>Overallotment Purchase Rights</B>&quot;) to be issued
under overallotment purchase rights agreements to be entered into between the Company and a bank or trust company, as rights agent for
such Overallotment Purchase Rights (the &quot;<B>Overallotment Purchase Rights Agreements</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">subscription rights to purchase ADSs, Shares and/or Preferred Shares of the Company (the &quot;<B>Subscription
Rights</B>&quot;) to be issued under standby underwriting agreements to be entered into among the Company and one or more underwriters
for such Subscription Rights thereunder (the &quot;<B>Subscription Rights Agreements</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">units comprising of one or more of the ADSs, Shares, Preferred Shares, Warrants, Overallotment Purchase
Rights, Subscription Rights, Capital Notes (as defined below) or Debt Securities (as defined below) in any combination (the &quot;<B>Units</B>&quot;)
to be issued under unit agreements to be entered into between the Company and the unitholder for such Units thereunder (the &quot;<B>Unit
Agreements</B>&quot;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">capital notes of the Company which are convertible into ADSs or Shares (the &quot;<B>Capital Notes</B>&quot;)
to be issued under purchase agreements to be entered into between the Company and the purchasers of such Capital Notes (the &quot;<B>Capital
Notes Purchase Agreements</B>&quot;); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">debt securities of the Company, which may include debt securities exchangeable for or convertible into
Shares or Preferred Shares (collectively the &quot;<B>Debt Securities</B>&quot;), each series of Debt Securities to be issued under indentures
to be entered into by the Company and the trustee for such Debt Securities (the &quot;<B>Indentures</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are furnishing this opinion as Exhibits 5.1
and 23.1 to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1</B></TD><TD STYLE="text-align: justify"><B>Documents Reviewed</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of this opinion, we have reviewed
only originals, copies or final drafts of the following documents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">The certificate of incorporation of the Company dated 27 March&nbsp;2018 and the certificate of incorporation
on change of name of the Company dated 8 October&nbsp;2018 issued by the Registrar of Companies in the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">The third amended and restated memorandum and articles of association of the Company as conditionally
adopted by a special resolution passed on 5 April&nbsp;2022 and effective immediately prior to the completion of the initial public offering
of the Company&rsquo;s ADSs representing its Shares (the &quot;<B>Memorandum and Articles</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.3</TD><TD STYLE="text-align: justify">The written resolutions of the board of directors of the Company (the &quot;<B>Board</B>&quot;) dated
1 May&nbsp;2023 and 22 May&nbsp;2023 (together, the &quot;<B>Resolutions</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.4</TD><TD STYLE="text-align: justify">A certificate from a director of the Company, a copy of which is attached hereto (the &quot;<B>Director's
Certificate</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.5</TD><TD STYLE="text-align: justify">A certificate of good standing dated 27 March&nbsp;2023, issued by the Registrar of Companies in the Cayman
Islands (the &quot;<B>Certificate of Good Standing</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.6</TD><TD STYLE="text-align: justify">The Registration Statement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2</B></TD><TD STYLE="text-align: justify"><B>Assumptions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following opinions are given only as to, and
based on, circumstances and matters of fact existing and known to us on the date of this opinion letter. These opinions only relate to
the laws of the Cayman Islands which are in force on the date of this opinion letter. In giving these opinions we have relied (without
further verification) upon the completeness and accuracy, as of the date of this opinion letter, of the Director's Certificate and the
Certificate of Good Standing. We have also relied upon the following assumptions, which we have not independently verified:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.1</TD><TD STYLE="text-align: justify">Copies of documents, conformed copies or drafts of documents provided to us are true and complete copies
of, or in the final forms of, the originals.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.2</TD><TD STYLE="text-align: justify">All signatures, initials and seals are genuine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.3</TD><TD STYLE="text-align: justify">There is no contractual or other prohibition or restriction (other than as arising under Cayman Islands
law) binding on the Company prohibiting or restricting it from entering into and performing its obligations under the Registration Statement
and a duly authorised, executed and delivered Warrant Agreement, Overallotment Purchase Rights Agreement, Subscription Rights Agreement,
Unit Agreement, Capital Notes Purchase Agreement or Indenture.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.4</TD><TD STYLE="text-align: justify">The Company will have sufficient authorised capital to effect the issue of the Shares and Preferred Shares
at the time of issuance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.5</TD><TD STYLE="text-align: justify">The Warrant Agreements and the Warrants, the Overallotment Purchase Rights Agreements and the Overallotment
Purchase Rights, the Subscription Rights Agreements and the Subscription Rights, the Unit Agreements and the Units, the Capital Notes
Purchase Agreements and the Capital Notes, and the Indentures and the Debt Securities will be legal, valid, binding and enforceable against
all relevant parties in accordance with their terms under the laws of the State of New York and all other relevant laws (other than, with
respect to the Company, the laws of the Cayman Islands).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.6</TD><TD STYLE="text-align: justify">The choice of the laws of the State of New York as the governing law of the Warrant Agreements and the
Warrants, the Overallotment Purchase Rights Agreements and the Overallotment Purchase Rights, the Subscription Agreements and the Subscription
Rights, the Unit Agreements and the Units, the Capital Notes Purchase Agreements and the Capital Notes, and the Indentures and the Debt
Securities, will be made in good faith and would be regarded as a valid and binding selection which will be upheld by the courts of the
State of New York and any other relevant jurisdiction (other than the Cayman Islands) as a matter of the laws of the State of New York
and all other relevant laws (other than the laws of the Cayman Islands).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.7</TD><TD STYLE="text-align: justify">The capacity, power, authority and legal right of all parties under all relevant laws and regulations
(other than, with respect to the Company, the laws and regulations of the Cayman Islands) to enter into, execute, unconditionally deliver
and perform their respective obligations under the Warrant Agreements and the Warrants, the Overallotment Purchase Rights Agreements and
the Overallotment Purchase Rights, the Subscription Rights Agreements and the Subscription Rights, the Unit Agreements and the Units,
the Capital Notes Purchase Agreements and the Capital Notes, and the Indentures and the Debt Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.8</TD><TD STYLE="text-align: justify">No monies paid to or for the account of the Company in respect of the Shares, the Preferred Shares, the
Warrants, the Overallotment Purchase Rights, the Subscription Rights, the Units, the Capital Notes or Debt Securities represent or will
represent proceeds of criminal conduct or criminal property or terrorist property (as defined in the Proceeds of Crime Act (As Revised)
and the Terrorism Act (As Revised) respectively).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.9</TD><TD STYLE="text-align: justify">There is nothing under any law (other than the law of the Cayman Islands), which would or might affect
the opinions set out below.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3</B></TD><TD STYLE="text-align: justify"><B>Opinion</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based upon the foregoing and subject to the qualifications set out
below and having regard to such legal considerations as we deem relevant, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">The Company has been duly incorporated as an exempted company with limited liability and is validly existing
and in good standing with the Registrar of Companies under the laws of the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify">The authorised share capital of the Company is US$50,000 divided into 500,000,000 shares comprising (i)&nbsp;400,000,000
Ordinary Shares of a par value of US$0.0001 each, and (ii)&nbsp;100,000,000 undesignated shares of a par value of US$0.0001 each, of such
class or classes (however designated) as the board of directors of the Company may determine in accordance with the Memorandum and Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.3</TD><TD STYLE="text-align: justify">With respect to the Shares, including those represented by ADSs, and the Preferred Shares, when (i)&nbsp;the
Board has taken all necessary corporate action to approve the issue thereof, the terms of the offering thereof and related matters; (ii)&nbsp;the
issue of such Shares or Preferred Shares has been recorded in the Company&rsquo;s register of members (shareholders); and (iii)&nbsp;the
subscription price of such Shares or Preferred Shares, (being not less than the par value of the Shares or Preferred Shares, as the case
may be) has been fully paid in cash or other consideration approved by the Board, the Shares or Preferred Shares will be duly authorised,
validly issued, fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.4</TD><TD STYLE="text-align: justify">With respect to each issue of Warrants, when (i)&nbsp;the Board has taken all necessary corporate action
to approve the creation and terms of the Warrants and to approve the issue thereof, the terms of the offering thereof and related matters;
(ii)&nbsp;a Warrant Agreement relating to the Warrants shall have been duly authorised and validly executed and delivered by the Company
and the warrant agent thereunder; and (iii)&nbsp;the certificates representing the Warrants have been duly executed, countersigned, registered
and delivered in accordance with the Warrant Agreement relating to the Warrants and the applicable definitive purchase, underwriting or
similar agreement approved by the Board upon payment of the consideration therefor provided therein, the Warrants will be duly authorised,
legal and binding obligations of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.5</TD><TD STYLE="text-align: justify">With respect to each issue of the Overallotment Purchase Rights, when (i)&nbsp;the Board has taken all
necessary corporate action to approve the creation and terms of the Overallotment Purchase Rights and to approve the issue thereof, the
terms of the offering thereof and related matters; (ii)&nbsp;an Overallotment Purchase Rights Agreement relating to the Overallotment
Purchase Rights and the Overallotment Purchase Rights shall have been authorised and duly executed and delivered by and on behalf of the
Company and all the relevant parties thereunder in accordance with all relevant laws; and (iii)&nbsp;when such Overallotment Purchase
Rights issued thereunder have been duly executed and delivered on behalf of the Company and authenticated in the manner set forth in the
Overallotment Purchase Rights Agreement relating to such issue of Overallotment Purchase Rights and delivered against due payment therefor
pursuant to, and in accordance with, the terms of the Registration Statement and any relevant prospectus supplement, such Overallotment
Purchase Rights issued pursuant to the Overallotment Purchase Rights Agreement will have been duly executed, issued and delivered.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.6</TD><TD STYLE="text-align: justify">With respect to each issue of the Subscription Rights, when (i)&nbsp;the Board has taken all necessary
corporate action to approve the creation and terms of the Subscription Rights and to approve the issue thereof, the terms of the offering
thereof and related matters; (ii)&nbsp;a Subscription Rights Agreement relating to the Subscription Rights and the Subscription Rights
shall have been authorised and duly executed and delivered by and on behalf of the Company and all the relevant parties thereunder in
accordance with all relevant laws; and (iii)&nbsp;when such Subscription Rights issued thereunder have been duly executed and delivered
on behalf of the Company and authenticated in the manner set forth in the Subscription Rights Agreement relating to such issue of Subscription
Rights and delivered against due payment therefor pursuant to, and in accordance with, the terms of the Registration Statement and any
relevant prospectus supplement, such Subscription Rights issued pursuant to the Subscription Rights Agreement will have been duly executed,
issued and delivered.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.7</TD><TD STYLE="text-align: justify">With respect to each issue of the Units, when (i)&nbsp;the Board has taken all necessary corporate action
to approve the creation and terms of the Units and to approve the issue thereof, the terms of the offering thereof and related matters;
(ii)&nbsp;a Unit Agreement relating to the Units and the Units shall have been authorised and duly executed and delivered by and on behalf
of the Company and all the relevant parties thereunder in accordance with all relevant laws; and (iii)&nbsp;when such Units issued thereunder
have been duly executed and delivered on behalf of the Company and authenticated in the manner set forth in the Unit Agreement relating
to such issue of Units and delivered against due payment therefor pursuant to, and in accordance with, the terms of the Registration Statement
and any relevant prospectus supplement, such Units issued pursuant to the Unit Agreement will have been duly executed, issued and delivered.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.8</TD><TD STYLE="text-align: justify">With respect to each issue of the Capital Notes, when (i)&nbsp;the Board has taken all necessary corporate
action to approve the creation and terms of the Capital Notes and to approve the issue thereof, the terms of the offering thereof and
related matters; (ii)&nbsp;a Capital Notes Purchase Agreement relating to the Capital notes and the Capital Notes shall have been authorised
and duly executed and delivered by and on behalf of the Company and all the relevant parties thereunder in accordance with all relevant
laws; and (iii)&nbsp;when such Capital Notes issued thereunder have been duly executed and delivered on behalf of the Company and authenticated
in the manner set forth in the Capital Notes Purchase Agreement relating to such issue of Capital Notes and delivered against due payment
therefor pursuant to, and in accordance with, the terms of the Registration Statement and any relevant prospectus supplement, such Capital
Notes issued pursuant to the Capital Notes Purchase Agreement will have been duly executed, issued and delivered.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.9</TD><TD STYLE="text-align: justify">With respect to each issue of the Debt Securities, when (i)&nbsp;the Board has taken all necessary corporate
action to approve the creation and terms of the Debt Securities and to approve the issue thereof, the terms of the offering thereof and
related matters; (ii)&nbsp;an Indenture relating to the Debt Securities and the Debt Securities shall have been authorised and duly executed
and delivered by and on behalf of the Company and all the relevant parties thereunder in accordance with all relevant laws; and (iii)&nbsp;when
such Debt Securities issued thereunder have been duly executed and delivered on behalf of the Company and authenticated in the manner
set forth in the Indenture relating to such issue of Debt Securities and delivered against due payment therefor pursuant to, and in accordance
with, the terms of the Registration Statement and any relevant prospectus supplement, such Debt Securities issued pursuant to the Indenture
will have been duly executed, issued and delivered.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4</B></TD><TD STYLE="text-align: justify"><B>Qualifications</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.1</TD><TD STYLE="text-align: justify">To maintain the Company in good standing under the laws of the Cayman Islands, annual filing fees must
be paid and returns made to the Registrar of Companies within the time frame prescribed by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">The obligations assumed by the Company under the Warrant Agreements, the Overallotment Purchase Rights
Agreements, the Subscription Rights Agreements, the Unit Agreements, the Indentures or the Capital Notes Purchase Agreements, the Warrants,
Overallotment Purchase Rights, Subscription Rights, Units, Capital Notes and Debt Securities issued thereunder will not necessarily be
enforceable in all circumstances in accordance with their terms. In particular:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">enforcement may be limited by bankruptcy, insolvency, liquidation, reorganisation, readjustment of debts
or moratorium or other laws of general application relating to, protecting or affecting the rights of creditors and/or contributories;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">enforcement may be limited by general principles of equity. For example, equitable remedies such as specific
performance may not be available, <I>inter alia</I>, where damages are considered to be an adequate remedy;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">some claims may become barred under relevant statutes of limitation or may be or become subject to defences
of set off, counterclaim, estoppel and similar defences;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">where obligations are to be performed in a jurisdiction outside the Cayman Islands, they may not be enforceable
in the Cayman Islands to the extent that performance would be illegal under the laws of that jurisdiction;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">the courts of the Cayman Islands have jurisdiction to give judgment in the currency of the relevant obligation
and statutory rates of interest payable upon judgments will vary according to the currency of the judgment. If the Company becomes insolvent
and is made subject to a liquidation proceeding, the courts of the Cayman Islands will require all debts to be proved in a common currency,
which is likely to be the &quot;functional currency&quot; of the Company determined in accordance with applicable accounting principles.
Currency indemnity provisions have not been tested, so far as we are aware, in the courts of the Cayman Islands;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">arrangements that constitute penalties will not be enforceable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">enforcement may be prevented by reason of fraud, coercion, duress, undue influence, misrepresentation,
public policy or mistake or limited by the doctrine of frustration of contracts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">provisions imposing confidentiality obligations may be overridden by compulsion of applicable law or the
requirements of legal and/or regulatory process;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the courts of the Cayman Islands may decline to exercise jurisdiction in relation to substantive proceedings
brought in matters where they determine that such proceedings may be tried in a more appropriate forum;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">we reserve our opinion as to the enforceability of the relevant provisions of the documents to the extent
that they purport to grant exclusive jurisdiction as there may be circumstances in which the courts of the Cayman Islands would accept
jurisdiction notwithstanding such provisions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">a company cannot, by agreement or in its articles of association, restrict the exercise of a statutory
power and there is doubt as to the enforceability of any provision in the Warrant Agreements, the Overallotment Purchase Rights Agreements,
the Subscription Rights Agreements, the Unit Agreements, the Capital Notes Purchase Agreements and the Indentures whereby the Company
covenants to restrict the exercise of powers specifically given to it under the Companies Act (As Revised) of the Cayman Islands (the
 &quot;<B>Companies Act</B>&quot;), including, without limitation, the power to increase its authorised share capital, amend its memorandum
and articles of association or present a petition to a Cayman Islands court for an order to wind up the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">if the Company becomes subject to Part&nbsp;XVIIA of the Companies Act, enforcement or performance of
any provision in the Warrant Agreements, the Overallotment Purchase Rights Agreements, the Subscription Rights Agreements, the Unit Agreements,
the Capital Notes Purchase Agreements and the Indentures which relates, directly or indirectly, to an interest in the Company constituting
shares, voting rights or director appointment rights in the Company may be prohibited or restricted if any such relevant interest is or
becomes subject to a restrictions notice issued under the Companies Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.3</TD><TD STYLE="text-align: justify">We express no opinion as to the meaning, validity or effect of any references to foreign (i.e. non-Cayman
Islands) statutes, rules, regulations, codes, judicial authority or any other promulgations and any references to them in the Warrant
Agreements or the Warrants, the Overallotment Purchase Rights Agreements or the Overallotment Purchase Rights, the Subscription Rights
Agreements or the Subscription Rights, the Unit Agreements or the Units, the Capital Notes Purchase Agreements or the Capital Notes, and
the Indentures or the Debt Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.4</TD><TD STYLE="text-align: justify">We have not reviewed the final form of any of the Warrant Agreements, the Overallotment Purchase Rights
Agreements, the Subscription Rights Agreements, the Unit Agreements, the Capital Notes Purchase Agreements, the Indentures or the Warrants,
Overallotment Purchase Rights, Subscription Rights, Units, Capital Notes and Debt Securities to be issued thereunder, and our opinions
are qualified accordingly.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.5</TD><TD STYLE="text-align: justify">We reserve our opinion as to the extent to which the courts of the Cayman Islands would, in the event
of any relevant illegality or invalidity, sever the relevant provisions of the Warrant Agreements or the Warrants, the Overallotment Purchase
Rights Agreements or the Overallotment Purchase Rights, the Subscription Rights Agreements or the Subscription Rights, the Unit Agreements
or the Units, the Capital Notes Purchase Agreements or the Capital Notes, and the Indentures or the Debt Securities and enforce the remainder
or the transaction of which such provisions form a part, notwithstanding any express provisions in this regard.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.6</TD><TD STYLE="text-align: justify">Under the Companies Act, the register of members of a Cayman Islands company is by statute regarded as
prima facie evidence of any matters which the Companies Act directs or authorises to be inserted therein. A third party interest in the
shares in question would not appear. An entry in the register of members may yield to a court order for rectification (for example, in
the event of fraud or manifest error).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.7</TD><TD STYLE="text-align: justify">In this opinion the phrase &quot;non-assessable&quot; means, with respect to shares in the Company, that
a shareholder shall not, solely by virtue of its status as a shareholder and in absence of a contractual arrangement, or an obligation
pursuant to the memorandum and articles of association, to the contrary, be liable for additional assessments or calls on the shares by
the Company or its creditors (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship
or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as specifically stated herein, we make
no comment with respect to any representations and warranties which may be made by or with respect to the Company in any of the documents
or instruments cited in this opinion or otherwise with respect to the commercial terms of the transactions, which are the subject of this
opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the filing of this opinion
as an exhibit to the Registration Statement and to the reference to our name under the headings &quot;Enforceability of Civil Liabilities&quot;
and &quot;Legal Matters&quot; and elsewhere in the prospectus included in the Registration Statement. In giving such consent, we do not
thereby admit that we come within the category of persons whose consent is required under Section&nbsp;7 of the U.S. Securities Act of
1933, as amended, or the Rules&nbsp;and Regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yours faithfully</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Maples and Calder (Hong Kong) LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maples and Calder (Hong Kong) LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>4
<FILENAME>tm2316412d2_ex5-2.htm
<DESCRIPTION>EXHIBIT 5.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"><IMG SRC="tm2316412d2_ex5-2img01.jpg" ALT=""></TD>
</TR><TR STYLE="font-size: 5pt; vertical-align: top; text-align: justify">
<TD STYLE="font-size: 5pt; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="font-size: 5pt; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May&nbsp;22, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Belite Bio,&nbsp;Inc</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">12750 High Bluff Drive Suite&nbsp;475, San Diego, CA 92130</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Re:</B></FONT><B><I>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Registration
Statement on Form&nbsp;F-3</U></FONT></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have acted as U.S. counsel to Belite Bio,&nbsp;Inc,
an exempted company incorporated under the laws of the Cayman Islands (the &ldquo;<U>Company</U>&rdquo;), in connection with the preparation
of the shelf registration statement on Form&nbsp;F-3 (the &ldquo;<U>Registration Statement</U>&rdquo;) filed with the Securities and Exchange
Commission (the &ldquo;<U>SEC</U>&rdquo;) on May&nbsp;22, 2023 under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;). The Registration Statement relates to the offer and sale from time to time, pursuant to Rule&nbsp;415 of the General
Rules&nbsp;and Regulations of the SEC promulgated under the Securities Act, of an indeterminate amount of the following securities: (i)&nbsp;ordinary
shares of the Company, par value $0.0001 (the &ldquo;<U>Shares</U>&rdquo;), including in the form of American depositary shares, each
representing one Share (the &quot;<U>ADSs</U>&quot;), (ii)&nbsp;preferred shares of the Company, par value $0.0001 per share (the &ldquo;<U>Preferred
Shares</U>&rdquo;), (iii)&nbsp;debt securities, which may be either senior or subordinated debt securities or senior or subordinated convertible
debt securities (the &ldquo;<U>Debt Securities</U>&rdquo;) to be entered into pursuant to an indenture (the &ldquo;<U>Base Indenture</U>&rdquo;),
as amended or supplemented from time to time pursuant to one or more supplements or officer&rsquo;s certificates to the Base Indenture
(the &ldquo;<U>Supplemental Indenture Documents</U>&rdquo; and, together with the Base Indenture, the &ldquo;<U>Indenture</U>&rdquo;),
in each case to be entered into by the Company, (iv)&nbsp;warrants to subscribe for ADSs, Shares and/or Preferred Shares of the Company
(the &ldquo;<U>Warrants</U>&rdquo;), in each case to be issued pursuant to a warrant agreement between the Company and a warrant agent
to be appointed prior to the issuance of the Warrants, (v)&nbsp;overallotment purchase rights to purchase ADSs, Shares, Preferred Shares,
Warrants, Subscription Rights (as defined below) and/or Units (as defined below) of the Company (the &ldquo;<U>Overallotment Purchase
Rights</U>&rdquo;) to be issued under overallotment purchase rights agreements to be entered into between the Company and a bank or trust
company, as rights agent for such Overallotment Purchase Rights, (vi)&nbsp;subscription rights to purchase ADSs, Shares and/or Preferred
Shares of the Company (the &ldquo;<U>Subscription Rights</U>&rdquo;) to be issued under standby underwriting agreements to be entered
into among the Company and one or more underwriters for such Subscription Rights thereunder; (vii)&nbsp;capital notes of the Company which
are convertible into ADSs or Shares (the &ldquo;<U>Capital Notes</U>&rdquo;) to be issued under purchase agreements to be entered into
between the Company and the purchasers of such Capital Notes and (viii)&nbsp;units consisting of two or more of these classes or series
of securities (the &ldquo;<U>Units</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Austin &bull; Century City &bull; Dallas &bull;
Los Angeles &bull; Newport Beach &bull; New York &bull; San Francisco &bull; Silicon Valley &bull; Washington, DC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Beijing &bull; Brussels &bull; Hong Kong &bull;
London &bull; Seoul &bull; Shanghai &bull; Singapore &bull; Tokyo</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"><IMG SRC="tm2316412d2_ex5-2img01.jpg" ALT=""></TD>
</TR><TR STYLE="font-size: 5pt; vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; font-size: 5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 5pt; text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In our capacity as such counsel, we have examined
originals or copies of those corporate and other records and documents we considered appropriate, including among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD>the Registration Statement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD>the form of the Base Indenture.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In our examination, we assumed the legal capacity
of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity
to original documents of all documents submitted to us as certified, conformed or photostatic copies and the authenticity of the originals
of such latter documents. We have also assumed that New York law will be chosen to govern the Indenture and that such choice is a valid
and legal provision. To the extent that the Company&rsquo;s obligations depend on the enforceability of any agreement against the other
parties to the agreement, we have assumed that such agreement is enforceable against such other parties. As to any facts material to the
opinions expressed herein which were not independently established or verified, we have relied upon oral or written statements and representations
of officers and other representatives of the Company. In addition, we have obtained and relied upon those certificates of public officials
we considered appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have also assumed that, at or prior to the time
of delivery of any Debt Securities, (i)&nbsp;the Registration Statement will be effective and will comply with all applicable laws at
the time any Debt Securities are offered or issued as contemplated by the Registration Statement (ii)&nbsp;an appropriate prospectus supplement
describing each series of Debt Securities offered pursuant to the Registration Statement, to the extent required by the Securities Act
and the applicable rules&nbsp;and regulations thereunder, has been prepared, delivered and has been or will be filed in compliance with
the Securities Act and the applicable rules&nbsp;and regulations thereunder, (iii)&nbsp;the Company is validly existing and in good standing
with the Registrar of Companies under the laws of the Cayman Islands, with all corporate power and authority to enter into the Indenture
and to perform its obligations thereunder, (iv)&nbsp;any Debt Securities have been authorized by all necessary corporate action on the
part of the Company, (v)&nbsp;any Shares or Preferred Shares that may be issued upon conversion of any Debt Securities will not exceed
the limits of the then remaining authorized but unissued amount of such Shares or Preferred Shares that the Company is then authorized
to issue, (vi)&nbsp;the execution, delivery and performance of any applicable Supplemental Indenture Documents have been duly authorized
by all necessary corporate action on the part of the Company and each such document has been duly executed and delivered by the Company,
(vii)&nbsp;there has not occurred any change in law or further action by the Board of Directors of the Company (or any authorized committee
thereof) affecting the validity or enforceability of the Debt Securities, and (viii)&nbsp;any Debt Securities will be issued and sold
in the manner contemplated by the Registration Statement and any applicable prospectus supplement. We have also assumed that none of the
terms of any Debt Securities to be established after the date hereof, nor the issuance and delivery of such Debt Securities, nor the compliance
by the Company, with the terms of such Debt Securities will violate any applicable law or public policy or result in a violation of any
provision of any instrument or agreement then binding upon the Company, or any restriction imposed by any court or governmental body having
jurisdiction over the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"><IMG SRC="tm2316412d2_ex5-2img01.jpg" ALT=""></TD>
</TR><TR STYLE="font-size: 5pt; vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; font-size: 5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 5pt; text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On the basis of such examination, our reliance
upon the assumptions in this letter and our consideration of those questions of law we considered relevant, and subject to the limitations
and qualifications in this letter, we are of the opinion that, with respect to any series of Debt Securities offered under the Registration
Statement (the &ldquo;<U>Offered Debt Securities</U>&rdquo;), when (i)&nbsp;the specific terms of the particular Offered Debt Securities
have been duly established in accordance with the applicable Indenture, (ii)&nbsp;the Base Indenture and the applicable Supplemental Indenture
Documents to be entered into in connection with the issuance of any Offered Debt Securities have been duly authorized, executed and delivered
by each party thereto, and (iii)&nbsp;the Offered Debt Securities have been duly authorized, authenticated, executed, issued and delivered
in accordance with the terms of the Indenture and the applicable underwriting or other agreement (including, in the case of &ldquo;book
entry&rdquo; Offered Debt Securities, such Debt Securities being entered under the names of the purchasers thereof on the books of a depositary)
against payment therefor, such Offered Debt Securities will be legally valid and binding obligations of the Company, enforceable against
the Company in accordance with their respective terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium
or similar laws relating to or affecting creditors&rsquo; rights generally (including, without limitation, fraudulent conveyance laws),
by general principles of equity including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing and
the possible unavailability of specific performance or injunctive relief, regardless of whether considered in a proceeding at law or in
equity, and by possible judicial action giving effect to foreign governmental actions or foreign laws affecting creditors&rsquo; rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The law governed by this opinion letter is limited
to the present law of the State of New York. We express no opinion as to the laws of any other jurisdiction and no opinion regarding the
statutes, administrative decisions, rules, regulations or requirements of any county, municipality, subdivision or local authority of
any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This opinion is being furnished in accordance with
the requirements of Item 601(b)(5)&nbsp;of Regulation S-K promulgated under the Securities Act, and no opinion is expressed herein as
to any matter pertaining to the contents of the Registration Statement, the base prospectus included in the Registration Statement or
any applicable prospectus supplement, other than as expressly stated herein with respect to the Debt Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We hereby consent to the use of this opinion as
an exhibit to the Registration Statement and to the reference to this firm under the heading &ldquo;Legal Matters&rdquo; in the base prospectus
constituting part of the Registration Statement. In giving this consent, we do not thereby admit that we are included in the category
of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Respectfully submitted,</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ O&rsquo;Melveny&nbsp;&amp; Myers
    LLP &nbsp;</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>5
<FILENAME>tm2316412d2_ex23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><IMG SRC="tm2316412d2_ex23-2img001.jpg" ALT="" STYLE="height: 42pt; width: 246.75pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the incorporation by reference in
this Registration Statement on Form&nbsp;F-3 of our report dated March&nbsp;15, 2022, with respect to the consolidated balance sheets
of Belite Bio,&nbsp;Inc and Subsidiaries as of December&nbsp;31, 2021, and the related consolidated statements of operations and comprehensive
loss, convertible preferred shares and shareholders&rsquo; deficit, and cash flows for each of the years in the two-year period ended
December&nbsp;31, 2021, and the related notes appearing in Belite Bio,&nbsp;Inc&rsquo;s Annual Report on Form&nbsp;20-F for the year ended
December&nbsp;31, 2022, filed with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We were dismissed as auditors on December&nbsp;12,
2022 and, accordingly, we have not performed any audit or review procedures with respect to any financial statements included in this
Registration Statement for the periods after the date of our dismissal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Friedman LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">New York,
New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">May&nbsp;22,
2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2316412d2_ex23-2img002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>6
<FILENAME>tm2316412d2_ex23-3.htm
<DESCRIPTION>EXHIBIT 23.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We consent to the incorporation by reference in this Registration Statement
of Belite Bio,&nbsp;Inc on Form&nbsp;F-3 of our report dated March&nbsp;31, 2023, with respect to our audit of the consolidated financial
statements of Belite Bio,&nbsp;Inc as of December&nbsp;31, 2022 and for the year ended December&nbsp;31, 2022, which report appearing
in the Annual Report on Form&nbsp;20-F of Belite Bio,&nbsp;Inc for the year ended December&nbsp;31, 2022. We also consent to the reference
to our firm under the heading &ldquo;Experts&rdquo; in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Marcum Asia CPAs LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">New York,
New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">May&nbsp;22,
2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.4
<SEQUENCE>7
<FILENAME>tm2316412d2_ex23-4.htm
<DESCRIPTION>EXHIBIT 23.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="tm2316412d12_ex23-4img02.jpg" ALT="" STYLE="height: 70px; width: 350px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#20013;&#22269;&#19978;&#28023;&#24066;&#21335;&#20140;&#35199;&#36335;1515&#21495;&#38745;&#23433;&#22025;&#37324;&#20013;&#24515;&#19968;&#24231;10&#23618;
200040</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">10/F, Tower 1, Jing An Kerry Centre, 1515 West
Nanjing Road, Shanghai 200040, China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#30005;&#35805; &nbsp;&nbsp;&nbsp;Tel: +86 21 6019 2600&nbsp;&nbsp;&nbsp; &#20256;&#30495;
 &nbsp;&nbsp;&nbsp;Fax:&nbsp;&nbsp;&nbsp; +86 21 6019 2697</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#32593;&#22336; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Web: www.tongshang.com</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">May&nbsp;22,
2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Belite Bio,&nbsp;Inc</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">12750 High Bluff Drive Suite&nbsp;475</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">San Diego, CA 92130</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Dear Sir/Madam,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">We have
acted as legal counsel as to the laws of the People&rsquo;s Republic of China to Belite Bio,&nbsp;Inc, a company incorporated under the
laws of the Cayman Islands, on certain matters in connection with the offering and sales from time to time of up to $300,000,000 of (i)&nbsp;the
Company&rsquo;s American Depositary Shares, or ADSs, representing ordinary shares, ordinary shares, preferred shares, warrants, overallotment
purchase rights, subscription rights, units, capital notes and/or debt securities in accordance with the registration statement on Form&nbsp;F-3
(the &ldquo;Registration Statement&rdquo;), filed by the Company with the U.S. Securities and Exchange Commission under the U.S. Securities
Act of 1933, as amended and (ii)&nbsp;the Company&rsquo;s ADSs previously registered pursuant to the Company&rsquo;s registration statement
on Form&nbsp;F-3 (File No.&nbsp;333-271549) (the &ldquo;Prior Registration Statement&rdquo;). The Registration Statement updates the Prior
Registration Statement and includes ADSs previously registered by the Company pursuant to such Prior Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">We hereby
consent to </FONT>the use and reference of our name under the headings &ldquo;Legal Matters&rdquo;, and <FONT STYLE="background-color: white">elsewhere,
and the filing of this letter as exhibit to, the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">In giving
such consent, we do not thereby admit that we fall within the category of the person whose consent is required under Section&nbsp;7 of
the U.S. Securities Act of 1933, as amended, or the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%"><FONT STYLE="font-size: 10pt">Yours sincerely,</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">/s/
    Commerce&nbsp;&amp; Finance Law Offices</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">Commerce&nbsp;&amp; Finance
    Law Offices</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>8
<FILENAME>tm2316412d2_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit&nbsp;107</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Calculation of Filing Fee Tables</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;F-3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form&nbsp;Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Belite Bio,&nbsp;Inc</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Not Applicable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of Registrant&rsquo;s Name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Table 1: Newly Registered and Carry Forward
Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 8%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 20%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 15%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 7%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 6%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 5%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 8%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 6%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 6%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 4%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 5%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 5%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; width: 5%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 1pt; border-top: black 1pt solid; border-left: black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-right: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; padding-right: 1pt; border-left: black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Security<BR>
    Type</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Security Class&nbsp;Title</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fee<BR>
    Calculation<BR>
    or Carry<BR>
    Forward<BR>
    Rule</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Amount<BR>
    Registered</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Proposed<BR>
    Maximum<BR>
    Offering<BR>
    Price Per<BR>
    Unit</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Maximum<BR>
    Aggregate<BR>
    Offering Price</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fee Rate</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Amount of<BR>
    Registration Fee</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Carry<BR>
    Forward</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Form<BR>
    Type</FONT></P></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Carry</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Forward</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">File</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Number</FONT></P></TD>
    <TD STYLE="white-space: nowrap; padding-right: 1pt; padding-left: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Carry<BR>
    Forward<BR>
    Initial<BR>
    effective<BR>
    date</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: black 1pt solid; padding-left: 1pt; padding-right: 1pt; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Filing
    Fee<BR>
    Previously<BR>
    Paid In<BR>
    Connection<BR>
    with<BR>
    Unsold<BR>
    Securities<BR>
    to be<BR>
    Carried<BR>
    Forward</FONT></TD></TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt; border-right: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="13" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 1pt; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Newly
    Registered Securities</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fees
    to be paid</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Equity</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Ordinary shares,
    par value US$0.0001 per share (1)</FONT></P></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">(3)(4)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-top: Black 1pt solid; border-left: black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fees
    to be paid</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Equity</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Preferred shares,
    par value US$0.0001 per share</FONT></P></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">(3)(4)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-top: Black 1pt solid; border-left: black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fees
    to be paid</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Other</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Warrants</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">(3)(4)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-top: Black 1pt solid; border-left: black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fees
    to be paid</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Other</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Overallotment
    Purchase Rights</FONT></P></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">(3)(4)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-top: Black 1pt solid; border-left: black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fees
    to be paid</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Other</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Subscription
    Rights</FONT></P></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">(3)(4)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-top: Black 1pt solid; border-left: black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fees
    to be paid</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Other</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Units</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">(3)(4)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-top: Black 1pt solid; border-left: black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fees
    to be paid</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Debt</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Capital Notes</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">(3)(4)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-top: Black 1pt solid; border-left: black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fees
    to be paid</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Unallocated (Universal)
    Shelf</FONT></P></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Unallocated (Universal)
    Shelf</FONT></P></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Rule&nbsp;457(o)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">(3)(4)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">$300,000,000</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">.00011020</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">$33,060.00</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 1pt; border-top: black 1pt solid; border-left: black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-top: black 1pt solid; border-right: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fees
    Previously Paid</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="13" STYLE="padding-right: 1pt; border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="13" STYLE="border-right: black 1pt solid; border-left: black 1pt solid; padding-right: 1pt; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Carry
    Forward Securities</FONT></TD></TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt; border-right: black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-left: black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Carry
    Forward Securities</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt"><SUB>&nbsp;</SUB></FONT></TD>
    <TD COLSPAN="4" STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt; border-right: black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-left: black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="padding-right: 1pt; padding-left: 1pt; padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">Total Offering Amounts&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">$300,000,000</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">$33,060.00</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt; border-right: black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-left: black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="padding-right: 1pt; padding-left: 1pt; padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">Total Fees Previously Paid&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">-</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt; border-right: black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-left: black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="padding-right: 1pt; padding-left: 1pt; padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">Total Fee Offsets&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">$33,060.00(2)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 1pt; padding-left: 1pt; border-right: black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="padding-right: 1pt; padding-left: 1pt; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: right"><FONT STYLE="font-size: 8pt">Net Fee
    Due&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">$0(2)</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; padding-left: 1pt; border-left: Black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt; padding-right: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Table 2: Fee Offset Claims and Sources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 9%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid; padding-left: 8pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-left: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Registrant or Filer<BR>
    Name</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Form&nbsp;or Filing Type</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">File Number</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Initial Filing Date</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Filing Date</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fee Offset<BR>
    Claimed</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Security<BR>
    Type <BR>
    Associated <BR>
    with Fee <BR>
    Offset <BR>
    Claimed</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Security Title<BR>
    Associated with Fee <BR>
    Offset Claimed</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Unsold <BR>
    Securities <BR>
    Associated <BR>
    with Fee <BR>
    Offset <BR>
    Claimed</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Unsold Aggregate <BR>
    Offering Amount <BR>
    Associated with <BR>
    Fee Offset Claimed</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fee Paid with <BR>
    Fee Offset <BR>
    Source</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; padding-left: 8pt"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></TD>
    </TR>
  <TR>
    <TD COLSPAN="12" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: bottom; padding-right: 2pt; padding-bottom: 1pt; padding-left: 8pt; text-align: center"><FONT STYLE="font-size: 8pt">Rule&nbsp;457(p)</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fee
    Offset Claims</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">Belite Bio,&nbsp;Inc</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">F-3</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">333-271549</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">May&nbsp;1, 2023</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">$33,060.00</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">(5)</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">(5)</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">(5)</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 1pt; border-left: Black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 8pt">$300,000,000</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 1pt; border-top: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt; padding-left: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">Fee
    Offset Sources</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">Belite Bio,&nbsp;Inc</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">F-3</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">333-271549</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">May&nbsp;1, 2023</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-bottom: 1pt; text-align: center; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 1pt; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 1pt; border-right: Black 1pt solid; border-left: Black 1pt solid; border-top: Black 1pt solid; padding-left: 1pt"><FONT STYLE="font-size: 8pt">$33,060.00</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; padding-left: 8pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 8pt">(1)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">These ordinary shares will be represented by American Depositary Shares, or ADSs, each of which
    represents one ordinary share of the registrant. ADSs issuable on deposit of the ordinary shares registered hereby have been registered
    pursuant to a separate registration statement on Form&nbsp;F-6&nbsp;(File&nbsp;No.&nbsp;333-264395).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 8pt">(2)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">The registrant previously filed a Registration Statement on Form&nbsp;F-3 with the SEC on May&nbsp;1,
    2023 (File No.&nbsp;333-271549), which was declared effective on May&nbsp;9, 2023 (the &ldquo;Prior Registration Statement&rdquo;),
    that registered an aggregate of $300,000,000 of an indeterminate number of securities to be offered by the registrant from time to
    time. All of the $300,000,000 of securities registered on the Prior Registration Statement, for which the registrant paid a filing
    fee of $33,060.00 in connection therewith, remain unsold, leaving all of the $33,060.00 in previously paid fees available for future
    offset (calculated at the fee rate in effect on the filing date of the Prior Registration Statement). In accordance with Rule&nbsp;457(p)&nbsp;under
    the Securities Act, the registrant is using $33,060.00 of the unused filing fees to offset the filing fee payable in connection with
    this filing. Accordingly, no additional registration fee is due to be paid at this time. Concurrently with the effectiveness of this
    registration statement, any offering of unsold securities pursuant to the Prior Registration Statement is hereby terminated.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 8pt">(3)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">Includes such indeterminate amount of ordinary shares as may be issued upon exercise, conversion
    or exchange of, pursuant to anti-dilution adjustments, or pursuant to a share dividend, share split or similar transaction with respect
    to securities that provide for such issuance, exercise, conversion, exchange, adjustment, share split or similar transaction.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 8pt">(4)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">Pursuant to Rule&nbsp;457(o)&nbsp;under the Securities Act, which permits the registration fee to
    be calculated on the basis of the maximum offering price of all the securities listed, the table does not specify by each class information
    as to the amount to be registered, proposed maximum offering price per unit or proposed maximum aggregate offering price. The aggregate
    public offering price of securities sold by the registrant will not exceed $300,000,000.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 8pt">(5)</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">Pursuant to Rule&nbsp;457(p)&nbsp;under the Securities Act, the registrant is offsetting the registration
    fee due under this registration statement by $33,060.00, which represents the portion of the registration fee previously paid with
    respect to $300,000,000 of unsold securities (the &ldquo;Unsold Offset Securities&rdquo;) previously registered on the Prior Registration
    Statement. The offering of the Unsold Offset Securities pursuant to the Prior Registration Statement associated with the claimed
    fee offset pursuant to Rule&nbsp;457(p)&nbsp;has been terminated.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>lg_belite-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_belite-4clr.jpg
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M -0  0 " @,! 0             '" 8) P0% @$! 0 " P$! 0
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M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!Q*>TJ*?J4!^MK4N^H#IZ* ^R;
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MFUQW>BK$<4<IUMNW:NN$)<Z7'M?'WGK:!6Y1J?59,"@% * 4 H!0"@% * 4
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MH*CW7-1N5"[IM'=U$N6U%S?8E4\,<H\>6Z;HQI_]RW^?6/,1]'_8=P_D3_\
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M#4AM)[0EU 6 ?B-;)U52A?M.U<E!YQ;7L=#M5DA% * 4 H!0"@% ?*T:TZ:
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M7!%7MQ<^;_S,LNX^8,1$*=(C1D)4@V[[NA:K_'5=S;.RZ+I#06(4G'S'VO\
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MIPH4 H!0"@.!XV5\790$>[EV9D<ORGQYN^(AI,+;2<RWE%J(#Q3/AAID)[U
M*)^"MD\&89)-:F10"@% :<N:_P ;V^?IS(??"ZO0R14GF=CA#C>-RUR1B]BS
M)[F,8R+<I:IC2 ZM!C1W'Q9*B ;Z+=M)2HJB*JRV2_\ EZ[<0DJ.]YQMW>Y,
M_NM0><^PF\M%<^</+?NWAI:<E(>9RFU)"D(BY)A2M:5JZ:7D*0C2K4/L=0L1
MUJ:$U(CE"A%>W=QYK:N48S&!F.PIS"@I+C"U-Z@DWTJTD7!MV&MVJFB=#8TK
MG1_<GE:R7)D7V,[$A,PLHE:&Q>6IYJ(^L(05)"5E2U([.G<*J<E)4+/-]VIK
M/^M5PJDY<->9?-<*X*7AL#MS&SG9KP>E3Y1>2^X$:O#02VH"R-:K?#44K?,2
MQG0DL_\ ,!W\1;\%,1\.N3_UZT\E&?-[B(N;O,!G.<6\*C-8:%BUX4O^$["+
MJEN)D:/967"KHG1T^$U)"'*:SGS$;;7F+QVYL+D&Q=<2?%?2#V$M/)6/K5N\
MC1&R?S#3%Y#CK:^0= 2Y+D,2%('8%.Q%J/UZ^1>1U7H+YNY\'\2*T#LM58[6
M7]X]%^/]J_0^/^]6ZO1R1^8MX^?O_P!6Y^)GLY!)$)[];63Y]I_?1KIN:H'Z
MM+*^5H7:SO\ 8?KKJ>T<CZ]SM>O[#N^:=-L!@/X8[]RK%[-%?H%__1=^%?65
M>OTM4)V0V#[/_DE@?HZ']P15RWX5Z#\M[E\U=^.?XF8_S'*?A\:[@DQG%-/H
M9;\-:"4J!+R ;$>JL7?"?4Z:MQGN-J,E55?U,HN!U]7HJH?I$E;87-^4V#M]
M&!AXB-+:2ZXZ9#KBT+47#>UDCN[JVC-K(\3N_2MO<=0[TKDHNB5$EP,I_P"*
M;/\ \WX9]?BN?G5MYLNX^-_8-C^;+V(CCDCD:1R/,ASYF,9@2XC7N_B,K4LK
M;"E+ .KT%2JT<F\SU>R;+';(2A&;G&3KBN/T1X>S;C>&WR.G\8PP?@\=%8/I
M;G\I=^"?X6;!J^@?EP4 H!0"@.-;:E*"@18=@-#)\H9*5A1/8+=IH8.:@% *
M 4!IRYJ_&]OGZ<R'WPNKT,D5)9D@>3/_ .PNV?VC)?ZO?K6YX3:WF;27[EOI
MZ1TM?OJD62'/,^SC'N"-YM9E1;A"/&5K!(^W)F,+8'0CH70@5);\1K/(U.U>
M*A9[A#$S,[Y:>9L5!0IR4^_B2A";GHV\EQ1Z>I)J&?B1-#PLK%Z_^FIB$L7P
M5Y7&>:MJ/;BC[I1C)<:2J/)Q_NY>4A'_ &:R0M-@NRN[NJ&=SE9+&%42I_\
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M)#W!@)29N'G(\6)*;2M"5H"BFX#@2KM![15-X%@]9N]S?M[QW7]- <E * 4
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< H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>fc_organization-bwlr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_organization-bwlr.jpg
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M +   0 !! ,!               ) 08'" ($!0,! 0$
M   !$  ! P(# @0+$ T(!@<(  <  0(#! 41!@<A$C$350A!(M*3TQ1TE!48
M&5%AT3)2DE.S5+34%C87-PEQD4*BLB-S-7655F8H@;%R,Z/CI.3"0R0TA+6A
M@D1D)44XP6)C@X4F1B?$9?##Q>'Q$0$! 0                   1'_V@ ,
M P$  A$#$0 _ -_@
M                                                    X2R1Q,62
M5[8XF[7/<J-:B>>J@8,SISK=,\DW%UMK:J*HG8KFN;%6T:+BQ[F*F#I478K0
M+17GU:5(JIVO(OG]N4790.2<^G2KV"3ORB[* \>G2KV%_?E%V4!X].E7L+^_
M*+LH#QZ=*O87]^4790'CTZ5>PO[\HNR@/'ITJ]A?WY1=E >/3I5["_ORB[*
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M
M
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M3Y&NU)(]714T5O2)BJJHW?DK57!.AC@!N&!1,<-NQ0*@
M
M
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M1$VS3=! K;?ZO9J)DZ_KYL5L_#K@C<P
M
M
M                           !;V>ODE=OR/\ I(!"5F_Z0+U^EZKWT\"6
MWFN)AI!E_9ATM;_S"H S2
M                                          (@.>+],D_<$/MTX5MM
M]7Q\C+[^2MOME<$;D@
M
M
M              +>SS\DKK^1_P!) (2LX?2!>E__ )O5>^G@2V\UQ<=(,O?T
M:[_F%0!FD
M                              1 <\;Z99^X(?;IPM;;?5\?(R^_DK;[
M97!&Y(
M
M
M  "W<]_)&[?D?]) (2LWKCG^]?I>J]]/ ELYK/T09?\ Z-=_S&H S6
M
M               (@.>-],L_<$/MTX6MM?J^/D;?OR5M]LK@C<H
M
M
M                                               !;N>_DC=OR/\
MI(!"5F_Y?WK]+U7OIX$MG-9^B#+_ /1KO^8U &:P
M
M!$!SQOIEG[@A]NG"UMK]7Q\C;]^2MOME<$;E
M
M
M                                 +=SW\D;M^1_TD A*S=MS_>OTO5>
M^G@2V<UKZ'\O?T:[_F-0!FL
M                                            1 <\;Z99^X(?;IPM
M;:_5\?(V_?DK;[97!&Y0
M
M
M                "W<]_)"[?D?]) (2<W?+^]?I>J]]/ EMYK2XZ09?_HUW
M_,:@#-8
M                            B YXWTRS]P0^W3A:VU^KX^1M^_)6WVRN
M"-R@
M
M
M%NY[^2%V_(_Z2 0EYN^7UZ_2]5[Z>!+7S6OH@R__ $:[_F%0!FL
M                 *?] %0* 5           %%5$X>CP 5
M                         (@.>-],L_<$/MTX6MM?J^/D;?OR5M]LK@C<
MH
M
M                                                         !;N
M>_DC=OR/^D@$)6;_ )?WK]+U7OIX$MG-:^A_+W]&N_YC4 9K
M            **J(F/0 ^7;46]N[<?L &3LD5=S%5\Q> #Z_9X0'#]@"H'QC
MJ8I5Z7';YJ 5=41L>D:XXK_[ /KB    .,DC8V[SN #XI6P+P8_: ^S'M>W>
M;P <))&1-65^*M3;YN& %89F3MWV8X>>!]    !\GU,;'[CL<?L ?1KD<B.3
M@7@ J                              B YXWTRS]P0^W3A:VU^KX^1M^
M_)6WVRN"-R@
M
M
M       %O9Z^2-V_(_Z2 0DYO^D"]?I>J]]/ ELYK7T/Y>_HUW_,:@#-8
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MSQOIDG[@A]NG"UMK]7Q\C;]^2MOME<$;E
M
M
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M/W##[=.!MM]7Q\C;]^2MOME<!N4
M
M
M                        MW/?R1NWY'_20"$K-_R_O7Z7JO?3P);.:U]#
M^7OZ-=_S&H S6                       HNQ,0.I<:N*CH)JQ[D2.-N\K
ML41,,<.%=@$7>7JOP=SC[S=:ICJ>C>RO1L\J;D:[]P5R8.=@FU//"MO^<9JY
MEB73:[6*TR-N]9=X'Q0LM\T-2Y'1OC?Z5CU5<>A@$:IZ2\W[..9,O7R^U-NJ
M:2DJ*F6OIXJBGJ8I'LEB;*S=_%*CN'#8H'IZ(<XEFDB2Y;SS9*]DT;<88EB9
M2.62:3C4PX]S'+TJ\& &XND.K=;J,E5<&6VJHK,U[74ZU,36[T4K%?&J/:JH
MNS#;CM T]YNW;%'K4V21BQ4V[1)O2-5O_:J=5VKL KK@Z23G(VZLI6K.QDUV
MQXI-_P!.V9.A]D#T.<I!56[/N7,PU%+-VB^>U-65&.1J<5&CG*KE1&[$3;M"
MNOK:MSN5LR]J+E:WU-?3VNFEWUI8752-6KE9 F*QHYNW>7A4(OK('/+LU1:;
M?EQEAN+KY"Z.%6(V#>WVM9%CQ:/5V&^OF!6WN1+_ '#,M@IKM<::6CGG:JK3
MSQ\5(W![V[6]#TJ*$8UYU4R)I=44[-LJSH_=X5W>UZA. #7GF19BL=AME1X<
MKZ>WO2EIT8VJFCIU5R33*J)QCF^:!9?.\N\NINI=MH\H6NMO"Q6^F@6KM\2U
MD"+!753W(KJ??VHUR.^PJ 95U,RQ<LG\V6EL%V3_ ,2@H;TD5.UKVR;TD\DJ
M)N/:URXH],-@&'<MY$N6=N;S/;Z6AJ'5R7"W.6G2*59'-92M57(QC5=@BKP@
M9.YM6H\%FTON]BS1_P"&W9E+5/CI*M64LSWR3N5K6QRN:Y55-J)@!;VBNGUZ
MDU@O^J%10U'@7PC62Q/XF5$<RNAD:Q6OW=Q4Z;AWOL ;(Z8<Z/*&I-_3+U'3
MRTU:YK%8LTM/@JR2LB:B(QZKCB_S ,\JJ)M5<$0"-3GBU,M;JY0+!$^2F976
MEW',;O,Q;&Y%3>3%-@&2M9Z^.HYL5#04?XRM\&;JP-P?)O)71.PW4Q7@\X*[
M^F]=1Q<VRZVV3%LSIJUZ1JJ([?6VM;P*N/"$8&T@R;<<V:0YRL5%2S/O:06U
ME!"V.1SG.=4S.?A&QJN=@UO00"X>;_SBY-$5N>1\XVBL[8;75,L3&Q,IU<F[
M#3-5$G<QR[87= #='2S5&Z:F.ENM-134-E1&NBBJHD;(Y$>^)Z(YN**N\Q5X
M0,K12+)CBQS,%PZ9, /H                        0_\ /$^F2?N"'VZ<
M*VV^KX^1M^_)6WVRN"-R@
M
M
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M^W3A6VWU?'R-OWY*V^V5P1N4
M
M
M                     MW/?R1NWY'_ $D A*S?\O[U^EZKWT\"6SFM?0_E
M[^C7?\QJ ,U@                        "CE1$V@,>AT0*X@4QVX 5  4
M5=J)YO1 J  HB8)L_E J 0    , *)CT0*@<6HQJJC41'>=P@<@      41R
M+P+B!4                         1 <\7Z9)^X(?;IPK;7ZOCY&W[\E;?
M;*X(W*
M
M
M   6[GOY(W;\C_I(!"5F[Z0+W^F*KWT\"6SFM?1!E_\ HUW_ #"H S6
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M<!N4
M
M
M MW/?R1NWY'_ $D A*S=](%[_3%5[Z>!+9S6OH@R_P#T:[_F%0!FL
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MIQB+''LPZ9,%"+\T#K9;EI7E:X3.<Y]5:+9.N\JJJ++11.5%Q5<.$#)@
M                 $/W/$^F2?N&'VZ<#;?ZOCY&W[\E;?;*X#<H
M
M
M                                                !;N>_DC=OR/^
MD@$)6;_E_>_TO5>^G@2V<UKZ(,O_ -&N_P"8U &:P
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M2MOME<!N2
M
M
M      MW/?R1NWY'_20"$K-_R_O7Z7JO?3P);.:U]#^7OZ-=_P QJ ,U@
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M7ZOCY&W[\E;?;*X(W*
M
M
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M=.!MK]7Q\C;]^2MOME<!N4
M
M
M                   MW/?R1NWY'_20"$K-_P O[U^EZKWT\"6SFM?0_E[^
MC7?\QJ ,U@
M                              "(#GC?3+/W!#[=.!MK]7Q\C;]^2MOM
ME<!N4
M
M
M  MW/?R1NWY'_20"$K-_R_O7Z7JO?3P);.:U]#^7OZ-=_P QJ ,U@
M
M             "(#GC?3+/W!#[=.!MK]7Q\C;]^2MOME<!N4
M
M
M                                             MW/?R1NWY'_ $D
MA*S?\O[U^EZKWT\"6SFM?0_E[^C7?\QJ ,U@
M                                                        "(#G
MC?3+/W!#[=.%K;7ZOCY&W[\E;?;*X(W*
M
M
M                             6[GOY(W;\C_ *2 0E9O^7]Z_2]5[Z>!
M+9S6OH?R]_1KO^8U &:P
M                                        !$!SQOIEG[@A]NG"UMK]
M7Q\C;]^2MOME<$;E
M
M
M             +=SW\D;M^1_TD A*S>B_'^]_I>J]]/ ELYK7T09?_HUW_,:
M@#-8
M                         B YXWTRS]P0^W3A:VV^KX3_ .S+[^2MOME<
M$;D@
M
M
M+>SS\DKK^1_TD A+SA\O[U^EZKWT\"6KFM?1!E_^C7?\QJ ,U@
M
M          "(#GB_3)/W!#[=.%;;_5\_(R^?DK;[97!&Y
M
M
M                                          "WL\_)*Z_D?]) (2LW
M]-G^]HFU4N]7CWT\"6KFLX_-!E_^C7?\QJ ,V
M                                                          "(
M#GB_3).O0[1A]NG VW^KY^1=\_)6WVRN W(
M
M
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M4_KIP-M?J]W*N3;\B]"*VX=<K@-R@
M
M
M                         %N9\8Z3*%V8QN\Y8<$3_K(!"3GILD.=K\N&
MZ]+G6.;_ "5#P+[RKSCM1,IV6FLEMNM;%34O&;B157%-_&2.E7!J1KAM<O1
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M;W4R5-:YJ1\9,[?=NHYSD3'!/5*!(U]7U&]F2[V]4Z5\5MW5^Q)7 ;C@
M
M
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MG)7L]=W]'\& JGU?.2D_U]=W]'\& JGU?>2O9J[OV/X,!Q\GSDKV>N[^C^#
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MSF,9CAQB] "\P
M
M
M          "BKMPPV>:!5                                      "
MB+T.B@%MZA+AD;,>"X+X,K?>\@(AWR'C\]UD5?3=O1>U 3,Y:^3EG[BIO:F@
M>H                                         "BJJ<"8@5
M
M
M
M                              MK4+Y#9B_1M;[WD AWR*O_ .[K)W=%
M[4!,QEGY-V?N&F]I:!ZH
M
M
M
M                                        "VM0_D-F+]&UOO>0+$.V
M1?INLG=T7M(1,SEGY-V?N&F]I:!ZH
M
M
M
M                                                 "VM0DQR-F+]
M&UOO>0"'?(J?_NZR=W1>T@3,99^3=G[AIO:6@>J
M
M
M
M
MMO4'Y#YB_1E;[WD AVR+]-]D[NB]I F9RS\F[/W#3>TM ]0
M
M
M
M
M       !;>H/R'S%^C*WWO(!#MD7Z;[)W=%[2!,SEGY-V?N&F]I:!Z@
M
M
M
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MCH=SM,OZOWA;-%15%#4KQJM[:=3LQ2*-'JJ(QZKT0-E
M
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M=]7#@K4=PTS%X<?/ DR
M
M             ?"M_P!SJ,?8W_@J!#KK*]L7.%NJQHN#)*)4_5L $J.B;U?I
M=E)R\*V6V+]NBB R
M                        **F(%0
M                                             U0Y]BJF0:/N:Z^U
M0@87^KS7&\5G=%3[UC D7
M
M               ?"M_W.H_)O_!4"'36?_U#W=$3_64/_+8 )4M$OHMRE^A;
M9[RB R
M
M                               -4.?9\@:/N:Z^U0@87^KR_/%9W14^
M]8P)%P
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MZ[VQM2E(M7#VTJ8\3QC-_!%5/2XX] #N@
M
M                                           !JAS[/D#1]S77VJ$#
M"WU>?YXK.Z*GWK&!(P
M
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MUT3V-GB>DK71N3^NX.+Z'G@;=.<UBKONV+T .28*B*G!AL^P!4
M
M                                                           U
M0Y]GR!HNYKK[5"!A;ZO/\\5G=%3[UC D8        IBN/ !4
M
M                                'PK?]SJ/R3_P5 ASUE_]0UV_*4/_
M "V "5/1/Z+LI?H6U^\H@,@  (W.?G'AG=DCW+@ZNH4<U%X$[23@0#*=1Q_B
M7Q]JHY8VVVS)@N.*_P"W4WF :_Z .<F2<X+NHY$M-V5<4Q7'$#$-EI+A66O-
M-11.>R..>EXQ(U<W:Y41-B 9HT#:K=*,Z-?O.D;17O?QVILA9C_*!WN8Q9Z;
M,&:LU4%5&K[=+);&SL5$79Q=:J;'(YO"G10#,&;.8S8);X^^TURK*>U1XU%1
M&ZKIHV*Y)'R.Z3M3!4W?-4"P;Y1-N-T;IQE+'XK6J18;A+'@CG4]0B2(N,2<
M6[!V]PLP \.Y\[6_Z=R1Y)R+;J)UNMR-BJGU--/Q[IZ95@D=C3U,;5Q;$S:K
M,<0-R.;MK2S6;*S+C/$R*NC8^29L<;HV8=LS1-P1\LKN"-.%0,T(BHJ(F&ZB
M?R@<@
M
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MUJN=->*"GN5&JK35,;98E=ACNN3%,<%5 .Z
M
M           'PK?]SJ/R3_P5 ARUDV<X6[?E*'_EL $JFB2XZ792_0UL]Y1
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M4#=7F@Z2WC3/*"+?&/CKJN-\;V21NB=TE9.],45SD]*Y -E@
M
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M6%(9,5W'8[V.'0"MV+%;[;:;72VVU-1E#31MB@8CG.P8U-B8O557^50CT@
M
M                                  ^%;_N=1^2?^"H$.>LO_J%NWY2A
M_P"6P 2HZ(_1;E/]#6SWE$!D( !U)+7;95WI:."1WJGQ,<NS[* ?>*"&!NY!
M&V)GJ6-1J;/.0#XSVVW54B35-)!-*U45LDD;'N14X%1515V =AK&,:C6M1&M
MX$1,, .K46ZVU4R35-'#/4-P5LDD3'N3#@VN15V =F-B,;N-:UK$X&M3!/M
M<9X63-1KXV2;47!Z(J)Y^T#DQ$C:C$1$1.!$X .M46NV5CD=5T4$[TV(Z6)C
MUV+CPN1>BH'9:R.)NZQB-8W@:U$1$Z.Q$ Y8JJIAZ50*@
M
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MN1,=@1(=&_?C8_U2(OVTQ Y@
M                                                          #X
M5O\ N=1^2?\ @J!#GK(F/.$NK5X4DHL5_P#IT $J.B*8:6Y3_0UL]Y1 9"
M%1%X>@  HB(U,$ J    *8)CCT5 J
M
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MIY-VIIGHVH@?&]-S%K%VN]2!N2U,&(U$P1$P1/L <DV)M J
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MU,*&LX57 #8;3C4JP:EV..\V"5TL;T>Y=Z)\.QLKXN!^WA8H%ZIP;>$
M
M                                     :H<^SY T7<UU]JA PO]7G^>
M*SNBI]ZQ@2+@    !1$\[:O" ^P!4 H "@#!,?/\T"H "B<*] "H
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M?JU^S]W_ %/7=C >*?JUR!=_U/7=C >*=JUR!=_U17=C >*=JUR!=_U17=C
M>*=JUR!=_P!45W8P'BG:M<@7?]45W8P'BGZM<@7?]3UW8P./BHZMXX?%Z\?9
M\#UW8P#N:CJVU43XO7A<>BEGKNQ@8ES)EJ[Y3NLMFO5+/15D>\O%U4,E.]6M
M>Z/'<D1%P56*!O\ _5](O@.M1R+NI W<\Y>W*D#>8
M
M                       :H<^SY T7<UU]JA PO]7GCX8K.Z*GWK&!(N
M
M          MG43Y#7_'W%+^"!"7J!A\?,TIT/"]P]\R 2]\V?<=I1;WL3AJ:
MM,>#_7. R\BHO!T *@
M                                     $/G.\<CM79]U,,*9^/?]6!L
M_P#5\.1;'7HJX_[.W#'NRI WD
M                      *N"8J!\9IVP-6639"U,7.X5^T!:,NJF38?3U4J
M?_(D7_V ?%-7<CJN"5<O6)/0 Y?.UDKW7+UB3T 'SM9)]UR]8D] !\[62?=<
MO6)/0 ?.WDGW7+UB3T 'SMY)]UR]8D] !\[>2?=<O6)/0 ?.WDGW7+UB3T '
MSMY)]UR]8D] !\[>2?=<O6)/0 ?.WDGW7+UB3T 'SMY)]UR]8D] !\[>2?=<
MO6)/0 ?.WDGW7+UB3T 'SMY)]UR]8D] !\[62?=<O6)/0 ?.UDGW7+UB3T '
MSM9)]UR]8D] !\[>2?=<O6)/0 ?.WDGW7+UB3T 'SM9)]UR]8D] !\[62?=<
MO6)/0 ?.UDGW7+UB3T 'SM9)]UR]8D] !\[>2?=<O6)/0 ?.WDGW7+UB3T '
MSMY)]UR]8D] !\[>2?=<O6)/0 ?.WDGW7+UB3T 'SMY)]UR]8D] !\[>2?=<
MO6)/0 ?.WDGW7+UB3T 'SMY)]UR]8D] !\[>2?=<O6)/0 ?.WDA/^UR]8D]
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MEZQ)Z #YW<D>ZY>L2>@!7YV\D^ZY>L2>@ ^=O)/NN7K$GH /G;R3[KEZQ)Z
M#YV\D^ZY>L2>@ ^=O)/NN7K$GH /G;R3[KEZQ)Z #YV\D^ZY>L2>@ ^=O)/N
MN7K$GH /G;R3[KEZQ)Z #YV\D^ZY>L2>@ ^=O)/NN7K$GH 475O)")_ODO6)
M/0 [=LU)RG=ITIJ*ID?*JHB(Z%[=J^>J><!=C'MD:U[>!R(Y/L+M Y
M                         %L:B_(:_P#<4OX($)FH"[N?<T*WA\+W#WS(
M!+WS9DPTFMW=-9[<X#+X
M                                         A\YWNS5V=/^ZO7_ !]6
M!M!]7PO_ (!6I_\  ;[\J0-XP
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MK@H$SNAEWJ+YIC8*VJ7>F6BHVN7##%>TX'+_ -+@,C
M             %L:B_(6_P#<4OX($)>H'R]S3^E[A[YD E\YL_T36[NFL]N<
M!E\
M                        0^<[WZ7I^Y7^_P"K V?^KW_,-=^0;[\J0-Y
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M,%2RF@;#3M<WBZ=OI4Q8W%$_E")C^;HF&DU@V88TE&N'_ TX&50
M                     "V-1?D+?^XI?P0(2]0/E[FG]+W#WS(!+YS9_HFM
MW=-9[<X#+X
M                               A\YWOTO3]RO\ ?]6!L_\ 5[_F&N_(
M-]^5(&\@
M     #5;GUICI6WNVD_GE CUT$P^=7*WF^%:'#S/Z]H$TEDQ\#6['W+#P?DV
M@=\
M                       LC5Q%73^]X="DJ5_P\H$*5\55S!.JI@J.;L7^
M@T"9#F[8?-/E]4Q_W.CQQ[AIP,J                               %L
M:B_(6_\ <4OX($)>H'R\S3^E[A[YD E[YLJXZ2V[NJL]N<!F
M
M          0]\[WZ7I^YG^_ZL#:#ZO?\PUWY!OORI WD
M                                          :K\^OZ*D[MI/YY0(]-
M!/I5RJG_ /-:'V]H$TMD_,UN[E@]K:!W@
M                                                    "RM6,/B#
M>\?<E3[WD A2S O_ -R5/]-GX#0)CN;M]$^7^XZ/WC3@94
M                 +8U%^0M_P"XI?P0(2]0/EYFG]+W#WS(!+US9/HEMW=5
M9[<X#,(
M                            A[YWOTO3]S/]_P!6!M!]7O\ F&N_(-]^
M5(&\@
M  #5?GU_14G=M)_/*!'IH)]*V5?TK0^WM FELGYFMW<L/M;0.\
M
M          63JW\@+WW)4^]Y (4K]\HZC^FW\!H$Q_-V^B?+_<='[QIP,J
M                             %LZB?(:_P#<4OX($)6H.S/N:?TO</?,
M@$O?-D3#26WI_P!ZK/;E S
M                                            (>^=ZF&KTW<KO?\
M5@;0?5[I_P" 5R__  &^_*D#>0
M                       !JOSZ_HJ3NVD_GE CTT$^E;*OZ5H?;V@32V3\
MS6[N6'VMH'>
M                               +)U:7#(%[[DJ?>\@$*5_7_P"XZC^F
MS\!H$Q_-V^B?+_<='[QIP,J                               %LZB?(
M:_\ <4OX($)6H/R]S3^E[A[YD E]YL^S2:W=TUGMS@,O
M
M     "'SG??2]-W*[W_5@;0?5\?F"M_(-]^U(&\8
M                                     #5?GU_14G=M)_/*!'IH)]*V
M5?TK0^WM FELGYFMW<L/M;0.\
M                                             61JY]'][[DJ?>\H
M$*5]^451_29^ T"9#F[?1/E_N.C]XTX&5
M    "V=1/D-?^XI?P0(2]0/E[FG]+W#WS(!+YS9_HFMW=-9[<X#+P
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MQ:7B!7^9TW1_ZH'?H\S6&X/2.CKHYGKP-;CT$QZ* >L
M    !#YSOOI>F[E=[_JP-H/J^/S!6_D&^_:D#>,
M                                    !JOSZ_HJ3NVD_GE CTT$^E7*
MOZ5H?;V@32V3\S6[N6#VMH'>
M                                            +)U;3'(%[[DJ?>\H
M$*5^3#,=1_39^ T"8_F[?1/E_N.C]XTX&5
M     "V=1/D-?^XI?P0(2M0?E[FG]+W#WS(!+YS9_HFMW=-9[<X#+X
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MKOR#??E2!O(
M         U7Y]?T5)W;2?SR@1YZ"_2KE;]*T/M[0)I;)^9;=W+![6T#O@
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MO.H6>-8[CE3,JM;;X+3+61,BGJ7MWVUU/"WI9)7M]+([;@!NF
M     LK5GY 7ON2I][R 0I7[Y25']-GX#0)C^;O]$^7^XZ/WC3@93
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MHHXT1SL48ZG:B]-CT0,GZA9XJ[AJ[0Z>V]W&V6&VLD?"QK'+OPUDM/Z?#?\
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M#Z@             A[YWGTO3]S/]_P!6!M!]7O\ F&N_(-]^5(&\@
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M25']-GX#0)C^;O\ 1/E_N.C]XTX&4P
M"V=0_D/?^XI?P0(2M0?E[FG]+W#WU(!+[S9_HFMW=-9[<X#+P
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M7H] #8H(            !#YSOOI>F[E=[_JP-G_J]_S#7?D&^_*D#>0
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M#4QQZ;#9@!H92YQS9IIGR\QZB9,O]YMSY8>UGV^WR0,5(XEXS![VQX[9&?:
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MG.^^EZ;N5WO^K V?^KW_ ##7?D&^_*D#>0
M                               !JOSZOHK;W;2?SR@1Y:#?2KE7]*T7
MM[0)IK'^9;;W+![6T#O@          !]D#&^KVED&J5AEL=0Z-(I62QO21\D
M:*V5FXNV-%4##.0.:17Z=33R9?K:"!LTBR8++4S+M:K/]9&O04#M6#F>6.+.
MU)G7,JPU=QI)::HB?35-4S\922,>SI5:UJX(P#)6L.AMBU2RLZP2QHV2.&&F
MI72S31L:R*H9-@JQXJOI0,!Y3YA-ILV8Z2[W22CFI*.6&H@C@JZWC$DAE:_'
MIF(B[$\T#,>M?-^I-4LOV_+M-)!!3T,*P1LJ9IV;./CFX8T<J^D ^V7M!8[%
MI;7:<ME@6*N=4/D<DLRLQJ:7M9>F5N\FSS@.CH)S<*#11U\[4="K+WVIVPD,
MU1*J]I\?N_UR)A_7+P 65;.9O;[!GUV;K!+2T\<RO?4,EJ*J25SI9^-?@CFJ
MU$5$3H@=_67F>Y>U)N\U\MJ0T]RJI'2U3ZNIJFM<NXQC=UL:.1,$:N('9T4Y
MHV7-++Q%F"I;%-=H>-8R2FJ:E[-R:-K%Z65&ICBB@;+.Q5%1JX. UQUIYKT&
MKUX2ZU\M,LC6K&Q))JB)=SCGRHF$353A>!Y]1S8<P2Y6=E9MQMZ43DF:K%?4
M<$V./3<7O=$"\]#^;IEO1_CJ^"-KKY.])99X9YY8E>Z)8WKNRX<*+LV 6UGS
MFM4N==2*#4.:2F[>H9Z&HC5\]2QR/H'-<WI&-W5]+T0+AU:YN=AU5RU;;9=F
ML?=+93MIJ:9T\\4*(LL;WXI&F*XHS9L M*T\U6?>H8,PU=)4T%#41U44=/+4
M,>DD3DW=NXW'I=Y -C[1;*>SV^FM=$U64E(W<C:JJY<,57A7:O"!:6K^27Y]
MR36V2+=[88V6H@WE>F,J4\T;4Z1%5=LG!@!@?FE^$].X[EIIFMCJ6KI.TZ>C
M=,Q:=DBXU4TFYQR,>[!'MQV; /7U1YIE#J1FVBS?-)3=NT;(HHGR3U+/Q<4\
MLZ=+&U6KMD SWEW+LMCRQ39>>]C^(8YB.8KE;TTCG\*HB]$#7&]<S6VW;-\^
M:EDIDJ)I)'XK452.PDF=+ANHW=X7 >YJWS7?G690,NL]*]+>Z5\".FJ(<'2M
M8U?ZINWTG1 R7I1IG)IKE>'+K9(GMIV0Q1<4Z1[49!"R)$QD1%7TH&OMSYCE
M'57V.^TT]$RKB5CHWOJ:S8L:(B=*C%0#+=QN$FA>FK:6JECK;A3)2PP4M$J2
M2N8CDC<K62HU51.BN &-^9YHE=,FQ56;LSTKZ:\U$<U%N2LGIY-QDT4K%6.5
MK4PZ7A VW5,45%X -3=0.9Q%G7.WQR=/1I4MXA8UDJ*MCD6G7%O2L8K>$"X:
M_FY9DJ\O/L,=RH&QO8UCMYT^'2O1W"D:KT +KT\T)H\AY,N>6:9T7;-U2J95
M2-EF?&K*R)D;TZ=,4VMZ" 6=IMS5J?3J\U]TM\M,CK@Z!TF[-4R+_L[9&IBD
MC<$_K%X /EEWFH4^7M0:K/5)+3-J*EL['_CZES_]HFXY>E<W= ^^8^:K1Y@U
M*AU$FEI^WHIX9U59ZEKL88&0)@QK=W@8!]-3^:S1ZDW*UW&NDIUDME-%2Q;T
M]1'@V&1TB;(VX+M=T0/6U#YNL>?<IV_+-5+3\70K4*U7RSL;_M&..UC<>B!Z
M&7M *"S:<.T^E=$ZC>M*Y49+,K<:1D;$Z941WW %FZ3<TVDTYKJ_CI:62VUT
M"4TD,$]2^3<<_>?MD:F&*8X;0+-SUS#[3F+,%QO-GDI(&5U1)/NU-56[V#W8
MIBC6N3@\P#-NE>@.7--\F5N58(T<EPAJ:>I=%/-(U8ZMJ(Y$63!4 P]F7F24
M]5FR7,N6IZ.D6>2225*FHJW/57-W$V(QR;$50/?TSYG]LT\S4W-$#Z;MO<2-
M[HZBJD54XZ*9>ED:B<,8&T;$W6HW'@ Y               63JU\@+WW)4^]
MY (4[[\HZG^DS\!H$R'-X^B?+W<5%[QIP,I
M      %LZB?(:_\ <4OX($)>H'R^S3^E[A[YD E\YM'T3V[NFL]N<!EX
M                 !@    '!P     !39P@,4QPZ(%0  !A@ PZ(%,,.! *
M@    !1,>BGV *@>%=\FY5OTG&WFT4U=)M7?GC1Z[<,>'^B@'UM65,MV)=ZS
MVNGHG+CMA8C.'!%X/L(![          !UZNAHZ^%U/6P,G@>F#HY$Q:J(N.U
M/LH!U+?EVQVISG6VWPTKG8[RQ,1N.*HJ\'V$ ],               !#YSOO
MI>F[E=[_ *L#:#ZOC\P5WY!OORI WC
M                            :K\^KZ*D[MI/YY0(\]!4QU5RK^E:'V]H
M$TMD_,MN[E@]K:!WP       /%S9F6@RAERX9EN;TCH+='QL[U:]R(U7(W@C
M:YW"O00#&^CFO5IU>\*K;(HV,MU754B.9QR;R4K8G8KQL;.%)$ ^]LU_R;6:
MBU6FM55-@S!#)2PPP)%5/5\E9$V9J;Z0\6G2N3[L#*SZB)DB1N=@]R8HF"\
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M93IJ2.)]CN%;;)96.E5RR4*JCL4?&U-N'054 S'M55Q38G H&-KNN1,UYH\
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M\=N*4Z^8!D/*V9K7FVST]ZM,W'4=1O[CT:]F/%R.C79(UJ\+5Z 'M
M   %DZMKAI_?.Y*GWO(!"E>UWLQ5'])GX" 3(<WCZ)\O=QT7O&G RF
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MQVIPH!9.2,Y)<JNJM-=(G;[)97,:FXU.*9NM39O8\./0 O\
M                 A\YWWTO3=RN]_U8&T'U?'Y@K?R#??M2!O&
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MF8)TS=J(H1KCE.FJ,CYAN$.0KM2+;;KVY<HUFG[91O;:*W=<J(J(NXQNQ-B
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M_,%;^0;[]J0-XP
M           &K7/G^BM.[:3^>4"/#03Z5LJ?I6A]O:!--9?S-;NYH?:V@=X
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M_P"XI?P0(2M0?E[FG]+W#WS(!+YS9_HFMW=-9[<X#+X
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M?2.65N\N]&N[BU -<]$LR47;>;=2;BB.KJJY)6TC41F\C:UBL>BM<[AZ?H/
MO;F9:8RYCS-=L]7^)LD#XIJ>&.5'*N_3U<3V+NR1N;ANX\#@.SS]KW5V2"WV
M6TTS**BJX95FEIHN*7&*J@5N+F*GV. "YM,=,<K9HR5::F_9@B6G2>&5:*DK
MXTE5Z0L7!\;V*BHJ.5JIYH&=LXW'+&DFD-;6V2+B:*FB8M.B)#QKT6J:U<=U
M8T=@LJ]$#6KF6Y3J\PYIO.?[FU4C95W"BA1V\CMQR4\[5P<U4_UG0>!OF
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MBE_! A*U!^7N:?TO</?,@$OG-G^B:W=TUGMS@,O@
M       M+4;*[,X97J+))Z662)^&&]_5O1W CF^9YH%DZ%6*&P91?EB!VZZ-
ML[L<%3#CY%7'!7.\WU0%K9DYI.6LS9IGS94W%D5PGDFE55I9'KC4.5SMJ534
MZ/J0/=?S>XZJH:VXW_MJ@1C6/I%HU8CF)@BIO-J,4Q;L OK)>EN3\B*^6Q4#
M(*N3!99VNE57*U'-1=U\CT38Y0,>:N<UO)VJ5QBO2R,MEX@XK<JEAEJEP@23
M=3=[9B:G3/QQPZ 'I:8\W^V:?S0U=3<$NM7!N+#(M.ZF5JM1Z+L2>1-J/_Z
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M>_2]/W*_W_5@;/\ U>_YAKOR#??E2!O(
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MO_<4OX($)6H/R]S3^E[A[YD E\YL_P!$UN[IK/;G 9?
M          !1414P5,4\\#S+58J*TR/DI6JU9&[KO2HF"+C]RU /4 >?T0
M              #KUM'%74SZ:;'BY$5KL,.!R*G11?- \ZSY:M%C5RT5.Q)I
M<-Z561H_I,<-K6M7[H#V0                             $/G.]^EZ?N
M5_O^K V?^KW_ ##7?D&^_*D#>0
M                       !JOSZOHK;W;2?SR@1YZ"ICJKE7]*T7M[0)I;)
M^9;=W+![6T#O@           !P=#"]R/?&USTVHY6HJHOV0.?!L3@
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M5J\*+M0 UK6I@UJ(GF(F %41$V)P    "F[MQQ4"H#S^B
M  63JTF.0+WW)4^]Y (4K]\HZC^FS\!H$Q_-V^B?+_<='[QIP,J
M                      %LZB?(:_\ <4OX($)6H/R]S3^E[A[YD E[YLOT
M36_NJL]N4#,
M #'S                               "'SG>_2]/W*_W_5@;/_5[_F&N
M_(-]^5(&\@
M       #5?GU?16G=M'_ #R@1ZZ!X?.ME7'E6A]O:!-)9?S/;NYH?:V@=X
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M&_?*6H_IL_ :!,?S=_HGR_W'1^\:<#*8
M  !;.HGR&O\ W%+^"!"5J#\O<T_I>X>^9 )>^;+]$UO[JK/;E S
M
M             (?.=[]+T_<K_?\ 5@;0?5\?F"M_(-]^U(&\8
M                                              #5?GU_16WNVD_G
ME CUT$^E7*J]'PK0^WM FDLOYFMW<L/M;0.\
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MU$^0U_[BE_! A*U!^7N:?TO</?,@$O?-E^B:W]U5GMR@9@
M
M       $/?.]^EZ;N5WO^K VA^KX_,%;^0;[]J0-XP
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M\Q_3:[VVV7?4*^1K&_,:4,L*2,?&[&C=60/\QB^F3TJ!&Y'0V;$ JBHNU
M                        LG5KY 7ON2I][R$$*=\^4M1_39^ THF/YO'T
M3Y?[CH_>-.!E,                               MG43Y#7_ +BE_! A
M*U!^7N:?TO</?,@$O?-E^B:W]U5GMR@9@
M                                                      $/G.]^
MEZ?N5WO^K V@^KX_,%;^0;[]J0-XP
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MLD59U578O9&CEQ7AV@7/J7HQEC5=8&YHC1[*3?6FWH8)]U9FL:[!)F/P](G
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M<E3[WD A3OFW,E0J>K9^ T"8_F\?1/E_N.C]XTX&4P
M            "V-1?D+?^XI?P0(2]0/EYFG],7#WS(!+WS9?HEMW=59[<H&8
M
M                     !#YSO?I>G[E?[_JP-G_ *O?\PUWY!OORI WD
M                                                       :K\^O
MZ*D[MI/YY0(\M!OI5RK^E:+V]H$TUC_,MM[E@]K:!WP
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MM_[BE_! A+U ^7F:?TQ</?,@$O?-E^B6W=U5GMR@9@
M
M   $/G.]^EZ?N5_O^K V?^KW_,-=^0;[\J0-Y
M                                   &J_/K^BI.[:3^>4"/+0;Z5<J_
MI6B]O:!--8_S+;>Y8/:V@=\                        =$
M                                            %E:L?(&]]R5/O>0"
M%*__ "DJ/Z;/P&@3'\W;Z)\O]QT?O&G RF
M     6SJ)\AK_P!Q2_@@0EZ@KAGW-/Z7N'OF0"7KFRMW=);<G#_M59[<X#,
M
M                     A\YWB)\[L^W_LS_ '_5@;/_ %>Z86&OV+M@;MZ'
M^^5(&\@
M    #5?GU_14G=M)_/*!'EH-]*N5?TK1>WM FFL?YEMO<L'M;0.^
M
M            65JRN&0;VO\ W2I][R 0HW]<<R5/]-GX#0)C^;M]$^7^XZ/W
MC3@94                               +8U%7#(U_P"XIOP0(3,_]-G[
M-."8XW>X>^9 )?.;3#+!I1;XYO3I4U:]!>&9WF 9>
M
M  $0'/!ADBU<E5S=U'4KE1<47AKJL#9WZOE[$R_6-QQ<L#4_QE2!O$
M                                                    U7Y]?T5)
MW;2?SR@1Y:#?2KE7]*T7M[0)IK'^9;;W+![6T#O@
M                                                           %
MDZM?("]]R5/O>0"%*_)_]R5"?^^S\!H$R'-W^B?+_<='[QIP,I@
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M3QV&HF=&Y(WQ)@Y6JB+A65..W #>4
M                          !JMSZ_HK:G_?:3^>4"/;02-7ZJY6P5$5+K
M0XX_EV@3261,+-;D\RE@]K:!W@
M                                             "R=6E1,@7O'9C25
M*;>YY (4[^B_&.HP5$7?;M=P>D:!,=S=E1=)\O[<<*2C1<.X:<#*@
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M+-'%2TR(K<(6.8F"R/DX'/?T7KT0+S
M                            :K<^OZ*V]VTG\\H$>FA&*:J95P=@];K1
M;/\ Y[0)I;'BEEMJ+P]JP8];:!WP
M                                               "R-7$8NG]\5ZX
M(E)4KCYZ4\H$*-\<R6_3JC]Z-7-Z;#_W$ F0YNJ(W2?+Z-X.U*-?\#3@95
M                              #
M             &L//A^BFH\SM:LQ_L0-4>8JQ%U&A?T42L1.]V@2F
M                                "F %0
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M#S&=X?WX#R@UP\QG>']^ \H-</,9WA_?@%^L&N'01G>']^!3R@UR\R/O#^_
M>4&N7F1]X?WX#R@UR\R/O#^_ >4&N7F1]X?WX#R@UR\R/O#^_ KY0:X>8SO#
M^_ >4&K_ #&=X?WX#R@UP\QG>']^ \H-</,9WA_?@4\H-<?,9WA_?@/*#7'S
M&=X?WX#R@UQ\QG>']^!1?K!KET$C[P_OP/)S)S[KE?K+6VES8G-JX9(7(M#A
MLDC<Q=O'+ZH#36KN#KC='5TK$:Z9R*YL;=U-C4;L3%?, F7YNN'S3V##W)1^
M\:<#*H
M                    UBY\/T45'<U7_P#V0-4>8I](<7V*SWNT"4L
M
M                                  !C76G2ZAU6RI)8*Q^ZG&1RL7BW
M2X.BWL.E;)'ZKS0-$)N8#F^.16Q7NI>W9M2TX=#NP#Y^('G%5_/-2G_TG_.
M/$#SERS4_JG_ #@#Q \Y<LU/ZI_S@#Q \Y<LU/ZI_P X \0/.7+-3^J?\X \
M0/.7+-3^J?\ . /$#SERS4_JG_. /$#SERS4_JG_ #@#Q \Y<LU/ZI_S@#Q
M\Y<LU/ZI_P X \0/.7+-3^J?\X \0/.7+-3^J?\ . /$#SERS4_JG_. /$#S
MERS4_JG_ #@#Q \Y<LU/ZI_S@#Q \Y<LU/ZI_P X \0/.7+-3^J?\X \0/.7
M+-3^J?\ . /$#SERS4_JG_. /$#SERS4_JG_ #@#Q \Y<LU/ZI_S@#Q \Y<L
MU/ZI_P X \0/.7+-3^J?\X \0/.7+-3^J?\ . /$#SERS4_JG_. /$#SERS4
M_JG_ #@#Q \Y<LU/ZI_S@#Q \Y<LU/ZI_P X \0/.7+-3^J?\X \0/.7+-3^
MJ?\ . /$#SERS4_JG_. /$#SERS4_JG_ #@#Q \Y<LU/ZI_S@#Q \Y<LU/ZI
M_P X \0/.7+-3^J?\X \0/.7+-3^J?\ . >-FOF29PRM8+C?I+E4U$-O@?4.
M8MLXI%2-,<-[MIV&/FX 8"RMDBLS3FF;*T#W0U<*3[[DCXQV-.N#DW-]OX0&
MR_B!YQPQ\,U./Z)_S@%/$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_.
M /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#
MSERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS
M4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG
M_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /
M$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SE
MRS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_
MJG_. /$#SERS4_JG_. /$#SERS4_JG_. /$#SERS4_JG_. >YEOF WZ.ZTE1
M=+],ZCC?C+"^U;J.:J*F"N2MQ0#?[(N5J?)N6+=E^F=OLHX(8E?NJS%8H618
M[JN?AZ3S0+C
M                         &L7/A^BBH[FJ_\ ^R!JCS%/I$B^Q6>]V@2E
M@
M                                        *?8 J
M                           !8FM*.72C-Z,V.\&3X*O]$"*_1#%-<KAO
M^FQN>/V=]0)BP                                      !14QV<'V
M*@                                          4Q3S0*KL0
M                      !K%SWT>[2FJP:JM;35>+OL\2!JCS%6O74>'=:J
MKA6;?^':!*6                                               %/
M/ ?^T U45,47$"H
M                                               "Q=9]FE.;E_\
MY;/^"!%9HJN.N-Q^S<_;% F-
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M /'MU8]ST_7Z[X0 \>W5CW/3]?KOA #Q[=6/<]/U^N^$ /'MU8]ST_7Z[X0
M\>W5CW/3]?KOA #Q[=6/<]/U^N^$ /'MU8]ST_7Z[X0!3Q[=6?<]/U^N^$ /
M'MU9]ST_7Z[X0 3GVZL>YZ?K]=\( KX]NK'N>GZ_7?" 'CW:L)_V>GZ_7?"
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M[ML-QI/ZJ5K5VIN[7-1W!M\T#T0
M                                                           %
MB:T?13F_]&3_ (($5FBGTXW'[-S]L4"8X
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M68[5<JJH$QFD7R)HOL,]IC OH
M                                                         !8N
MM'T4YN_1L_X($5FB:8ZY7%//N?MB@3&@
M                                                     !\JG^I?
M_)_.!#QK\O\ ^[T\ZJ__ ,C4 2B:".WM)\OKYO;GOZ<#)
M
M    #Q\V?)6^?H^K]I>!#%JR[?U<S&UB8.2MEZ9-B^D0"7K2'Y$T7V&>TQA:
MOL(
M                                   6+K-]%6;OT;/^"!%?HBG_ .]+
MC_2NGMB@3%
M                                !\JG^I?_ "?S@0[Z_P"W6].ZO_\
M(U $HF@:*FDV7D[M]_3@9)          &./
M                                            'CYL^2M\_1]7[2\"
M&'5A-[5W,;5X%K9?:T E[TA^1-%]AGM,85?80
M
M         L76;Z*LW?HV?\$"*_1'Z=;C_2NGMB@3%
M
M   !\JG^I?\ R?S@0[Z_?3@G=7_^1J )1M!?HGR__P 9[^G R.     %%5$^
MST "+YO#T0'G %39AC_* 1, *@ *+P+T// ;=B=#S0*@
M                                              \?-GR5OGZ/J_:7
M@0Q:K?2_F+NV7VM )>M(?D31?]7VF,*OL(       IM J  H!7[
M
M           !8NL_T59N_1L_X($5^B/TZW'[-T]L4"8H
M
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M'QF[TS7L1Z*BL545,%X0+R
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ME5#5PLW?QD$C)6]-BG"Q53H*!Z(
M                                           +%UG^BK-WZ-G_  0(
MK]$?IUN/V;I[8H$Q0       %'.:QJN>J-:G"JK@@%-]JHCFKO(O J;0/B^O
MH8YDII*F)E0JX)"Z1J/553'TJKCP =A%QVIP =9UPH&3I2NJH6U2JC4A61J2
M8NVHF[CCMQ [('Q6LI$E2%9XTF541(U>W>Q7@V8X[0/MBB<('!)HE=NI(W>]
M3BF(',
M         #Y5/]2_^3^<"'?7_P"G!.ZD_P"8U $HV@OT3Y?_ .,]_3@9'
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MEWL4Q7=Z"@7J
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M,I;5>ZA]3=U9A5/D1F]BV69S<5C>]J]+(G H1DK$"H
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MD*V:"
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MSJ&+'-/QF\QS=Q4W)',39BN&QH'K@
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M!(GE',$>9[!1WF)%:E3%%(J.1&KC)$R3@:YR?=>:![@
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M&9C7N:_B]YN^KD3%(Y)$3TOF@7<
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M55>''HJ!]@
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M+&7:&S,=O+3PQ,>N[N]-'$R-=F\[U/F@>\
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M$(D:YH&3;_D_3&DAO\3Z:IJ*>FPIGHS&-8EF14WF.<B\* ;"@
M                                                   ^53_4O_D_
MG AWU_\ IP3NI/\ F-0!*+H)]$V7_P#C/?TX&2        * 5  4VX[/Y0*@
M  %$VH!4
M         /(S7\EKY^CZOVEX$,>K*?\ [?S"O_?9?:T EZTC7')-%]AGM,85
M?(0   **UKMBHBIYX''B8L<>+;CYN" 5W&[45,47A3H <60P1JKHXVL5=JJU
MJ(O_ $ <U1%145,478J*!P9!#&JNCC:UR[55K41?^@#GM7'S ./%1\*-1'+]
MTB(B@<MF&[PH!Q;#$QRN;&UKEX7(B(J@<P
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M
M  /E4;87)_\ UP@0\\X!JIK@F.S_ &I/^8U $H>@F"Z39?PX/]L]_3@9(
M     8
M                 >1FOY+WON"J]I>!#)JUMU?S$UNU>W9=B?T$ EXTC3#)
M-%]AGM,8%]        %1%V*                           "F*8X=$"H
M                                                      +&UFVZ
M59M_1L_X($5VB:X:YW+S=ZY^V*!,4           *+CT%P J
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M #RA>9>2K7UFM^$ /*%YEY*M?6:WX0 \H7F7DJU]9K?A #RA>9>2K7UFM^$
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MA>9>2K7UFM^$ <O*&9EY*M?6:WX0 \H9F3#\U6OK%;\( )]89F3DJU]8K?A
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M >4+S+R5:^LUOP@!Y0O,O)5KZQ6_" *^4+S)R5:^LUOP@!Y0O,G)5KZS6_"
M'E"\R<E6OK-;\( >4+S)R5:^LUOP@"B_6%YEZ%JM?6:WX0 \H7F7DJU]9K?A
M #RA>9>2K7UFM^$ /*%YEY*M?6:WX0 \H7F7DJU]9K?A '+RAF9'-Z:U6M%Z
M&$%;\( XI]87F9%54M5K7S,8:WX0!R?]8?FA[41;1:4<FQ,(*W@[X V'T!YT
MM%K+<I[344\5/70QMD1*>&6-B[\O%IMDD?YH&QR*N.W^0"H
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MN]:OLP%/*()R?1=[5?9@'E$$Y/HN]JOLP#RB"<GT7>U7V8!Y1!.3Z+O:K[,
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MU(#R>FI/+]#WM4]2 \GIJ3R_0][5/4@/)Z:D\OT/>U3U(#R>NI7+]#WM4]2
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MAJW2QLF8D,4L:;LDCHTVR8=%J@9+YAS6/U.K%?AO)'2*G0VI4H!*@
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MPVON.G]J:"O1
M                           #27ZP:1WQ<L;.AQ=R_"H0-2N:FF.K--W*
M_P!O@ F/  4<F\U4\U (@^>$Q&:NW/#W5</?TP&RWU?&_P"!ZI<5P6GEZ/\
MWQ0-YP
M                (_OK"G/6HH=JX)1TZ88_][F QGS#$;\YM9LV\72>^4 E
M-                8$YW;4=H_>E7[FAN2_X"8"+G1=RMU+LBI_WKWG,!-K:
ML?!=%C[!%^ @'<
M                                  ,?:W/5NEV9VI]W;ZA%]:!"_G%O
M_P!U79/^\R?S@2I:4/<O-IS8Y?3)2WS#O10._P [WZ*;M^C;M[R>!%/D/'XQ
MPI_\.3\%0)Q\O_F&U]QT_M305Z(
M                                          :2?6"+_P#;UD\^.Y?A
M4(&IG-1^EJF[E?[?"!,<   1"<\3Z7[GC[JN/O\ F V5^KZ3"R5"^;!+[\4#
M>8
M            "/WZPG;4T7<<'ON8#&O,*^DRM_)4GOE )3
M  &!N=U]#U[[@N7O"8"+;1E/_P!E63_BO>DP$V]J_-=%W/%^ @';
M
M            ,>:X8?-AF7'D^H_  AASFG_W5=^Z7_S@2I:4.1>;5FQ>AVK?
M/>B@=[G>KAI5=?/MMV]Y/ BIR%\I(?R<OX*@3C9?_,-K[CI_:F@>B
M
M        &D?U@OR>LG]"Y?A4(&IG-1^EJF[E?[?"!,>   1"<\3Z7[GW5<??
M\P&ROU?'YDJ>YY??B@;S
M                               1^_6%?[S1=QP>^Y@,:<PKZ3:[\E2>
M^4"I30@              !@;G=?0]>^X+E[PF BVT9Q^<FR?\5[TF FVM7YK
MH>YXOP$ [@
M                             !CS7!/_ -89E_1]1^ !##G+Y57?NE_\
MX$J.DZ)XM.;4Z':M\]Z*!WN=]]%5T_1MV]Y/ BIR$N&8X?R<OX*@3CY?_,-K
M[CI_:F@>B
M                        &D?U@OR>LG]"Y?A4(&IG-1^EJF[E?[? !,>
M  1"<\3Z7[IW5<??\P&ROU?'YDJ>YY??B@;S
M                                               1^?6%?[S1=QP>
M_)@,:\PKZ3*W\E2>^4"I30@              !@;G=?0]>^X+E[PF BVT9^D
MFR?\5[TF FVM7YKH>YXOP$ [@
M                                            !CS6_P"C#,OZ/J/P
M (8<Y_*J[]TR?S@2HZ3_ /IHS;W+?/>B@=[G?_15=/T;=O>3P(J,A_*.'\G+
M^"H$Y&7_ ,PVKN.G]J:%KT0@
M                                      -(_K!?D]9/Z%R_"H0-3.:C
M]+5-W*_V^ "8\   B$YXGTOW3NJX^_Y@-E?J^=EDJ?/@E]^*!O,
M
M !'Y]85_O-%W'![\F QMS"OI,K?R5)[Y0*E,"               &!N=U]#U
M[[@N7O"8"+;1CZ2;)_Q7O28";>U?FNB[GB_ 0#M@
M                                          IMQ79LZ"@5
M        8]UO^C#,OZ/J/P (8,Y_*N[]TO\ YP)4=)__ $TYM[EOGO10.]SO
M_HJNGZ-NWO)X$5&0_E'#^3E_!4"<C+_YAM7<=/[4T+7HA
M
M:1_6"_)ZR?T+E^%0@:F<U'Z6J;N5_M\ $QX  !$)SQ/I?NG=5Q]_S ;*_5\I
M_P"!U"__  )??B@;S
M                            1^?6%?[S1=QP>_)@,;<PKZ3*W\E2>^4"
MI3 @              !@;G=?0]?.X+E[PF BVT8^DFR_\5[TF FWM7YKHNYX
MOP$ [8                         <(      &T
M     >>                       QYKA]&.9/T?4?@A4,.<_E7=^Z7_P X
M1*EI0B>+5FSS.U;Y[T4#N\[]/_U5=?T;=O>3P(J,AICF.'\G)^"H$Y&7_P P
MVON.G]J:"O1
M                          #2/ZP7Y/63^A<OPJ$#4WFH_2U3=RO]O@ F
M.   (A.>)]+]T[JN/O\ F V7^KY_,53^0E]^*!O(
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MQ5'Y"7WXH&\H
M                      $?OUA7^\T7<<'ON8#&O,*^DRM_)4GOE )3
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M7!RX-@1=@&3\LYLR]G"WMNF7*^.OHE1B\;%O8=.Q'IZ9$7:BHH'L\*X8?84
MNQ-H&(X><+DFISQ39%IZF"6Y5+J9D:MG=OJZKD;&Q-SB?-=ZH#Z:KZ^93TFF
MI8+X^%9:ILCFMEJ'08<4]K%X(I.BX#(]CO5)?K9#=*-S5IYFHYJM7>3:B+PX
M)YOF >BBHY$5-J+T0*@ .A>+I#9J":X5&'$PM<]^*[J(UK5<JXX+T$ PW'SH
MLB5=QDM%MEIZRZ1*Q)*5E2]KT61N\W'&##:@'KV3G$:>W&YI9[E<:>V7-V]N
M4[Y7RN5&[%79$U.'8!D3,68K?EVQU=_K9FLHJ*)\\CG*K6JV--NU$7#[0%A:
M;:Z97U.N-7;;(^%9J2IFI%6*=9E5T#-]5P6)F&SH8@95    %@:@ZN98TYC9
M-?:B**-[FL:Z21T>U[7N3TL;^@Q0._D'46Q:AV]UQLDL<M.C8WHL;UD14E5Z
M)M5C/4*!=LDC8HW2.7!K455_DV@8=S'SD<B9:S*S*U=54[;E)(L+&.G>UZN1
MK7+@U(7=!R=$#*UGNL%YMU/<J7!8*AC)&*U=Y,)&(]-N"=!0.\JKLV 8_P W
M:PY+RG+VK4U\$MSZ%(KWQNPWE8NWBW)L5 /&I=>LMM5JWMD5IA^ZDDG=(B)C
MMV)"G FT#(&7LU9=S13)66"OCKJ=V"[\6]ABYJ/3TR)T%Q ]H
M         &D_U@GR;LB?_#N7X5"!J5S4-FK=-W*_V^ "8T   B$YXGTOW3NJ
MX^_Y@-EOJ^?S%4?D)??B@;R@
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M=64K6+^+1J^D5P'FZ=Y2DN'.KKX;$UT^6Z:]R,?/$U5C6)::3<<N+MY,</-
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M+>_>B@=WG>_13=OT;=O>3P(J,A?*2#\G+^"H$XV7_P PVON.G]J:!Z(
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MH 5                   #23ZP/Y.V;\G<OPJ$#4OFI*OSM4W<K_;X )CP
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M*< %0'                     #23ZP/Y.V;\G<OPJ$#4KFI?2U3=RO]O@
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MB@                     1^?6%?[S1=QP>_)@,:\PKZ3:[\E2>^4"I30@
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MLJ4?$US&NQ2A>BXM1<>$#I\PVK@DRS70,V2(RB141,$_JZE0C<D
M            "/SZPK_>:+N.#WY,!C7F%?296_DJ3WR@5*:$
M   ,#<[KZ'KYW!<O>$P$6^C'TE6/_B_>DP$VUJ_-=%W/%^ @';  45S6HJN5
M$1.%5V(!HCJQSC,VT>L;,N98K*A+-3T:K4I'/4L;VQ'6S1.3=CE1J]*C=N &
M6->]>J.V9'K:W)5;4I>Z:&5\<4:R0N5V+-U%6%Z.X,< /-T@YUF7*K(4-PSU
M+4,NM.E-3S,;&^61TJT[%>JK-(KEZ?'%0,]Y2U!R_F[+ZYBM*3);V<8JI)%Q
M;_Q3E:[I<5Z* 6[7Z]Y!MU7-1U;ZMCX'OBD58.EWHW*U<%5R=% -=^<+KA<[
M=56[,^GF8*Q(&UL+ZBW+5S4],L,$6\YJQPRMQ1[F],G1Q RMIWSE,N7+)%LN
M699TBO"TT+JMD2*Y.,>B;V"OD5R[5Z*@=7)'.LL.=,VORS2T<S41L:ME=2RL
M15DE;%Z97JGW0&?KO<H+-;9KC.J-A@W=[S.G>C$\SHJ!K=I7SG*S5B\YQRRR
ME@I'62TW2M@JH(YX7<912Q0-Z=\CDQ_&X]*!:'-\U,SMF#6K..7[S>:NNM5'
M4VUD-/4UL\\4;9::H>Y(F22.:F*M3'!.@!N))<+=3/2*:JAA>[:UCY&,<N*X
M<"J@'V?/!$W?EE:QGJG.1$^VH&E6K^M6<[#KI;LKV.Z.2RRVM*F5K:R=D7&]
MN5,:HK8Y49CNL;T,0-RFWJT2(Y8J^FD<U,51LS'*GVE T^R)K!GR_<YF^Y.D
MN*NRS2UM\@ABDK)^*1M)-*D6#'2+&F"-3#!-G0 VYI,QV.NK9*&DJXIJN-&N
M>V-['+@[@X%4#77/W.?NV2]3$R1'04LT$BU>X]\<[Y-VE<YO"V5&]#S /2U&
MYS<^G%XH+/>*&!*BOJ8*6-&132XOJ$Q;Z61, +OMFKE[K[937=UOIV453&V5
MCE9*CMU_!BBOV<(&-K5J1K=<M1XH&T-O?E.1L+'/CJJASD59HVOP9QJMV-5>
M@%9MU"U(I,@4T5760OD@<QSW\7$Z5W2N:W8C53U01@#7GG,W&S9*HKIE5KJ:
M::OBB5STGII5:^GG>J?BY&KABUH'A6OG29@70*:^5T4K<U1T['\>B53NF=6J
MU<95DW_2;.'S@/%T8YUV;ER;>+KF&&6OK(J^J;2K4=MU2<6VGA>Q,7RJJ)CO
M;$ S;H#SC*[5^>>CN%M9155.R)[^*IYX6XRO>WAF>[H- V%  >%FG-UCR=;_
M  G?)TA@WVQHC=U7JK\41=U539L L71_5M=6*:2[T5,Z"V8+Q6_')"]71R<6
MY%:]SNB@&5P+,U4O55E_3_,=YH9'Q5=#:Z^I@>QSF.22"EDD:N+%14P5O04#
M7KFCZT9TU*O&9*#,$BST=!40112RS5$ST:Z&H?LXZ1Z)BK$QP VLJK5:Z_!:
MZB@J<%1R<?$R3!4V(O3(H!U/3TE.L-%#%!@B)&QB-C:F"^=A@!KEIUSBKQ?-
M1[QDG,5)%2T]#0U%=%4,9.F/%544#45\DBLX'*N")B!B;,O.8S/!SB4RQ;ZN
M>3*M)6OCJFP352Q\4ZD;(S%C9>+7%V/0 V.BYQ>0H;6^:1*U*F"%72)VLN"R
M,9BNW>Q7%0.&DO.$L.JURK+=;:>:)](V)RK)3OA1>-5R<+GN]2!<^JN>+ED"
MR)F"CIF5,#'QQR,D:]_IU=BNZQS5V(@'STIU:RWJG8*6[VMW%5$S9'NII6<2
M]J1SOA3I'.<Y,=W$#(B(B<"<(%%;BN/ H%OYJSG9<GTR55X=(V-<%3BF;Z],
M[=\U.B!9=RU_R!16VJKEFJ<((9)4_$^H8KO5><!J1;><_F3,6O<5'2W.O9D9
M*BN22.*>J:U(^U)'PXQ<:L?IT;T-@&U=RYQVGUJM4]9(^MD?3P.DP2GWL71L
M5WJ\=N '2T=YRF4]7:^XV^V0U,$]$M.UO'4SX$<M0DR\+WNQPXI0,37CG4YT
MFSY<LK6B@H%2@HIZ[INV68LIGN:N*I,B+P<& 58-+STM0IX;O<*JW4<5/;VQ
MOCW$K$:Y'H[>Q19UQPPZ 1F#+VN.JM^R['F"EMMH6D=&U^+Y9VNVQ-E]*LV/
M X*Z6@_.6S9J3J)=\L7:BHXJ.F[21CH$J-Y.V&JKL.,E>WH=! C;(#"?.(UL
M72"P05='$R>X57'LCCD9(]-Z.-'ILB>Q=N(&+\]ZT9^?I+;,\VU.U)ZNCMU2
MYL$E3"F-:V-Z[$D1WW714*V1T]S%\9LMT]S61)'R/E:JHY7;&/5O"JJH1=8&
M&-0=1=1,OUZ4UDM5#44JJU$DE6;?Z9JJOI)&@6DW5W5M'-=X&MZNV]*KJC=]
MM \K,VNNK.7[1/<Y[3:4;$U[G-22H<Y&MC<_'=2;'[D*N'FUZVYDU=2[R7>E
MIX64':G]3QR+_M';&.R61_L2!&Q      8^UN^B_,_Z/J/P0(8,Y_*N[=TR?
MS@2HZ48>+5FSS.U;Y[T4#N\[[Z*KI^C;M[R>!%3D/Y1P_DY?P5 G'R_^8;7W
M'3^U-!7H@                    ^3X&2+TW!T0/BVW4K7(Y&KBU<47%0.T
MB88(G @'"6%D[=V1,6^9P (H8X&[D:8)YZX\ '#M6'9L78N*;>B!R?3Q2;N\
MGI4P3:!5T37-5CO2*F&'V0.,%-%3HJ1(J([#'%<> #YK04RR<;NKO_97S<0.
MT!Q>QKTP<!\'T-/(J*Y%Q;M3:H'*&D@@<KHT5%7S5QX0/LYJ/16NX%V*!\XX
M(XEQ9L_E XSTD-1_6HJ_87 #Z1QMBC;&S8UJ8)CY@%CW+3V"Z9DIK]*Y$=32
M0RHBJ]%58'([H;.@!?$4:1,;&W@;L0#B^GCD<KG)BJI@NWH ?%UNIG;,%W5]
M,F*@?>.&.)FXQ.E^SB!Q6EB=@JHN*>>!\/!=&C][<7'TV.\O"!VVM1K41.@!
MQEA9.S<D3%O#LV ?&"WTU.[?B:J.\]54#M=                      #23
MZP3Y.V7\G<OPJ$#4SFH?2W3=R/\ ;X L3'!  !$+SQ?I?N?=5Q]_S ;*_5\_
MF*H_(2^_% WE                  '4N='X0H9Z/%$29CV8KP=.U6]#[(&J
MMRYF5LK=09<[Q5$+*J:HDJ)'.?4KBKV*S@QW>!0,]7C3&RY@R:W*5V:LM-&W
MI%9(]GXQ('0HN+5QPP<H&$]/>:/!D*YW">V5D$=OJG0JR%75#WHD39$VJ_'H
MO4#Q;ES*Z6JS-)F.GJX&5;G.?O.=4KZ:59<,,<.%0/=O7-9K,RRQ0WFX4\E&
MU5WV-2:-5:Y$1<%;AY@&9<I:5V+)F7%L5H:L:21-CE>Z21Z*Y(DB54WE5>!
M,'VCF=T%LU$BSJM3"]T512U"(U]1O8TJ,1-BKN_<@;3T-(RBI(:5GI8F,CZ/
MW#43H_8 [ &O6=.:]8\WY[=G2ID:E0]U2_;).BIVRY7+L:N[T0,]V^C;;Z.&
MCC])"QK&]'TJ(G1^P!:>IV0V:A99JLO3/:R&I2-';RN3^KGCF3:S;PL Q;HO
MS9J32BYS72EJ(G.E;(Q6M=,Y<))8I5_K//C V( U2U%YH=MS1G%F<J>HBAFC
MXM7K(^H5=R.1TKMC5W>B![&9-=M.\@4#M.EJ(:FYM1].Z-E4QKD=BDJ)NNQ=
MP2!5RZ"96M3J>KSE20NAEK*F=&(][G8QU$<,N*;<,-H1G "R]1,B-SU:WVUT
MK(D<B)B]7)P;WJ?L@:YY.YEM/DRKFJ[960,EG:UCW;U2_8Q=Y-CU4#V9N:;)
M<KJVMNEPIY(6\9@UO'L=@_%4X,.B!<>LG-BLNIR021/9!403LJ(W2R3X(^.)
M8VJJ,7H8@=BFYM=HGTTDR#>)&3[T5+"DT;YF,PII&2=!4=M5@&&*#F+5M'#)
M0ON=(Z@<KU2-O;6/XQ=NU=O H&?M#="[=H_12PTKFOEE2)%5KY7)^*;(U/ZQ
M?,D S*                     !'Y]85_O-%W'![\F QMS"OI,K?R5)[Y0*
ME,"               &!N=U]#U\[@N7O"8"+?1CZ2K'_ ,7[TF FVM7YKHNY
MXOP$ [8 #%^NFI-JTXR)=+I5R-6K6GD?34^^UCWK$^-';J/Q1<$>B@:7\T./
M+6:<Z9DS5F">.G;6U5U9#QDJQX,GXB5B=*J(NUZ@4O=%E?3WG(26RZ2LK,L7
M>KM]/QL4JQL8QE%$^15D<N/"Y>#@ \;,VGN2-1];H:>PSQQY3IXZR2JJWSR2
M11SPU$DC4=(Q<47=PV ;]:;.TX?8W6C(-R@N-L8DCG)3U"SJB/>N]M5<?3 8
M+YWN3;)29!K+I;6JVZ+/!CB]S_ZRI3?Z55PZ(&EFG^FENO\ ER&KN,2TU0O&
M[ZRND;BC9%:B8-5$X /*U'T^I+/4VZCMC%BBF@<Z:95>]JN:[8J;R]$"4+2K
M3?*N7\O6VK;TU=)'&_C$E?NXN:QZ)@J^:@%I<[?4QN3].JZQ6U.-S'=&0/H8
M6*QSU2GKJ=9,(WHN]TF]]@#!VC6C6J.5L@9AS)2U+:.2]45Q62GFI'K(^GK8
MHYUP1[53!=W!%0#%N@MIU"CUES!!8JIM/=Z6HH4KG.IDDQ<ZFG6/I5:N[@F]
MT ,^YMT2UTSOFF@OM5?*2&EHFPLDBFH'->Y(9GRKNJR-$VH_! -A\S9.O&;<
MJTEI94,I:IC94EDE8N"[[D5-C4V88 1P:MZ<RV36RDRS776FI^.MW;CJR1')
M$B=N5#-U<=N*[@&Q5CTMRM:ZVJJ+;G^QO8J1K*QLDCG*UO0Z9 K &EMKM?C"
M9FIKA?:.DMZ7*]M;<IG*VG<C9G[KD7AP?ATH1MAH/HQEZTYMGSA8<RVZ^0N9
M#TU!)*_^HD15]-LX4P"L3Y_?2MYV=NEN$C8*%B7MLDTB[K&JO&;N*^>H1Y>L
ME1?M:=8G7W)4;Y+'E6.AS"RLBB[9AQMR-XQ-]B?<JNW>V 7MIEJGJEJPEZTY
MHJQ($L\L5"Z66DA<Q.*1\R?U<>]MXG#:!F?F_P"2LW:=6^6ASO=::HEEDJ.+
MCCA6G7>FEC<STS47TK5 R]F":P4M&^[9@G924%(G3U4K^+C:CW(W%5\]51 (
MW-6,PW'77/[JME1'39"L:,F2>1K71OJ;=*]CF-FC1.F6.55W54#*^IFI^2Z?
MFSRVC)>$5)54JK!$M0VI=A%<(Y.%<57%=X#N\V#4G3W)NE=RFS/?:**I?=II
MFT[YVQ/5KJ*EPX?/:Y -F],<]93S];4NN69621/C21=R9LV#=]S$VM\]J@7^
M!151$557!$X5 T#YP-SJ]:M9X]-*&1K+?0T]5!.U41V,]MJI]N]&B/39T,0-
MY,LY=HLKVJ.TT+=V"-SW(BN<[:]RN7:[;T0/81>'9A@!8.MF/S5YQ1'HS&QW
M1-O1_P!BE T@YH&H%3E&^YJIH+'57?MJJ@1W:N"8<3#4><O#O?\ 0!G.7G6Y
MF=G:FR_#D*[LH9WP1K*O%JUO&R-8JJO%X[,<0,KZOUV<4T\J\QY0WJ2[T\+'
M1TKH6U$V\^HC8N#7-<BX-5W0 TPS=K)?LSY??0R6>JAS0R1T534/:S!T#8GL
M7")&HB8O=CC_ " 85TLNV=\LWC-%QMM%/55=,ZB=<5@IT?N*K)6Q[R.:J-Q1
MRX>:!DZ\Y]SG=LGR9@CWMR*O2BGBXB-7(](N,<BX-P14W@-MN:;3TEST[MV8
MY6*V[5;9UJ&J[!4XFMJ(V8M38G2M0#8&JIH:ZFEIINFCD:YCD1<-CDP7@^R!
MH#G6VW/0SG'6RIRZY:;+%WNMLHY&R,XW&!E/3RRIQDR+]UO;4X -^;17-N=I
MH+DQ<65E/#4-5,%V2L1Z<'V0.Z!;.;LC6#.=+VM>H'RL3#!&2/CX';WW*IT0
M-)^=52:5Z?Y=DRK9:22IS'7)+3L:RL<]6.JJ:3BE5CU55Z94^R!;?-URKE++
M^54N5^RI<+C57%D,SGT]1)"B/:DC78IM3;BG !ZV:]0M-;'FZU95I\G7&F6Y
MSTL+GR5JNP2KD6-=CDQ"MN\AZ39+RW!X=LM%-%65B,D<CYY),%CWVIL<N' ]
M0C06MEFI-7;NM$U632T=5#-BF]A"^9R/547@3SP+FU$L.7+;H>RILE9%45TM
M%5K7MCD6145D[4CQ157#%%4"[,A:?7FZZ9TEPHLS6ZGBXF)74TK%61%[4C>J
M+L7@1< /*YG%*E)JQF6EDJ&551 RW*Z2+8U=Y'N39]A< -_[Q=J*R6Z:XW"9
ME/3Q-5=^1R-3>1%5$Q7HK@!HE>;A<><GJ]24\4;F9/LD]'7352M1T*PO;'%.
MB2PHBHJ8+BJ\ &PMRN^E^9K'%H[07FDFN-O;%0MI&5*NEQM*(UR8(N]TJ1+B
M!KOS?M:+CI+F]FFN?7]JV63BH*62H;%2L957"HB?O;SVH]V#7.7=Q^P!O.RZ
MLNMH=<;#51U;)D8^EFAPD:K'*FU/-Q0# M=J?GW+EQ?0YFS'24<CU1L+)Z:&
M)<7KTO"Q%78!U[AK'F&W1I47#-MO90NVK(Z&!K<,41-NYYJH!B*\98S[F2W7
MC/D68Z&[V!*>IIWI24^U'1L69<7-8B;&+_TA5^\R=8D9FY%7&9W@S>V^9V[A
ML"-N@     QYK>N&E^9OT?4?@@0PYS^55V[I?_.!*CI/_P"FG-O<M\]Z*!WN
M=]]%5T_1MV]Y/ BJR#\I(?R<OX*@3C9?_,-K[CI_:F@>B
M        HO\ T@5  <4D:KUC^Z1,53S@.0  !3@0 FS!.$#JUERI*##MERMQ
MPPP15X<?,^P!]J>HBJH6SPKC&_'!53#@54_]@'U IBBN5,=J= "H   P
M     4P K]D  P                    !I+]8(J)EVR>?'<OPJ$#4OFH?2
MW3=R/]O@"Q,<$  $0G/$^E^Y]U7'W_,!LM]7PO\ X'4I_P# E]^*!O*
M                   , "HB\(%-H%0       .$L;98GQ.X'M5J]'8J8 8(
MS!S7,FY@S@F;:QT3ZE9N.>Q]#3R;=QK,-YVW:C0,U62S6^P6V"V6V"*GIH&,
M8C88VQ-56,:S>5K$1,51J =]%Q3$"H  !3H@5  439@G"!4
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M." !> "(3GB_2]<^ZKA[_F V5^KX_,E3W/+[\4#>8
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M2W3=R/\ ;X L3'!  O !$)SQ/I>N?=5P]_S ;*_5\?F2I[GE]^*!O,
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MX 6#S:\_SW//M501OXR%](QN^JO1>FJ86KL<B>:!N8
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MGO10.]SO?HINWZ-NWO)X$5&0?E)#^3E_!4"<?+_YAM?<=/[4T#T0
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M." !> "(3GB_2]<^ZKA[_F V5^KX_,E3W/+[\4#>8
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MRN2FW$1(7/<G2I*N/I_- ]G33F]9<TXJ:VKHI6R25;YU5$@XO94(Q%79([U
M'@T_-7RQ#G]V>W535G?+!+)3=K(F/:\38D17\=CM1OJ0/.S_ ,T'*^;[ZR_6
M^N;::O:KW1TJ3*JOE=([:Z=O#O>8!QS1S5LEUE%35M]KVN;;GNJ9JE](KU5J
M)YC9<=B>8!:%QTNNNHDU)DBT*L>2;?'VGVXWB]U64:+VN[B))&/Z9&-V?<]$
M#:3)^4Z#*-HCME#&UJ,5Z[R)NX[[M[@Q4"X0
M!'[]83_O%%W)![[F QKS"?I,KOR5)[Y0"4P               !@;G=?0]?.
MX+E[PF BWT8^DJQ_\7[TF FVM7YKHNYXOP$ [8
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M_P#:-UR],QR>EZ '0LN?*>PZUIE)DV+[@RMK%CP>FULDC>@U4V;OFA6S(0
M                           QYKA]%^9OT?4?@ 0PYQ^55V[ID_G E0TG
M_P#31FWN6^>]% [_ #OEPTINOGVV[>\G@159!^4</Y.7\%0)QLO_ )AM?<=/
M[4T#T0                        !P?%%(J+(QKU3@5R(O\X'/!.    XI
M&U%5>%5\T"CHVN5%553#S .8# #@D;4>Y^U5=AL7@V>8!S    #!%X0  #@^
M-),,55,%QV><!S Z\M#1S2)+-!')(FQ'.8UR[/LH!]T:UJ;K41&IP(FQ *@
M                        !I']8+\GK)_0N7X5"!J;S4/I;INY'^WP!8F.
M"  "(3GB_2]<^ZKA[_F V5^KY_,E1^0E]^*!O,                     !
MQ>QDC59(U',7A:J8HO\ (H'QIZ*GI=[B&(S>57*C41$Q7[")Y@'8   & #
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MV@:=: 9GS!H3K=)I%>DDDM=SJH*2![6ODC:VDIIIW[KYG0X8K,GI6?9 ^W/
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M^"H$XV7_ ,PVON.G]J:!Z(
M                                     :1_6"_)ZR?T+E^%0@:F\U#Z
M6Z;N1_M\ 6)C@@  B$YXOTOW/NJX^_Y@-E?J^?S)4?D)??B@;S
M
M 1^?6%?[S1=QP>_)@,;<PGZ3*W\E2>^4 E,                8&YW7T/7S
MN"Y>\)@(MM&/I)LO_%>])@)M[5^:Z+N>+\! .V
M    &NO.^LM5?,C6"BIHEEB3,=%)4-3#9"E+5M>JXJGJN@!Z]+E>ODYO$&6,
MI1.6NFHXF4[HL%5%95I(N#9'8<".^Z"L9Z$W/5_36VW.S9DRQ4W1TE15U%.L
ME33TO]8L36(B,9)T&+T>B$=7*^D6<M1=:ZK5#.-KEL5+;:ME5;*";BZI)$J:
M=T,K6S1R1*F[Q;%55C7'$*XZ6:(YKK=:)<[9VMDM)04M)4T%*DR,<CFMJ$FB
M<CHI45,5<NQ6_P H'C:]:<ZFYPUNLU9;+5/5V&BNLDL=2UT.Y%%)3QM5V#GM
M5<50(L[4K3#5+)>I]CSK;K/47Z.&SP4;V-=!2I$Z6HF5S=Y7R8[B+CZ7;B!Z
MW.:R?K5JE;\OW*CME546^22K1UM1U.](6;L43DXQ5C5=]6;W!L ZNHNCNK]Y
MTGREDZGBJ9::*TVITEO1D&$,M/"C-S%94558B;N.(&?M3=/+YEO0BZY+R#2/
M6HGIJ]JTL.[B]9D5S4_'/=PJOJ@,>\VFRW'0?)5XS+J6U]H=<):2;BYVXJ]S
MXW1JN,"R\#G>I UPM$6<[+F6;.]ZR'+>LJN@9#4Q.KXZ9B-IWI)*N^QKG^D:
MJ;&@;3:1ZRY)S)8;G8M/LNLL6:'=JL=;XJV:L>Z2/>D>W?FA:U-QC7]':!SY
MM&A=PR;'=\Z9DM;H,X5%/74D$LF"2+&LT,T*=)*YGIH_4@8QH=(]3+]SA;CF
MF[V:=:2.ZRS4=Q<L*I''-"]%<B->BKBOFH%>1D3)FK^D>L%QOE)EBIOM/<:.
M6B2J2:GHTC2IK8I>!5FQW4B\Q,<0CV===*-5,[ZAY8NM=:ZBX6Y\M>Z6E58$
M2%'0P-1-Y)&JN\K,>#H >MSA=-=4[[;,B6'+UKJ*^UVVALG'T4:PM;#+2NE8
M]%5[T5=QBHG"!E3-V8[KD#0V/+7%/ILX7"&JBH;?O(DD<K:OC=CMU[%WF/1V
MU4X0KJ<U+1JMRA37#-^96N2]W>I=<($D8C7)'6P,<]$5DKFKM5=NZG\@1M
M                             QYK?]&&9?T?4?@ 0PYR^55W[I?_ #@2
MJ:4_^FS-G<M[]Z*!V^=_]%5T_1MV]Y/ BJR#\I(?R<OX*@3C9?\ S#:^XZ?V
MIH'H@
M                   !I']8+\GK)_0N7X5"!J;S4/I;INY7^WP 3'   $0G
M/%^EZY]U7#W_ # ;*_5\_F2H_(2^_% WF
M                                            C]^L*_WFB[C@]]S
M8UYA/TEUOY*D]\H!*8                P-SNOH>OG<%R]X3 1;Z,?259//
M[:]Z3 3;6K\UT7<\7X" =L                          /%S39H;Y9ZBC
MEC;([=>Z+?1%P?Q;FHJ8HN"IO =#(EIJ[-9HZ"JW=V)K&QHBJNQ-Y5Z">:!<
M:TM*Y=Y88U=YNZF/\P'T;'&S^K8UOV$1/Y@#8V-VHU$5>C@!Q6"!7\8L;%DX
M=Y6ICC]D#C-24E1_O$$<V'!QC&NX/LH 6EIE8D:PQK&W'=9NINICPX)@!R6"
M!R(BQ,5&INM16IL1.@@%'T\4CE=(F^CMBL=@K?M*!@#G1:.9BU2RTRBRO.E/
M41-AC2/CUIX\&SI(J]*QVW #R,C5^:[38),I7W+UMGJIW2[CNU)98?\ :,&-
M1SGNX-NW8%>CIAH+-8\\U6>[BR.D=4U$U5%243F,@1*F*9BMXM8D5$;QG2IO
M; C8>.)K&[J(B)P8)P 4;3P,>LC8F->JXJY&HBJOV0.#J.D<[?=3QJ_U2L:J
M_;P YOIX)'->^)CG,QW5<U%5,>'#$#Y5D*/IY5CC8Z=(W)#OIBB.P7=\_#$#
M$U%I?69@S?\ &/-S\5I'Q34M-3/1T"N:Q&.1S)F/V*C4X' 9>B@B@B9#$U&1
MQM1K4:B)@C4P3@ ^@                             #'>N'T89E_1]1^
M !#%G+Y57=/^\O\ YP)5-*5_AKS8O_=;W[T4#M\[[Z*KI^C;M[R>!%5D+Y20
M_DY?P5 G&R_^8;7W'3^U- ]$
M                                       -(_K!?D]9/Z%R_"H0-3.:
MC]+5-W*_V^ "8\ !1W H$0G/#VZNW/NJX>_Y@-EOJ^/S)4]SR^_% WF
M
M      C]^L)_WBB[C@]]S 8UYA2__LRM_)4GOE )3                &!N
M=U]#U\[@N7O"8"+?1CZ2K'_Q?O28";:U?FNB[GB_ 0#M@
M           PQ^P!1$PP1. "H         !16HN"JG!M0"H
M                          QWKC]&&9?T?4?@ 0PYR^5-V[I?_.!*EI/_
M .FG-O<M\]Z*!WN=]]%5T_1MV]Y/ BJR%\I(?R<OX*@3C9?_ ##:^XZ?VIH'
MH@
M                !I']8+\GK)_0N7X5"!J9S4?I:INY7^WP 3'@ *+M10(A
M.>(F&KUS[JN'O^8#9;ZOC\R5/<\OOQ0-Y@
M                                            (_OK"?Z^B[D@]]S
M8SYA7TFUWY*D]\H%2FA               # W.Z^AZ^=P7+WA,!%OHQ])5C_
M .+]Z3 3;6K\UT7<\7X" =L
M                                           QYKA]&&9?T?4?@ 0P
MYR^55V[ID_G E1TG3^&G-O<M\]Z*!W^=\F.E-U\ZVW;WD\"*C(/RDA_)R_@J
M!./E_P#,-K[CI_:F@>B
M                                  &D?U@OR>LG]"Y?A4(&IG-1^EJF
M[E?[? !,>  +P 1"<\7Z7KGW5</?\P&ROU?'YDJ>YY??B@;S
M                                                           1
M^_6%?[S1=QP>^Y@,:<PKZ3:[\E2>^4"I30@              !@7G=?0]>^X
M+E[PF BVT9^DFR?\5[TF FWM7YKH>YXOP$ [@
M                                                        !CW6
M_P"B_,_Z/J/P0J&#./RJNW=,G\X1*GI1_P"FO-G<M[]Z*!W>=[]%-V_1MV]Y
M/ BIR!\I(/R<OX*@3C9?_,-K[DI_:FA:]$(
M                                                 #2/ZP7Y/63^
MA<OPJ$#4SFH_2U3=RO\ ;X )CP !> "(3GB_2]<^ZKA[_F V5^KX_,E3W/+[
M\4#>8
M               "/SZPK_>:+N.#WY,!C7F%?296_DJ3WR@5*:$
M      ,"\[KZ'KWW!<O>$P$6VC/TDV3_ (KWI,!-O:OS70]SQ?@(!W
M
M              #'NM_T7YG_ $?4?@A4,&<?E5=NZ9/YPB5/2C_TUYL[EO?O
M10.]SO45=*;M@O!;;M[R>!%3D#!,R0X[/Q<N/K5 G%R^J+8;7AP=J4_M30/1
M
M               #2/ZP3;EZR)A]Q<OPJ$#4WFI?2U3=RO\ ;X )C@ %%QP7
M#A B$YX:XZO7/S>VKACW_,!LK]7RN%EJ4X?Q$OOQ0-YP
M                                                      (^_K"=
MY:RA3#I>TX-O0_WR<#&_,*3#4VNZ*<52;4[I0"4P               !@7G=
MJB:/7O'HT-R1.\)@(M]&D_\ V39.A_O6W_A)@)MK3^:Z'N>+\! .X
M
M             8]UNP^;#,V*_P#E]1L\WI0(8,Y[,U7=>#_:7X?; E4TI5B\
MVO-BHO2]JWO%?^$4#M<[^1&:5W-%V*ZW79$[R>!%3D:5D6887/X-R3%?^JH$
MT-AS[EF.RVV)9WH]M+ UR)$_A2-J>8%>HF>\N+P3OZT_T @N>\N)_KW]:?Z
M%/CYESV=_6G^@ ^/F7/9W]:?Z #X^9<]G?UI_H /CYESV=_6G^@ ^/F7/9W]
M:?Z #X^9<]G?UI_H /CYESV=_6G^@ ^/F7/9W]:?Z #X^9<]G?UI_H /CYES
MV=_6G^@ ^/F7/9W]:?Z #X^9<]G?UI_H /CYESV=_6G^@ ^/F7/9W]:?Z #X
M^9<]G?UI_H /CYESV=_6G^@ ^/F7/9W]:?Z #X^9<]G?UI_H /CYESV=_6G^
M@ ^/F7/9W]:?Z #X^9<]G?UI_H /CYESV=_6G^@ ^/F7/9W]:?Z #X^9<]G?
MUI_H /CYESV=_6G^@ ^/F7/9W]:?Z #X^9<]G?UI_H /CYESV=_6G^@ ^/F7
M/9W]:?Z #X^9<]G?UI_H /CYESV=_6G^@ ^/F7/9W]:?Z #X^9<]G?UI_H /
MCYESV=_6G^@ ^/F7/9W]:?Z #X^9<]G?UI_H /CYESV=_6G^@ ^/F7/9W]:?
MZ #X^9<]G?UI_H /CYESV=_6G^@ ^/F7/9W]:?Z #X^9<]G?UI_H /CYESV=
M_6G^@ ^/F7/9W]:?Z #X^9<]G?UI_H /CYESV=_6G^@ ^/F7/9W]:?Z #X^9
M<]G?UI_H /CYESV=_6G^@ ^/F7/9W]:?Z #X^9<]G?UI_H /CYESV=_6G^@
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MO6&&-\KW;U&]$1K6-<N*KL0"(FKRUF&AF=3U=IK8)F*K7LEII6.14V+L<U%
M^"VB[NZ9:"I7[$+_ $ '@B[\':%3UE_H $L]WZ%!4]9?Z %?!%YY/J>LR>@
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MHZ6=T*I-6S*WI]S=VIM3:!K6VU7947=H*A<>'"%_!]H EINR8HE!4?8XE_H
M<O!%Z39X/J4_^3)U(%/!%YY/J>LR=2 \$7GD^IZS)Z #P1>>3ZGK,GH /!%Y
MY/J>LR>@!3P3>/<%3UE_H /!-X]P5/67^@ \$7?W!4]9?Z %/!%W]P5/67^@
M!7P1=_<%3UE_H /!-X]P5/67^@ \$WCW!4]9D] "O@B\\GU/69.I >"+SR?4
M]9DZD!X(O/)]3UF3T '@B\\GU/69/0 >"+SR?4]9D] !X(O/)]3UF3J0'@B\
M\GU/69.I >"+SR?4]9DZD!X(O/)]3UF3J0*>";Q[@J>LR>@ \$WCW!4]9?Z
M#P1=_<%3UE_H 4\$7?W!4]9?Z %?!%X]P5/67]2 \#WCD^IZS)Z %?!%YY/J
M>LR>@ \$7GD^IZS)Z #P1>>3ZGK,GH /!%YY/J>LR>@ \$7GD^IZS)Z #P1>
M>3ZGK,GH /!%YY/J>LR=2 \$7GD^IZS)U(#P1>>3ZGK,G4@/!%YY/J>LR=2
M\$7GD^IZS)U(#P1>>3ZGK,G4@/!%YY/J>LR=2 \$7GD^IZS)U(#P1>>3ZGK,
MG4@/!%YY/J>LR=2 \$7GD^IZS)U(#P1>>3ZGK,G4@/!%YY/J>LR=2 \$7GD^
MIZS)U(#P1>>3ZGK,G4@/!%YY/J>LR=2 \$7GD^IZS)U(#P1>>3ZGK,G4@/!%
MYY/J>LR=2 \$7GD^IZS)U(#P1>>3ZGK,G4@/!%YY/J>LR=2 \$7GD^IZS)Z
M#P1>>3ZGK,GH /!%YY/J>LR>@!1;1=E_[!4X_D7^@!5+3=DPPM]3BG_P7^@
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MUW]0WUB@/#UV]2WUB@/#]U]2WUB@/#]U]2WUB@4^,%U\QOK *I?KNO QOK%
MKX>N_J$ZVH%/#UW]0WUB@/#UW]0WUB@/#UW]0WUB@/#UW]0WUB@/#]V]2WUB
M@/#]V]2WUB@/#]V]2WUB@/#]V]2WUB@/#]V]2WUB@/#]V]2WUB@/#]V]2WUB
M@/#UW]2WUB@/#UW]0WUB@/#UW]0WUB@/#UW]0WUB@/#UW]0WUB@/#UW]0WUB
M@/#UW]2WUB@%O]UPVM;A_04"B7^ZIP-;ZQ0/E4W:X5<:Q2M3=7''!BHNT#X4
M=LN-QF2FH:2:HG<BJV.&-\CU1$Q7!&HJ\ $NVF>7KK0<WW,UFJ:6:*X5%->&
MQ4[XWMD<LM*K6HC'-1RXKP8(!G&Y>#^T:GPIQ?@_BI.VN._J^)W5W]['H;N.
M(&$KSXIW;LGAOXL]O;SN-X[<W]['IL?Y0KS$\3/#9\5,/^H _@S_ '4^\(*I
MXFG0^*GWA17^#;]U?O '\&W[J_> /X-OW5^\ ?P;?NK]X _@V_=7[P!_!M^Z
MOW@#^#;H_%7[P!_!K^ZOW@%/X-?W5^\ ?P:?NI]X0/X-/W4^\ ?P:_NI]X45
M_@U_=7[P GB;=#XJ_> /X-OW5^\ ?P;?NK]X!1?$UZ/Q4^\ K_!K^ZOW@#^#
M;]U?O '\&W[J_> /X-OW5^\ ?P;?NK]X _@V_=7[P!_!M^ZOW@#^#;]U?O '
M\&W[J_> /X-OW5^\ ?P;?NK]X 3Q-NA\5?O '\&W[J_> /X-?W5^\ ?P:_NK
M]X _@V_=7[P!_!M^ZOW@#^#;]U?O '\&W[J_> /X-OW5^\ ?P;?NK]X _@V_
M=7[P!_!M^ZOW@#^#;]U?O '\&W[J_> /X-OW5^\ JGB<=#XJ_> %\3?H_%7[
MP#C_  :=#XJ?>$%?X-OW5^\*'\&W[J_> /X-?W5^\ ?P:_NK]X!1?$TZ/Q4^
M\ ?P:?NI]X0/X-/W4^\ K_!K^ZOWA0_@U_=7[P!_!M^ZOW@#^#;]U?O '\&W
M[J_> /X-OW5^\ +XFV&WXJX?]0"G\&G[J?>$#^#3]U/O *+XF>&WXJ8?]0HH
MWQ,L4W?BICT/2 9!T\^9'C7_ #;>!^.Q?O\ @S=WL<&;V.'G;F/\@&2P@  L
M74+YJ^+C^<CP9Q>#>+\)[OI=YV[ACY^(&+6>)C@O%_%3#HX;@43Q,L=GQ4Q_
MZ@'T7Q-\=OQ5Q_Z@%/X-OW5^\ ?P;?NK]X _@U_=7[P!_!K^ZOW@%/X-/W4^
M\('\&G[J?> /X-/W4^\ ?P:?NI]X _@T_=3[P!_!I^ZGW@#^#3H?%3[P"O\
M!M^ZOWA0_@V_=7[P!_!K^ZOW@#^#7]U?O '\&W0^*OW@#^#;]U?O '\&W[J_
M> /X-OW5^\ ?P;?NK]X!3^#3]U/O"!_!I^ZGW@#^#3]U/O '\&G[J?> $\33
MH?%3[PHK_!K^ZOW@#^#7]U?O '\&O[J_> /X-?W5^\ ?P:_NK]X _@U_=7[P
M!_!M^ZOW@#^#;]U?O '\&W[J_> /X-OW5^\ ?P;?NK]X _@V_=7[P!_!M^ZO
MW@#^#;]U?O '\&W[J_> /X-OW5^\ ?P;?NK]X _@V_=7[P!_!M^ZOW@#^#;]
MU?O '\&W[J_> /X-OW5^\ ?P;?NK]X _@V_=7[P!_!M^ZOW@#^#;]U?O '\&
MW[J_> /X-OW5^\ ?P;?NK]X _@V_=7[P!_!K^ZOW@#^#7]U?O ./\&?[J?>
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8:G\&=I2=K<7VA@[C-W#<PPZ;'^3A"/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2316412d2_ex5-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2316412d2_ex5-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !H ' # 2(  A$! Q$!_\0
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MI-0N/V>O@=+K$I.L2?![X>S:LTF5F;4IO".BK/-(C896:Y2=6W@-YJ2+@,K
M?YM_[)G[.?B+]J_]H[X/? 70M-O)#XS\6V=SXMF@M[BY.D^ ?#TT&J^)]1D6
MWCD:V+Z59WVD3W$P2*&75+>"5XVN$5_].72=-MM%TJQTFPM3::?I6D:?IUG"
ML31I%:Z?#''#;(,+C8JE%0*."?EK_*3@5SQ>'J5I)<ETE)?"VFW92^&32FKV
M?WV?+_L'^UMS/AS <9^&'!.52H?6,KPE?$8W#TJM*53!4Z_LZ-+Z[2A4E4PK
MJRA>$<52PW-!.=N7EG+L****^V/\C HHHH **B\^#('G19.<#S$R<$ X&>Q(
M!]"1ZT">%@66:(J#M)$B$!O[I(.,^W6HC4IRY.6I3E[3G]GRU*<O:>STJ>SY
M9R]I[-IJI[/GY&FI\E@Z\OVOY?M?^ _%^!+4&#Z'\C0;JV4 M<0*&!8$S1@%
M0I<L"6Y 0%R1P%!8\#-/$L1VD2QD. R8=3N4C(9<'Y@1R",C%'M:?+S^TI\G
MM/9<_M*?)[7FY/9<_M.3VO/[GLN;VG/[GL^;W1V:=FFGV::?W-7_  /RG_:X
M_8PU3Q_%=?$KX86GV?Q=-:O;^*O!OGV\EOXJB !CO;2X9&:WU.+&SH9)%($9
MY 7\5O'7A^]T33=9T?Q%I4^DZO9*MP=-UG19K2>.<Y&'M;F*.4'LP,8()'':
MOZ[1.A&V$PED.V93N21&,?F!2J ,I,160 C)0AL8YKSKQS\)_AE\3-,EL?'_
M ((T/Q9 Z@3#6;"%KMP-J@?;+-(YV"\*%5\#(  )P?Y!\4_HNOB;,GQ-X=\8
MYUX9<01<'6R_*<YXOAP=4E&Z<ZF48+B.E"C*=^:7+AH4YOWG3NG?^CO"?Z0%
M#A2ADF0^(?".2>)>1X6FJ5#'YMDW"<N,:5**7+3CF>.X<G*M&$4HQ]I54X0M
M"-1*$$OXH]>T[1=6L$T_7-&TS5K(\#3+K3(Y!:XX_P!%NV3')_N'GH.G'#^"
MOV&O WQF\1V7AKX=?"'5_$>L7MXT<>F:#>7L-C8VJ@EIM4O8Q*EI"H!S)</&
MI[8!&?[ K?\ 8"_9!LKAK^/X-:!=2?=V_P!H>(+I$/H8X=<CB#8(X;L1D<BO
MIOP3\/\ P/\ #S1$TCP3X2T'PCIT08M9:'I,-E"0?[[Q0QWCA<'!9L*>1DYK
MY?A+Z,'B%A<3[7/O$O$Y&_:NDGPIBY9YS5=_9<N?S;IU+)^[*#J?].K']G9]
M^T@RW(N'YX3PQX$XDR[$J'NXSB#,Z7#^04_=UG4R;AZO[2:NX^Y["EI?WK7:
M_.G_ ()V?\$T?A3^PWI&H>*[3PSIUW\:_&.FV>F>)?$ULEY?#1-(:0"U\/:)
M=W4<S^4#M?6;^"0-+*@DN9!;QJ[?JSEWD\LJ60H W!QG R>F#@^GN<]:4'<
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MJD5B(SIRBYIQE&:E&<XOF@W=)[ZZVU],^)G_  5$_P""D?[*_AR;XJ_M>_\
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M>(&TN^\36]G;Q"2_DL=.WZA)I,862*$&>8^066O7OVZO^"EGC#]GSXO?#?\
M9(_9:_9[U7]J?]L/XM^'I_'NF?#F#6[7P;X*\"?#>&^;2Y?B#\2_%=V/(TS2
M6O8S90J[6J3W!1%N0Y2-Y?V4OV^_VJ?VAOC'IOPP^,'_  3#_:*_9=\'7VA:
MSK3_ !@^)/BKPUJ?A:QETW!L=&O+*S\/6C0ZCJ.?]"MI[A)WQYBI.BEF^7?^
M"A7[(G[<O@G]M[P+_P %,_V - \"?%_Q]I7P>?X(_&'X!^/]330KGQ=X"361
MX@B_X1'Q%-(MK:ZE'=!(_*MG65I5W1"0 @^MA<%EF*XKPV6\3<(<#Y%1H82M
M/+EA.(<=7R_BC$R@OJRXAQF$Q^-H8?DJ7BH?6Z$*D+J<J<7"2XJ]7&X3(_KF
M28_,LZJ<\5+Z[AL53J\B=Y.%.OA*$V[:KFAHWUU/J7]C[]JS_@HAXU^--W\#
M_P!LG]@.W^ ^GKX4UGQ;HGQQ^&?Q.T7XB?".632Y8H+7PI+%IHGOXM>G\P.-
M.:\^T&-3,;14#2+^N39P!A<=P<8S],X]>Y_Q_#[]B[_@L?H/QU^.=I^R7^TQ
M^SM\6OV,OVJ]1TA=4\/_  Z^*5M</H'CM+&">YOI/!.O7%C8KBY@@N'M()U=
MKJ"&62&>5X&W_M^2K*H!)XR-N&..F?EY_$?_ *OD^+,OQ>5YI"CC,HP>21K4
MXNF\NK4JV!Q#BW!U,'B:.)QN'KTIR7+>AC*\%-<KY9MI^ODU?"U\&UA,TQ.=
MZOWL?"=.IJTVI*M2I2NM7K%O?9;?S^_\&[_@7Q/X3_84^)&A?$?PEKWA*\UC
M]K#XZ:B=!\:>$]4\,76K:3X@?P\&N8]"\3V5I<7'A[7!%,+"\2W:QU%(Y1!+
M.L<BU]T_L5_\$VOV<?V!_$7QZ\5_ [PQ-8ZG\??B9=>.M5.I(MQ+X-TB]M/M
M%E\//"5TRW$\7@[2M?N=2U*.UAD%M%)K4HE.-*ADC_0>4VMA#)<22PPVL$4M
MQ/--(((XQ''YUQ<SK'$L20(A$T\\CK&J'S7*J0Y^-;K]JCQ9XYUW5](_9Y^#
MNK_%>PTF3[/<^.K[5X?#O@62YB7$]KI]S?*C7LL;?>2&5)!_'&":TXAXQSSB
M#/>-,W=3^PLIXJQ"Q&)P&!K.W,ZD:O)*,(MRITZD%*FG2;;7OQY7RCRW)<!@
M,ORB.*C[27#M-QH22YI;.-X15YS;3^SS-;*SU7Y,_P#!.[2/$GP[_P""EO\
MP7%^(/C'P7XVT?P5=?$7X=>*=)UBZ\)ZY#8>+K+PQX>\1F0>#[V:QCMO$4D<
M9:,1:1-=8GN8(F*F1:^</^"?'_!+_P"%/_!171_VB_V]?^"BOP0\3ZMXX_:+
M_:#\<Z]\,_ WC"Z\>?#_ %CP)\(_"EW/H/ALSZ5I]WH.NI!JEC::;+I^FWUN
M;6ZMO"?A^_@5[35 9_Z%_A]\:/BW=^,=*\"_%/\ 9Y\3^#[K5H))-,\4Z#JF
MD^)_!]F%C(Q>7=B'DT8[?E4I<ZD Q7+JO-9OCG]H?XBZ3\9=8^#OPZ^#T?C[
M4O#WAC0?$=S-)XPMO"\G]GZN8OM@@-Q:-9R&R,EN)'23:GF0F3B2,5[6.\2\
M^Q2S.67Y=A^'\[XBI\&<(ULPPE6G>. X&A2HT:BK4_<C0Q<L/#$3Q$ZU*BYJ
M,HU)J;Y>+_5O+X14<='VT8SG*,%%S2G/63:BY6TLE96?J?@Y_P %'_\ @B;^
MS]^SK^S3KG[2G_!/3X,ZWX)_:;_9V\;^#/C=X+3PSXD\?^-M?U^V\,:Y#=^)
M?"&AZ+J6H:Q=-?Z]9RLZ66G6AFFD0;(W\P(NU_P5\\1>+_VI_P!GS_@D=\6_
M"/PO^(5PWC+]K3X*>.O&7A>W\ >(KK5?!5CKOA[9XL7Q]X=GTN6_\,Z/H-S)
M+;:[=:_;V4&G/$BW\D+GYOW1T']IG5K?QQX=^&WQM^$^O_";7_&&+#PW>W6L
M:=XG\)ZQ?RC;'IIU6U"6,EXYSMMA+-<299=N#N7T[XU?&[P?\%-#T^^\16U[
MJ6LZW>R:=X/\'>'X1>:_X@OX$)G32+0P-\UK$Y-R8XG6(2#>K;G"Z9;XD9WA
M<QR/&YA5J<29WPMB*E7#XK'5)S52%6A[-T.>I&-.I"-1>WIN%6<:;]U=R,9P
MUEU; 9OE^#@J4>)8J-;1QC"S;;=VN6^ND^2[=]VV_5;#0=+LU7[)IEI9X0CS
M]/MXK,(H&-L9LI8KE2W0JAP<#GJ#_/+_ ,')OAWQCKO[+7[-MUX.\!^-?B#+
MX2_;%^&OC#5=%\!^%]<\5ZO%I'A_1O%RO/+8:#9:A=Q6@FGMXI+B2%85EDAC
M+AW4']8&^/'[4\,']NS_ +)M[)X?Q_Q[6WC;3I?%F.>?^$?6-K[.<@C[+GN1
MC%>V?"'XU>#/C?X<N=<\*-?VU]I5T=+\1^']<C>TUKP[J($FVTU.V@AE6")F
M@G2/42HBE%M( ^]&5/E^$.(L;PUQ/E/$<$LZK</U55C'&-J-6JXRBKRG9SBU
MNX*2NEHNOH9KED<RR:67X5^Q@TDD_=LKW?NR<7OM=?EK^.Q_X+^? F,9D_8[
M_P""C"H2%6-OV2]6"(WHKMKH+-[%02>O)R/CW_@I3\5-8^ W_!93]AS]K'6/
M@C\?_B3\+_ '[+7C'3O$\?PA^$>O>/\ 7=*UWQI<^/\ 1M*TRY@%H?"-EJFG
MV/B5;F>PDUFVU".)_,'EHR3'^C/X'_&F;XO7'Q+A7PT/#Q^'_CB;P7(T=X=1
M:]EMD'F7"[=,B0)DC+!63.0=BJQ%[X]_%/\ X47\,]5\?Q^'8M<.DW6EZ;'I
M<UR-/66*[G6&,K>06-XZ!I"(TBV!3)\JJK AO7P/%?#>29RL9E_ 6+ITY8?C
M'#8G"OC;C&HJ\,;AE1H0E5CA4XJC%U7",%*CCF^2G3E2Y82Y,3DF-Q.!Y,=G
MM>I).,E*$+-.$FW:,&Y/FOU2;T<G?5?DYX,_X+L?!7QSXO\ "O@S3_V1?^"@
MVGWWBKQ+HWA6SU77?V6=0TO0M+?7=;&E#4-;U.XUS[/I>G:/:J-2U6ZN/W6G
M6!:6X B_>'V']L?_ (*5^,_V)_C9HGA[X@_L;?M%>//V;M:\&BZ_X:1^"'A0
M_$W^P_B&T[L/!^N^";2#^TM*TU[<(/[>N[J.V$SATBE0.J_6_P 4OVBO%/@[
MQ/\ "KP7X/\ AA_PGGB+XI:"WB'2+:Z\36VB6UE(L/G^0UZ^E%)"L+LQ8;08
M]Q\M5!)RK[]J+Q=X O=&@^./P-U_X:>'=;U.+1D\:VVNZ%XHT6RU2?F(:H-
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MQNE\:!<#P<_@>6.^STQ_;+(^G8QW,N3TP,<Z'[.OPP^(5YX_\<?M#?&32HM
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2316412d12_ex23-4img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2316412d12_ex23-4img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !: < # 2(  A$! Q$!_\0
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M45Y0I*(S;0S8X!.#CZX-/HK,H^>[W3?B?XGU"YFEMM3C!D+>1YQ@A3' "*S
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MT/DW%JAC?!P2I((STR.#CT(]:O>$_B+X8T3PC9Z9J6DW-W>0+("WD1LAW.S
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MQ+=.55HRQ/RL,\D*"=V,'VZ4V7P1I^K^/U\/^&-1-Q9+&LDUY)(LH08RQ!4
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M.XJ*NTA/8\GU/1KS1M$O;N;P;HFC6TUN\8FO[E[B1F8?*L2EV*R]2#MXQDD
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HB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm2316412d2_ex23-2img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2316412d2_ex23-2img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !? KP# 2(  A$! Q$!_\0
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MVNO%/VDO^3>OCI_V1SXI?^H%XAK^5LJ_Y&V4?]CG)O\ U<Y0?U_G7_(DSO\
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M6?\ Y1T_M3_]DUD_].FG5_#+^P/_ ,GR_L9_]G7?L_?^K>\+5_<U_P %9_\
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MNI07EVFN^#O'?B+5;S6O$IUSPAKHU#2-7T2YUB72]/U&&X.CV\6GO H_0P"
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MG:9KVF>=#<P6=GK=G%/ 2D<\>GW$]M'<6[*QQ#<^0MS;]0(GCVMP&/\ I_\
M[+&KWOB+]F/]G7Q%JDJS:IKGP,^$NK:A,!_KKS4O F@WMQ( 2Q4-/<2E1DX#
M $\5_F0^'?!VL^--:\,_#?PTDE[X@\?ZCHG@C1A9PB:4:UXGU&ST6R6"-5,C
M0QS7BD10X<*$"@<D?ZC?PS\,0>!_AYX&\"VJQ):^"_!WA7PE;I -D8@\.Z+:
M:.C0Q *(80;)HX4  V1[ER&!/]??2QQD*&%X RFK[*6.P$\QIXN,90JU*<9X
M;+:3J.O&ZK4W.R5:'[N<X5%&7-2FE_&GT1J%6KCO$/-*,:L,'BH9?[&;O"E6
MG+,,RJ1C&'_+N4*'L8.G-^TBN64DH5(7['&)T'H?_CE?YB/[:2&3]JC]LI0N
MX_\ #5/[7Q"XR3M^/OQ-8]P!@ G)X&,G(XK_ $[0=TR'.<D<^W[S'Z5_F)?M
MI';^U-^V8P)4C]J;]L#D'!Y^/?Q.!Z<\@D>_2O%^B3&/^L7'$9N\?]6\OC)K
MK'_65IM>J=T?2?2Z<EP[P4]%-<5SWU2E_8-1:][-OIZ=#^B7_@M_^RS-K_[*
M7[(G[7_AC3&FO_AO\._AA\)?B?-:0-*[>#_&V@:1'\/M>OYH80%@TGQYJ \)
MP3SR_O=0\>:18%8[:YFGM_F;_@WU_:C7X6_M,Z[^SQKFI>1X4^/^A>1HZ3./
MLR?$?PDFI7^D",R.K"75="N-3TR#C==1VT;. VP+_5!JGP:\*_M"?L0Z;\$?
M&=K%<>'/BI^SAX8\&Z@[0I)-92:M\/M+32M9LI&7=;:KX?UF+3]?T6_A(N;#
M5],L+JV>.>))$_SP=1M_B?\ LN?'*6P$LFB_%_\ 9_\ BGY3W%M&]FB^-/AC
MXIDO(9@J.DLVG>)9+2!98VD)N-*U::Q??;2%']KPGJP\1_#;CGPQS=PK8O+X
MYI+(5*7[ZDL7F6;5<!6P]WSQEA,V6$HN4>5)8M6:7-?Y+Q:PL_#'Q'\/O$W*
MH5*6 S2AP_'./8PO&>+PV783+<X>*DTH268\,SJMPYI2GC,'[>I=1C;_ $>O
MVF_CEX?_ &;?@)\5?COXEFA^P?#7P=JFO6]A*Z1'5M?"QP^&]!B9V >YUO7Y
M+#2H57+>9=@(CX:O\XCP=X>^)/[57Q^TWP[;S2:U\6OVB?BG/9WEZ@FN OBG
MX@^(IM0US6&0$NFG:%;7%_?- 7\NTTO1VC\Y844#]Z?^"U__  46T/\ :#^
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M(%^UM_V7+QO_ .CH*_L<_P""'?\ RC/_ &??^NWQ%_\ 5C>+Z_CC_P""DO\
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M5J2Q5!83#WC)N;E.I4G9J&^+]E65"DOGNN5?]Z6+90A@ X8.?F.2-QW#@Y&
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M])UX8:E''XQ+"4L5.M4:A3C@5B:F.=W>7U2,8>\TC^&/P9X/^(O[0WQ<\.>
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MPR".&V@$=QQWJ:BG_P -]^C^]%=GV<9+RE%J49+LXR2:>Z:36J(%M8$&U8U
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M (;\-Z)ID3SWFK:SK.I20V>GZ?;P!YKR\N)A%;K':Q*CRZA"  >@45^#3?\
M!Q;_ ,$\M:U#7(OA%9_M8_M'^&?#NJW6CZO\2/V>?V1_C)\3/AO;7UDS-<Q1
M>+-/T"ULKI(;=6NS+;1W"2V06YA+HZ,_WM^QG_P4D_8Y_P""@7AS7O$'[*'Q
MLT#XDW7A*>*U\<>#9;#5_"WQ'\ SW-]=Z=;?\)C\/?%%CIGBK1K>XN["YAMK
M^XTX:7=R1R+#?@H5 !]WT5!;2&:".4D-O&X$+M!&>,#+$#ZDGUK\MOVN?^"R
M'[!W[%?Q.T_X&_%?XLZMXK^/^K007-A^SY\#O /BSXU?&18;ZS?4;%=4\(>
M]-U6;0[N[TV,ZI96.N3:7?7&E/'J8M&L)8KJ0 _5"BOQ5^%O_!?/_@G?\1?B
MMX6^"OB_QK\6/V8OB5X[FCM/ GA_]KWX%_$7]GJR\8WT]]IMA;V&B^(_'&CV
M/AUKVYN-1M[>T@O=7LA<75Q%;Q/)-);0S_M%;2B59!O$C1RO&Y&T$'"NJE5
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MEZ'I]QJVH3Q6T2O-<NME9W 2VMXY+B5V7RD8HPH Z*BO!/V7_P!I;X1?MA_
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M+"1-)*J#SX06(E4D$W8_?BBOP(3_ (.7?^"2\MK'=6WQE^+=U#-;I=6LUO\
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MZ'97UQ;P7NISQQS:C<)#864>Z6\N(HP6KZ19Y! 7 59!&6 8,ZJVW/S*H1V
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M(>'/&=U$\S>%M.\9W5C%X;\3:SI@BF@UFW\/ZA?C3+J":UNVBN(94%O]J_\
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M>/;_ $;[.VL67@?P)H%M?>*/$[Z6-2T6/5Y])TNZLM#FU;2H-9O+*?7M"2^
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MM[OX]?$NY9 TUI9V7AF9_#UOJ2&UCAN-6GDM66.TD4_'?[7?P2\-_P#!"_\
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MWP<\&E@550,,6=F 'S,69LDDGZ]G9(67;\A<IG:!L<*R+Y94X7=(N(U<@E5
MY"KQ\A_\$\?^3!_V&O\ LS[]F[_U3?@NOKVY@:9E7:VW:0SK)L=><CRS@E6.
M-K,,$JY&[C! 2LK7O_2_R/Y.8XOVU/\ @D[_ ,%*?^"@'[3&I_\ !/SXG?MT
M?L]_MI^*?"WC_0/C[^S2_A?Q3\>OA#H'A;0Q%J'PO\0^%O$DUOJEUX;M9'AE
MLM#35/#NB"ZTV/4=/OM6>[B@TOUKXG?\%Y/^":/QT^%GBOX1_M_?LC?M>_!/
MX3>-[5O#WBS1OVL/V0O$VM_#Z0W$GV027.M^%%\>:+I-]IAE&J:;XE@N;:YT
M*ZMX=9L;^UOK2.59_P!J/_@J-^V[_P $A?C+\5/$?_!1'X3V/[1?[ _Q)^)_
MVG]G;]I']GC4_AUX/\?_  CTG6GLK:V^#OCCX*ZWKNB>)/%4OAXH]Q+XMMK[
M4%NUO#,GB"_6Z.AZ!\U_%/\ X.D_V*OVMO"VI_LQ?L??LN?';]J/X^_'+3?$
M7P\\ ?"_XM:#\)OA;\/M0UKQ%H>H65E<>)?%'B_XAZGID.DVTLP:>V,-O<7$
M<9A%Y:&3[5&"TOOU_K^F?TP?L7^&OV</!W[,7P.\,_L?3^&+S]EW1?AIX;LO
M@;?>#_$VJ>,] N_ (MA+I-S8^*M>U'5]>UDSF2=KN[UK5-0U26Z61]0G6\,T
M2?4M?E5_P1;_ &,?B3_P3_\ ^"=WP&_9@^,>J:/??%'PQ#XX\8^,M.\.7+7O
MAGPIJ_Q+\=Z_X\G\$>';X37$-]I7@W^WU\/)?6[K:WMS8W-W81FRGAED_56@
MH9)G8^"5.TX(&2,#J!WK\?/^"T?[=?B?]B/]BW5KCX.1S:U^U3^TAXGT3]FK
M]DOPM87"R:U?_&'XH.^D6?B*U@ENK>]>+P)I4]SK\EXC2QQ:['H5A<O;0ZB)
ME_8.0,4<(%+%2%#9"DD8&XCG'KCG'2OY$KWX">#/^"^7_!5?]I'4/BUK_C_2
M_P!C#_@EU*G[/_PFT7X?>-/$'PL\;Z_^U+J=_:ZMX\^(]OK7A^]T[Q'HEKX;
M&C-IND:C#%9SWXMM.>"1H(WH);MTZ;G/?M4_\$V-?_X)#_L2_P#!/S]M#]EV
MRG\1?';_ ()@:A<^+OVQ-9TM/(U3]IGX._'&^MM7_;%N_%MT+M+OQ+8Z?X@F
MFUSP^OB"?6]5\+_#K3H]*T[5'?PYILT?]9'P@^*?@?XV?"WX??%_X;ZU'K_@
M'XF^$-"\<>#]85D/V[P_XBTZWU2PDE"/*(IXH+A8;N!I96MKF.6!Y"T9K\6-
M;_X-S?V#/$>G:IHNN?$']NG5M#US3[S2M9T;5?VXOCUJ>EZG8:E ;?4+74=/
MU#Q)>6NH6MW"\L5U:7J3VEVDCQ7%N\+;1X5_P0Z\8^+?V3OCC^V3_P $4?BC
MK6J^)+G]CKQ GQ8_99\47UTFL?VU^R?\5+Z"]T/0-4U*W>Y:VUCP'K>K0H+#
M6'TV6XT_Q!#8:?IAM-'FD4%S]CZ(_P"#D,B#_@C[^U5+&?(>.Y^%1CDC5!(C
M1_%#P>8C$Q1U1XV):)B L;<DJ,FOSW^,'P:^)_\ P0V^)&C?\%.?V,_ FI>*
M_P#@GM\;?#O@34/^"E'[&/P]LX;*U^'.KZIH-A:0_M9?L_>&+2!=+\-+H.HZ
MC'?>.O"^CP6&BQZ:;_3IX-'\&W]AXD^$WZ#?\')7_*'K]JS_ *^?A;_ZL[PA
M7["?#_2+37/@Y\-M+U&RL]3TJ_\ AKX9L=4TO4;:WO=.U&POO!MK97=GJ%G=
MI+:WMC>6T\UC=V5S!-;W$%V_FQD(*"F[*Y_/K_P6T^.'PO\ VD/^">'[$WQR
M^"/CC2?B+\+OB3_P4!_8?\2^#/&.@74TUEJ^E7/Q@TQ82R3QV]]IVHV4T<MC
MJ>D:E!;ZIHVJ6MWIVH1)>VLQ/],;@%'! (*MD'D'@]J_@1_X*S_L$_&3_@F;
M\4?@IX)_9NU:QE_X);_M6?M__LN_$R?X(:IJMM=7O[,O[16C?%W0=3O;+X56
M>HRQWVG?#CQY92W3V^EZ0NH6VE20#3]2AMK?3])NKG^^YP65E!()4@$$@@D>
MHY'U'/I0"=_P/YY?@[A?^#E_]L-%PJ_\.W/V?3M  &?^%AZSR!] N2.P4'H*
M_=/XJ_#/X<?&7P5KWPO^+W@'P;\4/AMXPL'TSQ5X%^(/AS1O%?A'Q!8.VX6N
MJ:%KMG?:?J&V=()((Y;<O;W"PW<#I- IK^.+]O3_ (*N?!3_ ())?\%_?V@/
MC#\=? 7Q+^(&A?$_]AKX&_#W1+#X8KX=N=3L=8L/$VK:]-<ZE'XIU71K=--:
MU,D5O]AO!*DW,\$X(V?2OPJ_X.>+/]MNXOOAQ_P3N_X)]_'3XW?'^\M[W3_"
M&C?$[XG_  &^$/@:QUR2WAEL;[Q!KFN_$07=QIMO+);W5Q::; ES<PQ36Z7-
MM*Z,03;37;Y_\,>P?\$(VN?V>?VF_P#@K1_P3.\-:CK.M_ O]C?]H'P7XM^
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MH"VL].M+2)(K*RL(H_%*BVM;.&.*"UBC"K!%'&B!508^#?V9OA3X>_X(@_\
M!8OP=^R7\/\ 7?&&J?L;?\%3O FHZ[X%L/&?B?6/B+XR\&?M8_#A+W4-6U#7
M-=U29M;O-.\>Z1->P:AKVHPZHS7USIAO+JV6WO+E0$[_ "/Z=?V@BK_ CXW
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M2ATV6ZMVELKS64U:]TZ>;3[FU<A*W^_^O^"?F+_P4%\&:/\ M^?\%ZOV'?\
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L2-5/) P><\CCD]R.F?;TJ2@I.Z3[A1110,**** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm2316412d2_ex23-2img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2316412d2_ex23-2img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Y KP# 2(  A$! Q$!_\0
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M?!?PE^'OAW_@DOIWP!^+7[4WC'Q-\5?$]YIVD2?%'5=)\6>#KOXN:_\ 'O\
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M[W]B.R\*^+_CA>ZC\6_COJFHZKINC'QSH.OZ=X,?P7X0\'^%@#^U@7$)8)O
M8J' 8,F58D @L #@CY@#E-T>\+YD>ZAKNO:'X6T35_$OB;6=*\.^'/#^F7VM
M:]X@UW4;32-$T/1M+M9;W4]6UC5=0FM[#3-,TZS@FN[Z_O;B"TM+:*6>XECB
MC9Q^&_P?U[XTP?MH^*_V2?B4/C;X<^#?[!_CGXS?MF2?&!O%GBJ_\.?'CX/?
M'2SUJ_\ V2? 6O\ BJ[FU7QKXO\ #_PNU+QS^UA\/_%?P^F>]O\ 6-?_ &/?
MA5XBU'Q1KOAZ\OO U]^GWQA^+7[-^J?LL^+_ (T?%M]%\7?LOS_"ZP^*GB34
M-6\%ZWXYT'Q%\,[G2]/\8:9JL7@G3M#UCQ%XA:]LWL+W3/#]OX<NO$-Q>BUC
MAT5KB2V60 P?V7?V]/V2_P!LVP\0WW[.7Q@L?'#>%;#1-;UO1]7\+>._AKXJ
MM_"GB>P&I>%O'UKX-^*?A;P3XLU3X9^*[=+N/PK\3])T6^^'WB:_TG7]*T+Q
M+J&J>'M=L]/[;P-^UM^S+\2/A=H_QM\(?'3X::A\(O$6M>+O#WA[XC7WBG3?
M#_A'Q!JG@7Q!KGACQ3'H6M>(Y=)M-9M-.UCPWK4<6IZ;)=:7J=C9'6=)O+[1
MI[74)_QX_9>^*/[)G_!67]H7XJ_$+XG2^"_%%Y-^S3XF^!'@S]DO4_"VOW6O
M>'/V8_%7QD\#>*?BEXG_ &AOB'#H^D>%?&WC#XO>+/"/P5L/^%-:%XL\9>"O
M@UH?A?6]/T#Q)\0)_BE\2[R;TK]A#]GCQ=XO_P"">GA[X>?#34/ WP4UKPI^
MU-^VM!X:N_&_P>\4>+-/\*>!V_:^_: TRULO!?A7PI\4?@7J_A?4!X;DT>;P
M+KEEXHG\,:1;VFG7<O@_Q/IC65K; 'ZE? WXX_#CX_\ A;5_''PQ\16_B+0-
M"^+'Q>^$>HW-N;>22W\9?!GXH>+?AAXNMO*AO+]DMIM9\+:AJNC7I<1^(O".
MI:/XRLK>QTW6;1;;Y-^%W_!7G]@3XU>,?!7@7X7?%7XB^,-;^(GB6T\)^"[[
M3_V6OVLH/!NO:O?:M)H=K);?$74/@=9_#Z'0Y-4AFM6\57GB>V\+Q>3-/-K,
M=M#),OT1^RO^SQKW[-?PYUKX9ZG\3[CXI:6_QJ^./Q3\->)-8\+QZ'XQ73/C
ME\6/%'QHUC1OB%J,&NZMIGC7Q;8^._'WC25O'/AO1OAMINHZ-<Z!87'@6*\T
MG5-6\0_D1_P1I^!_[<^E?L@_L9^*M2_;)T#0O@9;:')JFH?LSZK^Q]H-AXTM
M/"X\9^+4E\#7'Q@N_BI;ZY9W+3W-NUQXDN? ']IF.&'&FVTEQ<*P!^[_ ,,O
MB=X%^,?PX^'WQ<^&GB"#Q7\.OBIX(\)_$?P!XGL[74+6V\1>"?'/A[3_ !5X
M3UZ"TU*TLM2LX-:T#5+#4;:VU.RLK^..Y6&YM8+E9(4[1;NV9'D6>-EB!,N&
M!,6(DF(E4?-&RQ2QR,KJK*DB,0 ZY_CI^#_BSP5H/P;_ &4O!7_!0SXQ?MF_
MLW_#_1/^"5_["-M_P3UM/V<?$_[07PWO?%'C>W_9J^&Z_M&^(;#3_P!F?3]=
MU3X@_M)>!/BY=_"7P]X7^#_[1.D>(=+:RD\/Q>!_@IXHTCQ%\0;[Q)AZ7\5O
MVE]3^&7Q5O?VY/B5^V)\(_\ @N7IOA+P'?\ [#7[/GPKUGXF:!\)/%-WIW@/
M3K[]G9M/^$7P/B\2?L:_%'PG\8?CM9?$OPW^U-=?'!O$TOP^\/W/CVW\5W_P
M-\"^%/ 5[X6 /[-DECD+!"3M."2CA2< _*S*%?&<$H6 =70X>-U7R;XL?'OX
M.? JZ^%5I\8/B'X<^';_ !N^*VC? [X63^)[J33[#Q=\6O$GAOQ9XL\.>!+3
M4WA;3;'7/$6C^"/$@T"/5[O3[?6M8M+/PUID]UXDUK0])U+\H/V-[^Q\(_'?
M_@H?^U3^T?\ $'XQ:;J/A?\ ;@;]F3P38>*OB;\9=4^"WA#P3\0/A%^Q+'HF
M@^"/@Q!KFO\ PJM#JOQR\67NE0?$FQ\//K.F2WFIZ1-XOL/#[^(;2/TC_@JG
M\&_"'[1.M_\ !-/X5_$3P??>*_A_XH_X*$W&F^-M.@;5;*[T;3+O_@G_ /MY
M6UIXCLO$.@7%OJ7A'7_#/B.[T34/"?CSP_JVG:UX/\;VN@ZWX7UW3O$=CIEY
M" ?I'-\:?AC!\7]-^ DWBNVC^+NK_##6OC/I_@IK'5A?3_#+P[XIT#P5K7BI
MKW^S_P"R(+:Q\4>)]#TA[&YU&'5I9K[SH+"6UMKR>W]-,T0+ N,H</P3L)56
M&[ (&0RE<XW9PN2"*_CJ_;7\;?MY^#?VB&TGQ;X?^)\_CWX.?L$:W\+OVC?V
MKO!/AO6/"&B_$_\ 9&OOVUOV?]1^+W[4_P +]2^#=CX@U#X=>/\ 4O@]HFK:
MO\6OAI\(/ 'BGXT?!749_&UQ\.? _B[2[/X3>.Y/9O@-XC^/OPM^%?Q%_;1_
M9\\??%[]IS]F;]FOQWX/^,6A?L^I\2?VK/B'H/B7P=?>'/B-\+OVR?#_ ,)O
MCG^UUX2\$?$_XS>%_!'@_7_"_P"T7IGPZNM-^/<_A;]H3X ^*/A=\,?&6E^-
M/BMXK^&'A4 _JN$T97<I9AM+#;'(Q(&,X55+$@G!4 L&RN,@@>;^&_C'\-?%
MWQ!\>?"K0?%%O<_$3X9VWAC4/&/A*ZL-7TG5K'1/&FGOJ/A3Q1IL6KZ?81^)
M?!NNK;ZCING^-/"\NL^%)?$>A^)/"AUA?$WAGQ!I&F_@5^S2/V\'^-O[.?[,
MGC?XJ_$O5?#_ ,4?%/PV_P""G?QQ\>>(;[5;F^\&_":X^$.D-XY_8Z\*^,;W
MPS?:/>^'-;_;_N_"_C#2/!WA3Q+X8U3P?\ &\9?#[6%U/P/=VD?BKZ<_X*Q?
M 4^*;#]GCXS?#/7O&WPQ^,VI?&/P!^QCXH^*7PQOM;L_'>H?LC?MI?$GP=\-
MOCYX,76-$U.TM](>VM(/#OQ3^'GQ#U&RUO5/A%\0_"5CXP\,#2M4U+Q)/J(!
M^G'P'_:-^#'[3G@O4_B-\"?&B?$/P%I?CCQO\.QXQT[0O$^F^'-;\3_#KQ%?
M^$_%_P#PAVKZ]HNDV7COPYIWB+2M2TNT\;^"YM?\$Z[/87C^'_$.J06\LJ]-
M\6OB[\._@7\*OB/\;?BKXDC\*?##X1^"/$_Q&^(GBA].UC6%\-^#?!NBW7B+
MQ)K$ND>']/U;7]0.FZ-9W%[_ &;I&E:AJUX$6"PL+JYEBA?^??\ :N\.?!CX
M(?'^;X$?'GX@?M/_ +*W[('PN_9(^%'A'_@F#X,_8_UK]H+P/I6L?&M+CXB:
M+\9DL8OV:M'US4_BI\;OAU%H7[->G?!KX1?'Z/QEX>\2MXQ\43>&?A-\1[OQ
M#X[N+7P;]H?P#^U%\6_V-?VUOB)^VEJ'QIL/VE_A9_P0/\!ZAXF^$?A7XC^)
M/#WP7;]HSXN^!?\ @I7X(^,&M>(?@G\)/$I^#7C[Q]>>&[/P?;O_ &CIGB/2
MO#$B^&-3\/Z3H6KZ'HE[8@']66@Z]I/B?1=(\1:%>IJ.BZ_I6G:YH]_&DT4=
M]I6K6<&H:=>Q1W$<,RQ75I<0S()(D==Y21$D5T7SCXI_'SX-_!'5/A+HWQ;^
M(?AWX?W_ ,=?BAIGP5^$R^);F2PM?&GQ6USP_P"(_$^A>!=/U%H6TZUU[7]*
M\)ZXN@VVJ75BFMZO!9>'-*EN_$.LZ-I>H?CM_P $ZOC1XA^!_C#QEX#_ &_O
MB-KWAS]J7XIS_!'2/@_I:W?C&+]EGQ;^S[J[6/@7]G;3/V4]!OK)T\/:S::U
MXC@\(_M$Z7X^)^+5E\<=:BO?$FI7'PN\6_!2^O\ VS_@J%\%_!/[17C[_@F?
M\,OB5X,N?&WPT\5?MP^*[;QGI40UJSDL=(F_8,_;/CTOQ+:^)/#]QI_B7P!X
MBT77GT2^\&>.O#NK>&O&'@OQHNB:OX0UO1_%D&D:I  ?;GQB_;,_9M^ 7C*S
M\ _%OXC/X2\477A;1?'=Q:GP9\0-=T[0/A_K?C_3/A@GQ%\9^(?#7A76?#G@
M3X<Z'XUUG2M-\;>/_&>K:#X.^'EC?6_B+QYK?ASPT_\ :X[[Q7\??A'X)^*_
MPC^!WB/Q?%:_%?XZ0>.[[X8^"[+1_$.MZEKNC_#/05\1^.?$FHSZ%I.I:=X1
M\)>'[&;3K&X\7^,[WP_X8NO$NO>%_!NGZM=^+O%?AO0]5_%#X,>"?B9XN_X*
M;^)?@-^UOX2UKXJ6_A7_ ();?$CX#^-OBKXH\#6]O\)_VH?AEXQ_:@\,QZ)K
M0\A[SPS/K_B3X;:A_P ([\9_!!>RO='\9V?BIETW4?"&J>$-7OO3_P#@DE^S
MF/"NM_M(?$CQYJ7B/QGX^^"7QD^)W_!/O]GWQ!XU@UW^TOAU^Q7^R]XCM-#^
M%O@/P_+XCUG7KJ]O?%>J;_&7Q ^(_G)JGQ5N;'PA)KB7EOX4T6YC /U=^+W[
M0GP4^ EEX.O_ (P?$CPSX$B^(?Q#\(?";P%;:Q=R/JOC/XC>.O$&G^&/#/A'
MPOHMC#=ZQKFK76K:G;?;TTVQN8=!TN/4-?U^;2] TG5=3LO"_B;_ ,%&?V*/
M@W\=-*_9O^)?Q_\ "OA;XN:E<>$[&[T>YTOQ9?>&/!^J^/S<+X T+XG_ !-T
MGP]?_"_X1^(O'[P)'X#\.?%'QEX0UWQI+J&B1>&=/U637]#34/E3_@J]\ OA
MWX@\%?!7XVCX9Z%XD^-OA/\ :]_8#\*^&/B ^AG6O%W@[P5JG[<O[/.I^,X/
M#-U/;ZB?">FZC;Z/%<^+M1TNWM3?Z+IL=OKUU=:18"T'R)^UG\6_ 'A#X8?\
M%5OV&?$VC^.Q^U]^V;JOQRE_9:^'.F?!WXG>([SXTZC\9/V=/"?P^^ GC7P?
M\0?#_@;5O!2:?X.\>>$Y;77?%NI^+M-'P,/@2\UWQE<>%-$T72M4D /UG\0_
M\%%_V+_"O[0^B_LKZ_\ '+1[#XTZ[XOT7X<VVD?\(QX]NO!>G?$_Q+H[:]X9
M^%'BCXPV7A6Y^#?@SXM^)=,?39/#GPK\7>/M#^(6O77B7P7IND^&[S4O'/@^
MTUR*S_X*-_L6W_[1FH_LHVWQPTUOC=I?C=OA?=:-+X0^(EMX+?XJ)X4M/&[_
M  HL?C%<^$(?@UJOQ67PU>"];X9:7X_O/'0N;+6M).@?VSH&N:?I_P"'_P 7
MOB/H^E?LY?MM?\$WD3QWIG[?'[2'[<G[2'C/]G[X<:=\.?B3<ZGXKT_XM_M5
M:A\>O@5\=M(^*^@>#[WP1H_P\\)_"BQTKQG>_&F?Q;H^G_"+_A7/B'0;S6-(
M\=?#2YL[;4T'XE:'J/[,_P .?^"9;S>+;W_@H-X"_P""C?PB^)'B?X77O@;X
MH2:IHVB>!_\ @J%X5_;A\<_&K4/BYK?AX?#Z;PI>_LP1ZG\51\3(O'[:=XMU
M#7$\!:-?WGQ.\06/@*8 _<G2_P!OC]D+6?VC;G]DVP^-_AQ_CO!/KVFV_A:Y
MTOQ3I^@:YXG\*6UM?>*_A]X3^)FH:#:_"SQG\5?"VG3SZGXF^$GA/QKK7Q,\
M/Z5H_B?5-8\)V6G^$O%%SI'UZS (S=@I;(!/ &>  2>.P!)["OY*/V1O!G_"
M&^//V#_@A:_&/]H;QC^VA\(_B7X?N_VE?V)OB?\ LV:TW[-/PC\#:.-?T_XN
M_&_PG::_X,T[P-\+?'?@[7O$6G^/O /[>7@[XJ>+O$7[4GC_ ,4:^EA:Z_X7
M_:5U[PYX9_K%U&5DT6_FC(#)I=U*A >,!EM)'4@,8WC&0, LCKW*D9#C'FE&
M*=G*48I]G)J-_ES7^1G6FJ5*K5:NJ5*K5:6[5.E4J-?-4VOF2^;"^QO.C"E#
M*C;AAHQMW2 GC8 Z88':P=6!*L#7QU\=/^"A_P"Q?^S)\4O#'P9^.OQZ\,_#
MSX@^++'2=5@T[4]*\6ZAHGA?1=?UY/#'A_7OBCXVT+P]JG@;X.>'O$'B!VTG
M0=?^+/B3P7HVM7MM?1:9?77]GWQMOSY_8A\6Z[XA\9?LEWO@3XL_M%?$3Q1K
M_P !-(U?]MO2_B[+X]OO"NFMJ_P;\+7OPVUR/3O$_AZU\#>"_%$GCM[6U\,/
M\(]1TUO&O@BY\4>)?$I\=16[^,K?SC_@HC^W!^R#X0\:_M!?L#R>(/!OP<\2
M_'[0=.M?VW?C]XI^$VOZ[I?AKPKXW^$'A#PM;V>G^$;/X<>(Q^T)\=/%?P&M
MO"WA'PPNJVEW\-_A9X<&@:OX_P#$NKZEX9T+X/>*?1S;+:F58FGA95O;O]Y&
MHW%PE!TYU:;;C*4W:<J7/2DIN-6C4IUHJ,9I+S<GS99QA_K$:3I4X*/)JVI*
M<8M6;C%Z1DN9.,7":E%JZ/W0\4_&SX3^"O'GPN^%WBKQ[X>T7XC?&K4O$&E?
M"SP/=W9/BCQG<>%/!GB/X@^);G2]&A26^31]!\)^%-:U'5=?O8;70K&YBL-&
MN-137-;T33=1\$UK_@H3^QKX>_:#L?V6]8^.OART^-5_KVG>#UT$:1XNN?"U
MAX]UFRDU'1?AEKOQ3M/#T_PG\-_%?7+)8)]#^%7B#QOIGQ%UD:GH::9X8NI/
M$&AIJ'S;\7?V</@SX1_:O_X)Z?&_X=?#31$^(_BW]I;4?"/B_P"*=OHMWJ/B
MZ\^&?AS_ ()L_MS:=X7TG4_$.HBYU30/"JZG!X=:?2[6;1-%U/Q1<6%SK46J
M>*7MKQ/@#X]_M@?\$]?C-\4]=_X)WVNJ^&/@Y^S[I'[3_A_Q;^T%KNF_#OQ]
MX9U'XK?M)>#/VC=/^+/B7X2_"WPIIWPGN5NSXZ^/&BZ%>?%O]HE-6LM,U2TN
MO%VB_#;5Y?&6KO\ $7P]YIZQ^[G[07[5/[/W[+/A;3O%WQW^)FC^!].US6(O
M#_AG2TLM;\5^-?&6N/'%=7.D^!/ASX*TOQ'\0?'5_H^CO-XH\26W@_PQK<OA
M?P7IVM>./$:Z7X0T'6M;L+P_:;_9WE^!>I?M.V/QK^&6L?LZZ1X-\0?$&^^-
MWA_QCHGB/X8)X,\*_;1XB\0P>,]"N]1T*]L=(FTW4;.[-E>W$R:C87NF+$VH
M6LULGY3?\%"?C?X1TGXS_LL^//$7QU^*'[*7P%\#ZK^U#X;UK]M/X-^$['Q;
MXM\(_M#V5QHGPYM/V:]>\*_$#X)?'WX<VGPT\>Z%IWQ:\7>(/%?Q'^$UYX/O
M?'OP5^'L?@OQSH?B^71H]>_+SQ?\&OVT]7_X)J?"/X$:7^QQ=_$']DKX1^$?
MV[?$?Q$LO#OC*R_9T\7?M+C0?''CK4/V3?C1\3_@]\9?$]U\6]#T/XJ:?KFL
M_M;?&GX3:E?2^(OB;\98_#.G^(?#6B_#[5=:^&FK@']!WQ/_ ."I7["7P=^%
MOPA^,OCOXYM;^!/CO\)-,^/?POD\,_##XR?$'Q;KGP3U?PUI/BVT^*^J?#7X
M??#WQ1\2?!OP_31=>T3^T/%7C?PEX<T?2-7U;3O#>K7=EXCO(-)?WGXO?M7?
M 7X'_![1_C[XY\;W-[\(O$+^%/\ A'O&?PS\&>/?C=:^(+7QS;I>>$M7T'3?
M@KX7^(&MZSX>UVREAOK+Q+INF77A\V,\%[+J4=K/#*_\[_[/G_!1'X9?L8_L
M(_\ !.'X?7/@WP1\(/VP?BU_P3H_9(T[Q9\0/B]X6\<WGPY^&_P=^%WPCU'P
MW\'?B!\6-=^&'AYO$OQAO+W6[S4=?\)_LS^$?$^C^-]"L/'7B*U\8^(?A'%/
M<^)]<_5O]E3X@_L<?LD_L&:38? 'QEK'C3X"?LG?LC?\+VO)]+\*^(;?Q=XC
M^&49^+'B+4/'5MX4/ACP\8?$'Q'\8_";XQ:@O@#PUHVD66@ZK877AW0/!GA_
MPU<>%=-M@#M_"'_!63]@'QKX&^.7Q(T[X[W.@^$?V;M)\*:Q\9KWXC_"+XY_
M"34O"47C[SD^'VEVWAOXJ?#/P;XF\6>*?B'=0QZ7\/O!G@O1_$7B[QUKE_HV
M@>$]$UC6M=T6PO\ KK/_ (*7?L,7GP#U?]I@_M#^%=-^$V@>/+[X4:U<>(-'
M\9>&?B%IGQ=L9)53X.7?P2\1>&M+^-D7QDUBV2'5O"WPE/P]_P"%B^,?#VHZ
M+XE\*>&=9\/Z[HVI7_YRKI-Q\)OV7OV,OVX?COX=\=:S#J7[6P_X*.?M\SV/
MA+Q;\:M?^'R?%+]BKX[?#SP?>P?#?P%X7U[Q;K?@7]E;5O%/[+W@S0H/#OA#
M4M4^&?PU^#NB_$[7I9+OP-X@\7#Y_P#B9\7/ 'C[]K/X3_\ !2[P?X7\?>)?
MV!?AK^UEX<U;XF_%_2_@K\2KG2;S7/ /[#7[7_P$N_VA+?X:KX*/Q \9> /A
M?\2/B-\./ACJWQ^@\'7ND^&)]%N1I>J7?A#P3JNN>'0#]E=0_P""F/[$.F?L
M]^'?VHKGXX6\GP>\6?$:[^#OAR]L/ 'Q4U7X@:K\7=-U77='U?X56_P1TSP/
M>?&X?$K0KGPOXENO$7@27X=Q^*?#VB>']:\2:WI5AX>TR]U2'Z=^#7QI^%O[
M0GPX\-?%OX,^--*\>_#WQ=!>S:'XATH7<"R2Z7J%SH^M:7J.F:G;6.M:#K_A
M_6K*^T+Q+X;U[3M,\0>&]=L+_1-=TS3]5LKJTB_FN\/_ !CT#P5^W"G_  5!
M\5^(_&=K_P $Y/%WQP_:I\.^"_BG+X%^+M[X>C\=_$#]FG]@+X+?#[XEWWPP
M'A"3QKH/@W6/'?[/?[2WPOT3XO'P98Z%/>WD4MGXHN/"OQ=T?4M<_6'_ ()<
MQ7^K^#OVK_BQ!I>O:9\.?V@_VW_CM\<O@5+XAT;5O"UUXD^#OBO3O 6B:-XZ
MLO!VO6FF:[X9T3QSXG\*^+?$NAQZSHNC7OB/3[^/QO\ 8YO^$IEO[P _4"BB
MB@ HHHH **** "BBB@ HHHH *B;:Y*YVD,N>,YRIX'ID9^F,U+5:13N9LC 9
M&/J1@*1^?/MFIDD[*7P:N;[)1;3>_P!I16B>K7J3*3BKQ7-.\5"/=N44[;+2
M+D]7T[V3\X^*WQ8^'GP8\$ZI\0OB7KQ\.>$-'NM&L[[4QI.M:U<'4?$>O:;X
M7\/Z98:)X>TW5M=UG5]=\1ZSI.B:-I.D:9?:EJFHZA;6UE:SO,HK*G^,GP^M
MOAYX,^)\VJZVO@[X@GX=1^%+Q?!'CM]8NW^*=UH]AX)34O"$7AE_&/AMKZXU
M[2TU9?$N@Z0?":RW,WB\:##IVI26OS7^W5\)M+^*_P -OAMI&J3^.H8-,_:>
M_9FN8Y?A]XT^(?@/5X[;5?C[\//"_B&YGU3X>:]H.M2)IF@ZEJMW8ZE+<11^
M&)H+;Q3IUQ87NBV.IVWPI^T-X-\;^$T\:?$SPUX]_:!M==T[_@H7^QA\&M%A
MM_BE\4[SPUIGP/O?&O[)MEXOL+3PC+JPT#6;+7[2^\37'C#QKJNFZ[XAU:2_
MU]+[Q(L$VI6E?293D66YI1RN5?'_ %3,<1/$3Q%.K!/#480;P^&<I1J+FE45
M+GE42E&FI4X<CGK+X_-L_P TRZOG,:&5O&99@J="-"I1<UC*TYT57Q$:4>6W
M)2E/E7,X-U%)QE*-FOW-::*!?,D=-IR5).-T@)XC)P)"V2H$>=YP 26 KDO$
M7Q&\$^%=?^'_ (9UW6XM.\0_%;Q#JWA+P!8R6>H7)\1:_H/@[Q)X_P!4TV*X
ML[.XM+%K?PAX2\1ZP;C5)["TGBTU[2WGEU"XL[2X_ _]EWQ!^T3XO^,O@/5O
M$'Q0\1>%_P!J6Q\9Z[J/[6?P6NM0_:-\=>&;;2[R&XG\3_#.\^'.M^%=3_9T
M^''@CPG<RZ/8?![XI^ /B(8=4L['3Y-+^(OQ@NO%%\?$.';C2O\ A8G[(VJZ
M7XY_:K\5_M%Z1XB^/_B#]IO0OB,_QFNO"G@3XI:S^PQ^U)>H9](\=^&(/!?P
MUU&T\4RS:%\*T^%ESX7TWQ1\/X=*U"Q'C31I],U^X]M\ +#XVM@9YOA<7AXX
M*O>>2T*]:C1E"6:TZ%6KB9JC0^I8FK2P"H8B"J0Q.'Q$Y0]A).*\VGQEB<5A
M*>)I9)CL%RXJE4A_;7(N?#2AE:JU:4<-+$U5.FJF;QE"<8U:-7!MU*,HR2G_
M $9">+8KQLCA@9(FC$LID1@6&WRT9Y8S@LOE!E.P]<-35FBN!($="D9E0%5(
M7>&:-H]Y7:41D9"03Y<BNDA5NOX?_ WX(>)?&7B_]EGP-XW^,W[6FI^&/CS^
MQ%J7QY^.=Q=?&WXCZ#?^(_C%X/U+]GOP[X8MFUKP_<Z%=_#*VBT#XM^-;>^\
M!?#>Y\%:!XG;PYH=]XAT;5=2\%2W\OQGXR^+?Q7\:_ WX7:9J^O_ +25U^TW
M>?L/Z-XF^'=]<?&/]H[P#XE\3?&.#PGXKCT?4_A7\&/@O\-[OPM\7OB!J?B7
MPW9KXMD^*?BG4KZQ\06&DVGB'PUI.AZO_:?B<CX>8.ICW@\/Q-E]6I3JT8XB
MLLLQF"I4(8O&XC!4:TL1/.*4>26,RS-'BI1JM4\NP>75)SYY25,EQYB883ZS
MB.&\PC*3E&C3CF5+'U*E2C3PF)J0^KT,DH5'*,<5@HP_>TU*K7DH<ZHU(']1
MR&&3+QRQR+N5E96CV,7E96&[A<HV5'4DE<C#IGR9_CK\)8?&MG\-&\;64?CG
M4?B5>?"&P\/"RU@SO\1].^"UM^T%=>%4NTTS^STF@^#=_:>/7O9;Q-,>VN/[
M+COGUY9-+'Y">.X/B5\3M#_;Q^/,7Q4^/EIKOP.^"_P?^-?[.VF> ?&OBOPW
M\.T^(-I^R1X6^*CZ]8>!O#QLM*^)<7B3Q9I,.E:]X(\1V_B3P==:5?7VFZ?H
MMGK?B'6KI;_[1%KXBTG]HOQ-K^EV&KZ=_9O[<_QTU_3M=M[2_MX=/CL_^"$&
MDZ=8:W%J<,2QVMK%KUH]A!J_VB*SCUFU;31>IJRQ6C^=+A+"X?%RP6*SBGB*
MSP-24H8-SC&C7JY93Q]"G*OCJV*593]O["7U26%J0JQM)WE"-'T)\0UJN$6)
MH97*A"CBJ*E]9CB?WM%XN&&G.,*,X<CA##NK^_A7ARN+C&Z;E^Y"%8I0[$$M
M$^"T8C9 !OD. H=A,R>8XP=GE$MTR+0NDP,Y4LT:C*N S$*6"$KAU^92'3<C
M ,0QVL5_%7X&_$#P5X8\;?"[XC>"_BY^U#XGU;2/!/B2^_;P'QLN?C%K7P^\
M*^"HO@_JWB]/%FJ:%J_AZQ^$_@3XLZ?\9-,^'NF>!?#OP+M]&T;7/AUXK^*=
MQX5\$:YX0L['6_"^O\8M934/VE?BCIWQU^(/[7'@[6YQX1T_]B#PU^S]?>-]
M T7Q7HR^#=!U/QGK'@V'P9I5[\./&_Q6'Q)OM4\/>,D_:*N]0\!^%/!T?@>?
M6M'\->#;[Q!XBU7@_P!694*U:BLPJ35"E'%JC4I5H5ZL_;2P']GQI8C%5ZDG
M*4UF+K?6(T%@J:Q,%",O9'91XB@\)#$O+X*=64I*-*I0G32Y:7O2J4,+AZ<&
M^;53I2J*I'V<YSGRQ7[!RSPF4ACR0P7]W/AB3-\I81;#&P9MN7V/M<(S%6"S
M021"9<[P,MEO)F #$.3&':,)A68@H#D2;4(WE5/X8Z-X@%U\9]'M+'XK_M77
M/[=3?M?Z-'X_^#]_J/Q)C^$VG_ &[^*WAZQ\<Z?)X&F\/1?L])\ ]*_95UB;
MQ?X$^)=E<S^*;OXC-H6DVGQ'UOXLV\_@T<'^S-\+/'_Q,^&O[+WC/QU\8OVJ
M8/$_QB_;!_;&^#?Q*2U^,OQ0\+06WP-\(ZW^VSXZ\#^%]/TRRO-/NO"EG-XA
M^#'PVN(_'L;P>/=1T77-1\$6WCF7P'>>%O"^D>K2X'A#"UJT^(J=*.%C"C%R
MR7%KZW7^KYI).CB%F#A/#U%D..J4\P]FJ-2=6*=&FY0C/S)\68F6(I4J/#];
M$NO/FYEG>%7LU+ZO74IX>IE$)1G?'7>#>(=2,82@\0Y14I?T,I+!*N(I8Y!E
M6!4@AD<;D=2"0T;<[67*MR <@BK2?=QZ$@_7.3_.OSA_X)Q>(OB)J7P[_: \
M(^/M:\7>(+;X-_MD_M-_!?X::GXZGU35/%,GP>^''Q!ET;X<VNI>*M<#Z[XU
M-IHTGE6_BK6KS4]0U.W"(^HW<5O$X_1R+)5B>N]_T)']*^3QF&>!S'%X",X5
MZ6%CAYTL1"_+56(IQJW7-[RO"K3<HSUA-5(7?(F_KLOQL<=@Z>(Y/9<\ZL%3
M=[J5"I.E52O&+:A.G-7LE)<LHW316>QCDCEB,UTBS"57,-Q);R!)\"58Y;<Q
M21N0/W=RCK=VY):VN(7PPE%M&-^6=C("')8?-N;>=R@!7RV>'5E5"8E"PDQG
M\Q?B?XR_X*UZ?\1?&%G\%OA#^Q9KGPJM-2CC\#ZS\1_B1\5;#QIJND?8K5GN
MM?L='@;3+34/MK749MK>"W@6!(W$C.2&X(>._P#@MVY.[X%_\$^1CIL^*OQI
M)/..0($ ]>IZ^I-?383@[&8O"X;%+B3P[HQQ-.%14J_'^44Z])5*<:BA6I2R
ME2IU8J7+4IR=X34H-MQ=_GJW&.$HU:M+^P.-ZKI-INAP?F-6,VI<K]DXYBO:
M+2Z:M>/O>1^NALT,K2^== M$8B@N90FTL[!@H88D7S'5901(%*C=^Y@,4BP*
MI4AG)!!))7#D%SDJ%"*Q:1BSQ+&[<!F*C%?D1_PG'_!;C_HAG_!/W_PZGQJ_
M^(H_X3C_ (+<?]$,_P""?O\ X=3XU?\ Q%=7^HN,_P"BH\-__%@Y-_\ .PR_
MUVPW_1,>(7_B#YG_ //0_7GRO^FDI. &)?[P!S]W&Q2<D%XU1\8PP(4AAMHR
M,$R8)D8J'(5C*79MZKA77,C_ ".&3+;BI95*_D3_ ,)Q_P %N/\ HAG_  3]
M_P##J?&K_P"(H_X3C_@MQ_T0S_@G[_X=3XU?_$4?ZBXS_HJ/#?\ \6#DW_SL
M#_7;#?\ 1,>(7_B#YG_\]#]=%M(DB\D$^7N$FT+$H\[S3.TV$C4"22<F9R
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M!+E)60^8NW:2RX9T4KQ!(7M]A,1B,*I&OY%_\)Q_P6X_Z(9_P3]_\.I\:O\
MXBC_ (3C_@MQ_P!$,_X)^_\ AU/C5_\ $4?ZBXS_ **CPW_\6#DW_P [ _UV
MPW_1,>(7_B#YG_\ /0_71K.)GCD9IB\6[83/*0 RRJ0 6(5L2L/-7$Q4(AE*
M*%KCM7^&G@G7_%_@WQYK>A0:KXL^'<7BJ+P+J][-=2R^%?\ A-K&QTSQ1/I$
M'GK:1W^J:98)IG]J303ZG8Z5>:OI&F7EEI>M:M9WGY>?\)Q_P6X_Z(9_P3]_
M\.I\:O\ XBC_ (3C_@MQ_P!$,_X)^_\ AU/C5_\ $4?ZBXS_ **CPW_\6#DW
M_P [ _UVPW_1,>(7_B#YG_\ /0_7MD#(4!91@ ,C%67&,$'V('!!5APP9208
M!:1JYD1[A&)3<%N)2A",6P8F9HOF!,;.$$GE;(E=4A@6+\B_^$X_X+<?]$,_
MX)^_^'4^-7_Q%'_"<?\ !;C_ *(9_P $_?\ PZGQJ_\ B*/]1<9_T5'AO_XL
M')O_ )V!_KMAO^B8\0O_ !!\S_\ GH?KDME$H8*\X4XX$S]?EW.S9WR2OL4M
M/,TDX(RDBDDET5G##'Y41D1-BI@2-N*KOP/-_P!=G+D@B0%<*J%5!4_D7_PG
M'_!;C_HAG_!/W_PZGQJ_^(H_X3C_ (+<?]$,_P""?O\ X=3XU?\ Q%'^HN,_
MZ*CPW_\ %@Y-_P#.P/\ 7;#?]$QXA?\ B#YG_P#/0_746R>:)B\K.(WC!9Q\
MJNZ.=N%&PED7=L*AP%60.(X@D9L(2LD9:=HY0-Z--(Z$^68CD.6#(Z']Y ^Z
MVED+S2PO-)+(_P"1W_"<?\%N/^B&?\$_?_#J?&K_ .(H_P"$X_X+<?\ 1#/^
M"?O_ (=3XU?_ !%'^HN,_P"BH\-__%@Y-_\ .P/]=L-_T3'B%_X@^9__ #T/
MUU^RH&#!Y5PQ<*'^0.5E4N%((5B)G+;=H=L,X9AFFO9HZ"/S)0@ 0H&!C:/I
M)$\3*T31RH6C92AV(W[@Q,L;)^1G_"<?\%N/^B&?\$_?_#J?&K_XBC_A./\
M@MQ_T0S_ ()^_P#AU/C5_P#$4?ZBXS_HJ/#?_P 6#DW_ ,[ _P!=L-_T3'B%
M_P"(/F?_ ,]#]=A:Q@YW2XW!@@D9(P!MP@CC*(8_E&8R"K9;>&WON:+4 */.
MGRN\@[D +N0WF-&L8B9U<%T#1E%9CA,! GY%_P#"<?\ !;C_ *(9_P $_?\
MPZGQJ_\ B*/^$X_X+<?]$,_X)^_^'4^-7_Q%'^HN,_Z*CPW_ /%@Y-_\[ _U
MVPW_ $3'B%_X@^9__/0_07P?^S/\&? FJ?'+6_#GAK5TUG]I#Q(WBGXRZMK?
MCOX@>+M3\5WZ^&+;P98Z997WB_Q3KMUX-\(:!X8M8]'\)^ _ LOAGP1X-MWN
M9/"GA[1KF[NIYO4/"O@OPUX(\.^'?"/A/2[?P_X8\):+HWAWPWH6E*+#3=(T
M3P_IT.E:/IEK!:B(?8[+3[:WM8K>4R1"*&)2A\J/;^57_"<?\%N/^B&?\$_?
M_#J?&K_XBC_A./\ @MQ_T0S_ ()^_P#AU/C5_P#$4?ZBXS_HJ/#?_P 6#DW_
M ,[ _P!=L-_T3'B%_P"(/F?_ ,]#]=&LXG01NTSH%"A7FD<@"/R\B1V,HDP
MWG"03B3+B0,\A>=$V*%W.YZEG;<S,>I/15R>=J*D:]$15P!^0G_"<?\ !;C_
M *(9_P $_?\ PZGQJ_\ B*/^$X_X+<?]$,_X)^_^'4^-7_Q%'^HN,_Z*CPW_
M /%@Y-_\[ _UVPW_ $3'B%_X@^9__/0_7QT$BLC?=88/0\?B"/TJ!K6-\[VD
M.[820PC?>NX%Q)$J2JSHQC;:X41YC145F#?D5_PG'_!;C_HAG_!/W_PZGQJ_
M^(H_X3C_ (+<?]$,_P""?O\ X=3XU?\ Q%'^HN,_Z*CPW_\ %@Y-_P#.P/\
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M_P!$,_X)^_\ AU/C5_\ $4GP)C&FO]:/#>S5I?\ &P,FU3Z+_A,!\:X5V?\
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M_)8^,?\ @M@69V^ O_!/<LR[68_$_P",Y9D^;*LQCR5^9N"<?,W')R@\:_\
M!:Y2#_PHG_@GNNT8ROQ2^,P*JN&P/E7 &]21D !P>XSE+P_QE1OVG$_AH[N5
MF_$/(XV7/!TFYSR-N#A%XAN?/>,Z\Y*34I3BWQKA8*\.$^.X<MK-\!9FVHQ;
M4;*&82FW&FH02C&4O=?*G=1?Z\1V\2&23Y][[(VR1A5C^8(JKA ,ECN"AN<
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MZ^$K/7;WX3PW.LW'@[4/'/@)^W%^UG^TOXP^+/P@^+7_  40^%W[%F@?LZ_
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M94_Y?R_^5E/RI/\ GG'_ -\K_P#%T>5)_P \X_\ OE?_ (NKE%%I?SR^Z/\
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M SQ[\6K'X7RW?Q)OOA#X%^)/B3XE6G@#P]XQ\;7/A>+PQX)\7:IHG*0_MQ_
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MSXZU+X0^--4T[PM\3+'PMKM[;:?*6E_/+[H_YA[*G_+^7_RL^H?*D_YYQ_\
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MLW=\E/3]W'3:[Z][>SM?_@/=(XVQ_P""IG_!>69;)W_;Q_X)ESQ2R0!Y+?\
M:3_8/E6:,S)"TB&U\0L"UPXEC1+?)^TQSV\(WPXKZWTW_@X+_:._9Y_X*"?M
MN>$/VIO%^@^./V:OV;?@YKFM>$_A]X,\!Z%;:SXC^)TR?"O1/ &B1>/?#EIJ
M+#3O%'C/Q9J5G%KEU']ABLKI+H+=2V*6-Q\\?\$3O^#>OX%_M-?LU_%#Q]_P
M4B^#7[4?P,^,'A'X[ZMX<\':3XDU3Q;\!S>_"#1?AA\,O$MCK,N@^,/#<3ZI
MIUEXUU;QS97VM6V^."XMYK:Z2VDMGKU?]F__ ()O>._B1_P7 _X**>"_CK^S
MS\9- _9 ^.'P$^/7PGT;XN^+OAIXEL?A]J.C7ND?"C0?"NM^#?B7JWA^/P?J
M7B?1+S0QXET?4=,UJYM(?$MO]LL84NH[FWMA.:^TMT_X5-;>C'RP_D^:J3C)
M?X91C&47VE&49+1III,_6[_@@K^U#_P4:_X*"^$_BA^V/^U5\2/!%E^SYK?B
M;Q?X%^!OP.\&^!?#-E=Q:G9ZS:7>M^(M5\;Q0V?B"71?!4$2^!= L[J&2Z\2
MWLNM>(;][:UM=.BNOZ.[.,Q0!"5(#N5V8"!"WR*H4E0$7"84X)4D 9P/XN/^
M#=KPS^VY_P $\?VK_P!IG_@GI^T/^S_\>+?]G7Q%XM\5:G\)/CA-\'_%LOPH
M'Q8\#:A#HYUBS^(FF:&_AN/P1\8OAQ9Q^)-)U>YOH=,L-4\,:=IUQ,=5\6$+
M_:5;OYD>\#"EGVC!7"ABH!0@/&PQAXY%5XY Z,H*U"IQ4G/7F=]>>KRZ[VI^
MVE17DU2371J[N[16R>R5Y3E5E9)*W/5C*H]KZU'=[WTM1O="T74OL8U+2M/U
M(:=J%KJ^GKJ%I#?+8:K8L7LM4L5NDE6SU&S<EK6^MQ'<V[',,J&N;\5?##X;
M^/+;3[/QUX \&>-[32+V34=)MO&/AG1O%,&E7\H >\TV+7;._2PN"BI&);18
M72*..%"L4:(O<T58'%^(/AO\._%FJV6N^*O 7@SQ-K>FV%YI6G:QXA\+Z)K6
MJV&EZB&&H:;9:CJ5C<WEK87P=A>6<$T=M<AF$T;@G/16^CZ7:/<RVFGVMK+>
MW,E[>R6T*6\EY?2Q6T$E_=O"$:ZOG@L[6![V<R730V\41EV(JC2HH YJ]\%^
M#]2OO[4U'PKX<U#4_P#B1@:E?:+IMWJ 'AC6+CQ#X:"WMQ;27*CP[K]W=:YH
M(64#1]7N9]2TX6U[-),VC!HND6MY>:A;:;9V]_J/V?\ M&^@@CAN]1^R0&UL
MSJ%S&%FOC9VI:VLS=/*;6W9X+<QQ,R'4HH \^\/?"7X5^$;#5M+\)_#7P#X7
MTO7[Z+4]>TWPYX0\/Z%I^N:E ZO!J&L66EZ?:6VJ7L+HK1W5]%/,A4%7&*Z.
MT\*^&+"_;5+#P[H=CJ;2ZO,VH66E6-K>M-X@O--U#7Y6NH((YVDUV_T;1[W6
M7+EM5NM)TRXOS<2V%JT6]10!YUKGP@^$WB?3-%T3Q+\+_AWXAT7PV]Q)X<T?
M7/!7AO5M*T"2[_X^Y-$TZ_TVXL])DNO^7E["&W:?CS2^!5O6_A?\-?$NMZ%X
MF\2?#WP1XA\2>%Q /#7B'7?"FA:QKOAX6MP]W:C0]7U&PN=0TD6UU(]Q;BPN
M;<03,TL01R37=44 <C?^ ? FIZ\?%NI^#/">H^*5TG^PQXFU'P[I%]X@70UO
MAJBZ-_;-S:2:E_9":BB7Z:8+H627:)<)"LR*XXKX3?"SPS\,-%U_0M!GU:]A
M\4?$7XE?$G7;C7+BRN[V_P#$/Q*\9Z[XPU=#_9^DZ/86NF:;/J$6C:-96UA;
MR6NE:/86VH7&K:K%J6M:M['5>/\ @_ZZ2_\ LU '&ZM\+_AKK_BC2/'&O?#[
MP5KOC;P]%:0:!XQUKPMHFJ^*]#AL+B>\L8M'\1W]C<:QID=G>75U>VR65[ L
M%Y=75W&%N+B:1]IO"?A=X;>VD\.:');6>M2>)+2W?2K)[>U\1S:M<Z_-XAMH
M6@,4&NS:[>7>M3:Q$J:C-JUS/J,ERUW*\S=!10!\F?%O]D;X4?&KXM?L_P#Q
M.\96*74OP%\2_%KQ/9^$3I'AW4O"/C_4/BU\)M5^#OB,?$6QU72[RXUV.T\.
MZI+)9.TRF:]M-/CU9KM;:VBC]Q\0?"3X5>+-)T'0/%7PS^'_ (FT'PHEO%X6
MT3Q#X-\.ZUH_AF*TMH+.UC\/:9J6G7-CHL=M:6UM:P)ID%JL5O;PPH%CB15[
MU?O_ (2?^C*EH Q;OPYH-_?:7JE]I&GWNJ:)+=3:+J=W:Q7&HZ1+?6QL;]],
MOIE>ZL&O[$M87WV66+[98/)97/FVLCPMS&M?"7X5^)/#T/A'Q%\-? .O^$[;
M5;O7;;PMK?@_P]JWARUUN_GU&YO]8M=#U#3KC2[;5+ZYUC5[F\OX;6.ZNKG5
M=2N)Y9)K^Z>7T&B@# A\*>&;:XL;NVT#2+6[TO2/^$?TN[M;"VMKO2_#YFT^
MX;0=-N8(XY]/T.2?2M,EETBSDATZ5]/LS);/]GBVXVG?#+X;Z1XMU/Q]I/P_
M\$Z5X[UJ.2+6?&VF^%="L/%VK13&V,T6I^)+6PBUF_BF-G:>='=WLR3"VMQ(
MK"&,+W%% 'F^F?!OX0Z)'J\.B_"OX<:1%X@&N#7HM+\#^&=/CUQ?$\=M%XE7
M6$M-,A74U\0Q65G'KBWHG&K):6JWXN%MX0GH5O;P6D$%K:P0VUK;0QV]M;6\
M:0P6\$*+'#!!#&JQQ0Q1JL<<<:JD:*JJH4 5-10 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%-GRVP"<8.%7<W#
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M?#'0M%\(^'?#/C7Q%J?CG0M$_9UT;X%:1:ZM+?Z).LO@C7_$GA36_M(_>'_
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B5VZ LX( #$@DA550,!54#%+W7_>3_P! :GIT/U_H* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm2316412d2_ex5-2img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2316412d2_ex5-2img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$617AI9@  34T *@    @ ! $[  (
M   9   (2H=I  0    !   (9)R=  $    R   0W.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %)A;6%S86UY
M+"!696YK871E<VAW87)A;@    60 P "    %   $+*0!  "    %   $,:2
MD0 "     SDY  "2D@ "     SDY  #J'  '   (#   "*8     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
M   ! @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P ! @,1! 4A,082
M05$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X
M.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3
ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+C
MY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ ^D:*S]=UNS\.Z+/J>HN5
M@A&2%&68G@*!ZDUBW/AT>-]!@;Q.]Y;1W""0V%G=O"J C@.R$,YP>03MSVXR
M:Y7R\W0GF5^4ZH$'.#G!P:*^;/B!\&M2^&MG-XO^%FL:A:I:#S;NT,V62,<E
M@?XU')*L#QD\]*WD^*4WC;X#MJ3/]DU:*\CL[OR&*9<?/N7N RC./7([55*#
MJ34%U%4GR0<GT/=:*^=_&]WJ6EZ/X6C2_O(WETM9I")F!9G8MSSUYQ7L/PZU
MPZ_X%T^YE<O/$GD3$G)+)QD^Y&#^-=%;"NG352]TW8QIXA3J.G:S.GHKYP^(
MGBV^U#QS?_8;ZXAMK9_L\:Q2LH.S@G@]VW<^F*]^O=9T_1-)2[U>\BM80@^>
M1NIQT ZD^PI5L+*E&#>KET"EB(U)22Z&C17,Z3\1/"VMWRV>GZLC7#G:B21O
M'O/L6 !^G6N%\=ZA=V_QKT""*[GC@9K3?$DC!6S,0<@=>*5/#3G/DEH[7U*G
M7C&/,M=;'L%%8^D>+="UZ[>UTC4HKJ>-"[1J""%R!GD>I'YTNI^*M$T?48K#
M4M0C@NIE#1PD$LP)('0=R#6'LYWY;.YKSQM>YKT5SVN>._#?AVX^SZKJ<<<_
M>*-6D9?J%!Q^-7=(\3:/KMC)>:3?QW,,0S(5!!3ORI (Z=Q3=.:CS-.PN>#?
M+?4U**YS_A8'A;^SY;[^V8/L\3!&;#9W$$X QDG /046/C[PSJ.G7%]:ZK&T
M%J 9]R,K1@G )4C.,D<]*?L:EK\K^X7M(7M='1T50TC7--U^T:ZT>[CNX5<Q
MLZ9X8 ''/L15>U\4Z)>ZU)I%IJ$<U_$S*\" DJ5^]DXQQ4\DM5;8KFCIKN:]
M%%%04>7?'9I1X7TY5SY)O/G_ -[8V/\ V:O1=)U&#5M'M+^T8-#<1+(N.V1T
M_#I5;Q)X?M/$^@SZ7?Y$<H!5U^]&PZ,/I_\ 6KS30M'^(G@&Z>STVRAUK2V8
ML$$RA1[KD@H?4<CZ]:[XJ%:@H72E&^_6YR2<J=9RM=/MTL>MW:0R6<R7>WR&
MC82[NFW'.?PKPW]E32+JT\$ZMJ<ZNL%_>*L 8\,(U(+ ?5B,_P"S[5ZD+;5_
M%6A7%EXBL1HMO=1^7+%;7GF3.A^\NX* @(XXR<$\@\UNZ?I]II6G06&FV\=M
M:6Z".*&)<*BCH *XI1<79G4G=7/)OBM#'<?$OPQ!,H>.0QHZGH09L$50\+Z\
M?A[-XPT2Y?#6JM-9[S]Y\[%_[Z#1GZ UUWCCPAJ^N>.M!U/3H8WM;%HS,S2!
M2,2[C@'KQ65\3?AOJGB3Q)#J6A11-YD(2XWR!,,IX;GKP0/^ U[%*K2E3A2F
M]&M?5.YYM2G44Y5(+6_Z'E^K:,;'P=HFI3 ^?J4UU)N8<E%\M5SZ\[C^-==\
M2[QKWXD:;975K/?6MI!%BS@SNEW#<P&!G)X'T%=5\1?A]J6L:3X?L/#D,<D6
MF0R1-OD"8!$87KU^Z:E\>^ ]7U+5=/\ $/AB5%U.SC16B9PI8H<J5)XSS@@\
M$5K'%4YN$I/^;Y7>GIH9/#SBI12_E^=MSA/%J#6;>U_L#P%J&CW,$F3+%;,-
MRXZ8"CG.#FK_ (AFN;GXI>"I[Y62ZEM].>97!!#F3+ @]#G-;%UIGQ1\67=M
M!J6S1+:%OGFMYQ'G.,DA7)8XZ#@5I>)O ^L:A\2]#U:QC62PL?LPDDDF&_$<
MA9C@\DX_.DJT(M1DUL^M_P 1NG*2;2>ZZ6_ YJ>'_A!/CM#(I\NQOY=P]-DN
M01]%?] *2V9_%?Q:UG75 DM-&CDFBW<J3$NV/\V&_P# UVWQ2\%77BS3+.32
M41K^TE.-S[<QL.1GZA3^=3?#?P7)X8\+7%MJL2?;+V1C<*K!@$QM5<CKQD_\
M"-8_6*?L?:7]^W+_ ,'[C7V,_:\EO=O?_@'DG@F\MDGOK[5/"MWXEFF?[XC,
MBQDY+$\'YB2.?\:V_"4-]:_$"^N;/0=0TK2[ZUG4Q30N$B'EEL$D 8W+Q]<5
MI6?A+QUX U:\_P"$1A@U*PNCP)&7@ _+N4LI##)&1D&MSPEX9\7-?:EJ_BR^
ME$EQ#(D-@+C<@9AUP"5 '0 >M;UJT&I235FN_P"G0RI4IIQBT[I]OUZG&?!W
MPKI'B.ZU6;6;470M%B6.-R=OS[\D@=3\H_.G^%M'LX/C%J^@0QE=/FCN;5HR
MQ.(R,XR>>,#GVKL_A/X.UCPE_:W]M0QQ_:O)\K9('SMWYZ=/O"H=&\%ZS9?&
M"\\0W$,:Z?*\S*XE!;## XZUG4Q"=6K[VEM->NFQ5.@U3I^[K?4Y?P%KC^ =
M9\2Z-JK<6\,DT:GC?)&#C _VE(/X"MOX):/))%J7B2]R\]W(88W8<D9W.WXL
M1_WR:POC5IUK)XPT^33G66^O80DL*$$D@A4;ZG./^ U[%X<T>/P_X<L=+AQB
MVB"L0,;FZL?Q))_&HQ-2/L.=;SM?Y%4*;]KR/:&WS-.BBBO'/3"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ J&\M_M=C/;&1XO.C:/>F-RY&,C/<5-11
ML!P?ASX1Z'X>U>+4O/N;V>!MT0F*[4;LV .2.U=Y116E2K.J[S=R(4X4U:*L
'%%%%9EG_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
